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Abstract 
Non-toxic and stable photoactivatable platinum compounds, which can be activated 
by visible light to toxic anticancer drugs, could strongly reduce side-effects shown 
by cisplatin by providing site-specific cancer treatment. In this thesis, the synthesis 
and characterisation of novel photoactive Pt amine compounds, which can be 
converted into reactive Pt species by visible light irradiation, are presented and their 
potential as photoactivatable prodrugs investigated. 
Pt azide complexes of the type cis, trans-[Pt1"(N 3)2 {(OH)2/(OAc)2 } {(NH3)2/(en)}] 
were synthesised with the aim to produce stable precursors of highly reactive Pt" 
am(m)ine species. They were fully characterised by NMR spectroscopy and X-ray 
crystallography. The stability and photoreactions of these complexes were studied by 
1D/2D NMR spectroscopy and ESI-MS. No hydrolysis of the Pt' s' complexes was 
observed over three months. No reduction to Pt" occurred during the reaction with 
glutathione. Rapid binding of Pt" to the N7 position of 5'-GMP and d(GpG) could be 
initiated by the irradiation of the Pt" complexes with light of A. = 457.9 run. The 
same was observed for a DNA 14mer duplex containing a GG sequence. The 
mechanism of these photoreactions involves photoreductive elimination of the azide 
ligands followed by rapid binding of the Pt" am(m)ine photoproduct to N7. 
Irradiation with light of A. = 647.1 nm also led to binding to d(GpG). 
Pt" complexes of the type trans, cis-{Pt"(CBDCA){X 2/ L2 }(NH3)2], X = Cl, Br, I, L 
OH, have been synthesised with the aim to produce photoactive precursors of the 
anticancer drug carboplatin, [Pt"(CBDCA)(NIH 3)2]. A novel X-ray crystal structure of 
carboplatin, [Pt"(CBDCA)(NH 3)2].DMF, was obtained exhibiting a puckered 
cyclobutane ring in contrast to known structures, which show a planar conformation. 
X-ray crystallographic analysis of trans, cis-[Pt"(CBDCA) {(OH)2/ 12 } (NFL3)2] 
showed a strong influence of the axial ligands on the position of the cyclobutane 
ring. Photoreactions of trans, cis-[Pt"(CBDCA){1 2/ Br2 }(NH3)2] using light of A. = 
457.9 nm were studied by UV/VIS and NMR spectroscopy showing photoreduction 
EL 
from piV  to Pt". The redox chemistry of trans, cis-[Pt"(CBDCA){C1 2/ Br2 }(NH3)2] 
was investigated by cyclic voltammetry and coulometry concluding that two 
irreversible one electron reductions take place for both complexes. 
Mixed valence Fe'-Pt"-Fe" complexes have been prepared by the redox reactions of 
[Pt"(NH3)4] 2 , cis-[Pt"{X2IL2IL-L} {(NH 3)2/(en)}], where X = Cl, I, L = H 20, L-L = 
CBDCA, oxalate, and [Fe ... (CN) 6] 3 . A X-ray crystal structure of the complex 
[pt'(NH3) {Fe"(CN)6 } 2][Pt"(NH 3)3 ] 2 .6H20 was obtained exhibiting three H 20 
molecules less per unit than a reported structure. The formation of Fe"-Pt"-Fe 
analogues was confirmed by IR spectroscopy. The photochemistry of 
[PtJV(.J}T3)4 {FelI(CN) 6 } 21 4  was investigated by 1D/2D NMR- and UV/VIS 
spectroscopy using light of ?. = 488/ 568.2 nu-n. A light-induced back reaction to the 
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1.1 Platinum chemistry 
Platinum (Pt, atomic number 78, mass number 195.08) is found in Group 10 of the 
periodic table. There are six naturally occurring isotopes of platinum of which "Pt is 
NMR active with a nuclear spin quantum number /2. 
Table 1.1 Some atomic and physical properties of platinum. 
Property Property 
Atomic number 78 Electronic config. [Xe]4f145d96s' 
Isotopes 190pt (0.01%) 
' 92Pt (0.78%) 
'94Pt (32.9%) 




Effective ionic radius/ A 
of oxidation states V 0.57 
IV 0.63 
II 0.80 
Atomic weight 195.078(2) Density (293 K)! gcm 3 21.45 
Melting point' K 2042 Electrical resistivity 
(293 K)/ tohmcm 
9.85 
Boiling point' K 	4443 
The abundance of Pt in the earth's crust is approximately 0.01 ppm. The world's 
major deposits of Pt are in Bushveld/ South Africa, Sudbury/ Canada and Noril'sk-
Talnakhl Russia. The current annual world production of Pt is approximately 150 
tonnes.' In the massive state Pt is very resistant to atmospheric corrosion at ambient 
temperatures. Compounds of Pt in the oxidation states 0, II, IV, V and VI are known. 
The oxidation states II and IV are by far the most important and form a vital part of 
early as well as recent coordination chemistry. 
1.1.1 Uses of platinum 
Approximately 3540% of Pt is used for jewellery and ca. 18% in the petroleum and 
glass industry. About 35-40% of Pt is used in the catalytic control of car-exhaust 
emissions.' Here platinum promotes the conversion of unburned hydrocarbons, 
carbon monoxide and nitric oxides to water, carbon dioxide and nitrogen. Due to its 
2 
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inertness, platinum also has widespread uses such as electrodes, thermocouple 
elements, electrical contacts, wire and crucibles for laboratory use, dentistry, and 
coating for jet engine fuel nozzles. 
1.1.2 Coordination chemistry of platinum 
Pt11 complexes. The Pt" complexes are d 8 and diamagnetic. The vast majority of 
these complexes are square-planar due the strong splitting of the d-orbitals, see 
Figure I.I. This splitting of the d-orbitals provides the opportunity to place all 8 
electrons in four lower-energy orbitals leaving the uppermost d(x 2-y) orbital empty. 
As a third row transition metal, the d orbital splitting is sufficient to offset the energy 
required to pair-up two electrons, leading these complexes to favour a square-planar 
geometry (Figure 1.1). 
Pt" shows soft or class-b characteristics preferring CN and ligands with nitrogen or 
heavy donor atoms like 1 and t-bonding ligands rather than oxygen or F - . Aqueous 
solutions of red [PtC14] 2 are a common starting material for the preparation of other 
Pt" complexes by successive substitution of the chloride ligands. Complexes with 
ammonia and amines, especially those of the types [PtL 4] 2 and [PtL2X2], are 
numerous. The colourless [Pt(NH 3)4]Cl2 .H20 was the first of the Pt ammines to be 
discovered in 1828 by G. Magnus. A well-known salt is Magnus's green salt 
[Pt(NH3)4][PtC14]. The green colour is due to the crystal structure of the salt, which 
consists of the square-planar anions and cations stacked alternately to produce a 
linear chain of Pt atoms only 3.25 A apart. The interactions between the metal atoms 
are responsible for the colour change from red to green.' 
3 
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Figure 1.1 The splitting of d-orbitals in crystal fields of different symmetries, and 
the resulting electronic configurations of a d 8 ion. 
In discussing the coordination chemistry of Pt(II) complexes, the so-called 'trans-
effect' is of special importance. The trans-effect is defined as the 'labilisation of 
ligands trans to other, trans-directing ligands. 2 By comparison of a large number of 
reactions, it is possible to set up a 'trans-directing series'. The ordering of ligands in 
this series is as follows: 
CN CO NO H- > CH3 SC(NH2)2 —SR2— PR3 > S03H 
> NO2- 1 SCN > Br > Cl - > py> RNH2 NH3 > OH- > H20 
The trans-effect is best illustrated in the following scheme. It can be used to provide 
the desired isomer in an otherwise complicated system. 
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Scheme 1.1 
The group trans to the most influential trans-director is printed in bold. In step 2 the 
principle was used that the Pt-halogen bond is more labile than the Pt-nitrogen bond. 
This is why the chloride ion trans to another chloride ion will be replaced more 
readily than a nitrogen atom trans to a chloride ion. The higher trans-directing 
ability of bromide compared to chloride is illustrated in step 3 where pyridine 
replaces the chloride ion trans to the bromide ion. 
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The lability of a metal chlorine bond results in preferential replacement of the 
chloride ion in step 2, and the trans-directing property of the bromide ligand 
determines the final geometry. 
The third isomer may be formed as follows: 
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The trans-effect predicts the formation of the cis-isomer in the first step and the 
replacement of the ammonia molecule in the third step. The lability of the Pt-Cl bond 
directs step 2. In step 3, we have both influences: the trans-directing effect of the 
chloride ligand on the one hand, and the lability of the Pt-Cl bond on the other hand. 
This is an example of the fact that the trans-effect provides qualitative information 
on which ligands will be more labile (compared to what they would be in the absence 
of a trans-director) but no information on the absolute lability of the various ligands. 
The trans-effect must be kinetically-controlled since the thermodynamically most 
stable isomer is not always produced. It is also evident that the best it-back-bond 
acceptors are also the best trans-directors. The trans-effect discussed above can 
therefore defined as the kinetic trans-effect, 'the effect of a coordinated group upon 
the rate of substitution reactions of ligands trans to it'? The thermodynamic trans-
influence on the other hand means 'the extent to which that ligand weakens the bond 
trans to itself in the equilibrium state of a complex'. The kinetic trans-effect and the 
thermodynamic trans-influence are different which is reasonable because substitution 
in Pt"-complexes are second-order reactions and involve a 5-coordinated metal ion in 
the transition state. 
Pt" complexes. All complexes in this oxidation state which have been characterised 
are octahedral and diamagnetic with the low-spin 6  configuration. In contrast to 
Pt", Pt's' shows nearly hard or class-a characteristics. Pt" complexes are both 
thermodynamically stable and kinetically inert. Pt(IV) tends to be reduced by P-, As-
, S- and Se-donor ligands to Pt'1 .' Complexes with halide, pseudo-halide and N-donor 
ligands are especially numerous. K 2 [PtC16] is the most common commercially 
available form. The chioroammine Pt"' complexes were extensively used by Werner 
and other early coordination chemistry chemists in their studies of the coordinate 
bond in general and on the octahedral geometry of Pt" in particular. 
An interesting pathway for changing the axial ligands in Pt" hydroxy complexes was 
developed by Giandomenico et al.,' see Scheme 1. This pathway was used for the 
preparation of the orally active anticancer drug JIM2 16, trans, cis- 
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[Pt"(OAc) 2C12(NH3)(cyclohexylamine)]. This reaction, centred one atom away from 
the Pt centre, is ideally suited for ligand transformations on kinetically inert metals. 
A series of Pt" carboxylates, carbonates, and carbamates were prepared using this 
kind of reaction.' 
OAR 





o o 	 OH 





R 	 O 	NHR , 
I.cI N=-=O 	R1 H2  N.....,.. 
excess 	R2H2N 401, 
O 1/ N HR 
0 
Scheme 1.4 Pathways for axial ligand substitution in Pt" hydroxy compounds! 
1.2 Platinum anticancer drugs 
1.2.1 Cisplatin 
The compound cis-[PtC1 2(N}{3)2], clinically known as 'cisplatin', was discovered to 
be cytostatically active and became a very effective antitumour drug in the 1960's. 5 
It is one of the most widely used and successful drugs in cancer chemotherapy. It is 
highly effective in the treatment of a number of tumours, e.g. testicular and ovarian 
cancer. In combination therapy with other drugs, cisplatin is also used to treat 
cervical, bladder and head/ neck tumours .6  It has become well-known that cisplatin 
reacts with cellular components such as DNA and proteins. 78 A key reaction step in 
the mechanism of action appears to be the binding of the cis- {Pt(NH 3)2 }"moiety to 
cellular DNA at two neighbouring guanine bases, and specifically at N7 positions.' 
Despite the successful therapeutic use of cisplatin, there are still serious drawbacks 
of this drug: (1) severe toxicity (e.g. nausea, ear damage, vomiting, loss of sensation 
7 
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in hands and kidney toxicity), (2) poor solubility in saline, (3) the development of 
resistence. 6" ° Also, the applicability of cisplatin is still limited to a narrow range of 
tumours. These drawbacks have led to the search for new generations of Pt drugs 
which can circumvent these problems. 
1.2.2 Mechanism of action of cisplatin 
After administration, either by injection or infusion, cisplatin circulates in the blood. 
Because of the relatively high chloride ion concentration in blood (100 mlvi), the 
hydrolysis of cisplatin is inhibited and it remains almost unchanged before entering 
both normal and tumour cell. The mechanism by which cisplatin enters cells is still 
unclear. Once inside a cell, cisplatin hydrolyses to give active forms of aqua-species 
such as cis-[PtCl(NH 3)2(H2O)1 and cis-[Pt(NH3)2(H20)2] 2 because of the much 
lower chloride ion concentration inside cells (ca. 4 mlvi). Hydrolysis is known to be 
the rate-limiting step in the binding of cisplatin to DNA." A summary of the 
hydrolysis reactions is given in Figure 1.2 and the experimentally determined 




/ 1 + 
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Figure 1.2 Hydrolysis scheme of cisplatin in aqueous solution. 
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Table 1.2 pKa  values of aquation products of cisplatin. 
Reference 12 13 14 15 
k, Is- '] (1.9±0.2)x10 P1<a1 6.85±0.1 6.41±0.02 
k 1 [M's'] (6.0±1.5)x10 2 pK, 5.93±0.1 5.37±0.09 5.24±0.05 
k2 Es'] (2.3±0.3)x104 pK,3 7.9±0.1 7.21±0.09 7.42±0.10 
k.2 [M's'] (9.8±1.4)x1O' 
A large variety of biological molecules could be the potential targets of Pt 
compounds. From the hard-soft acid-base principle, S-donor ligands in proteins 
would bind strongly and generate the most stable bonds. Binding to lone pairs of 
mtrogens would also be expected to be strong. These types of binding would involve 
amino acid side chains from cysteine, methionine, histidine, and also the solvent-
exposed N7 atoms of adenine and guanine in double-stranded DNA. The N3 atoms 
of cytosine and Ni of adenine would be additionally accessible in single-stranded 
DNA and RNA. 16 
It is generally accepted that the interaction of cisplatin with DNA is responsible for 
its antitumour activity.' Approximately 1% of the intracellular cisplatin reacts with 
genomic DNA and yields a variety of mono-adducts and intra- and interstrand 
crosslinks. Using enzymatic DNA degradation experiments, it has been shown that 
binding at N7 of two adjacent guanines to form intrastrand d(GpG) crosslinks is the 
preferred binding site of cisplatin.' 7 Besides GG intrastrand crosslinks (70%), the 
other major DNA adducts of cisplatin are intrastrand AG (but not GA) crosslinks 
(15%). The minor adducts are 1,3-intrastrand and interstrand crosslinks involving 
two non-neighbouring guanines." 
Due to the importance of the d(GpG) intrastrand crosslink, many structural studies 
have been carried out to determine the nature of this cisplatin adduct. These studies 
have been recently reviewed. 18  The first X-ray crystal structures determined were of 
cis-GG crosslinks on the dinucleotide d(GpG)' 9 and trinucleotide d(CpGpG) 20 , 
shown in Figure 1.3. 
The dinucleotide structure (Figure 1.3 (A)) has the two guanine rings in a 'head-to- 
9 
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head' configuration, with the two 06 atoms on the same side of the Pt coordination 
plane. The bases are forced to destack with an average dihedral angle of 81.10.  A 
hydrogen bond is also present between one of the Pt ammine ligands and an oxygen 
atom on the 5'-phosphate group. 
Studies on double-stranded DNA have also been carried out. An important X-ray 
structure was determined of the Pt adduct of the double-stranded dodecamer 
d(CCTCTG*G*TCTCC)/ d(GGAGACCAGAGG) (G*  means platinated G at N7) by 
Takahara et al. 2 ' The structure is shown in Figure 1.4. The basic structure is kinked 
with a bending of the helix of about 45°. The dihedral angle between the guanine 
bases is 300,  considerably less than that of the d(GpG) structure. An overall 
consequence of the Pt binding is a widened shallow minor groove. 
The fate of cells following cisplatin exposure depends on both the extent of damage 
induced and on the cellular response to damage. It has been shown that bent DNA is 
recognised by DNA-repair systems, e.g. the mobility group proteins (HMG). An X-
ray crystal structure has been determined of a HIV1G1 protein domain A bound to a 
16-mer duplex DNA containing a cis-GG adduct. 22 It is suggested that HMG 
specifically recognises locally bend and unwound DNA, such as is the case for 
platinated DNA at neighbouring G-N7 sites. This may shield the DNA repair and 
may lead to cell death. 
10 
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Figure 1.3 (A) X-ray crystal structure of d(GpG) with a cis-GG Pt adduct. 19 , ( B) X-
ray crystal structure of d(CpGpG) with a cis-GG Pt adduct. 
20 
Figure 1,4 	X-ray crystal structure of d(CCTCTG*G*TCTCC) 
d(GGAGACCAGAGG), containing a cis-GG platination site. 
21 
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Cells can become cisplatin-resistant through repeated exposure to the drug, Three 
main processes for cellular resistance have been proposed and it is likely that a 
combination of these factors plays a role. These processes are - changes in 
intracellular accumulation of the drug, - increased production of intracellular thiols 
and - increased capability of cells to repair cisplatin-DNA adducts. 23 A schematic 





















Figure 1.5 Schematic picture of reactions of cisplatin in the cell (based on ref. 24). 
A good comprehensive review of the chemistry and biochemistry of cisplatin was 
published in 1999 containing all important aspects discussed above. 25 
Platinum In cells 
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1.2.3 New developments in platinum anticancer drugs 
The drawbacks of cisplatin mentioned in section 1.2.1 (severe toxicity, poor 
solubility in saline, development of resistence) have been the impetus for the 
development of an improved Pt anticancer drug. Since the introduction of cisplatin, 
thousands of Pt compounds have been synthesised and evaluated for anticancer 
activity, but only a few made it into clinical trials. 26 Only carboplatin, [Pt'1(1,1-
cyclobutanedicarboxylato)(NH 3)2] (Figure 1.6 (A)), received worldwide approval 
and achieved routine clinical use. The higher stability of the CBDCA ligand 
compared to the chloride ligands of cisplatin results in a lower reactivity towards 
biomolecules. Carboplatin is therefore less toxic than cisplatin and can be given to 
patients at a much higher dose (2000 mg/dose compared to 100 mg/day for 
cisplatin).' 6 Two other Pt compounds have received limited approval in recent years. 
Oxaliplatin, [Pt"(oxalato)(dach)] (Figure 1.6 (B)), has been approved for treatment of 
metastatic colorectal cancer in several European countries . 2 ' Nedaplatin, 
[Pt"(glycolato)(NH 3)2] (Figure 1.6 (C)), has received approval for use in Japan. 27 
All of the above complexes adhere to the set of 'classical' structure-activity 
relationships. These criteria for activity of Pt complexes were derived from early 
systematic studies, as summarised by Cleare and Hoeschele. 28 These relationships 
state that for a Pt complex to show antitumour activity, it has to have the following 
features. 
A cis-complex of the form PtX 2(amine)2 for Pt", and PtX2(amine) 2Y2 for Pt", 
(with Y ligands trans). 
- The X ligand (leaving group) should be an anion with intermediate binding 
strength such as Cl -, citrate, oxalate, and other carboxylic acid residues. The Y 
ligands can be Cl-, Off, or O(CO)CH2+ ,. 
- The complex should be uncharged, as it is believed they are taken into the cell by 
passive transport through the lipophilic cell wall, a pathway less available to 
charged compounds. 
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interactions with DNA. These H-bonds (to 06 of guanine or the 5'-phosphate 
group) are important thermodynamically to stabilise the DNA adduct, and 
kinetically, directing the Pt to the N7 position. 
H3N 	0 	-O 







Figure 1.6 Second generation Pt anticancer drugs. Carboplatin (A), oxaliplatin (B) 
and nedaplatin (C) are clinically approved, ZD0473/A1vID473 (D) is in phase I and II 
clinical trials. 29 
This structure-activity relationships dominated Pt drug design for over 20 years and 
remained valid until relatively recently. However, it has become quite evident that 
mere analogues of cisplatin or carboplatin will probably not offer any substantial 
clinical advantages over the existing drugs. 26 
A number of new approaches towards compounds that violate the structure-activity 
relationships have been undertaken with the hope that such compounds would 
exhibit a completely different cytotoxicity than cisplatin. Such compounds would be 
ideal for use against cisplatin resistant cells. Some of these new approaches showed 
remarkable success, one compound (BBR3464, Figure 1.7 (A)) recently entered 
phase II clinical trials." Some of the important recent strategies for the design of Pt 
anticancer drugs are outlined below. Pt" compounds are mentioned separately in 
14 
Chapter 1 Introduction 
section 1.2.4. 
Sterically hindered Pt complexes. The Pt" 2-picoline complex ZD04731AMD473 
(Figure 1 (D)) is currently in phase I and II clinical trials." This compound was 
designed to circumvent cell resistance by sterically hindering glutathione and other 
cellular thiols in reactions with the complex which may deactivate it. AMD473 
possesses activity against cisplatin-resistant cell lines and against an acquired 
cisplatin-resistant subline of a human ovarian carcinoma xenograph both by injection 
and by oral administration. 32 Chen et al. 33 ' 34 studied the hydrolysis and binding 
properties of this compound to 5'-GMP, glutathione and a DNA 14mer duplex 
oligonucleotide. The X-ray crystal structure of the complex shows that the 2-picoline 
ring is almost perpendicular (102.7°) to the Pt square plane . 3 ' The 2-methyl group 
lies directly over the Pt square plane and introduces steric hindrance to an axial 
approach of the Pt from above. This axial steric hindrance seems to be the reason for 
the strongly reduced hydrolysis rate of the chloride trans to NH3 of AMD473 
compared to cisplatin (t,,2 AMD473 = 8.7 h, t cisplatin = 1.8 h). 33 Reactions with 
glutathione were also much slower than those of cisplatin which could explain its 
high activity against cisplatin resistant cell lines. It was also shown that AMD473 
forms predominantly one stereoisomer with a DNA 14mer duplex oligonucleotide. 34 
Multinuclear Pt complexes. An approach to the design of Pt drugs that can 
circumvent Pt resistance in tumours is to develop compounds that from radically 
different Pt-DNA adducts than the current Pt drugs. Multinuclear Pt complexes with 
bridging ligands are such an example. Farrell et al. have extensively investigated 
binuclear complexes with the general formulas [{PtCl m(NH3)3m } .LH 2N-R-NH2 
(m or n = 0-3, and R is a linear or substituted aliphatic 
linker) .31-3'  The binding of these complexes to DNA was reported to be faster than 
for cisplatin, and completely different Pt-DNA adducts were observed that were 
totally inaccessible to mononuclear Pt complexes. The most important multinuclear 
complex is the trinuclear complex BBR3464 (Figure 2 (A)) which is in phase II 
clinical trials. BBR3464 is the first complex to have entered clinical trials which 
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does not adhere to the 'classical' structure-activity relationships. 38 
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Figure 1.7 New 'classical' structure-activity relationships breaking Pt anticancer 
compounds. (A) BBR3464 (in phase II clinical trials), (B) [{cis-Pt(N}{ 3)2 } 2(j.t-OH)(t 
-pz)] 2 
The central Pt moiety of BBR3464 has no leaving groups and is capable only of 
forming hydrogen bonds with DNA. The high charge dramatically increases the 
DNA affinity. 40 The bifunctional DNA binding of BBR3464 is characterised by the 
rapid formatioon of long range intra- and interstrand cross-links. About 20% of all 
cross-links are interstrand cross-links which is significantly more than for cisplatin 
(10%). 0  It was also shown that intrastrand cross-links of BBR3464 are not 
recognised by high mobility group 1 proteins, as it was observed in the case of 
cisplatin, but effective removal of the adducts by nucleotide excision repair was 
observed. 40 Polynuclear Pt compounds seems therefore to represent a novel class of 
Pt anticancer drugs that act via a different mechanism than cisplatin and its 
analogues. 
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Another interesting type of multinuclear Pt complex is [{cis-Pt(NI{ 3)2 } 2(.t-OH)(.t - 
pz)] 2 (Figure 1.7 (B)). 39'4 ' This complex was synthesised with the aim of producing a 
complex able to form 1 ,2-intrastrand cross-links with minimal distortion of the 
DNA. Such a kind of DNA adduct could be a trigger to induce cytotoxic effects and 
be favourable for escaping from the DNA recognition and repair systems in cells. 39 
Indeed, it was shown that above compound forms 1 ,2-intrastrand GG cross-links 
with DNA with less local distortions than in the case of cisplatin and its derivatives. 
It is also reported that this complex shows a much higher cytotoxicity against human 
tumour cell lines than cisplatin. 39 
Trans Pt complexes. Farrell and colleagues have compared the cytotoxicities of 
three series of trans complexes with the general formula trans-[PtC1 2(L)(L')] where: 
(i) L = L' = pyridine, N-methylimidazole, thiazole, (ii) L = quinoline, and L' = 
RR'SO (R = methyl, and R' = methyl, phenyl, benzyl), (iii) L = quinoline and L' = 
NH3 An example is shown in Figure 1.8, complex (A). The Pt compounds in these 
three series showed comparable activity to cisplatin in sensitive cell lines and also 
activity in cisplatin-resistant cell lines. 42 Interestingly they also showed higher 
activity than their cis counterparts. In particular the complexes showed activity in 
cisplatin resistant cell lines where the mechanism of resistance was known to be due 
to reduced Pt accumulation and enhanced removal of and/or increased tolerance to 
Pt-DNA adducts. Coluccia et al. have also demonstrated the activity of the trans 
geometry with a series of Pt(II) complexes with iminoether ligands. 26'43 Trans-[Pt {E-
HN=C(OMe)Me} 2C12] (Figure 1.8, complex (B)) is more active than its cis isomer 
although, in this trans isomer, the methyl groups of the ligand lie on the same side of 
the coordination plane leaving access to the Pt ion for binding on the opposite side. 
In the cis isomer however the methyl groups are on opposite sides of the plane 
hindering substitution at platinum. Thus the hindrance around the Pt and reactivity of 
the complex cannot be directly correlated with the activity of the compound. 
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Figure 1.8 Trans Pt complexes which showed antitumour activity. (A) trans-
[PtC12(pyridine)2]
1 
 (B) trans-[Pt {E-HNC(OMe)Me} 2C12]. 
1.2.4 Pt" complexes 
Since the early studies by Rosenberg and colleagues, it has been known that Pt" 
complexes also have antitumour properties. 45 The development of Pt drugs in the two 
decades after the introduction of cisplatin was mainly dominated by Pt" complexes. 
Attempts to develop an orally active Pt drug have reinitiated the interest in Pt" 
compounds in the last ten years. 26  These attempts have resulted in the lead compound 
JM2 16 (Figure 1.9 (A)), which was developed by Johnson Matthey and entered 
clinical trials in 1992 and is now in phase II trials . 4' Two other Pt" complexes have 
been in clinical trials, iproplatin (Figure 1.9 (B)) and tetraplatin (also known as 
ormaplatin, Figure 1.9 (C)). However, these compounds were abondoned due to 
severe neurotoxicity in the case of tetraplatin and the lack of superior performance in 
the case of iproplatin. 27 
The ability to deliver a Pt drug orally would allow much greater flexibility in dosing 
of the drug and increase the potential for the use of Pt drugs. The properties of 
cisplatin and carboplatin rule out the possibility of an effective oral formulation of 
these drugs. Studies showed that only 37% and 22% of cisplatin and carboplatin 
respectively, are absorbed by mice when administered orally in arachis oil. 47 J1M1216 
and JM22 1 (Figure 1.9 (D)) show improved absorption values of 71% and 76%, 
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respectively. 47 JM2 16 and JM22 1 were also evaluated in a number of cisplatin-
resistant cell lines. The two complexes showed a lack of cross-resistance with 
cisplatin in some cell lines, which was associated with the greater lipophilic nature of 
these complexes enabling them to circumvent resistance due to decreased Pt 
accumulation." 
Pt" complexes are much more inert against substitution reactions than Pt" 
complexes.48 This is the reason why it is generally believed that Pt"' complexes must 
first be reduced to Pt" before reacting with DNA. Numerous studies support this 
hypothesis.495 ' The mechanism for this redox reaction and the effects of the 
coordinated ligands on the reduction are still poorly understood. The reduction of 
Pt` complexes by thiols, which have been proposed to be the major biological 
reducing agents, is discussed in section 1.2.5. 
However, Pt" 5'-GMP adducts have been reported in the literature, but they are only 
minor products .12,11  Choi et al. 54 found evidence of an intermediate 5'-GMP adduct of 
tetraplatin. This adduct is then rapidly reduced to a Pt" adduct by 5'-GMP. More 
recently, Galanski et al. 55 showed that the formation of a Pt"-5'-GMP adduct which 
is stable over several weeks without reduction. Addition of the reducing agent 
sodium ascorbate however led to a rapid reduction of the Pt"-5'-GMP adduct to pt". 
It was also shown that the Pt"-5'-GM.P adduct is more easily reduced than the intact 
Pt" complex. 
These results show that it is likely that Pt" anticancer drugs are reduced to Pt" 
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Figure 1.9 Pt'v anticancer complexes. (A) JIM2 16, (B) iproplatin, (C) tetraplatin or 
ormaplatin, and (D) JM22 1. 
1.2.5 Reduction of Pt' complexes by thiol -containing biomolecules 
Ptt" complexes undergo ligand substitution reactions much more slowly than Pt" 
complexes. 56 Therefore, biotransformation of Pt" complexes is generally assumed to 
involve reduction to Pt" prior to reaction with DNA 49 Thiol-containing biomolecules 
and ascorbic acid have been proposed to be the major cellular components 
responsible for that reduction. The most abundant reducing agent in cells is 
glutathione which usually exists at concentrations of 5 - 10 mM. 
Knowledge of the reactivity of Pt' compounds towards reduction by bio-reductants 
is therefore important for understanding the mechanism of their antitumour activity. 
Several studies have recently been carried out on the kinetics and mechanism of the 
reduction of Pt" complexes by thiols and ascorbic acid. 51 '5760 The structures of Pt" 
complexes whose reductions have been studied are shown in Figure  1.10.17-59 
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Figure 1.10 Pt" complexes whose reductions by thiols and ascorbic acid have been 
studied . 5759 
The reduction reactions follow the second-order rate law: 
-d[Pt(IV)] / dt = k Ob1, [Pt(IV)] = k [RSH],O, [Pt(IV)] 
where k denotes a pH dependent second-order overall rate constant. The rate 
constants are pH-dependent due to the different protolytic species of the thiols 
present in solution. Deprotonated species of thiols are much more reactive than 
protonated ones. 57 An example for the big difference of reactivity between the 
protolytic species of thiols are the rate constants of the reduction of (2 J1M335) by 
glutathione. 
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The rate constant for reduction by GSH is 0.48 ± 0.01 M' s' and for the reduction 













































It can therefore be concluded that thiolate (GS) will be the major reductant at 
physiological conditions. 
The reduction rate of Pt" compounds with Cl only in cis positions to each other (1, 
3) are much slower than for their analogues with Cl in trans positions to each other. 
No reduction at all of compound (1 JM149) by thiols was observed at 298 K at 
neutral pH. 58 The half-life of compound (2 J1M335) under the same conditions was 23 
s. The reduction rate of compound (3 JM2 16) by ascorbic acid was more than three 
orders of magnitude slower than the one of its trans analogue (4 JM5 76). 
Mechanistic studies on reductions of Pt" complexes by inorganic and biological 
reductants have shown that electron transfer involves reductive elimination through 
nucleophilic attack by the reductant on a halide coordinated trans to a good leaving 
group, followed by loss of the trans ligand (see Figure 1.1 l).' 
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Cl .......................... 	 tIV 
......... .......................... Cl 
Figure 1.11 Cl bridged reductive elimination mechanism 
A Cl trans to Cl is therefore a good target for a reductant, as Cl is a good leaving 
group. There is no Cl trans to Cl in compound (1 JM149), only a OH group trans to 
a OH group. An attack on a Cl trans to a strongly bound am(m)ine ligand is 
energetically unfavourable and explains the large difference in the reduction rate 
between compounds 3 and 4,58  The reduction products of 3 and 4 are cis-
[Pt"C12(cha)(NH3)] and trans-[Pt 11(OAc)2(cha)(NH3)], respectively. The reduction of 
complex 3 must therefore work by a different mechanism than the above chloride-
bridged reductive elimination mechanism. Lemma et al. 59 proposed an outer-sphere 
mechanism and Ranford et al.6° an oxygen-bridge electron transfer mechanism via 
the carboxylate ligands. 
Furthermore, complexes 2 and 4 are reduced much more slowly than complex 6. The 
half-lives of complexes 2 and 6 in the presence of glutathione (6 mM) under 
physiologically relevant conditions (310 K, pH 7.4) were estimated to be 23 s and 
less than 1 s, respectively. 57 '58 Both complexes exhibit a Cl trans to Cl. This large 
difference in the reactivity of the two complexes is due to the hydroxide ligands in 
complex 2 which stabilise the Pt` state . 6' Another mechanism was reported by 
Kratochwil et al. for the reduction of trans, cis-[Pt"(en)(OH) 21 2] by glutathione. 63 
The reduction consists of initial attack of the thiol on an iodide ligand of the 
complex, forming a five-coordinated transition state, which then undergoes a ring-
opening reaction. This leads in the end to the product [W(en) 121. 
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Reduction potentials of Pt" complexes 
Table 1.3 List of reduction potentials of different Pt" compounds. 
Compound Reduction potential (my) 
Trans-[Pt'(CN)4X 2], X = Cl, Br' -399 




R = CH3 , -546 
CH2CH3 , -521 
CH2CH2CH3 -493 
[Pt"(en)C1 4}" -224 
Cis, trans-[Pt"(en)C1 2(OH)2 ] -884 
Cis, trans-[Pt"(en)C1 2(OCOCF3)2] 52 0 
[Pt"(dach)C14]52 -90 
Cis, trans, cis-[Pt"C12(OH)2(ipa)2]52 -730 
Cis, trans, cis-[Pt"C12(OCOR)2(NH3 , cha)] 52 , 
R=CH3 -250 
R=C3H7 -150 
Since it is believed that reduction of the Pt" anticancer drug to Pt" is necessary prior 
to binding to DNA, studies to find out any correlation between the reduction 
potential and the amount of binding to DNA or the cytotoxicity of Pt" compounds 
were carried out.52,M  The influence of the nature of the axial ligand on the reduction 
potential was also studied. Ellis et al. observed a direct correlation between the 
reduction potential and the amount of binding to DNA.' They proposed that this is 
due to direct binding of Pt'' to DNA following the loss of one of the axial ligands. 
The more readily an axial ligand is lost the greater the DNA binding. 
Ellis et al.M  and Choi et al. 12  showed that there is a direct correlation between the 
reduction potential of [Pt" (en)(C1) 2Z2] compounds and the axial ligand Z (see Table 
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1.3). The reduction potentials increase in the following order depending on the axial 
ligand Z: OH < OCOCH 3 < CH2CH3 < CH2CH2CH3 <Cl < OCOCF3. The reduction 
potential reflects therefore the lability of the axial ligand in a Pt" complex. 
Choi et al.52 did not find any correlation between the reduction potential of Pt'' and 
their cytotoxicity towards cisplatin-sensitive L1210/0 cells. The reaction kinetics for 
the reduction of Pt" complexes by bio-reductants is however not directly related to 
the reduction potential. 59 Steric hindrance by bulky groups can slow down reactions 
of plV  with bio-reductants and therefore plays an important role. For example, 
Lemma et al. showed that cis, trans, cis-[PtC12(OCOCH3)2(a, cha)] (3 JM2 16, a = 
ammine, cha = cyclohexylamine) reacts faster with the reductant ascorbic acid than 
does the sterically more hindered cis, trans, cis-[Pt"'C12(OCOC3H7)2(a, cha)] 
(JM221) although the latter has a higher reduction potential. 59 
1.3 Photochemistry of coordination compounds 
Photochemistry can be defined the following way. It is the branch of chemistry that 
deals with the study of causes and courses of chemical deactivation processes of 
particles from their electronically excited states, usually with the participation of 
UV, visible or near-infrared light. 65 Chemical changes of particles that are the 
consequence of the electronic excitation of these particles due to external energy 
effects are called photochemical reactions. Photochemical reactions differ from 
spontaneous (dark) reactions, which denote chemical changes without previous 
electronic excitation induced by external effects. 
This section introduces the individual processes in the sequence of a photochemical 
reaction. Therefore, the physical conditions for the formation of complexes in 
excited states via photoexcitation are introduced first, then the different types of 
electronic transitions are described. Then, photophysical and more in detail 
photochemical deactivation reactions will be considered. 
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1.3.1 Photoexcitation of coordination complexes 
The most intensive and important transitions of atoms and molecules are based on 
the interaction of the electric component of an electromagnetic field with a dipolar 
charge distribution in a system. This is called an electric dipole transition. Other 
types of transitions (magnetic dipole or electric quadrupole transitions) are not of 
interest in photochemistry. A photoexcitation is a resonance process which can take 
place if the difference between the energy of any of the excited states and the ground 
state is equal to the energy of a photon interacting with the complex: 
EES - EGS  = hv 	 where EES is the energy of the excited state, EGS  the 
energy of the ground state, h is the Planck's constant, v 
the frequency of the radiation 
The probability of light absorption for a certain transition is expressed by means of 
the oscillator strengthf(t transition dipole moment, m e mass of an electron, e charge 
of an electron): 
8rmv i ,u 2 	p 	 = wavefunction of 
3he 2 ground/ excited state 
R = dipole moment operator 
The transition dipole moment can have a value of zero for certain transitions. 
Transitions for which the transition dipole moment is zero are called forbidden 
transitions. Conditions under which the transition dipole moment adopts a value of 
zero are expressed by selection rules: 
- electric dipole transitions between states of different multiplicity are forbidden 
(spin-forbidden transitions). 
- electric dipole transitions between states of equal parity (g -* g, u -* u) are 
forbidden (orbitally forbidden transitions). 
- electric dipole transitions involving the simultaneous excitation of two or more 
electrons are forbidden. 
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Light absorption. The amount of light absorbed in a homogeneous medium is 
defined by the Beer-Lambert law: 
I = 	Ø.cI 
where I and I are the light intensities at the front of the absorber, and at distance, 1, 
within the absorbing medium, respectively; and c is the extinction coefficient in units 
consistent with the pathlength of the light, 1 (usually in cm), and the concentration of 
the absorber, c (usually in mol-l"). The absorbance or optical density is defined as 
A = 1og 10(I/ I) = c•c•l 
and is therefore proportional to the concentration and the pathlength. 
Quantum yields. The quantum yield or quantum efficiency of a photochemical 
reaction is normally defined as the fraction of photoactivated molecules that undergo 
some change. This is also called the overall quantum yield of products. The quantum 
yield of any stable product X for example from the photodecomposition of a 
compound M (M + hv - X) is defined by 
= d[X] Idt = No. of molecules or ions of X formed! cm 3 •s 
I. 	No. of quanta absorbed by M/ cm 3 •s 
The above quantum yield is measured irrespective of whether X is formed directly in 
a primary process or in a secondary thermal reaction involving free radicals or 
atoms. 
1.3.2 Types of electronic transitions 
A process of excitation A 4 A*  is characterised according to the localisation of the 
electron density transfer in the complexes. Such electron density transfers can take 
place within a complex, or exchange of an electron may occur between the complex 
and its environment. However, it is important to know that despite talking about 
electron transfer between molecular orbitals to achieve a spectroscopic excited state, 
the whole electron system of a complex is always changed (e.g. interelectronic 
repulsion is changed, in addition to degenerations of levels, energy of orbitals, etc.)." 
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Electronic transitions get classified in photochemistry according to the localisation of 
the molecular orbitals involved. Four fundamental types of electronic transitions 
exist. 
Transitions between molecular orbitals (MOs) localised on the central atom. 
These can be divided into - ligand-field or LF transitions (electron density 
transfer between d- or f-orbitals of the same 
principal quantum number) 
- Rydberg transitions (transfer between orbitals 
differing in principal quantum number) 
- inter-valence charge transfer or IT transitions 
(transfer from one to the other central atom in 
polynuclear bridged complexes) 
Transitions between MOs localised on ligands. These can be either intraligandf 
IL transitions (electron density transfer between MOs localised on one ligand) or 
ligand-to-ligandi LLCT transitions (electron transfer from one ligand's HOMO 
to the other ligand's LUMO). 
Transitions between MOs of different localisation. Depending on the direction 
of electron density transfer, there are 
- metal-to-ligand charge transfrrl MLCT transitions 
(displacement of negative charge from the central 
atom to the ligands). 
- ligand-to-metal charge transfer/ LMCT transitions 
(displacement of negative charge from the ligand to 
the central atom). 
Transfer of an electron between the complex and an environmental particle. Such 
transitions are called charge-transfer-to-solvent/ CTTS transitions (transitions in 
which electronic charge moves to the solvent). 
The different types of transitions that can occur in an octahedral coordination 
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Figure 1.12 Molecular orbital diagram for an octahedral coordination complex and 
the various kinds of electronic transitions that may occur between the orbitals. 
1.3.3 Deactivation processes from excited states 
Generally, deactivation processes can be divided into photophysical and 
photochemical deactivation processes. Photophysical processes are those which 
result in a return of the system to the ground state while photochemical processes 
result in different products. Figure 1.13 represents an outline of the many choices of 
pathways through which the excited system can dissipate the energy it gained in 
absorbing a photon. 67 
Photoactive species undergo a very rapid thermal equilibration with their 
surroundings, resulting in a Boltzmann population distribution, which means that 
most molecules drop back to the lowest vibrational level of the excited electronic 
state. This process is called vibrational relaxation and is shown in Figure 1.13 by the 
short, downward arrows. After the vibrational relaxation, the excited molecule may 
decay back to the original ground state by luminescent emission or by a non-
radiative decay, or it can also form photoproducts either directly or via a reactive 
intermediate. 
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Figure 1.13 Jablonski diagram summarising the various pathways available to an 
excited molecule or complex. 67 (IC = internal conversion, ISC = intersystem 
crossing) 
Internal conversion (IC) and intersystem crossing (ISC) are transitions between two 
excited states with identical and different multiplicity, respectively. In the case of 
non-radiative deactivation of an excited state, the energy is released into the 
environment in the form of heat. Other ways of deactivation of an excited state of a 
complex are interactions with another particle in the medium which is then called the 
quencher Q. In that case, the quencher absorbs the energy difference between the 
excited state and ground state. 
1.3.4 Photochemical reactions of coordination compounds 
The interest of photochemistry lies in the photochemical deactivation pathways of 
complexes in excited states. The extent to which photochemical products are formed 
will depend on how well the photochemical pathways can compete with the various 
photophysical decay processes described in the previous section. This is dependent 
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on the reactivity of the excited states which are chemically different from the ground 
state. Almost all types of reactions can be classified as either unimolecular or 
bimolecular. 67 
The most relevant types of photochemical reactions of coordination complexes will 
be shown here together with some examples. The following types of reactions will 
be discussed: 
- photoredox reactions 
- photoisomerisation reactions 
- photosubstitution reactions. 
Special attention is given to photoredox reactions, and especially to the photoredox 
chemistry of Pt. 
1.3.4.1 Photoredox reactions 
Photoredox reactions of complexes are classified as follows: 
reactions of the complex producing changes in the composition, e.g. 
elimination and addition reactions, 
reactions of an electron exchange between the complex and particles 
of the environment in which the complex composition and structure 
are preserved, and 
reactions of the complex producing changes in structure in which the 
composition of the complex is preserved, e.g. inner-complex rearrangements. 
Our main interest lies in group a). Photoredox elimination and addition reactions are 
characterised by changes in the oxidation number of the central atom and the 
coordination number of the complex. An increase in the oxidation number of the 
central metal is normally accompanied by an increase in the coordination number, a 
decrease in the oxidation number with a decrease in the coordination number. These 
two reactions are called oxidative additions and reductive eliminations. 
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As a charge-transfer from ligands to central atoms and vice versa are involved in 
oxidative additions and reductive eliminations, ligand-to-metal (LMCT) and metal-
to-ligand (MLCT) charge-transfer excitations of complexes are mostly the reason for 
oxidative addition and reductive elimination reactions. Some general characteristics 
of LMCT and MLCT are given below. 
LMCT. These transitions are usually orbitally- and spin-allowed, and they are 
represented by intense bands in the visible and UV regions with values of c z 10'- 
10'  I.mol'•cm'. For a complex with a central atom M and a ligand L, the energy of a 
LMCT transition is not remarkably influenced by the other ligands in the 
coordination sphere, chromophore symmetry and environment of the complex. 65 
Octahedral low-spin d6 complexes like Pt" complexes show LMCT bands at 
relatively short wavelengths since the acceptor orbital a d * occurs at quite high 
energies and has a large influence on the metal-ligand bonding. The reorganisational 
energy for such an excitation is then quite large and contributes considerably to the 
energy of LMCT transitions. 68 
MLCT. These transitions are also usually orbitally- and spin-allowed and are 
represented by intense bands in the visible and UV regions with values of Cm 103_  
15 l•mol'•cm'. MLCT transitions are expected when the ligand possesses low-lying 
empty orbitals (usually itK  LUMO) and the central atom is easily oxidisable. MILCT 
transitions decrease in energy as the ligand becomes more reducible and/ or the 
central atom becomes more easily oxidisable. The majority of complexes which 
display typical MLCT spectra include those of reducing d 6 (e.g. Fe", Ru"), d8 (e.g. 
Pt"), d' ° (e.g. Cu'), and s2 (e.g. TP, Sn2 , Sb3 ) metals. Especially organometallic 
compounds with metals in low oxidation states and it-acceptor ligands are often 
characterised by long-wavelength MLCT absorptions. 69 
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Reductive elimination reactions. LMCT transitions can often lead to reductive 
elimination of a ligand. Reductive elimination reactions of Pt" (d 6) complexes have 
been studied, mostly of halo and azido Pt" complexes. In most cases these 
compounds are mixed ligand complexes, but their photochemical reactivities were 
found to be basically determined by the ligands X and N3 . 67 The primary step of the 
photoredox chemistry of Pt" compounds upon excitation into a LMCT band is the 
reduction of Pt" to Pt" 1 or Pt". Pt" complexes are labile and very reactive and 
undergo either reoxidation to Pt"' or further reduction to Pt". Two good examples of 
reductive elimination reactions are the photoreactions of the complexes [Pt"(N 3)6] 2 
and [Pt"(CN)4(N3)2] 2 . 
Irradiation of [Pt"(N3)6] 2 with X = 313 nm in acetonitrile led to a clean conversion to 
[Pt"(N3)4] 2 indicated by spectral changes in the UVIVIS spectrum: 7° 
[ptV(N)]2 -> 1pt"(N3)4 +3N2 
Bubbles were formed during the photolysis due to released N 2 . The solutions of the 
product [Pt"(N3)4] 2  are light-sensitive. Further irradiation of the solution with 
300 mn led to the precipitation of colloidal platinum: 
[Pt"(N3)4] 2 --> Pt° + 3 N2 + 2 N3 
The mechanism of these reductive eliminations is of interest. It would be expected 
that the above reaction takes place via a Pt" intermediate in two consecutive 1e 
transfer steps. Investigations by Vogler et al. 7 ' on [Pt"(CN)4(N3)2] 2 in ethanol with 
< 400 nm led to the conclusion that the following reaction takes place by 
simultaneous two-electron reduction without formation of a Pt" intermediate. 
[Pt"(CN)4(N3)2]2 hv > [Pt"(CN)4] 2 + 2 N3 
Vogler et al. 7 ' identified CH 3CHOH radicals in ethanol at 77 K, but no Pt" signals. 
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The presence of these CH 3CHOH radicals plus the finding of free azide were taken 
as evidence for the presence of N 3 radicals which can obviously be reduced by 
ethanol. 
Halo Pta' complexes however exhibit different kinds of photoreactivity than their 
azido counterparts. Irradiation of [Pt"(CN) 4C12] 2 into its LMCT transition in ethanol 
(X = 254 nm) leads to efficient reduction to [Pt"(CN) 4] 2 . In aqueous solution, 
however, the photoredox reactivity was almost negligible, but efficient 
photoaquation was observed instead 12 
[Pt"(CN)X]2 
hv 
 [Pt"(CN)4X(OH)] 2 + H + X 
The primary photoproduct of above reaction is suggested to be the [Pt ' 11(CN)4Cl] 2 -Cl 
pair. A similar photoreactivity was also found for the corresponding ammine 
compounds [Pt"(NH 3)4X2] 21 . 73 
Oxidative addition reactions. An example of an oxidative addition is the 
photoreaction of [Pt 11(bipy)C12} with ? = 280 nm in CHC13. The primary step is an 
oxidative addition with a solvent molecule" 
[Pt"(bipy)Cl2] + CHC13 hv > [Pt ... (bipy)Cl3] + CHC12 
[Pt"1(bipy)C13] + CHC12 	> [Pt''(bipy)Cl 3] + CHC12 
[Pt1"(bipy)Cl3] + CHC12 	> [Pt"(bipy)Cl4] + : CHC1 
The Pt" complex is a stable end product, while the monochiorocarbene reacts with 
another solvent molecule to give 1,1 ,2,2-tetrachloroethane. 
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1.3.4.2 Photoisomerisation reactions 
Photoisomerisation reactions are light-induced processes in which the composition 
of compounds is preserved, but their structure and properties are changed. Different 
kinds of photoisomerisation reactions can take place, for example" 
- photoisomerisation of geometrical isomers 
- photoisomerisation of optical isomers (photoentiomerisations) 
- photoisomerisation of coordinated ligands 
- phototautomerisation reactions of complexes 
- photoisomerisation reactions of spin isomers 
The photoisomerisation of geometrical isomers is of special importance for this work 
and is therefore mentioned in more detail. During the conversion of geometrical 
isomers, a change in the symmetry of the complex takes place while the complex 
composition stays unchanged. Studies have been undertaken on cis-trans 
photoisomerisation of square-planar complexes of the [MA 2132] type and of 
octahedral complexes of the [MA 4132] type, and mer-fac isomerisations of the 
octahedral complexes of the [MA 3133] type, where A and B are the donor atoms of 
ligands.65 
The suggested mechanism for trans —p cis (mer —fac) is shown in Figure 1.14 (for 
the reverse course the Figure is analogous). 
The studies reported so far on photoisomerisation have been carried out on square-
planar Pt" and Pd" complexes. The mechanism via the intermediate I is called the 
intramolecular 'twisting' mechanism. This mechanism was proved by means of the 





It was shown that no labelled free chloride ions entered the coordination sphere in 
the above reaction. 
An example for a solvent-assisted mechanism involving intermediate III is the cis- 
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trans photoisomerisation of cis-[Pt"C1 2(py)2] in CHC13, during which pyridine was 












Figure 1.14 Cis-trans photoisomerisation reaction of a square-planar complex. A 
and B denote different ligands, S denotes solvent molecules, or another molecule 
present in solution in excess. I and II represent intermediates, I has tetrahedral and II 
trigonal structure. 
It is thought that photoisomerisation of octahedral complexes takes place through the 
same mechanism as shown in Figure 1.14. Studies on octahedral complexes showed 
that the photochemically active excited states are mostly spin-forbidden ligand-field 
(LF) states. 
1.3.4.3 Photosubstitution reactions 
Photosubstitution reactions denote photochemical non-redox transformations during 
which an exchange of ligand(s) between the primary and secondary coordination 
spheres takes place. The composition of the complex changes, but the coordination 
number of the central atom is retained. Most photosubstitution reactions differ 
distinctly from the thermal substitution reactions of a given complex in their kinetics 
and the composition and stereochemistry of the products. In general, 
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photosubstitutions take place much more rapidly (up to M orders of magnitude") 
than thermal substitution reactions and last for a few picoseconds. 
Photosubstitutions take place generally from ligand-field (LF) excited states. LF 
excitation leads to labilisation of ligands due to the population of the a orbitals 
which can subsequently lead to the substitution of one of them. For example, 
photosubstitution of the complexes [M(NH 3)6] 3 , where M = Cr, Rh or Ir, was 
observed in aqueous solution": 
[M(N}I 3)6] 3 + H20 hv>  {M(NEI 3) 5(H20)] 3 + NH3 
The photosubstitution quantum yields for the Rh ... and 1r11 ' complexes did not depend 
on the irradiation wavelength, and it was shown that the lowest triplet LF state 3 Tig 
was photochemically active. 
Examples of how photosubstitutions can differ from thermal substitution reactions 
are shown below. 
[Cr(NH 3)5X] 2 + H20 —--* [Cr(NH 3 ) 5(H20)] 3 + X -  (X = Cl, Br, NCS) 
However, the photochemical reaction leads to different products formed by 
photosubstitution of a NH 3 ligand: 79 
[Cr(NH3)5X] 2 + H30 -- cis-[Cr(NH3)4(H2O)X]2 + N}1I 
Another difference between thermal and photochemical substitutions can be the 
stereospecificity. This is illustrated in the following example": 
trans-[Cr(N}i3)4C12]' + H20 A > trans-[Cr(NH3)4(H2O)Cl]2 + Cl 
trans-[Cr(NH3)4Cl2] + H20 hv>  cis-{Cr(NH 3)4(H2O)Cl]2 + C1 
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Photodynamic therapy has become more and more widely used as a treatment for 
cancer in recent years. The treatment involves the injection of a light-absorbing 
compound (photosensitiser) to the patient and later irradiation of the tumour tissue 
with light of the correct wavelength and power. Further processes inside the cell lead 
to the death of the cancer cells. 
So far, only one photosensitiser has gained regulatory approval for photodynamic 
therapy. It is available commercially under the name photofrin and is used to treat a 
wide variety of cancers." Photofrin is approved for treatment of esophageal cancer in 
the USA, Canada, Japan, France, and the Netherlands and for lung cancer in Japan, 
France, the Netherlands, and Germany. It is also used to treat gastric and cervical 
cancer in Japan and is additionally in clinical trials in several countries for treatment 
of head and neck cancer." It is a complex mixture of porphyrins known as 
haematoporphyrin derivative (HpD). HpD contains porphyrin monomers, dimers and 
higher oligomers with ether, ester and carbon-carbon linkages." 
Typically, the patient is given an intravenious injection of photofrin as an outpatient 
at a dose of 1-2 mg/kg of body weight. After a waiting period of 1-2 days, the 
patient returns to the clinic and the tumour is illuminated for 10 to 30 minutes. Laser 
light of 630 nm is used for illumination using fiber optics." The patient can go home 
the same day. There is just one side-effect when using photofrin: photofrin stays in 
the skin for approximately 30 days after treatment making the patient sensitive to 
strong light, but indoor room lighting is safe. 
The photophysical mechanisms involved in PDT are shown in Figure 1.15. In 
summary the photosensitiser absorbs light and becomes excited to an energetically 
higher electronic state and can then undergo further reactions shown in the Scheme 
as type I and type II mechanisms. In type I mechanisms, it participates in an electron 
transfer process with a biological substrate to form radicals and radical ions which 
interact with oxygen to generate products such as the superoxide ion 02. In the type 
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II mechanism, it produces the short-lived and highly reactive and toxic singlet 
oxygen '0 2 . This singlet oxygen 1 02 has a lifetime of about 0.06 j.is in water and ten 
times longer in a lipid cell membrane. This means that '0 2 cannot diffuse through a 
single cell membrane and so, it cannot damage other tissues. It is generally accepted 
that singlet oxygen is the key agent that kills tumours in PDT. 
A lot of research has been carried out in this area with the aim of producing better 
photosensitisers than photofrin. There are several disadvantages of photofrin. 
- It is a mixture of compounds, of which some are not PDT active. Chemical 
purity is very important in the interpretation of dose-response relationships. 
- Porphyrins present in photofrin have their maximal absorption around 400 run. 
The light in that region is effectively absorbed by the living tissue. Light at the 
red end of the spectrum is much less attenuated by the tissues which is a reason 
why photofrin is excited at 630 nm where it does not have its absorption 
maximum. 
- Photofrin also localises in healthy tissue and is only slowly cleared which makes 
the patient photosensitive to solar radiation, sometimes up to a month after the 
injection. 
The aim is to find photosensitisers with an absorption maximum over 630 nm, which 
accumulate selectively in tumour tissue, which are quickly cleared from the body, 
which have a high quantum yield of singlet oxygen when it is excited, which are 
soluble in water and lipophilics, and which do not show severe side-effects. 
Several compounds are now in clinical trials as new photosensitisers, all are based on 
tetrapyrroles (porphyrins, chlorins and phthalocyanines). One example is m-THPC, 
better known as Foscan, which is undergoing clinical trials for a wide variety of head 
and neck cancers (Figure 1.16). It was tested on patients suffering from early cancers 
of the oesophagus and bronchi using 653 nm laser light. Seventy-seven percent of 
the patients showed no recurrence, but beside prolonged skin phototoxicity, some 
other complications such as the narrowing of the airways have been observed. 8 ' 
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Another interesting example is lutetium texaphyrin (lu-tex) which absorbs light with 
a wavelenght of around 730 nm. It can be illuminated only 3 hours after injection, 
and it seems to be highly selective for tumours as opposed to healthy tissue. In one 
trial, lu-tex was used to treat 74 breast cancer lesions, and 42 % of these underwent a 
complete response, and 23 % had a partial response. 
A very different approach is the use of a precursor instead of the preformed 
photosensitiser. For example 5-aminolevulinic acid which has been developed under 
the name Levulan is converted to the naturally occurring photosensitiser 
protoporphyrin IX. For excitation, light of 400 rim is used. The proposal is to use 
Levulan to treat skin cancers, and so the use of blue light would not be a 
disadvantage. 
There are also possible applications for PDT for diseases with similar characteristics 
such as cancerous tumours because photosensitisers tend also to accumulate there. 
PDT has shown some potential in treating age-related macular degeneration which 
leads to blindness, psoriasis, bone marrow purging, arthritis and purifying blood 
infected with various viruses, including HI V. 82 
With the cost of diode lasers coming down, delivering light at the red end of the 
visible area and the near infrared, PDT is a very promising technique for treating a 









leading to photobleaching 
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Figure 1.15 Photophysical mechanisms involved in photodynamic therapy (PDT) 
based on reference . 
(A) 
Figure 1.16 Photosensitisers for photodynamic therapy. (A) Photofrin, which is in 
use in clinics, and (B) Foscan (m-THPC), a new photosensitser which is in clinical 
trials. 
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1.5.1 General aims 
The general aim of this work was to develop Pt prodrugs which can be activated into 
anticancer drugs by visible light. The wavelength of the light should be ideally in the 
red region because light penetrates deeper into tissues as its wavelength increases. 80 
The Pt prodrug should have the following properties: 
- better water solubility than cisplatin (8 MM),  cis-[Pt"C1 2(NH3 )2 ] 1  
- high stability towards hydrolysis in water, 
- high stability towards substitution reactions and reduction by biological reducing 
agents such as glutathione, 
- fast conversion from the prodrug to the active species. 
The above conditions for a good Pt prodrug have directed attention towards Pt" 
complexes due to their inertness against substitution reactions. 48 Therefore one of the 
strategies was the development of an inert photoactive Pt" prodrug which can 
effectively be converted into an active Pt" drug (Scheme 1.16). 
Pt 	 hv •u. 	 ___________ 	
". .pt') 
010, 
Pt" 	 Pt" 	 Pt"-DNA adduct 
Scheme 1.16 Strategy for the development of a photoactive Pt" prodrug. An inert 
Pt" prodrug is converted into a Pt" complex by visible light. These Pt" complexes 
would then react rapidly with DNA (shown is the major DNA adduct of cisplatin at 
two N7 positions of adjacent guanines). 
1.5.2 Specific aims of this work 
Chapter 3: The preparation and characterisation of mixed valence Pt"-Fe" 
complexes which could release a Pt" drug when irradiated into their metal-to-metal 
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charge transfer band. Studying of the photochemistry by inverse 1 H-{' 5N} and ' 3C 
NMR spectroscopy via ' 5N, ' 3C isotope labelling of the complexes and by IR- and 
UV/VIS spectroscopy. 
Chapter 4: Synthesising and characterising photoactive Pt" derivatives of the 
widely used anticancer drug carboplatin. Test of their photoactivity by UV/VIS and 
NMR spectroscopy. Determination of the mechanism of the photoreactions with 
the help of inverse 'H-{' 5N} NMR spectroscopy. Demonstration of release of 
carboplatin when irradiating the Pt" complexes with visible light. Synthesising and 
characterising am(m)ino Pt" and Pt' oxalate complexes and testing of their 
photoreactivity. 
• Chapter 5: Synthesising and characterising mono- and diazido Pt' v and Pt" 
complexes. 
• Chapter 6: Studying the stability and photoreactivity of the Pt" and Pt" diazido 
complexes via inverse 'H-{' 5N} NMR spectroscopy and ESI-MS. Studying the 
stability of Pt" diazido complexes specifically towards hydrolysis, chloride ions 
and biological reducing agents. Studying the photoreactivity of Pt" diazido 
complexes in the presence of nucleotides and oligonucleotides and characterising 
the adducts. 
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Table 2.1 lists NMR properties of nuclei studied in this thesis. Due to their 
importance in this thesis, the most important aspects of ' 5N and "'Pt NMR 
spectroscopy are reviewed here. The heteronuclear single/ multiple-quantum 
correlation NMR technique, which was often applied during this thesis, will also be 
mentioned. 
Table 2.1 NMR properties of nuclei studied in this thesis.' 
Nucleus % Natural 
abundance 
Receptivity 
(relative to ' 3C) 
Nuclear spin 
quantum no. I 
Frequency (MHz) 
at 7.046 1 
1 H 99.984 5680 V2 300.130 
"C 1.108 1 V2 75.468 
15N 0.366 0.0219 V2 30.424 
14  N 99.634 5.690 1 21.687 
33.80 19.100 V2 64.414 
2.1.1 195Pt NMR spectroscopy23 
195Pt is a reasonably sensitive nucleus for NMR detection, with natural abundance of 
33.8%, nuclear spin quantum number I = Y2, and a receptivity relative to 'H of 3.4 x 
iO. The limit of detection (ca. 10 mM) precludes detection of natural abundance 
`Pt signals in physiological fluids. The receptivity can be improved by a factor of 
three by isotopic enrichment of `Pt (> 95%). The spin-lattice relaxation time (T) 
for ' 95Pt is usually in the range of 0.3 to 1.3 s. 
The ' 95Pt chemical shift range is very large, about 15000 ppm (usually in the range 
from -6000 to 9000 ppm relative to [PtCI 61 2 ), and often allows easy differentiation 
between Pt" and PC, which tend to have chemical shifts at the high-field and low-
fields ends of the range, respectively. The ' 95Pt chemical shift in monomeric 
complexes is sensitive primarily to the set of bound donor atoms. Some caution is 
required in searching for peaks, because the shifts of Pt''' halides alone span 12000 
ppm. Also, usually there are ' 95Pt chemical shift differences between geometrical 
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isomers and between diastereomers (chiral ligands). For ' 5N-enriched ligands, the 
splitting pattern in the ' 95Pt spectrum indicates the number of non-equivalent ' 5N 
atoms coordinated. These characteristics of the "Pt chemical shift can be utilised in 
the detection of different intermediates formed during the reactions of Pt complexes 
with biomolecules. Sometimes even isotopomers are distinguishable: the "Pt 
isotope shift difference for 95Pt35I'37Cl  is 0.17 ppm and for ' 95Pt- 79181 Br is 0.03 ppm. 4 
It is therefore in principle possible to count the number of Cl and Br ligands bonded 
to Pt via the isotope splitting pattern. In practice it is difficult to resolve because of 
line broadening, which is usually due to either relaxation mechanisms or poor 
temperature control of the sample. The latter is a problem because of the strong 
temperature dependence of ' 95Pt NMR resonances (0.5 to 1.1 ppml K). 
The quadrupolar effects of natural abundance ' 4N (i.e. 99.6% ' 4N, I = 1) from 
am(m)ines which coordinate to Pt can broaden the "'Pt resonances. Such 
quardupolar effects of ' 4N have the beneficial effects of shortening the "Pt 
relaxation times and allowing rapid pulsing without saturation effects. 195Pt- 14N 
couplings in ' 95Pt NMR spectra are usually better resolved at higher temperature, 
because of the decreased quadrupolar relaxation rate of ' 4N due to the decrease in 
correlation time. Even in the absence of ' 4N ligands, ' 95Pt resonances can still be very 
broad owing to chemical shift anisotropy (CSA) relaxation, which can be the 
dominant relaxation mechanism for Pt complexes at high magnetic field stength. 
Similarly, ' 95Pt satellites in ' 5N and 'H spectra of Pt" complexes are often broadened 
beyond detection owing to CSA relaxation of ' 95Pt. The linewidths of "Pt satellites 
of 'H NIVIR resonances are dependent on the spin-lattice relaxation time of 195Pt: 
Av(H) = [irT2 *(H)]' + [27ET,(Pt)]' 
where [irT2*(H)]'  is the natural linewidth plus the contribution from magnetic 
inhomogenity broadening (measurable from the linewidth of the centre peak). The 
contribution to ' 95Pt T, relaxation from CSA is given by: 
[mT,(Pt)]' (CSA) = (6/7)x[itT2(Pt)]' (CSA) = (2/15) x 'y, 2 x B02 x A&x t 
In general, ' 95Pt satellites (and "'Pt resonances) are sharper in Pt" complexes which 
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are six coordinate and hence more symmetrical (smaller anisotropy Aa) and are 
broader at higher fields of measurement (B 0) and in larger molecules (longer 
correlation time ;). 
2.1.2 15N NMR spectroscopy 
' 4N NMR spectroscopy can be useful for am(m)ine complexes, but ' 4N is a 
quadrupolar nucleus, and quadrupolar relaxation is dominant when the environment 
of ' 4N has a low symmetry. This can lead to very broad lines and a consequent 
reduction in sensitivity. On the other hand, short relaxation times also have the 
advantage of allowing rapid pulsing so that a large number of transients can be 
acquired. Thus it is possible to follow reactions of cisplatin in blood plasma and cell 
culture media at millimolar drug concentrations and to detect ammine release.' 
By using ' 5N enriched am(m)ine complexes, the broadening of ' 95Pt signals caused 
by the quadrupolar effects of ' 4N can be avoided. Both ' 5N NIMR chemical shifts and 
'J(195Pt- 15N) coupling constants are sensitive to the nature of the trans ligand in Pt 
am(m)ine complexes, which can provide useful information for identifying the 
ligands in the coordination spheres of both Pt" and Pt" complexes. Typical ' 5N and 
'H shift ranges for Pt"-NH 3 are shown in Figure 2.1. In general, ligands with high 
trans influences give rise to smaller ' 95Pt-' 5N coupling constants (S<I<Br<Cl<H 20) 
and cause a low-field shift of the ' 5N resonance. The usefulness of 'J(195Pt-'5N) 
values is limited by the difficulty in determining them for larger molecules especially 
at high observation frequencies on account of the dominance of relaxation via 
chemical shift anisotropy (CSA). The 'J(' 95Pt-' 5N) values for Pt' v are smaller by a 
factor of about 1.5 to 1.2 and are 1.4 times larger than 'J(' 95Pt-' 4N) values. 
\ 
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Pt(IV) 	 Pt(II) 
70 	 50 	 30 
Figure 2.1 Variation in 'H and ' 5N NMR chemical shifts with the trans ligand in Pt-
N}13 complexes. A similar picture is obtained for amine complexes, but the shifts are 
offset in both dimensions, e.g. for ethylenediamine Pt complexes the 'H resonances 
are shifted to low-field by ca. 2 ppm and the ' 5N resonances to low-field by Ca. 40 
ppm. 
The low receptivity of ' 5N (3.85x10 6 relative to 'H) limits to some extent its 
usefulness for directly-detected ' 5N NMR studies of Pt am(m)ine complexes. 
However, the sensitivity of detection can be improved by ' 5N isotopic enrichment 
combined with enhancement by polarization transfer from 'H (e.g. ' 5N-{'H} DEPT 
and INEPT pulse sequences). The maximum enhancement in ' 5N signal intensity 
achievable via polarization transfer is only 9.8 (yHJ'yN), which means that inverse 
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('H-detected) 15N methods are usually preferred due to the superior enhancement for 
' 5N-detection. The repetition time of the pulse sequence is governed by the 'H rather 
than the longer ' 5N spin-lattice relaxation time (T), which is an additional advantage 
because it allows more rapid pulsing. For example, ' 5N-{'H} DEPT sequences enable 
detection of rapidly-changing intermediates in the reaction of ' 5N-cisplatin with 
glutathione, and also ammine release following reaction of ' 5N-cisplatin with 
intracellular components in intact red blood cells at concentrations as low as 1 mM. 6 
2.1.3 Inverse detection methods 
The sensitivity of ' 5N can be greatly improved by the use of inverse detection 
methods ('H-detected ' 5N), by a theoretical maximum of 306 with respect to directly 
detected ' 5N, such that signals can be detected in aqueous solutions at concentrations 
of physiological relevance (5 tM). 2 'H-detected inverse methods are applicable to 
any system which contains a 15N atom with a measurable spin-spin coupling to 'H 
(i.e. 'J(' 5N-'H) in ammine, primary and secondary amines, but not tertiary amines 
although a longer range can sometimes be utilised). In practice the best applications 
are for those systems with large one-bond couplings (e.g. ca 73 Hz for "NH3)' 
Besides the high sensitivity, inverse detection also brings a simplification of 
complicated spectra because it detects only those protons directly attached to the 
labelled ' 5N atoms in the sample. This is very important for investigations of 'H 
NMR spectra of body fluids or cell culture media which consists of thousands of 
overlapping resonances. 
Although 'H NMR resonances can be detected from N}1 protons with ' 4N present in 
natural abundance (99.6%), they are often broad because of the quadrupolar 
relaxation of ' 4N (I = 1). It is also necessary to work in H 20 (as opposed to D 20), 
since N}I protons in Pt am(m)ine complexes usually exchange with deuterium within 
minutes. The exchange of NH protons with solvent is much faster for Pt"' than for 
Pt" complexes at neutral pH, since, for example, NH 3 ligands on Pt" have lower pK 
values. Introduction of ' 5N by synthetic labelling usually gives rise to a sharp 'H 
NMR doublet for a Pt-"NH group in H 20 together with (CSA-broadened) "'Pt 
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satellites. The resonances move progressively to lower field on changing from Pt-
NH3 to Pt-NH2 and to Pt-NH. Both ' 5N and 1 H NMR resonances for Pt"-"NH 
complexes are to lower field than those for Pt" complexes. Pt" anticancer complexes 
can be studied by the 'H-{' 5N}NMR if NH exchange is slowed down by lowering the 
pH or by other means. 
2.1.4 Heteronuclear single (multiple)-quantum coherence experiment 
The heteronuclear single-quantum (and multiple quantum) coherence (HSQC and 
HMQC) technique belongs to the family of inverse detection techniques. An 
important feature of the experiment is that the proton magnetisation which is 
detected during t2 originated as proton magnetisation at the start of the sequence. The 
main advantage of this technique is the enhanced sensitivity and relatively short 
repetition time according to the T, of the protons and not of the X-nuclei.' Therefore 
it is possible to detect species at concentrations of physiological relevance (mM or 
even tM) in D 20 or aqueous solution (90%! 10% D 20) where labile NH protons can 
be observed. By means of selective labelling ' 5N, this technique can also simplify a 
complicated spectrum in which only those protons directly attached to I N atoms are 
detected. The basic HSQC pulse sequence is shown in Scheme 2.1. 
A 1D 'H spectrum containing only resonances from Pt-"NH species is obtained by 
acquiring only the first increment in a two-dimensional experiment. If ' 5N 
decoupling is employed during acquisition (e.g. the GARP method), then each 
distinct type of Pt-NH resonance appears as a singlet, sometimes together with the 
broadened "'Pt satellites. In practice the water resonance is so intense that it is 
usually necessary to use additional solvent suppression techniques (e.g. 
presaturation). The use of pulse sequences in which coherence selection is achieved 
by the use of pulsed field gradients allows greatly improved water suppression. By 
use of the HSQC sequence of Stonehouse et al.' (Scheme 2.1), it was possible to 
detect N}I peaks within a few Hz of the water resonance at concentrations as low as 
about 10 tM without the need for additional solvent suppression techniques.' 
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1800 	900 	 900 	1800 
X 	 fl ti 	fl I I GARP(dec.) 
Scheme 2.1 Basic HSQC pulse sequence. The delays A = V2 J(X,H), where J is the 
one-bond HX coupling constant, and one-dimensional ' 5N-edited spectra are 
obtained by setting the evolution period ti to zero. Spectra may be recorded with or 
without decoupling of ' 5N spins (GARP) during the acquisition period. 
The combined detection of 'H and ' 5N in a 2D inverse NMR experiment is especially 
powerful, since both the ' 5N NMR chemical shift and the one-bond coupling constant 
'J('H-' 5N) are diagnostic of the trans ligand. As shown in Figure 2.2, the "'Pt 
satellites (when not broadened beyond detection by the effects of CSA relaxation) in 
a 2D ['H, ' 5N] spectrum appear as diagonal peaks which correspond to the 2J( 195Pt-
'H) coupling constant in the F 2('H) dimension and to the 'J( 195Pt-' 5N) coupling in the 
F 1 (' 5N) dimension. Pt" and Pt' am(m)ine complexes can be distinguished by the 
combination of 'H and ' 5N chemical shifts. 
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6(15N) 
Figure 2.2 General appearance of a 2D ['H, ' 5N] HSQC spectrum. The ' 95Pt 
satellites are usually more intense for symmetrical Pt species (Pt" rather than Pt"). 
ii-1. Ii ii'R !1L!1 	41 iII.4i..1.i.] !i 
As mentioned in the previous section 2. 1, NMR spectroscopy and especially 'H-
{ '
5N} inverse detection NMR experiments are a powerful tool to characterise Pt 
am(m)ine complexes and follow their reactions in solution. Our aim was therefore to 
use NMR spectroscopy for monitoring photoreactions of Pt am(m)ine complexes. 
Scheme 2.2 shows the setting up of an experiment to follow a photoreaction directly 
by NMR spectroscopy. 
The light source is a Coherent Irmova 70C Ar-Kr ion laser (1, Scheme 2.2). This 
laser provides different lines throughout the visible spectrum of light and near UV. 
The major lines are at 457.9 nm, 488 run, 514.5 nm, 520.8 nm, 530.9 run, 568.2 nm, 
647.1 nm. Additional there is a multiline mode in the near IJY region (350.7-356.4 
nm). The light is then coupled into a fibre optic 6 (FT-600-UMT, diameter 600 jim, 
Elliot Scientific Ltd.) via an adjustable optical lens 2. The end of the fibre optic 5 is 
inserted into a screw cap NMR tube 4. The NMR tube gets then lowered into the 
NMR probe 3 with the fibre optic attached to it. Spinning of the NIVIR tube is 
therefore not possible. 
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Scheme 2.2 General setting up of an experiment in which a photoreaction is directly 
studied by NMR spectroscopy. I Coherent Innova 70C Ar-Kr ion laser, 2 adjustable 
optic lens, 3 Bruker 500 MHz DMX NMR spectrometer, 4 amberized screw cap 
NMR tube, 5 fibre optic. 
In general, the photo-experiment were carried out according to the following order: 
The laser was switched on and adjusted to the desired wavelength. 
The light power was measured by a power meter at the end of the fibre optic. 
The light switch at the laser was closed. 
The sample in a screw cap NMR tube was mounted onto the fibre optic. The 
distance between end of fibre optic and solution was about 2 mm. 
The NMR tube was lowered into the NMR probe and the NMR experiments were 
set up. 'H and/ or 1D/2D ['H, 'N] HSQC NMR were acquired to check the 
sample and experiments. 
The kinetic NMR experiments were programmed. 
After setting up the NMR experiment, the light switch was opened and the NMR 
experiment was started simultaneously. 
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The above technique is also suitable to measure quantum yields of photoreactions by 
using chemical actinometry. 8  In a chemical actinometer photochemical conversion is 
directly related to the number of photons absorbed which means that they have a 
defined quantum yield. The number of photons in a beam can be determined per unit 
time by using a chemical actinometer. A good chemical actinometer in the blue 
region of the visible light spectrum and the UV region is ammonium ferric oxalate 
([Fe 11'(C2O4)3](NH4 )3) which can be used to measure light intensities in the spectral 
region of 250-570 nm. 
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Inorganic donor/ acceptor complexes containing intervalent (IT) metal-to-metal 
charge transfer (MMCT) bands have received much attention due to their potential 
applications to solar energy conversion and/ or photocatalysis. Particularly, 
homobinuclear mixed valence complexes of Ru (Ru"! Ru 11 ' sytems) have been 
extensively investigated.' These compounds exhibit IT absorption bands at low 
energies (near infrared). This range of light energy is not easy accessible by 
conventional irradiation sources and light detection devices. In contrast to these 
compounds, the IT bands of heterobinuclear compounds are often found at higher 
energies in the visible region of the optical spectrum. 
Bocarsly et al. developed a trinuclear mixed valence Pt" compound which exhibits 
an IT absorption band in the visible region. This compound was studied in depth 
with UV/VIS-, JR spectroscopy and electrochemistry. 2 This complex was also 
modelled using the Marcus-Hush theory.' We decided that this kind of complex had 
interesting features which we perhaps could use for the design of photoactivatable 
Pt" anticancer drugs. 
I will summarise the most important features of this compound reported in literature 
in the following. 
The structure and formula of the trinuclear complex is the following 
H3N 	 NC 
N 
	
C 	 V I - 
- 
U 	__Ptrn.. 
NC:FCN I\ 	NC\ 
t CN 
NC 	H3Nt 
C 	 NH 3 
[(NC)5Fe"-CN-Pt"(NH 3)4-NC-F&'(CN) 5] 4 (1) 
This compound was prepared via the redox reaction between K 3 {Fe ... (CN) 6] and 
[Pt1 '(NH3 )4](NO3)2 in aqueous solution. Upon mixing the compounds, the yellow 
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solution of ferricyanide changed to red. The red colour of above compound can be 
attributed to the IT (intervalent) charge transfer band between the iron and the 
platinum centres which is centred at 436 nm and exhibits a tail which extends up to 
550 nm. Bocarsly et al. were able to grow diffraction-quality single crystals of 
[(NC)5Fe11-CN-Pt"(NH3)4-NC-Fe 11(CN) 5 ] [Pt"(NH3 )4] • 9H20 in which [Pt11(NH3)4] 2 
acts as counter ions. 2 
Direct evidence that the Pt and Fe centres are linked via a cyanide bridge was 
provided by the presence of both bridging and terminal cyanide stretches in the 
infrared spectrum of this complex. The stretching frequency of cyanide complexes is 
very dependent on the oxidation state of the metal as well as whether or not the 
cyanide ligand is terminal or bridging.' Also the energy of the ammine NH stretches 
are dependent on the oxidation state of the Pt atom. JR spectroscopy is therefore an 
important tool for characterising this complex. 
An equilibrium constant for the formation of complex 1 was approximated in water 
at room temperature. 
2 [Fe111(CN)6] 3 + [Pt"(N}-I3 )4] 2 -_ 	[(NC)5Fe"-CN-Pt"(NT-1 3)4-NC-Fe"(CN)5] 4 
[(NC)5Fe"-CN-Pt"(NH 3 )4-NC-Fe"(CN) 5 ] 4 	
= 106 
[Fe"(CN) 6 3 ] 2 {Pt"(N1I3 )42 J 
It could be shown that both the IT band and also the above equilibrium are strongly 
solvent dependent. A linear correlation between the IT band energy and the electron-
accepting ability of the solvents was observed. The IT band in DMF is for example 
centred at 570 nm compared to 436 nm in water. This shift of the IT band is 
attributed to the ability of a solvent to form hydrogen bonds to the nitrogen lone 
pairs of the terminal cyanide groups. Water readily forms hydrogen bonds with the 
lone pairs, whereas hydrogen bonds are almost non-existent in DMF. Such hydrogen 
bonding lowers the energy of the ferrocyanide molecular orbitals and therefore 
increase the IT band energy. 4 
61 
Chapter 3 Platinum(II)/(IV) - Iron(II)/(III) redox system 
The equilibrium was found to be similarly dependent on the electron-accepting 
ability of the solvent. It was found that the equilibrium lies on the left in DMF and 
methanol in contrary to water. Dissolving of complex 1 in methanol led therefore to 
the decomposition of complex 1 to the reactants [Fe ... (CN) 6 ] 3 and [Pt"(NH 3)4] 2 . 
Furthermore, [(NC) 5Fe11-CN-Pt"(N}1 3)4-NC-Fe"(CN) 5J4 (1) was found to decompose 
at temperatures above 318 K in water. This decomposition and the dependence of the 
IT band and the equilibrium on the solvents was explained by the temperature and 
solvent dependence of the Fe"! Fe"redox potential. 4 
Photochemistry. The most interesting feature of complex [(NC) 5F&'-CN-Pt' V(N}13)4-
NC-Fe"(CN) 5 1 4 (1) is its reported photochemistry upon irradiation into the IT band. 
Bocarsly et al.' irradiated an aqueous solution of complex 1 using 488 nm light 
which resulted in the decomposition of complex 1 into the reactants [Fe "(CN) 6] 3 and 
[P0(NH3 )4] 2 . The quantum yield for the formation of ferricyanide was determined to 
be 0.02 with 488 nm irradiation. This value was reported to be wavelength 
independent over the range of 460-560 nm. The photolysis process was reversed in 
the dark according to the equilibrium. No photoreaction was observed at high 
complex concentrations most probably due to the rapid back-reaction to complex 1. 
In contrast, no back-reaction to complex 1 was observed at sufficiently low 
concentrations. 2 
The photoreaction can be summarised as follows 
[(NC)5Fe"-CN-Pt''(NH3)4-NC-Fe"(CN)5]4- 	
dark 	
2 [Fe111(CN)6] 3 + {Pt"(Nll3)4] 2 
It can be seen that this photoreaction results in a pt" compound. [Pt"(NH 3)4] 24 is a 
very stable complex and therefore exhibits no cytotoxic activity. But if the above 
photoreaction mechanism could be used to release a cytotoxic Pt" complex instead of 
[Pt"(NH3)4] 2 , then such photosensitive compounds could be very useful in the 
development of photoactive anticancer drugs. A new approach was therefore taken, 
which is summarised below in Scheme 3.1, to develop photoactivatable Pt' s' 
62 
Chapter 3 Platinum(II)/(IV) - Iron(II)/(i11) redox system 
compounds which can be activated by visible light. 
I 	 Ci 	
NC 76- 
NC CN 
	 NC 	 ci ,CN ,.CI 	 CN 
	
H3N 	Pt + •. 	 ________ 	I 
H 	
C 	
NC_— Fe CN . 	 " CN_Pt_NC I 3 hvvisible NC__e 	
NC 
NC 	 HN 	 CN CN 	 NC 	3 
CN 	NH3 
Pt anticancer drug 	redox partners 	 photoactivatable PtIV anticancer drug 
Scheme 3.1 Novel approach to get a photoactivatable Pt" anticancer drug. The 
possibility of the introduction of cisplatin (cis-[PtC1 2(NH3)2]) is shown as an 
example. 
This approach takes advantage of the high stability which Pt coordination complexes 
display for the II and IV oxdiation states, and the high instability of such complexes 
toward the Pt" oxidation state. Two redox partners, which each donates one electron 
to the Pt" centre, are needed. This is because the complex forms via a redox 
expansion of the coordination sphere of Pt from Pt" to Pt1V  Pt" complexes are 
generally square-planar and Pt' v complexes generally octahedral. The irradiation of 
the desired complex must lead to the formation of the Pt" oxidation state via charge 
transfer. Once this occurs a rapid thermal reaction back to one of the stable oxidation 
states II or IV is expected. Another important factor is the stability of the Pt" redox 
product in water in the absence of light. A low stability would lead to the 
decomposition of the compound and therefore to the release of a cytotoxic drug. 
The aim of the work in this chapter was to form Pt"' derivatives of Pt" anticancer 
drugs via a redox reaction with [Fe ... (CN) 6] 3 . Such a Pt" should be stable and inert in 
water and exhibit an IT band in the visible region of light. An irradiation into this IT 
band should lead to a back-reaction to the reactants and so to the release of the Pt" 
anticancer drug. 
First of all, the photoreaction of [(NC) 5Fe"-CN-Pt"(NH 3)4-NC-Fe"(CN) 5] 4 (1) was 
studied by inverse 'H-{' 5N} NMR spectroscopy. Then, mixed valence Fe"-Pt"-Fe" 
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complexes were prepared by the redox reactions of active Pt" anticancer compounds, 
cis-[Pt"{X2/L2 }(NH3)2], where X = Cl, I, L = H 20, L2 CBDCA, [Pt"(en){X 2/L2 }], 
where X = Cl, I, L = oxalate, and [Fe "1 (CN)6] 3 . These reactions were studied by 
UV/VIS-, IR- and NMR spectroscopy. 
3.2 Experimental  
3.2.1 Reagents 
K2 [PtCl4] was purchased from Johnson Matthey. KI, NH 4CI were purchased from 
Fisher. AgNO3 and D20 were purchased from Aldrich, DMF and MeOH from 
Prolabo and K3 [Fe(CN)6] and K4[Fe(CN) 6].3H20 from Fisons. H20 was deionised 
with a USF Elga deioniser. Other solvents were generally dried over 3 A molecular 
sieve and purified by standard methods. 
3.2.2 NMR spectroscopy 
NMR spectra were recorded at 298 or 310 K on a Bruker DMX 500 ('H 500.13 
MHz; ' 5N 50.7 MHz) or on a Bruker DPX 360 ('H 360 MHz; ' 5N 36.5 MHz) NMR 
spectrometer, using 5-mm NMR tubes. Screw cap NMR tubes were used for the 
observation of photoreactions. A fibre optic (FT-600-UMT, diameter 600 j.im, Elliot 
Scientific Ltd.) was inserted into the NMR tube to irradiate the sample. All data 
processing was carried out using XW1N-NMR software version 1.3 (Bruker 
Spectrospin Ltd.). All samples were prepared in 90% H 20/10% D 20 and the pH 
adjusted to ca. 5 with 0.1 M perchioric acid (HC10 4) unless otherwise stated. The 
chemical shift references were as follows: 'H, TSP sodium 3-
(trimethylsilyl)propionate-2,2,3,3-d4 (internal, 0 ppm) or dioxane (internal, 3.764 
ppm), ' 5N (external, 1 M ' 5NH4C1 in 1.5 M HQ. All spectra were recorded at 298 K 
unless otherwise stated. For 'H NMR, typical acquisition conditions for 1D spectra 
were as follows: 45-60° pulses, 16-32 k data points, 1-3 s relaxation delay, collection 
of 32-128 transients, final digital resolution of 0.2-1 Hz/point. The water resonance 
was suppressed by presaturation, or via pulsed-field-gradients. 2D ['H,' 5N] HSQC 
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NMR spectra (optimized for 1H) = 73 Hz) were recorded using the sequence of 
Stonehouse et al.' The "N-spins were decoupled by irradiation with the GARP-1 
sequence during acquisition. Water suppression was achieved by pulsed-field 
gradients. Typically, 8 scans were acquired for each of 128 increments of t 1 and the 
final resolution was 6 Hz/point for the F2 dimension and 8 Hz/point for the Fl 
dimension. 
3.2.3 UVIVIS spectroscopy 
UV/VIS spectra were recorded on a Shimadzu UV-2501 PC spectrophotometer using 
1 cm path length quartz cuvettes. Spectra were referenced to solvent alone. Data 
were processed with Microcal Origin 5.0. 
3.2.4 HR spectroscopy 
Infrared spectra were recorded on a Perkin-Elmer Paragon 1000 FT-JR spectrometer 
using KBr discs. 
3.2.5 CHN elemental analysis 
Microanalyses were carried out at the University of Edinburgh on a Perkin Elmer 
2400 CHN Elemental Analyser. 
3.2.6 X-ray crystallography 
X-ray crystal structure analyses were performed by Dr. Simon Parsons at the 
University of Edinburgh. Crystallographic data were collected on a Stöe Stadi-4 4-
circle diffractometer at 150 K using Cu iç radiation at A. = 1.54184 A. 
3.2.7 Photoreactions 
A Coherent INNOVA 70C Argon-Krypton Ion laser system was used for the 
irradiation experiments. 
65 
Chapter 3 Platinum(II)/(IV) - Iron(II)/(III) redox system 
3.2.8 Preparations 
cis- [Pt"C12(NH3)2 1 (2) 
The synthesis was carried out after the method of Kukushkin et al.': 
K2 [PtC14] (0.5 g, 1.2 mmol), CH3CO2NH4 (0.4 g, 5.2 mmol) and KC1 (0.5 g, 6.7 
mmol) was refluxed in 6 ml water and stirred in a 25 ml round-bottomed flask for 
two hours. The colour of the solution turned from dark red to brownish orange and 
then to greenish yellow. A precipitation was observed. The hot solution was filtered 
through a hot BUchner funnel which was preheated to 353 K in the oven. The yellow 
filtrate was cooled and then put in the fridge overnight. The yellow precipitate was 
filtered cold, then washed several times with ice-cold deionised water and dried in 
air at room temperature. 
The compound was recrystallised from a 10 ml solution of boiling 0.1 M aqueous 
HCl. 
Yield: 144 mg (40 %) 
CHN: Found: C, 0; H, 2.03; N, 9.14; Calculated for C1 2H6N2Pt: C, 0; H, 2.00; N, 
9.33. 
JR (cm') KBr disc: 3284 (s), 1624 (m), 1543 (m), 1312 (s), 797 (m). 
cis- [P0(NH3)2(0H2)21 2+  (3) 
Slightly less than two mol equivalent AgNO 3 (57.7 mg, 0.34 mmol) was added to a 
suspension of cis-[Pt(NH 3 )2C12] (52.2 mg, 0.17 mmol) in 4 ml deionised water. The 
reaction mixture was heated for 2 h at 313 K in the dark. The solution with a white 
precipitate at the bottom was filtered twice. 
Cis-[Pt"1 2( 15NH3)2] (4) 
K2PtC14 (928.82 mg, 2.24 mmol) was reacted in 10 ml of water with 10 mol 
equivalent KI (3.86 g, 23 mmol). The solution was stirred for 30 min at room 
temperature. Two mol equivalents of ' 5NH4C1 (243 mg, 4.47 mmol) were added and 
the solution was adjusted to pH 10 with 2 M KOH solution. A yellow precipitate 
formed which was collected. The remaining solution was adjusted to pH 10 again 
with 2 M KOH. The procedure of collecting the solid and adjusting the pH was 
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repeated until the solution was clear pale yellow. The yellow precipitate was washed 
several times with small amounts of water and ethanol and dried over silica gel in a 
desiccator. The yield of cis-[Pt"1 2(' 5NH3)2] was 998 mg (2.06 mmol, 92 %). 
'H NMR (90% H20/ 10% D20): (ppm): 3.88, 'J(' 5N-'H) = 72.6 Hz, 2J(' 95Pt-'H) 
57.4 Hz. 
2D ['H, ' 5N] HSQC NMR: ('H, ' 5N/ 3.9, -53.05), 'J(' 95Pt-' 5N) = 274 Hz, 2J(' 95Pt-'H) 
=59 Hz. 
Cis-[Pt"C12(15NH3)2] (5) 
Water (10 ml) was added to cis-[Pt(II)1 2( 15NH3)2] (3) (998 mg, 2.06 mmol). Slightly 
less than two mol equivalent of AgNO 3 (698.5 mg, 4.11 mmol) was added to the 
yellow suspension. The solution was stirred in the dark overnight. The solution was 
filtered twice to remove the white AgC1 precipitate. NaC1 (2.42 g, 41 mmol, 10 mol 
eq) was added to the clear solution. The solution was heated to 223 K in a waterbath 
for 10 mm. The yellow precipitate was filtered off and washed with water, ethanol 
and ether and dried under vacuum. 
Yield: 485.9 mg (70 %) 
CHIN: Found: C, 0; H, 1.90; N, 9.88; Calculated for Cl 2H6 15N2Pt: C, 0; H, 1.99; N, 
9.94. 
'H NMR (90% H201 10% D20): (pm): 4.05, 'J('5N-'H) = 73 Hz, 2J(' 95Pt-'H) = 64.7 
Hz. 
2D ['H, ' 5N] HSQC NMR: ö('H, ' 5N/ 4.02, -68.77), 1J( 195Pt -' 5N) = 329 Hz, 2J(' 95Pt-
'H) = 64 Hz. 
[Pt"(' 5NH3)4] Cl2 (6) 
15NH4CL (28.45 mg, 0.522 mmol) was added to a suspension of cis-[Pt"Cl 2(' 5NH3)2] 
(51 mg, 0.169 mmol) in 3 ml water. 2 M KOH (300 p.1) was added over a period of 
15 mm. The solution was refluxed for 6 h. The solution was reduced in volume by 
heating. Dropwise addition of ethanol led to a white precipitate which was filtered 
off. The precipitate was purified by stirring in CH 3CN : DMF = 1: 1 at 323 K for 30 
mm. The white precipitate was filtered off and washed with ethanol and ether and 
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dried over silica gel in a desiccator. 
Yield: 52 mg (0.154 mmol, 91%) 
CHN: Found: C, 0; H, 3.68; N, 17.23; Calculated for C1 2H, 2 15N2Pt: C, 0; H, 3.55; N, 
17.75. 
'H NMR (90% H20/ 10% D20): &ppm): 3.92, 'J('5N-'H) = 72 Hz, 2J(' 95Pt-'H) = 58 
Hz. 
2D ['H, ' 5N] HSQC NMR: ('H, ' 5N/ 4.04, -68.62), 'J(' 95Pt -N) = 283 Hz, 2J(' 95Pt-
'H) = 63.7 Hz. 
K4 [Fe"( 13CN)6 ] (7) 
Deionised water (10 ml) was added to Fe"SO 4 (39.42 mg, 0.26 mmol) and the 
solution was heated to 363 K and stirred until all Fe' 1 SO4 was in solution (30 mm.). 
K' 3CN (525.4 mg, 8.08 mmol, ) was added to the solution. The colour of the solution 
changed immediately to yellow-green and Ca. 10 s later to dark blue. A colour 
change of the solution to bright yellow was observed 5 min later. The solution was 
stirred for another 30 min at 363 K. The solution was then filtered and put on ice. 
Slow addition of ice-cold ethanol yielded in a yellow precipitate. The whole solution 
was put into the fridge at 277 K. The slightly yellow precipitate was filtered under 
vacuum. The obtained slightly yellow powder was washed with cold ethanol and 
dried under vacuum. The compound was stored under Ar. The filtrate was reused. 
The ethanol was evaporated on the rotaevaporator. The remaining solution was 
heated again on 363 K. Fe"SO 4 (20 mg, 0.13 mmol) were added to this solution and 
the whole was stirred for 2 h. The colour of the solution changed immediately from 
grey to yellow. An orange precipitate was also observed. The solution was stirred at 
363 K until the precipitate disappeared. The solution was put on ice and ice-cold 
ethanol was carefully added. The obtained precipitate was filtered and washed with 
ethanol and ether and dried over vacuum. This procedure was repeated. 
Yield: 200 mg (40 % to initial K' 3CN) 
IR (cm') KBr disc: 2000 (s), 1619 (m), 1122 (s), 619 (m), 574 (m). 
13C-NMR (90% H 20/ 10% D20): ö(ppm): 178.2 (s). 
UV/VIS (H20): 325 nm (shoulder). 
68 
Chapter 3 Platinum(II)/(IV) - Iron (11)1(111) redox system 
Cyclic voltammetry (H 20; electrolyte KBF 4): E, 12 = 0.21 V. 
Oxidation of K4 [Fe"(' 3CN)6] (7) to K3 [Fe"(13CN)6] (8) 
The following procedure was found to be the best after trying different routes: 
K4 [Fe(II)( 13CN)6] (synthesised, 23.5 mg, 0.07 mmol) was placed in a 25 ml round-
bottomed flask. Bromine water (2 ml, 0.2 M) was added and the solution was stirred. 
A colour change of the solution from orange to yellow occured. The solution was 
stirred at room temperature until the solvent was fully evaporated. The slightly 
yellow powder was recrystallised from ethanol. 
UV/VIS (H20; nn): 260, 305, 325, 430. 
Cation exchange from [Pt"( 15NH3)4] 2  ((NC)5Fe"-CN-Pt"(' 5NH3)4-NC-Fe"(CN) 51 to 
Na4 [(NC) 5Fe"-CN-Pt"(' 5NH3)4-NC-F&'(CN) 5 1 
Dowex 50WX4-50 ion exchange resin was washed thoroughly with deionised water 
until the water solution above the resin was clear. It is important not to let the resin 
dry out. A column (diameter 2 cm) was loaded with the water suspension up to 5 cm. 
The column was washed with water until the pH of the solution was 7 according to a 
pH paper. An aqueous solution of NaCl (2 M, 75 ml) was placed on the column. The 
column was then washed again with water until the solution was pH 7 according to 
pH paper. An aqueous solution of [Pt"(' 5NH3 )4] 2 [(NC) 5Fe"-CN-Pt"( 15NH3)4-NC-
Fe"(CN) 5] (0.25 ml, 62 mM) was added dropwise onto the column using a pasteur 
pipette. The solution was let slowly through the column and the whole column was 
protected from light using aluminium foil. An orange-red solution was collected in a 
sample vial after 10 mm. The orange-red solution was then frozen using liquid 
nitrogen and put in a freeze drier. The red powder obtained was used directly for 
NMR experiments. 
'H NMR (90% H20/ 10% D 20): 6(ppm): 6.4, 'J( 15N-'H) = 72 Hz, 2J(' 95Pt-'H) = 43 
Hz. 
2D ['H, ' 5N] HSQC NMR: ('H, ' 5N/ 6.41, -46.44), 'J(' 95Pt-' 5N) = 229.6 Hz, 2J( 195Pt-
'H) = 43.1 Hz. 
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IPt"(en)(CD 2 I (9) 
K2 [PtC14] (2.02 g, 6.53 mmol) was dissolved in water (50 ml). Ethylenediamine (1 
mol eq, 437.3 p1, 6.53 mmol) was added to the clear red solution. The solution was 
stirred at room temperature for 30 min which led to colour change to yellow. The 
solution volume was reduced by rotary evaporation until a yellow precipitate 
appeared. This precipitate was filtered and washed with ice cold water and ether and 
dried under vacuum. The volume of the filtrate was reduced by rotary evaporation 
which led to more yellow precipitate. This precipitate was again filtered and washed 
with ice cold water and ether and dried under vacuum. This process of reducing the 
solution volume and filtration of the precipitate was repeated until the reaction 
solution was pale red. 
Yield: 898.1 mg (42%) 
CHN: Found: C, 7.37; H, 2.47; N, 8.59; Calculated for C1 2C2H8N2Pt: C, 7.31; H, 
2.15; N, 8.07. 
IR (cm') KBr disc: 3250.4 (s), 3202 (s), 1567.3 (m), 1135.8 (s), 881.4 (m), 563.4 
(m), 301.8 (s). 
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3.3.1 Reaction of [Pt"(NH 3 )4]2 with [Fe ... (CN) 6] 3 
UVIVIS spectroscopy. Figure 3.1 shows the spectrum of [Pt"(NH 3)4] 2 [(NC)5Fe11 -
CN-Pt"(NH3)4-NC-Fe"(CN) 5]. 
[(NC)5Fe(1I)(CN)-Pt(IV)(NH 3)4-(NC)Fe(1I)(cN) 5f (1) 







/ 	 [Fe(III)(CN) 6] 3 (1 mM) 
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Figure 3.1 UV/VIS spectrum of an aqueous solution of [Fe 111(CN)6] 3 in comparison 
with the spectrum of [Pt'(NH 3 )4 1 2 {(NC) 5Fe11-CN-Pt"(NH3)4-NC-Fe"(CN) 5 1 (293 K). 
The concentration of both compounds was 1 mM. 
This complex was prepared by adding 0.67 mol eq [Fe m(CN)6] 3 to a 50 mM aqueous 
solution of [Pt(NH3)4] 2 . The solution colour changed from yellow to red after 5 mm 
and the spectrum was acquired 10 min after mixing the compounds. It can be seen 
that the broad band centered at 430 nm extends up to 650 nm. This band is the reason 
for the colour change to red. Absorption above 475 nm must be solely due to this 
band because [Fe ... (CN) 6] 3 does not absorb at wavelengths longer than 475 nm. 
Bocarsly et al.' assigned this band to an intervalent (IT) metal-to-metal charge 
transfer (MMCT) in which the Fe" centre transfers one electron to the Pt 1" centre. 
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Figure 3.2 UV/VIS spectra of an aqueous solution of [Pt"(NH 3)4 1 2 [(NC) 5Fe"-CN-
PtIV(NH3)4NCFe(CN)51 (0.5 mM) before and after 10 min and 1 h irradiation with 
a halogen lamp, respectively. 
Figure 3.2 shows the light sensitivity of compound [(NC) 5Fe11 -CN-Pt"(NH3 )4-NC-
Fe"(CN)5] 4 (1). A low concentration of 0.5 mM was used for the irradiation reaction. 
It can be seen that the broad band centered at 430 nm decreases upon irradiation with 
the halogen lamp and the absorption bands of [Fe ... (CN) 6] 3 appear again. This clearly 
shows that irradiation of complex 1 with visible light leads back to the reactants 
[Fe ... (CN)6] 3 and [Pt' 1 (NH3 )4] 2 . If the irradiation is stopped, the IT band centered at 
430 nm increases again indicating the reformation of complex 1. 
The rate of the formation of complex 1 is strongly concentration dependent. For 
example, if [Fe"(CN) 6] 3 (0.67 mol eq) is added to a 50 mM solution of 
[Pt"(NH3)4] 2 , a colour change from yellow to red is observed after 5 mm. If 
[Fe ... (CN)6] 3 (0.67 mol eq) is added to a 1 mlvi solution of [Pt"(N}I 3)41 2 , no colour 
change is observed even after 10 mm. 
NMR spectroscopy. It was the aim to follow the photochemistry of [(NC) 5Fe"-CN- 
Pt"(NH3)4-NC-Fe"(CN)5] 4 (1) by inverse 'H-{' 5N} NMR techniques. The 'H and ' 5N 
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chemical shifts are sensitive to the oxidation state of the Pt centre and to the ligands 
trans to the amniines (section 2.1.2). This technique can therefore unambiguously 
confirm the photo- and dark-reaction of complex 1. Other aims were to follow the 
kinetics of the photoreaction of complex 1 with different excitation wavelengths and 
to characterise the complex further by ' 3C NMR via ' 3C isotope enrichment of 
[Fe m(CN)6J 3 . 
[Pt"(' 5NH3)4]C12 was used for the preparation of ' 5N labelled complex 1. 
[Pt"(' 5NH3 )4]Cl2 and 0.67 mol eq [Fe ... (CN)6] 3 were reacted with each other in 
aqueous solution. The 2D ['H, ' 5N] HSQC NMR spectrum of the red solution of 
[Pt"(' 5N}-13)41 2 [(NC)5Fe"-CN-Pt"(' 5NH3)4-NC-Fe 11 (CN)5] exhibited only a cross-peak 
at 3.97/ -67.66 ppm which could be identified as the cross-peak of [Pt"(' 5NH3)4] 2 . 
No cross-peak for a Pt 1" ammine compound could be detected. It is not clear what led 
to the absence of the Pt' ammine resonance. It was therefore decided to remove all 
[Pt"(' 5NH3)4] 2  cations and replace them with Na via cation exchange. The 2D ['H, 
' 5N] HSQC NMR spectrum of Na4 [(NC) 5Fe 11-CN-Pt"( 15NH3 )4-NC-Fe"(CN) 5] showed 
a cross-peak at 6.41/ -46.44 ppm. These chemical shifts are typical of Pt' ammine 
compounds with Pt"(NH 3) trans to N. 9 Trans, cis-{Pt"(OH) 2 (N}-13)4] in comparison 
was found to have chemical shifts of 5.73/ -45.99 ppm. 
Photoreactions. The photoreactivity of Na4 {(NC) 5Fe"-CN-Pt"(' 5NH3 )4-NC-
Fe"(CN) 5] towards laser light of 488 rim and 568.2 nm was investigated by 'H and 
2D ['H, ' 5N] HSQC NMR spectroscopy using the technique described in section 2.2. 
There is no absorption due to [Fe ... (CN) 6] 3 at wavelengths longer than 475 nm which 
means that irradiation with light of 488 and 568.2 nm leads solely to excitation of the 
IT band of [(NC) 5Fe"-CN-Pt"( 15NH3)4-NC-Fe"(CN) 5 ] 4 . The kinetic NMR 
experiments were programmed the following way (from left to right) 
Experiments: 2D ['H, ' 5N] 'H 	Delay 	2D ['H, ' 5N] 'H 	Delay 
Time: 	33.05 min 1 3.78-4 .. I I I 
mm 
The spectra represent the average spectra at the midpoint of the NIMR acquisition 
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time. 
Figure 3.3 shows the 2D ['H, ' 5N] HSQC NMR spectra of the photoreaction of 
Na4[(NC)5Fe11-CN-Pt'( 15NH3)4-NC-Fe 11(CN)5] with 488 nm light and the following 
reaction in the dark at a 3 mM concentration. [Pt(' 5NH3)4] 21 (6) is produced upon 
irradiation (spectrum (B)) and complex 1 disappears. Another cross-peak 10 
appeared during the irradiation at 6.4/ -50.5 ppm. This peak can be assigned to 
Pt"(NH3) trans to 0. A small amount of ' 5N}{4 was detected simultaneously in the 
same spectrum which suggests that OH 2 has replaced an ammine ligand. The release 
of ammonia ligands during photoreactions was also observed in other Pt" ammine 
compounds like e.g. cis, cis, trans-[Pt"(N3)2(OH)2(NH 3)2 1 (see chapter 6). Spectra 
(E) and (F) show that the photoreaction gets reversed after the irradiation is stopped. 
Complex 1 could be unambiguously identified as the product of this back reaction. 
[Pt(' 5NH3)4] 2 (6) disappears slowly again taking part in the formation of complex 1. 
This back reaction to complex 1 proves that the equilibrium between [(NC) 5Fe"-CN-
Pt"(NH3 )4-NC-Fe 11(CN)5] 4 (1) and [Pt(' 5NH3)4] 2 (6) lies strongly on the side of 
complex (1) at room temperature in water. 
Figure 3.4 shows the time course of complex 1 and 6 after the end of the irradiation. 
It can be seen that most of complex 6 reverts back to complex 1. The reason why 
there is only 60% of complex 1 after 8 hours instead of the expected 80% is either 
due the formation of products other than complex 1, or the inaccuracy of the Pt 1" 
NH3 integrals. It is known that Pt" NH 3 integrals are sensitive to pH changes in 
solution.' But it is clear from Figure 3.4 that complex 6 mainly reverts back to 
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Figure 3.3 2D ['H, ' 5N] HSQC NMR spectra of the photo- and back reaction of 
Na4[(NC)5Fe'-CN-Pt"(' 5NH3)4-NC-Fe"(CN) 5] using laser light of 488 nm (ca. 20 
mW, 3 mM, 298 K, pH 3). (A) Before irradiation, (B) after 0.55 h irradiation, (C) 
after 1.78 h irradiation, (B) after 3 h irradiation, (E) 3 h after end of irradiation and 
(F) 13.77 h after end of irradiation. Assignments: 1 [(NC) 5Fe"-CN-Pt''(' 5NH3)4-NC-
Fe"(CN) 5 ] 4 , 6 [Pt"(NH3)4] 2 , 10 [(NC) 5Fe"-CN-Pt"(' 5NH3 )3(0H2)-NC-Fe"(CN) 5 ] 4 . 
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Figure 3.4 Time course of the complexes [Pt(' 5NH3 )4] 2 (6) and [(NC) 5Fe'1 -CN-
Pt"(NH3)4-NC-Fe"(CN) 5] 4  (1) after the irradiation with light of 488 nm (20 mW) 
derived from the integrals of the cross-peaks of 2D ['H, ' 5N] HSQC NIvIR spectra. 
Figure 3.5 shows the time course of the Pt" NH 3 'H NMR integrals of [(NC) 5Fe"-
CN-Pt"(' 5NH3 )4-NC-Fe 11(CN)5 ] 4  (1) during the irradiation of 488 nm (graph (A)) and 
568.2 nm (graph (B)), respectively. The light power was adjusted to 20 mW at the 
end of the fibre optic for both photoreactions. It can be seen that the photoreaction 
with light of 488 nm is more rapid than with 568.2 nm. This corresponds to the 
reduced absorbance at 568.2 nm compared with the one at 488 nm (see Figure 3.1). 
The kinetic data derived from the first order exponential decay fit are summarised in 
Table 3.1. 
The kinetic data show that the photoreaction is approximately four times faster for an 
irradiation with light of 488 nm than with light of 568.2 mu. This is in agreement 
with the differences in absorption which is ca. five times larger at 488 nm than at 
568.2 nm. However, this is in contradiction to the studies of Bocarsly et al. who 
reported that the quantum yields for the [Fe ... (CN) 6] 3 formation is wavelength 
independent over the range 460-560 nm.2  They used UV/VIS spectroscopy for the 
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determination of the quantum yields which involves the problem of overlapping 
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Figure 3.5 Time course of the Pt'" NH 3 'H NMR integrals of {(NC) 5F&'-CN-
Pt"( 15NH3)4-NC-Fe"(CN) 5] 4 (1) during the irradiation using light of (A) 488 nm (20 
mW), and (B) 568 nm (20 mW), respectively (293 K, 3 mM, pH 3). The data for 
both reactions were fitted to a first order exponential decay. 
Table 3.1 Kinetic parameters from the least-squares fits to data in Figure 3.5 to a 
first order exponential decay. 
Irradiation 	wavelength 
(nm) 
k (s') t, 12 (h) 
488 5.6 ± 0.3xl0' 0.42 
568.2 1.6 ± 0.07x10' 1.36 
' 3C NMR. Complex [(NC) 5Fe"-CN-Pt"(NH 3 )4-NC-Fe"(CN) 5] 4 (1) was further 
characterised by ' 3C NMR spectroscopy. A sample of [(N' 3C)5Fe"-' 3CN-Pt"(NH 3)4-
N' 3C-Fe"(' 3CN)5] 4 was prepared the following way: [Pt"(NR 3)4](NO3 )2 (29.1 mg, 
0.08 mmol) was dissolved in 0.3 ml water and then added to an aqueous solution of 
[Fe"( 13 CN)6] 3 (7) (0.3 ml, 0.04 mmol, 133 mM). D 20 (0.2 ml) was added to the 
solution which was stored in the dark for 2 h and then filtered and used for N. 
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The Pt" : Fe" mol ratio was 2 1 and the final concentration of [(N' 3C) 5Fe"-' 3CN-
Pt"(NH3)4-N 13C-Fe"(' 3CN) 5 ] 4 was approx. 20 mlvi. The large excess of [Pt"(NH 3)4] 2 
was chosen to ensure that all [Fe ... (' 3CN)6 ] 3 (7) undergoes a reaction. 
Figure 3.6 shows the ' 3C NMR spectrum of the above sample. It exhibits 3 peaks at 
(' 3C) 177.57 a, 173.55 (triplet) b and 170.24 (sextet) c ppm. The coupling constants 
2J( 13C- 13C) of the peaks b and c are very similar with 9.49 Hz and 9.83 Hz, 
respectively. The integral ratio of the peaks b and c is 4 : 1. Peak b was therefore 
assigned to four terminal cyanides which couple to two other magnetically 
equivalent ' 3C atoms. Peak b is a triplet because of the almost identical coupling 
constants to the other two ' 3C atoms. The splitting pattern of peak c (sextet) confirms 
that the splitting is due to coupling to 5 magnetically equivalent 13C. It is not clear 
why peak a is so broad. The peak is not likely be due to free [Fe"(' 3CN) 6] 4 which has 
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Figure 3.6 ' 3C NMR spectrum of [(N' 3C) 5Fe"-' 3CN-Pt"(NH 3 )4-N 13C-Fe 11 ( 13CN)5 ] 4 in 
90% H20/ 10 D20 (273 K). Assignments: a bridged cyanide, b cyanides above 
andbelow Pt-Fe axis, c terminal cyanide on Pt-Fe axis. 
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Stability towards glutathione. 
'H NMR spectra of complex 1 were recorded in the presence of GSH (5 MM) just 
after mixing and after 13 h in the dark. No peaks due to a Pt" NH 3 compound was 
detected in the spectrum showing that complex 1 is not reduced by glutathione. This 
shows that compounds such as 1 could survive long enough in the body until 
activated by light. 
X-ray crystal structure. Orange-brown needles suitable for X-ray diffraction were 
found at the bottom of the NMR tube of the sample prepared for the 13C NMR 
experiment. Since the X-ray coordinates have never been deposited, the X-ray 
structure was determined. 
Figure 3.7 X-ray crystal structure of [Pt(NH 3)4] 2 [Fe(CN) 6Pt(NH3)4Fe(CN)6].6H20. 
The Fe-Pt bond distances are similar for both Fe centres which confirms that both Fe 
centres have the same oxidation state. The [Pt"(NH3)4 ]21 counter ions are close to the 
Fe centres and not the Pt centre of inversion. The average nearest-neighbour N-Pt-N 
and C-Fe-C bond angles are ca. 90° and the Pt-N-C and Fe-C-N angles are 
approximately 1800. 
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Table 3.2 Crystal structure data for C 12H 12Fe2N 16Pt (N4H 12Pt) 2 .6H20. 
Empirical formula C 12H 12Fe2N 15Pt 
(N4H 12Pt)2 .6H20 
Density (calc.) (mg/m') 2.286 
Formula weight 1429.81 Absorption coefficient (mm') 24.562 
Crystal description Orange-brown needle F(000) 1364 
Crystal size (mm) 0.77 x 0.12 	x 0.12 
mm 
0 range 	for data collection 
(deg) 
2.94 to 70.09 
Crystal system Monoclinic twin Reflections collected 2854 
Space group P2 1 /c Independent reflections 2854 
Unit cell dimensions (A) a = 15.3 14(5) 
b = 8.488(3) 




Volume (A3) 2077.3(13) 
Temperature (K) 150(2) 
Conventional R 0.0689 
wR2 0.1981 
Table 3.3 	Selected bond lengths (A) and angles (0)  for C 12H12Fe2N 16Pt 
(N4H 12P02.6H20. 
Ptl -Nil 1.984(12) Fel - CIl 1.903(14) 
Ptl -Ni 2.059(14) Fel -C13 1.947(13) 
Pti -N2 2.06(2) Fel -Cl2 1.899(18) 
Pt2-N4 2.019(17) Cil-Nil 1.12(2) 
Pt2-N3 2.044(19) C13-N13 1.119(19) 
Pt2-N5 2.030(15) C12-N12 1.13(2) 
Pt2-N6 2.051(14) C13-Fel -C12 87.5(7) 
Ni -Ptl -N2 87.7(7) C13-Fel -C15 90.6(7) 
Nh -Ptl -NI 88.6(5) C14-Fel -C15 87.9(7) 
Nil -Pti -N2 89.3(7) Cli -Fel -C13 178.2(6) 
The symmetry at the Pt centre is almost a perfect octahedron. The structure reported 
here is similar to that reported by Bocarsly et al. 2 who reported the structure with the 
empirical formula C 12H 12Fe2N 16Pt (N4H 12P02 .9H20 which contains 3 more water 
molecules in the structure than that reported here. However, the above structure 
confirms that the solutions studied by NMR and UV/VIS spectroscopy contain solely 
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the trinuclear Fe`-Pt`-Fe" compound and confirm the purity of the samples. 
3.3.2 Reaction of cis4Pt °(NH3)2(OH2)21 with [F& 11 (CN)6] 3 
The aim of these experiments was to introduce an active anticancer drug into this 
redox reaction as described in the introduction. C'S-Ipt"(NH3)2(OH2)2 ]21 is a 
hydrolysis product of the anticancer drug cisplatin (cis-[Pt"C1 2(NH3)2]) and is 
believed to be the active species." It would be very exciting if cis-
[Pt' 1(NH3)2(OH2)2] 2 (3) could be incorporated in a stable Pt` complex and released 
again by light. The reaction between cis-[Pt' 1(NH3)2(OH2)2] 2 (3) and [Fe "1(CN)6] 3 
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Figure 3.8 UV/VIS spectrum of the reaction of cis-[Pt"(NH 3) 2(OH2)2] 2 (3) with 
[Fe "(CN) 6] 3 (0.67 mol eq) in water at 293 K. The concentration was 1 mM. 
Figure 3.8 shows that a new broad band centered at 420 nm appears when cis-
[Pt"(NH3)2(OH2)2 ] 2 (3) is reacted with K 3 [Fe' 11 (CN)6] (0.67 mol eq). This band 
extends to 600 tim. The solution colour changed from yellow to orange-red over a 
few minutes. This band is attributed to an IT metal-to-metal charge transfer band and 
indicates an oxidation of the Pt" centre. The rate of this reaction was found to be 
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strongly dependent on the mol ratio of the reactants and also on the pH value. 
Figure 3.9 shows the reaction solutions I h after adding (a) 0.67 mol eq and (b) 2 
mol eq of K3 [Fe"(CN)6J to a 5 mlvi aqueous solution of cis- [Pt"(NH 3)2(OH2)2] 2 (3) at 
pH 2.5. An excess of complex 3 increases the reaction rate remarkably. The reaction 




















Figure 39 UV/VIS spectrum of the reaction between cis- [Pt 11(NH3 )2(OH2)2] 2 (3, 5 
mM) and [Fe 111(CN)6] 3 in water at pH 2.5 at mol ratios of (a) 3:2 and (b) 1:2. 
IR spectroscopy. Red-brown precipitates were obtained when 0.67 mol eq or less of 
K3 [Fe ... (CN) 6] was added to aqueous solutions of cis-[Pt"(NH 3)2(OH2) 2] 2 (3) with 
concentrations of >20 mM. An JR spectrum of such a precipitate was acquired after 
centrifugation, washing the precipitate with water and drying it under vacuum 
(Figure 3.10). 
The band at 3429.9 cm' is assigned to H 20 stretching bands from water which is still 
present in the sample. The cyanide stretching region of 2000-2200 cm' exhibits two 
bands, one at 2072.9 cm' and one at 2114.3 cm'. K3[Fem(CN)6]  and 
K4[Fe11(CN)6].3H20 were reported to have cyanide stretching frequencies at -2120 
82 
C 
Chapter 3 Platinum(II)/(IV) - Iron(II)/(III) redox system 
cm' and at -2050 cm', respectively. 6 The cyanide stretches shift to higher frequency 
when the cyanide ligand is bridged. 6 [Pt(NH3 )4] 2 [Fe(CN)6Pt(NH 3)4Fe(CN) 6] for 
example exhibits two cyanide stretching frequencies at 2050 cm' and 2125 cm' 
which are assigned to terminal and bridging Fe" cyanides, respectively.' 
Accordingly, the bands in Figure 3.10 at 2072.9 cm' and 2114.3 cm' are assigned to 
terminal (2072.9 cm') and bridging (2114.3 cm') Fe" cyanides. The broad band at 
3287.7 cm- ' is assigned to Pt" v(NH 3 ) vibrations. 6 
The cyanide stretches show that a reduction took place from Fe" to Fe". The Fe" 
bridging cyanide stretching frequency gives evidence that the Fe" centre is bound to 
Pt via a cyanide bridge Fe"-CN-Pt. The presence of a Pt" stretch at 1384 cm -'  
confirms that some Pt" was oxidised to Pt". [Fe ... (CN) 6J 3 is therefore oxidising cis-
[Pt"(NH3)2(OH2)2] 2 (3) by simultaneous binding to the Pt centre via a cyanide 
ligand. 
CM-1 
Figure 3.10 JR spectrum (KBr disc) of the precipitate from the reaction of cis-
[Pt"(NH3) 2(OH2)2] 2 (3) and [Fe ... (CN) 6] 3 (0.67 mol eq). 
Photoreactions. The same solution of which the precipitate, used for acquiring the 
JR spectrum of Figure 3.10, was obtained was also used to investigate the 
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photoreactivity of the reaction product of cis-{Pt"(NH 3)2(OH2)2] 2 (3) with 
[Fe "(CN) 6] 3 . The dark red solution was irradiated with a halogen lamp for I h. The 
solution colour changed to weakly orange during the irradiation and a precipitate was 
observed. This precipitate was isolated and washed with water and dried. The JR 
spectrum is shown in Figure 3.11. 
3510 	300 	256 	2O0 	 15!OO 	 icioO 	 51!lO 
CM -1 
Figure 3.11 IR spectrum (KBr disc) of precipitate obtained after irradiation of the 
same reaction mixture from which the precipitate used for Figure 3.10 was obtained. 
All major bands in the spectrum of Figure 3.11 appear at the same frequency with 
the exception of the bands in the cyanide region 2000-2200 cm'. The two bands at 
2072.9 cm' and 2114.3 cm' have shifted to higher frequency to 2126.8 cm' and 
2197.4 cm', respectively. These bands are assigned to terminal and bridged Fe" 
cyanides, respectively, because Fe" cyanide stretches appear at higher frequency 
than Fe" cyanide stretches. 6 This means that the Fe" centres got oxidised to Fe" 
during the irradiation. The Pt" 8(NH 3) frequency at 1383 cm' is still present which 
indicates that there are still Pt a' centres present after the irradiation. It therefore 
seems likely that the Fe" centres are oxidised by the irradiation without reducing the 
Pt" centres. The stretching frequency at 2197.4 cm - ' further gives evidence that there 
exists a Fe" cyanide bridge which most likely bridges the two metal centres Fe"- 
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CN-Pt" 
It is known that irradiation into the intense charge transfer band of [Fe' 1(CN)6]4 at 
about 250 nm leads to oxidation producing [Fe "(CN) 6] 3 and a hydrated electron." 
Irradiation into the same band is also known to lead to photosubstitution of one 
cyanide ligand with water." Such reactions could have occurred during the 
irradiation of above sample with a halogen lamp because a halogen lamp also emits 
light in the UV region. 
The colour change during the irradiation from dark red to weakly orange additionally 
indicates that no simple back reaction to the reactants took place as observed for the 
reaction of [Pt"(NH 3 )4] 2 and [Fe ... (CN) 6] 3 
NMR spectroscopy. Figure 3.12 shows the reaction of cis-[Pt"(' 5NH3)2(OH2)2] 2 (3, 
5 mM) and [Fe ... (CN) 6] 3 at pH 3.14. The 'HI ' 5N chemical shifts of the reactant 3 (A) 
were 4.50/ -86.9 ppm which is in agreement with literature.' 0 [Fe "1(CN)6] 3 (2 mol eq) 
was added directly into the NMR tube and the solution colour changed to red. The 'H 
NMR spectrum (B) showed dramatic changes: two doublet peaks at 7.06 al and 2.43 
a2 appeared, besides a broad doublet peak at 6.47 b and a very weak broad peak at 
4.2 c. All these peaks exhibit the typical 'J('H-' 5N) coupling constant of 73 Hz. 
Spectra (C) and (D) show the reaction mixture 0.55 h and 5.55 h after the adding of 
[Fe 111(CN)6] 3 . The cross-peaks al and a2 disappear with time. The 'HI ' 5N values of 
al and a2 are unusual with 6.94/ -103.75 and 2.36/ -86.77, respectively, and do not 
fit into the range expected for Pt` W  ammine compounds (see section 2.2). 9 The 
cross-peaks due to b and c exhibit chemical shifts of 6.17/ -52.1 and 4.1/ -73.6, 
which are more typical for a Pt" NH 3 trans to 0 and Pt" NH 3 trans to 0, 
respectively. 
The 'H/ ' 5N chemical shifts of the cross-peaks al and a2 show strong pH 
dependences. Table 3.4 illustrates this pH dependence. It can be seen that only peak 
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not peak a2. In the ' 5N dimension, the peaks show opposite effects by increasing the 
pH: al shifts to high field by 7 ppm from -103.75 to —110.5 ppm, a2 shifts to low 
field by 14 ppm from —86.77 to —72.3 ppm. Further increase of the pH value to 10.41 
led to the disappearance of all peaks. This is due to exchange of the NH 3 'H with the 
solvent because lowering of the pH value led to the reappearance of the peaks. 9 
- 	al 
O C 
- 	 O.55h 
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Figure 3.12 'H and 2D ['H, ' 5N] HSQC spectra of the reaction of cis-
[Pt"(' 5NH3)2(OH2)2] 2 (3) and [Fe ... (CN) 6] 3 at pH 3.14. (A) shows 3 before and (B) 
directly after adding of 2 mol eq [Fe ... (CN) 6] 3 . Spectra (C) and (D) show the reaction 
after 0.55 h and 5.5 h, respectively. 
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Table 3.4 pH dependence of the 'HI ' 5N chemical shifts of the cross-peaks al and 
a2. 
pH al a2 
(' 5N) 
3.14 7.06 -103.75 2.43 -86.77 
5.60 7.03 -105.2 2.45 -84.0 
7.03 8.2 -110.0 2.45 -73.2 
8.43 8.4 -110.5 2.40 -72.3 
3.3.3 Reaction of cis-[Pt"(CI) 2(N H 3)2] and [Pt"(en)(C1) 21 with [Fe °'(CN)6] 3 
UV/VIS spectroscopy. The reactions of cis-[Pt"(Cl) 2(NH3 )2] (cisplatin) with 
[Fe "1(CN)6] 3 were much slower than the reactions of the diaqua adduct cis-
[Pt"(NH3)2(0H2)2 ] 21 . Figure 3.13 shows the UV/VIS spectra of aqueous cisplatin 
solutions (5 mM) at different pH values 1 h after adding [Fe ... (CN) 6] 3 (0.67 mol eq). 
It can be seen that the intensity of the broad IT band extending to 600 nm depends on 
the pH value of the cisplatin solution. No reaction was observed at pH 10.8, the most 
intense IT band is observed at pH 2.2. The same characteristics were also found for 
the reaction of the hydrolysed cisplatin species cis-[Pt"(NH 3 )2(0H2)2] 2t This 
similarity plus the slow reaction of cisplatin with [Fe ... (CN) 6] 3 suggests that it is not 
cisplatin but its hydrolysis products cis-[Pt"(NH 3)2(OH2)ClJ and cis-
[Pt' 1(NH3)2(OH2)2] 2 which react directly with [Fe ... (CN) 6] 3 to form a Fe"-CN-Pt" 
compound which exhibits the IT band visible in Figure 3.13. Further evidence for 
this was also found by the NMR studies. 
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iTh1 
Figure 3.13 UV/\TIS spectra of aqueous cisplatin solutions (5 MM) 1 h after adding 
[Fe ' 11(CN)6] 3 (0.67 mol eq) at different pH values. The concentration of all reactants 
is 1mM. 
IR spectroscopy. Table 3.5 lists the cyanide stretching frequencies of the products 
of the reactions between different amino Pt" compounds and [Fe ... (CN) 6] 3 . 
Reaction with cisplatin: [Fe "(CN) 6] 3  (1 mol eq) was added to an aqueous solution 
Of cis-[Pt"Cl 2(NH3)2] (6 mlvi) and the mixture stirred at room temperature. A colour 
change of the reaction mixture occurred after 2 h from yellow to red. The volume of 
the solution was reduced by rotary evaporation until a red precipitate was observed. 
This precipitate was collected was washed with water and dried under vacuum. An 
JR spectrum was acquired of this precipitate using a KBr disc. 
The cyanide region of 2000-2200 cm' contained two bands, one at 2111 cm' and 
one at 2061 cm'. Compared to this, K3 [Fe111(CN)6] only contains one stretching 
frequency in the cyanide region at 2117 cm'. The band at lower frequency of 2061 
cm' can be assigned unambiguously to a terminal Fe"-cyanide stretch because Fe"-
cyanide stretches shift to lower frequency compared with Fe"-cyanide stretches. 
K4 [Fe"(CN) 6].3H20 exhibits a cyanide stretch at 2040 cm' in comparison. The band 
at 2111 cm' is due either to a bridging Fe"-cyanide stretch or a terminal Fe"-cyanide 
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stretch, but more likely the former as it is expected that all [Fe "(CN) 6] 3 will have 
reacted with cisplatin. This result suggests that [Fe "(CN) 6] 3 is reduced and formed 
cyanide bridges Fe"-CN-Pt". The formation of this bridge is also responsible for the 
colour change to red due to the metal-to-metal charge transfer band. 
Reaction with [Pt(en)ClJ: [Fe ... (CN) 6] 3 (1 mol eci) was added to an aqueous solution 
of [Pt"(en)C1 2] (5 mlvi). The yellow solution was stirred in the dark for 4 h at 353 K. 
The solution colour had changed from yellow to red after 2 h of stirring. The solution 
was freeze dried which led to a red precipitate. This precipitate was analysed by IR 
spectroscopy using a KBr disc. 
The cyanide stretching region of the JR spectrum of above compound exhibited two 
bands at 2066.4 cm' and 2116.5 cm'. These bands were assigned similarly as for the 
reaction of [Fe ... (CN) 6] 3 with cisplatin, the bands at 2066.4 cm' and 2116.5 cm' are 
assigned to a terminal and bridging Fe"-cyanide stretches, respectively. 
The two reactions above were also carried out in DMF but no reaction was observed. 
This is in agreement with Wu et al. 4 who reported that the equilibrium of the reaction 
[Fe(CN')6Pt(NH3)4Fe(CN)6] 4 2 [Fe m(CN)6] 3 + [Pt"(NH3)4 
]21 in a solvent with a 
low dielectric constant like DMF lies on the right and not on the side of the trinuclear 
complex. The same is therefore valid for the reactions with cisplatin and 
[Pt"(en)(Cl) 2]; a redox reaction is readily observed in water but none in DMF. 
Table 3.5 Cyanide stretching frequencies of reaction products of Pt" amine 
complexes and ferricyanide ([Fe ... (CN) 6] 3 ) in water. 
Complex CN stretching 
frequencies (cm') 
Complex CN stretching 
frequencies (cm') 
[Pt(NH 3)4] 2 2125 2055 [Pt(en)(Cl) 2 ] 2117 2066 
[Pt(NH 3)2(OH2)2] 2 2114 2073 [Pt(en)(ox)] 2111 2063 
Cis-[Pt(CI)2(NH 3)2] 2111 2061 [Pt(NH3)2(CBDCA)] 2117 2058 
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NMR spectroscopy. Figure 3.14 shows the 'H NMR spectrum of the reaction 
mixture of cisplatin (5 mM) and [Fe ... (CN) 6] 3 (2 mol eci) after 5 h reaction time. Two 
new broad peaks appeared at 7.42 bi and 2.63 ppm b2. These peaks have ' 5N 
chemical shifts of —59.55 and —110.38 ppm, respectively, which were derived from 
2D ['H, ' 5N] HSQC spectra. Even after 5 h reaction time, most cisplatin has not 
reacted indicating the slowness of the reaction. The similarity of the peaks bi and b2 
with the peaks al and a2 from the reaction between the hydrolysed species of 
cisplatin, cis-[Pt"(NH3)2(OH2)2] 2 , and [Fe ... (CN) 6 ] 3 (see section 3.3.2) suggest that 
the hydrolysed species of cisplatin reacted and not cisplatin itself. 
A similar solution of cisplatin was prepared in 100 mM NaC1 aqueous solution. No 
reaction was observed even after 5 h of reaction time. The reaction with cisplatin 
either does not take place at all or is extremely slow. 
2a/b 
• 	7 	6 	5 	4 	3 	ppm 
ö(1H) 
Figure 3.14 'H NMR spectrum of the reaction of cisplatin (5 mM) and [Fe ... (CN) 6] 3 
(2 mol eq) 5 h after adding [Fe ... (CN) 6] 3 . 
3.3.4 Reactions of other Pt" amine complexes with [Fe m(CN)6] 3 . 
Reactions of [Pt(en)(ox)], [Pt(CBDCA)(NH 3)2] (carboplatin), [Pt(en)1 2] and cis- 
[Pt12(NH3)2] with [Fe ... (CN) 6] 3 were carried out. Reactions in DMF showed no colour 
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change which means that no reaction took place. Reactions were however observed 
in water for all compounds. 
The reactions with [Pt(en)1 2] and cis-[Pt1 2(N}13)2] yielded insoluble black precipitates 
whose JR spectra exhibited broad bands at 2053 cm'. This band is assigned to Fe e-
CN stretches and indicates that reduction of Fe 111 took place. The products were not 
further investigated due to their insolubility in common solvents. 
[Pt(en)(ox)] is hardly soluble in water. [Pt(en)(ox)] (12.2 mg, 0.04 mmol) was 
therefore suspended in MeOH and heated to 323 K. K 3 [F&"(CN) 6] (23.4 mg, 2 mol 
eq) in 1 ml water was added and the yellow suspension was heated under refluxing in 
the dark for 5 h. No reaction occurred during this time. The reaction mixture was 
further stirred for 2 d in the dark at room temperature. A dark red precipitate was 
observed which was filtered and washed with ice cold water and dried under 
vacuum. The IR spectrum of this product exhibited two bands at 2110 cm' and 2062 
cm' which were assigned as previously to Fe" bridging and terminal cyanide 
stretches, respectively. No bands due to the reactants were found indicating that the 
redox reaction was complete. The product was only slightly soluble in water. 
[Pt(CBDCA)(NH 3)2] (carboplatin, 12.4 mg, 0.03 mmol) was dissolved in 3.5 ml 
water and K3 {Fe ... (CN) 6J (2.5 mol eq) added. The clear yellow solution was stirred 
for 2 d at room temperature in the dark. The solution colour changed to dark orange. 
The solution was freeze dried which led to a red precipitate. The IR spectrum of this 
precipitate showed two bands at 2116 cm' and 2058 cm'. These two bands plus the 
colour change to dark orange showed that a redox reaction took place. The 
precipitate was almost insoluble in water. 
The complex {Pt"(N}l 3)41 2 [(NC) 5Fe"-CN-Pt''(NH 3)4-NC-Fe"(CN) 5] (1), which is the 
product of the redox reaction between [Pt"(N}-I 3)4] 2 and [Fe"(CN) 6] 3 , and its 
photoreaction upon irradiation with visible light was studied using NMR and 
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UV/VIS spectroscopy. The photoreaction is much more rapid than the redox reaction 
back to complex 1 which is a good example how such a redox reaction could be 
exploited to release an active drug by photoactivation. Furthermore, the structure of 
complex 1 was characterised by an X-ray crystal structure and by ' 3C NMR using ' 3C 
labelled [Fe ... (' 3CN)6] 3 . 
The same redox reaction was employed for cisplatin and related Pt" am(m)ine 
complexes. Redox reactions with [Fe 111 (' 3CN)6] 3 were found in water for cis-
[Pt"(NH3 )2(OH2)2] 2 , cis-[Pt"Cl2(N}-13)21 1  [Pt"(CBDCA)(NH3)2] 1  [Pt(en)C1 2] and 
[Pt(en)(ox)]. No redox reaction at all was observed when DMF was used as solvent. 
All redox reactions led to colour changes of the solution from yellow to red and to 
Fe"-cyanide stretching frequencies in the JR spectra due to terminal and bridging 
cyanide ligands. The redox products showed all poor solubility in water. 
'H-{' 5N} inverse NIVIR spectroscopy experiments were carried out to follow the 
redox reactions of cis-[Pt"(NH 3 )2(OH2)2] 2 , cis-[Pt"C1 2(NH3)2J and [Pt(en)C' 2] and the 
photoreactions of their redox products. The results of these experiments were 
unexpectedly very complicated giving resonances at unusual ' 5N chemical shifts for 
Pt ammine complexes of for example 6(' 5N) —110 ppm.9 The reactions between cis-
[Pt"(NH3 )2(OH2)2] 2 , cis-[Pt"Cl 2(NH3)2] and [Pt(en)C' 2] and [Fe ... (CN) 6] 3 can 
therefore not simply be explained by a redox expansion of the coordination sphere of 
the Pt" complexes to the Pt" complexes. Further work is needed for elucidating the 
real nature of these reactions. 
3.5 Future Work 
It is clear that the redox reactions are strongly dependent on the redox potentials of 
the reactants. Therefore, the redox potentials of the Pt" am(m)ine reactants need to 
be determined. In order to get more insight into the structural properties of the 
products, ' 3C NMR experiments should be earned out using the ' 3C labelled 
[Fe ... (CN) 6] 3 . These experiments would give insight how many different cyanide 
ligands exist in the products. Photoreactions should also be followed additionally by 
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3̀C NMR spectroscopy. A photooxidation of Fe" to the paramagnetic Fe" should be 
detectable by ' 3C NMR. EPR spectroscopy should also be employed to detect the 
paramagnetic photoproducts. 
Furthermore, more attempts should be carried out to obtain crystals suitable for X-
ray diffraction. These would help to understand these complex redox reactions. 
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wImvTrrrr.T.! 
Pt1'' complexes undergo ligand substitution reactions much more slowly than their 
Pt" analogues.' It is therefore generally assumed that Pt 1" anticancer complexes act as 
prodrugs and are first reduced to Pt" species before reacting with DNA. The 
inertness of Pt" complexes makes them ideal candidates for photoactivatable 
prodrugs. The ideal Pt" prodrug would be totally inert to transformation in the 
absence of light, but would be reduced efficiently and irreversibly to a Pt" species 
which would act as the active drug. Ideally, the Pt" photoproduct should be a known 
active drug which is used in clinics, because such a photoactivation would release 
site specific a drug whose properties and side-effects are well known. 
To be a potential photoactive Pt" prodrug, the Pt" complex must contain 
photoactivatable ligands which are able to donate two electrons to the Pt" centre 
upon irradiation. Halide and azide ligands are known to exhibit ligand-to-metal 
charge-transfer bands at long wavelengths and to undergo photochemical reaction.' 
They are therefore potentially suitable as photoactive ligands. 
The common route to synthesise Pt` complexes is by oxidative-addition of a pt" 
precursor giving two additional axial ligands. Carboplatin was chosen as a Pt" 
precursor compound for several reasons. Carboplatin is routinely used in clinics and 
is less toxic than cisplatin (see section 1.2.3). The cyclobutanedicarboxylato 
(CBDCA) chelate ligand undergoes slower displacement by H 20 compared to the 
chloride ligands of cisplatin (cis-1Pt"C1 2(NH3)2J). Pt"' analogues of carboplatin 
should be more inert than those of cisplatin because of the chelate effect, and 
because of the stronger Pt-O bonds vs. Pt-Cl. The bulkiness of the cyclobutane ring 
of the CBDCA ligand could additionally slow down any reduction reactions with 
biological reducing agents. The ammine ligands can easily be ' 5N-labelled which is 
very important in order to follow the reaction mechanism by 'H-' 5N NMR inverse 
detection methods. Finally, carboplatin is a well characterised compound and the 
NMR signals of the cyclobutane CH 2 protons of the CBDCA ligand can provide 
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Figure 4.1 Structures of the anticancer drugs carboplatin and oxaliplatin. 
Analogues of the anticancer drug oxaliplatin were also used as Pt" precursor 
compounds. Amino Pt" oxalate complexes are readily accessible and the oxalate 
ligand has the advantage compared to the CBDCA ligand that it does not exhibit any 
steric hindrance for the introduction of axial ligands. The step from Pt" to Pt" is 
therefore expected to be easier for Pt" oxalate complexes compared to Pt" CBDCA 
complexes. Another reason for the choice of the oxalate ligand was the knowledge 
that Pt"(ox)L 2 complexes are reported to undergo reductive elimination processes 
upon irradiation with UV light. 2 
Pt(C204)L2 hv -3 PtL2 + 2 CO2 
The products of such reductive elimination processes are reported to be 
very reactive and could therefore be useful for our purposes.' 
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4.2.1 Reagents 
K2 [PtC14] was puchased from Johnson Matthey. Ku, NH 4C1, NaOH, 55 % HI and 
bromine were puchased from Fisher. A9 2SO4, AgNO3 and 1,1 
cyclobutanedicarboxylic acid (CBDCA), oxalic acid and 1,1 0-phenanthroline were 
purchased from Aldrich. Iodine (99.9%) was purchased from BDH and 30% H 202 
was purchased from Prolabo. Ba(OH) 2 .8H20 was purchased from M & B 
Pronalys *AR. d7-DMF, d4-MeOD and D20 were purchased from Aldrich. H 20 was 
deionized with a USF Elga deionizer. Other solvents were generally dried over 3 A 
molecular sieve and purified by standard methods. 
4.2.2 NMR spectroscopy 
NMR spectra were recorded at 298 K on a Bruker DMX 500 ('H 500.13 MHz; ' 5N 
50.7 MHz) or a Bruker DPX 360 ('H 360 MHz; ' 5N 36.5 MHz) NMR spectrometer, 
using 5-mm NMR tubes. d7-DMF was used as solvent unless otherwise stated. For 
'H NMR, typical acquisition conditions for 1D spectra were as follows: 45-60° 
pulses, 16-32 k data points, 1-3 s relaxation delay, collection of 32-128 transients, 
final digital resolution of 0.2-1 Hz/point. 2D ['H, "'Pt] HSQC NMR spectra 
(optimized for 2(PtH) = 52 Hz) were recorded using the sequence of Stonehouse et al. 4 
"Pt chemical shifts were measured against an external standard of Na 2 [PtC16 ] in 
D20 at 0 ppm. 
4.2.3 X-ray crystallography 
X-ray crystal structure analyses were performed by Dr. Simon Parsons at the 
University of Edinburgh. Crystallographic data were collected on a Bruker Apex 
Smart CCD diffractometer at 150 K using molybdenum radiation X = 0.71073 A. 
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4.2.4 UVIVIS spectroscopy 
UV/VJS spectra were recorded on a Shimadzu UV-2501 PC spectrophotometer using 
1 cm path length quartz cuvettes. Spectra were referenced to solvent alone. Data 
were processed with Microcal Origin 5.0. 
4.2.5 IR spectroscopy 
JR spectra were recorded on a JACSO FT/IR-410 Fourier Transform Infrared 
Spectrometer using KBr discs. 
4.2.6 CHN elemental analysis 
Microanalyses were carried out in the Department of Chemistry on a Perkin Elmer 
2400 CHN Elemental Analyser. 
4.2.7 Photoreactions 
A Coherent INNOVA 70C Argon-Krypton Ion laser system was used for the 
irradiation experiments. The laser line at 457.9 nm or the multiline in the near UV 
region (350.7 - 356.4 nm) were used for irradiation. 
4.2.8 Electrochemistry 
All the elctrochemical experiments were conducted on an ECO Chemie AUTOLAB 
PGSTAT 20 Potentiostat run on GPES (General Purpose Electrochemical System) 
Version 4.5 software. 
A three electrode system was used comprising of a glassy carbon working electrode, 
a silver I silver chloride reference electrode and a platinum wire as counter electrode. 
To ensure that dissolved oxygen was not contaminating the redox reactions the 
experiments were carried out in argon purged solution of DMF meaning that all 
dissolved oxygen had been eliminated. 
Tetrabutylammonium tetrafluoroborate [CH 3(CH2)3]NBF4 was used as the electrolyte 
at a concentration of 0.1 M and was dissolved in the DMF solution. 
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4.2.9 Preparations 
[Pt"(CBDCA-O, 0 ')(NH3)2] (carboplatin) (1) 
A solution of KI (4.23 g, 25 mmol) in water (30 ml) was added to K21PtC141 (I g, 2.4 
mmol). The colour changed from red to almost black immediately. The reaction was 
protected from the light and stirred for 35 minutes. NH 4C1 (0.256 g, 4.79 mmol) was 
dissolved in deionised water (1 ml) and added to the reaction mixture. 
The pH of the reaction mixture was adjusted to 10 by the dropwise addition of 0.5 M 
aqueous NaOH. At this point a yellow precipitate began to form and the solution 
turned a brownish yellow. Again the reaction was protected from light and stirred for 
3 hours. 
The yellow precipitate was filtered off and washed with deionised water and 
diethylether and dried under vacuum. 
Yield: 0.946 g, (1.96 mmol, 81.7%). 
CHN: Found: C, 0.36; H, 1.15; N, 6.73; Calculated for H 6N2I2Pt: C, 0; H, 1.25; N, 
6.80. 
A92SO4 (0.608 g, 1.95 mmol) was dissolved in water in an ultrasonic bath and added 
to cis-[Pt1 2(NH3 )2] (2, 0.946 g, 1.96 mmol). Deionised water was added to —50 ml. 
The reaction was protected from light and stirred overnight at 323 K to form cis- 
[Pt(NH3)2(OH2)2] 2 . 
Slightly less than 1 mol eq of A92SO4 was used so that no silver ions would be left in 
solution. The AgI precipitate was removed by filtration through an inorganic 
membrane filter (Whatman, Anotop 10, 0.02 gm) to give a colourless solution. To a 
solution of CBDCA (0.317 g, 2.2 mmol) in water (-30 ml), Ba(OH) 2 .8H20 (0.606 g, 
1.9 mmol) was added a little at a time until all had dissolved. This solution was then 
added to the colourless solution of cis-[Pt(NH 3)2(OH2)2] 2 , which led to the formation 
of white BaSO4 precipitate. After standing for 1 h at room temperature, the 
precipitate was removed by filtration through an inorganic membrane filter 
(Whatman, Anotop 10, 0.02 gm). The filtrate was reduced in volume to give white 
carboplatin crystals and some impurities which were removed by dissolving in water 
and filtering. 
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Yield: 438 mg, 0.59 mmol, 60%. 
CHN: Found: C, 18.83; H, 2.92; N, 7.32; Calculated for C 6H, 2N2O4Pt: C, 19.4; H, 
3.26; N, 7.55; 
JR (cm') KBr disc: 3267.8, 3140.5, 2186.9, 1636.3. 
'H NMR (d7-DMF): 6 (ppm) 4.36 (s, N-H 3), 2J('H-' 95Pt) = 56 Hz; 1.73 (, 3J('H-'H) 
= 7.4 Hz; 2.78 (t). 
Cis, trans- [ Pt"(CBDCA-O, 0 ')(NH3)2(OH)2 1 (3) 
An aliquot of [Pt"(CBDCA-0,0')(NH 3)2] (1) (0.137 g, 0.37 mmol) was dissolved in 
deionised water (-P2 ml) and hydrogen peroxide (0.23 ml, 2.20 mmol, 6 mol eq) was 
added via a syringe. 
The reaction mixture was then protected from light and stirred at 328 K overnight. 
A white precipitate formed. The reaction was then cooled down to room temperature 
and the mixture placed in the fridge overnight. The white powder was then collected 
by filtration and washed with cold water and ether and dried under vacuum. 
Yield: 142 mg, (0.17 mmol, 95%). 
Crystals suitable for X-ray crystallography were obtained from an aqueous solution 
at 277 K in the fridge. 
JR (cm !) KBr disc: 1395, 1595, 3095, 3225, 3431. 
'H NMR (d4-MeOD): 6 (ppm) 2.03 (q), 3J('H-'H) = 8 Hz; 2.73 (t), 3J('H-'H) = 7.7 
Hz. 
Cis, trans- [Pt"(CBDCA-O, 0 ')(NH3)212] (4) 
Crystalline [Pt"(CBDCA-0,0')(NH 3 )2] (1) (0.072 g, 0.20 mmol) was ground and 
transferred into a 50 ml round bottomed flask. Iodine (0.18 g, 1.4 mmol, 7 mol eq) 
was dissolved in CHC13 (15 ml) and added to the flask. The suspension was heated 
and stirred under reflux for 4 d. The product was then filtered and the excess iodine 
removed by washing thoroughly with chloroform and diethylether. The remaining 
dark red solid was dried under vacuum. 
Yield: 65 mg (0.10 mmol, 51%) 
Recrystallisation from methanol yielded crystals suitable for X-ray crystal structure 
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analysis. 
'H NMR (d7-DMF): ö (ppm) 1.94 (ci,), 3J('H-'H) = 7.8 Hz; 2.71 (t), 3J('H-'H) = 7.9 
Hz; 6.26 (septet), 'J('H-'4N) = 105 Hz, 2J('H-' 95Pt) = 52 Hz; 
2D ['H, ' 95Pt] HSQC NMR (d7-DMF): 5 ('H, ' 95PtJ 6.25, -952.35), 'J(' 95Pt-' 4N) = 420 
Hz. 
JR (cm') KBr disc: 1385, 1605, 3065, 3210. 
UV/VIS (DMF): 366 nm (broad, extends to 500 nm), 295 rim. 
Cis, trans- IPt"(CBDCA-O,O  ')(NH 3)2Br2] (5) 
Hydrobromic acid (0.1 M, 2.5 ml, 0.25 mmol) was added dropwise to the solid cis, 
trans- [Pt"(CBDCA-O,O ')(NH 3)2(OH)2] (3, 26 mg, 0.07 mmol) and stirred at room 
temperature overnight protected from light. The volume of the solution was reduced 
and the solution stored in the fridge at 277 K for one day. Unreacted cis, trans-
[Pt"(CBDCA-O, 0 ')(NH3 )2(OH)2] (3) precipitated and was removed by 
centrifugation. The solution was then filtered with an inorganic membrane filter 
(Whatman, Anotop 10, 0.02 pm) and the solvent evaporated.to  dryness on the rotary 
evaporator to give an orange crystalline solid which was washed with water and 
ether. 
Yield: 28 mg (0.05 mmol, 81.5%) 
CHN: Found: C: 13.52; H: 2.16; N: 4.77. Calculated for C 6H, 2N204Br2Pt: C: 13.57; 
H: 2.28; N: 5.28. 
'H NMR (d7-DMF): 8 (ppm) 1.96 (q) , 3j( 'H-'H) = 7.6 Hz; 2.51 (t), 3J('H-'H) = 8 Hz; 
6.1 (septet), 'J('H-' 4N) = 105 Hz, 2J('H-' 95Pt) = 50 Hz; 
IR (cm') (KBr disc): 1634.4; 3180. 
UV/VIS (DMF): 372 nm (broad), 322 run. 
Cis, trans- [Pt"(CBDCA-O,O ')(NH3) 2C12 1 (6) 
Hydrochloric acid (0.02 M, 12.5 ml, 0.25 mmol) was added dropwise by pipette to 
the solid cis, trans- [Pt"(CBDCA-O, 0 ')(NTI3)2(OH)2] (3, 49 mg, 0.12 mmol) in a 50 
ml round bottomed flask. The solid cis, trans-[Pt"(CBDCA-O, 0 ')(NH3)2(OH)2] (3) 
dissolved immediately to give a colourless solution. The reaction was protected from 
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light and stirred overnight at room temperature. The solution turned pale yellow and 
was filtered. The filtrate was evaporated to dryness to give a yellow solid. 
Yield: 29 mg, (0.04 mmol, 87%). 
CHN: Found: C:16.39; H: 2.43; N: 5.96; Calculated for C 6H, 2N2O4C12Pt: C: 16.30; 
H: 2.74; N: 6.34. 
'H NMR (d7-DMF): 6 (ppm) 1.97 (q), 3J('H-'H) = 7.6 Hz; 2.50 (t), 3J('H-'H) = 7.9 
Hz; 6.14 (septet), 'J('H-'4N) = 106 Hz, 2J('H-' 95Pt) = 53 Hz. 
JR (cm') (KBr disc): 3179.1; 1623.8. 
EPt"(oxalate)(en)l (7) 
[Pt"(en)1 2] (0.104 g, 0.21 mmo1) was added to an aqueous solution of AgNO 3 (0.070 
g, 0.39 mmol; 1.96 mol eq). AgCl precipitated immediately. The suspension was 
stirred at 323-333 K overnight in the dark. The AgC1 precipitate was then twice 
filtered off with an inorganic membrane filter (Whatman, Anotop 10, 0.02 tm). 
Na2C204 (0.3 g, 2.2 mmol, 10 mol eq) were then added to the colourless solution. 
The volume was reduced by rotary evaporation at 333 K and the solution cooled 
down slowly to room temperature and then stored overnight at 277 K in the fridge. 
The next day, pale yellow needles (0.023 g) were obtained by filtration. The needles 
were washed with ice cold water and dried in a desicator over silica gel. The needles 
were suitable for X-ray crystal structure analysis and a crystal structure of complex 7 
was obtained. 
Yield: 23 mg (40%) 
CHN: Found: C, 13.98; H, 2.27; N, 8.08; Calculated for C 411804Pt: C, 14.00; H, 2.35; 
N, 8.16. 
'H NMR (d7-DMF): 6 (ppm) 5.87 (s), 2J('H-' 95Pt) = 60 Hz; 2.60 (s). 
IR(cm'): 3220, 3140, 1650, 1400. 
[Pt"(1,10-phenanthroline)C1 2] (9) 
Into a 100 ml round-bottomed flask containing a solution of K[PtC1 4] ( 1.05 g, 2.53 
mmol) in deionised water (30 ml) was placed 1,10-phenanthroline (0.381 g, 1.92 
mmol) in acetone (10 ml) with stirring. The temperature was raised to 343 K and the 
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solution was allowed to stir for 12 hours in the absence of light. The orange 
precipitate was collected by hot filtration, washed several times with hot water and 
dried under vacuum. 
Yield (1.03 g, 94%). 
CHN: Found: C: 32.67; H: 1.55; N: 6.33. Calculated for C, 2C12H8N2Pt: C: 32.29; H: 
1.79; N: 6.28. 
'H NMR (d6-DMSO): 8.15 (s), 8.25 (s), 9.02 (d), 9.7 (s). 
[Pt"(oxalate)(l ,10-phenanthroline)1 (10) 
A solution of A92SO4 (0.132 g, 0.42 mmol) in water (10 ml) and was added to a 
solution of [Pt"(,hen)C1 2 1 in water (0.2 g, 0.43 mmol). The solution was stirred at 
223 K overnight in the dark. Deionised water (100 ml) was added. 
Ba(OH) 2 .8H20 (0.127 g, 0.40 mmol) was dissolved in deionised water. The two 
solutions were mixed and then heated to 243 K for 1 h. The white BaSO 4 precipitate 
was then filtered hot twice through inorganic membrane filters (Whatman, Anotop 
10, 0.2 tm). A bright orange solution resulted. Oxalic acid (0.062 g, 0.49 mmol) was 
added to the hot solution and the pH was adjusted to 7 with 0.1 M NaOH. The 
solution was heated to 243 K for 1 h. The volume was then reduced by rotary 
evaporation until a dark red precipitate appeared. The solution was then placed in the 
fridge at 277 K overnight. The dark red precipitate was collected by filtration and 
dried under vacuum. 
Yield: 92 mg (49%) 
Crystals suitable for X-ray crystallography were grown from water in an NMR tube. 
CHN: C, 36.46; H, 1.74; N, 5.62; Calculated for C, 4H8N204Pt: C, 36.29; H, 1.70; N, 
5.62. 
UV/VIS (H20):385 nm, 475 nm. 
ESI-MS:463.39 mlz (calc. 463 mlz). 
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4.3.1 Synthesis and characterisation of complexes 
4.3.1.1 [Pt11(CBDCA-0,0')(NH3)2] (carboplatin) (1) 
The method of Harrison and McAuliffe' was generally used for the synthesis of 
carboplatin. However, crystals of carboplatin with a novel structure, which will be 
discussed later, were obtained by the method of Pasini 6 in DMF. 
The method of Harrison and McAuliffe' involves the following synthetic steps (H 20 
is used as solvent): 
K2 [PtC14] + 4 K1 	' K2 [Pt14] + 4 KC1 
K2 [Pt14] + 2 NH4 C1 	> cis-[Pt1 2(NI-13 )2] + 2 KI 	 (2) 
cis-[Pt12(NH3) 2] + A92 SO4 	> cis- [Pt(NH3)2(0H2)2]SO4 + 2 Ag! (s) (3) 
cis-[Pt(NH 3)2(0H2)2]SO4 + Ba(CBDCA) —* cis-[Pt(NH 3)2(CBDCA)] + 
BaSO4 (s) 	(4) 
Coordinated chloride ligands are replaced by iodide ligands in step (1). The high 
trans effect of coordinated iodide ensures that the cis configuration is attained in step 
(2). Compound cis-[Pt1 2(NH3)2] (2) was isolated during the reaction. It is important 
to use slightly less than one mol eq AgSO 4 in step (3) in order to be able to eliminate 
all silver salt from the solution afterwards. The best way to remove AgX (X = Cl, I) 
salts was to filter the solutions through inorganic membrane filters of 0.02 .tm. In 
step (3), protection from light and heating to 223 K are important for complete 
reaction. Ba(CBDCA) was prepared separately in situ by the addition of 
Ba(OH) 2 .8H20 to a 1,1 -cyclobutanedicarboxylic acid solution. It was also, in this 
case, important to use less than one mol eq Ba(OH) 2 .8H20 compared to cis-
[Pt12(NT43)2] (2) to make sure that no Ba 21  ions were left in solution after step (4). 
BaSO4 is practically insoluble in H 20 and precipitates immediately out of solution 
after addition of Ba(CBDCA). The BaSO 4 is filtered off the same way as the Ag! 
salt. The precipitation of BaSO 4 left behind the diaqua species cis-[Pt(NH 3)2(OH2)2] 2 
104 
Chapter 4 Am(m)ino Pt(ll)/Pt(IV) CBDCA and oxalate complexes 
which then reacted further with CBDCA to give the product [Pt(CBDCA)(NH 3)2] 
(1). Concentration of the solution led to the precipitation of complex 1 as a white 
crystalline solid. 
This method yielded products with high purity and was therefore also used for the 
synthesis of compounds related to carboplatin. 
The 'H NMR spectrum of [Pt' 1(CBDCA-0, 0 ')(NH) 2] (carboplatin) (1) in d 7-DMF is 
shown in Figure 4.2, (A). The spectrum is ' 4N decoupled ( 1 H-{' 4N}) which led to the 
very good resolution of the "'Pt satellites of the NH 3 proton peak la. The NH3 
chemical shifts of 4.36 ppm and the coupling constant of 2J('H-' 95Pt) = 56 Hz are 
typical values for Pt" ammine complexes! The chemical shifts and coupling 
constants of the CH 2 protons of the CBDCA ligand also agree with the literature 
values. 14  The CH2 peak of the ethyl protons lb and I  overlaps with the solvent peak 
at 2.78 ppm. 
4.3.1.2 Pt" carboplatin derivatives 
Two approaches can be used to obtain Pt" complexes from Pt" complexes: 
direct oxidation of Pt" complexes with X 2 (X = Cl, Br, I), and 
via intermediate axial dihydroxo Pt" complexes which are obtained by 
oxidation of the Pt" complexes with 30% H 202 . These dihydroxo Pt'" 
complexes can then be reacted further either with diluted FIX acids to 
replace the hydroxo ligands with halides' or to Pt" carboxylates by the 
carboxylation of the hydroxo ligands as shown by Giandomenico et al.' 
(see Scheme 4.1). 
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Scheme 4.1 Oxidation of Pt" diammine complexes by H 202 and further reactions. 
The synthesis of each compound is discussed separately below. 
Cis, trans- [Pt"(CBDCA-O,O')(NH 3)2(OH) 2 ] (3). 
Complex 3 was characterised by an X-ray crystal structure (see section 4.3.2), NMR 
and JR spectroscopy. Complex 3 was prepared in high yields (> 90%) by treating 
carboplatin 1 with 6 to 10 mol eq of H202 and stirring the solution at 328 K 
overnight in the absence of light. The 'H NMR spectrum showed that it was all 
oxidised to cis, trans- [Pt"(CBDCA-O, 0 ')(NH3 )2(OH)2] (3) with no free carboplatin 
present. Further proof that carboplatin was oxidised completely comes from the JR 
spectrum of the product. The v(N}-1 3) asymmetric and symmetric stretching 
frequencies at 3400-3000 cm' of Pt-N}i 3 complexes are directly dependent on the 
oxidation state of the Pt centre. The v(NH 3) stretching frequencies are at lower 
energy in Pt'" complexes than in Pt" complexes, e.g. V(NH 3)a are reported to be 3150 
cm' for [Pt"(NH3)6]C14 and 3265 cm' for [Pt"(NH 3)4]C12 .' 0 The v(NH3) stretching 
frequencies of cis, trans-[Pt'v(CBDCA-O, 0 ')(NH3)2(OH)2] (3) are 3225 cm' and 
3095 cm' compared to 3268 cm' and 3141 cm' of carboplatin. The appearance of a 
strong band at 3431 cm' is due to v(OH) indicating the presence of the axial 
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hydroxide ligands. The two bands at 1595 cm- ' and 1395 cm- ' are due to the carbonyl 
stretches indicating the presence of the CBDCA ligand. 
Complex 3 was reacted further as shown in scheme 4.1 to give other Pt" complexes 
which are described below. 
Cis, trans- [Pt"(CBDCA-O, 0 ')(NH 3)212] (4) 
In order to synthesise this compound, both the direct oxidation of the Pt" complex 
with iodine and the substitution of the hydroxide ligands of cis, trans-[Pt"(CBDCA-
O,O')(NH3)2(OH)2] (3) were tried. Hodges and Rund" described the oxidation of 
[Pt(phen)X 2] (X = Cl, Br, I) complexes by 1 2 in CHC1 3 . They reported that an 
oxidative addition of an iodo (I) or triiodide (1 3 ) ligand in axial position occurred 
during this reaction depending on the stoichiometry and reaction conditions. 
Kratochwil' 2 reported the synthesis of cis, trans-[Pt"(en)Cl 212] (11) by refluxing 
[Pt"(en)C1 2] (12) in CHC13 in the presence of 40 mol eq 1 2 overnight. Complex 11 
was obtained as a pure precipitate. 
It was therefore decided to try to use a similar strategy for the synthesis of cis, trans-
[Pt"(CBDCA-O, 0 ')(NH3 )212] (4). Crystalline carboplatin 1 was ground before use in 
order to assist complete oxidation of the carboplatin by iodine. After having tried 
numerous different reaction conditions, it was found that a small excess of iodine (5-
10 mol eq) was more suitable than a large excess. A large excess of iodine leads to 
the introduction of triiodide ligands" or the loss and degradation of the CBDCA 
ligand. The reaction time was much extended compared to Kratochwil from 12 h to 4 
d. A dark red solid resulted which was then characterised by X-ray crystallography, 
NMR and JR spectroscopy. 
NMR spectroscopy 
d7-DMF was used as solvent for the NMR studies because of the good solubility of 
cis, trans- [Pt'(CBDCA-O,0')(NH 3)2 I2] (4) in DMF and the possibility to monitor 
the NH3 protons. NH3 protons exchange in other solvents such as D 20 and d4-MeOD, 
and their 'H resonances cannot usually be detected in such solvents. The NH 3 proton 
chemical shifts and 2J('H-' 95Pt) coupling constants provide important information 
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about the oxidation state (Pt" or Pt") of the Pt centre. 13  Spectra (A) and (B) in Figure 
4.2 are for carboplatin 1 and cis, trans- [Pt"(CBDCA-O, 0 ')(NH3)2I)] (4) in d7-DMF, 
respectively. Spectrum (B) shows that there is still unreacted carboplatin present in 
the dark red product. About 40% of carboplatin did not react with iodine. Although 
the reaction conditions were altered numerous times (e.g. increasing amount of 
iodine added, prolonging of reaction time, solvent volume) in order to obtain more 
Pt" product, there was always unreacted carboplatin in the product. The NH 3 'H 
resonances of complex 4 (6.26 ppm, peak 4a) are shifted to low field compared to 
carboplatin (4.36 ppm) which is indicative of a Pt" complex. 13  Peak 4a shows 
coupling to ' 4N ('J('H-' 4N) = 105 Hz) and to 195Pt (2J(1 1-1- 195Pt) = 52 Hz). The 195Pt 
satellites for peak 4a are well resolved compared to peak la. The broadening of "Pt 
satellites in 'H spectra is due to the chemical shift anisotropy (CSA) relaxation, 
which is the dominant relaxation mechanism for Pt compounds at high magnetic 
field strength. 13  The CSA relaxation is smaller for Pt" compounds than for Pt" 
compounds because of their higher degree of symmetry. The sharpness of the NH 3 
proton resonances of peak 4a also indicates that the peak must be due to a Pt" 
complex. The CH 2 resonances of complex 4 are also shifted compared to carboplatin 
1. The quintet shifted by ca. 0.3 ppm to low field (peak 4d) and the triplet shifted to 
high field by ca. 0.1 ppm (peak 4b/ 4c). 
In order to characterise complex 4 further, an attempt was made to detect the 195Pt 
resonance of the complex. Pt" and Pt''' complexes tend to have "'Pt chemical shifts 
at the high field and low field ends of the range, respectively, and can therefore often 
be differentiated by their ' 95Pt chemical shifts. The ' 95Pt chemical shift range is about 
15000 ppm and it is therefore a difficult task to locate the ' 95Pt resonance of a novel 
compound. The shifts of Pt" halide compounds alone span a range of 12000 ppm. 13 
An additional problem of direct detection of "'Pt resonances is the limit of detection 
which is about 10 mM. After having failed to find the ' 95Pt resonance for complex 4 
by direct detection, it was decided to monitor the 'H NMR resonances and decouple 
the ' 95Pt resonances ('H-{' 95Pt}). The ' 95Pt decoupling frequency was varied and the 
195Pt satellites of the NH 3 proton resonances were monitored. The disappearance of 
the "Pt satellites indicated the correct decoupling frequency and therefore the 'Pt 
108 
Chapter 4 Am(m)ino Pt(lI)/Pt(IV) CBDCA and oxalate complexes 
chemical shift range of complex 4. The obvious advantage of this technique is the 
much faster acquisition of spectra due to the high sensitivity of proton signals. The 
' 95Pt chemical shift of carboplatin 1 was found to be ca. —1700 ppm and for complex 
4 ca. —950 ppm. Neidle et al.'4 reported a "'Pt chemical shift of —1723 ppm for 
carboplatin in 1120 which is in agreement with the above value. 
It was decided to use ['H, ' 95Pt] HSQC experiments to detect the 195  Pt resonance due 
to the much improved sensitivity compared to direct detection of ' 95Pt. Figure 4.3 
shows the 2D ['H, `Pt] HSQC NMR spectrum and the corresponding 'H NMR 
spectrum. The reason for the presence of 9 cross-peaks is the coupling of the NH 3 
protons and 195Pt to ' 4N of NH3 . 
Scheme 4.2 shows how the ' 95Pt chemical shifts of Pt" (CBDCA) amine compounds 
are dependent on the axial ligand. The shielding of ' 95pt increases with decreasing 
strength of the Pt-(axial ligand) bond. 
After the characterisation of cis, trans-[Pt"(CBDCA-O, 0 ')(NH3)212] (4), an attempt 
was made to ' 5N label the NH3  groups in order to study photoreactions of complex 4 
by inverse 'H-{' 5N} NMR techniques. But unfortunately, unreacted carboplatin 
could not be removed from the product. It was therefore necessary to purify complex 
4 by other methods. First, it was tried to recrystallise complex 4 from solution. 
However, carboplatin 1 always crystallised from the solution together with complex 
4 and it was not possible to separate them by hand. It was then tried to exploit the 
different kinetics of substitution reactions between pt" and Pt" compounds to 
separate the complexes. Pt" complexes are generally more substitution inert than Pt" 
complexes.' 6 The mixture was stirred in pyridine at 373 K for 1 h. It was hoped that 
pyridine should only react with the more reactive Pt" compound carboplatin but not 
with cis, trans-[Pt"(CBDCA-O, 0 ')(NH3)212 1 (4). The Pt" pyridine adduct should 
then be soluble in pyridine but not complex 4 which could then be filtered off from 
the solution. But no reaction at all was observed between carboplatin and pyridine. 
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Scheme 4.2 Dependence of the "Pt chemical shift of Pt 1 V(CBDCA) amine 
compounds on the axial ligand in d7-DMF (Na2 [PtC161= 0 ppm in D20). a taken from 
ref. 15. 
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The same method was reported to work for the separation of the complexes 
[Pt"(en)1 2] and trans, cis-[Pt"(en)(OH) 212]. Pyridine reacted only with [Pt 11(en)12] 
which dissolved, but not the Pt 1" analogue which could be filtered off from 
solution. 12 
The chelate ligand CBDCA of carboplatin must be much more inert to substitution 
than the iodide ligand. 
The properties of carboplatin and cis, trans[PtR(CBDCA0,0 ')(NH 3)212] (4) are so 
similar that other techniques will be needed to separate them e.g. HPLC. 
Cis, trans- [Pt"(CBDCA-0,0')(NH 3)2Br2j (5)/ cis, trans- [Pt"(CBDCA-
0,0 ')(NH 3)2C12] (6) 
Two routes were used for the synthesis of cis, trans- [Pt"(CBDCA-O, 0 ')(NH3)2Br2J 
(5): via the intermediate cis, trans- [Pt"(CBDCA-O, 0 ')(NH3)2(OH)2] (3) and further 
reaction with HBr, and via direct oxidation with bromine. The pure product cis, 
trans- [Pt 1"(CBDCA-O, 0 ')(NH 3)2Br2] (5) however was obtained only by the route via 
the intermediate cis, trans-[Pt"(CBDCA-O, 0 ')(NH3 ) 2(OH)2] (3). 
For the synthesis of cis, trans-[Pt"(CBDCA-0, 0 ')(NH3 )2C12] (6) only the route via 
the intermediate cis, trans-[Pt"(CBDCA-O, 0 ')(NH3)2(OH)2] (3) and further reaction 
with HC1 was carried out. This was due to reports from Shamsuddin et al.'5 who 
stated that direct oxidation of [Pt 11(1,4-DACH)(CBDCA)] (DACH = 
diaminocyclohexane) by chlorine gas yielded [Pt 1"( 1 ,4-DACH)C14]. It was also 
reported that high concentrations of HCl in the presence of cis, trans- [Pt"(CBDCA-
0,0 ')(NH3 )2(OH)2] (3) leads also to the formation of the tetrachloro Pt" complex 
because of Pt-O bond cleavage in the axial and equatorial positions. 
Indeed, these observations by Shamsuddin et a!)5 were confirmed. During the 
attempt to prepare the complexes cis, trans- [Pt"(CBDCA-O, 0 ')(NH3)2Br2] (5) and 
cis, trans- [Pt`(CBDCA-0, 0 ')(NH3)2Cl2] (6), crystals suitable for X-ray analysis of 
the complexes cis-[Pt"Br 4(NH3)2] (13) and [Pt"C1 4(NH3)2] (14) were isolated and 
characterised by X-ray crystallography (see section 4.3.2). The complexes were 
obtained from reactions of cis, trans- [Pt"(CBDCA-O, 0 ')(NH3)2(OH)2] (3) with HBr 
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and HC1, respectively. It was found that for the synthesis of complexes 5 and 6 only 
a small excess of acid can be used (2-4 mol equivalent compared to Pt). It was also 
important to carry out the reactions in the dark, otherwise a mixture of products was 
obtained. 
Spectrum (C) in Figure 4.2 shows the 'H NIVIR spectrum of complex 5 in d 7-DMF. 
The splitting pattern for the NH 3 protons (peak 5a) is similar to that for peak 4a and 
the 'H chemical shift is in the expected range of a Pt 1" ammine complex." No peaks 
for Pt" impurities are present, unlike in spectrum (B). The ratio of the integrals of the 
peaks 5a, 5b/5c and 5d in spectrum (C), Figure 4.2 is 5a : 5b/5c : Sd = 6 : 3.9 : 1.82 
which is in agreement with the structure of cis, trans- [Pt"(CBDCA-O, 0 ')(NH3)2Br2] 
(5). 
Attempts were made to grow crystals of complexes 5 and 6 suitable for X-ray crystal 
structure determination, but were unsuccessful. 
4.3.2 X-ray crystal structures 
4.3.2.1 Carboplatin 
The data collection and refinement parameters for {Pt"(CBDCA-O, 0 ')(NH3)2] DMF 
are summarised in Table 4.1. The crystal structure is shown in Figure 4.4 and 
selected bond lengths and angles are listed in Table 4.2. [Pt"(CBDCA-
0,0 ')(NH3)2]DMF crystallised in an orthorhombic crystal system with the space 
group P2,2,2 1 . The environment of the Pt atom is square-planar. The six-membered 
dicarboxylate chelate ring is in a boat conformation, with the atoms Pt and C3 as 
prow and stern, out of the plane of the other four atoms 01, 02, C  and C2. The 
cyclobutane ring is puckered as opposed to planar as can be seen in Figure 4.4 (B). 
The crystal structure contains one DMF molecule per carboplatin molecule and there 
are four of each per unit cell. There is extensive hydrogen-bonding to give infinite 
three-dimensional networks (Figure 4.4 (B)/(C)). Along the b axis the structure 
consists of lines of carboplatin molecules with DMF molecules in between two 
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adjacent carboplatin molecules. The square-planar planes of the carboplatin 
molecules around the Pt atoms of two adjacent lines face each other building 
hydrogen-bonds between ammine nitrogens and 01 and 02, respectively. 
Three carboplatin crystal structures have been published by Neidle et al. ' 4 Beagley 
et al.'7 and Alston et al.'8 The bond lengths for this new carboplatin structure 
compare well with the published values. All four crystal systems are orthorhombic. 
The crystals of Neidle et al.'4 and Beagley et al.'7 belong to the space group Pnma, 
whereas this crystal and the one of Alston et al.` belong the space group P2,2,2,. 
The crystals of Neidle et al.'4 and Beagley et al.'7 contain no additional molecules, 
but the crystal of Alston et al. 18  co-crystallised with a-cyclodextrin. Interestingly, the 
crystals of Neidle et al. ' 4 and Beagley et al.'7 exhibit a planar cyclobutane ring in 
contrast to the crystal of Alston et al.'8 and this crystal where the cyclobutane ring is 
puckered. The planarity of the cyclobutane ring was accounted to crystallographic 
constraints which are imposed on the structure.' 4 The angle Pt - Z - C4 (see Figure 
4.4 (A)) of 94.13° shows that C4 is situated at a right angle above Z (Z = centroid 
between the atoms 01 and 02) which is in the square-planar plane around the Pt 
atom. Introduction of axial ligands should increase this angle and push the 
cyclobutane ring further away from the Pt centre. 
4.3.2.2 Pt" carboplatin dervatives 
The data collection and refinement parameters for the crystal structures 
[Pt"(CBDCA-O, 0 ')(OH)2(NH3)2] •4H20 and [Pt(CBDCA-0, 0 ')12(NH3)2 ] 2MeOH 
are summarised in Table 4.1. The X-ray crystal structures of both complexes are 
shown in Figure 4.5, and selected bond lengths and angles are listed in Table 4.2. 
Carboplatin trans-(OH) 2 (3). The X-ray structure and selected bond lengths and 
angles for {Pt"(CBDCA-O,O ')(OH) 2(NH3)2]•4H20 are shown in Figure 4.5 (A)! (B)! 
(C) and Table 4.2, respectively. [Pt"(CBDCA-O, 0 ')(OH) 2(NH3)2]•4H20 crystallised 
in a triclinic crystal system with space group P-i. The geometry around the Pt atom 
is as expected for a Pt" complex octahedral with angles N  - Pt - N2, 01 - Pt - 02 
114 
Chapter 4 Am(m)ino Pt(ll)/Pt(/V) CBDCA and oxalate complexes 
and 05 - Pt - 06 of 89.9(3)°, 92.4(2)° and 178.0(2)°, respectively. The six-
membered dicarboxylate chelate ring adopts a boat conformation. The cyclobutane, 
as in the carboplatin structure, is puckered and not planar. The Pt-N ammine bond 
lengths compare well with those of the carboplatin structure, but the Pt-U CBDCA 
bonds are shorter, e.g. Pt - 02 2.006(5) A in 3 compared to 2.029(4) A in 
carboplatin. The other bond lengths compare well with the carboplatin structure. The 
Pt-U hydroxide bond lengths of 1.996(6)! 2.009(6) A compare well with values for 
Pt"-OH bonds of structures (R < 0.05) published in the Cambridge Structural 
Database (CSD) with an average bond length of 2.008 A ± 0.006. The Pt - Z - C4 
angle has clearly increased compared to that for carboplatin, from 94.13 0 to 122.970 . 
This indicates that the presence of two axial hydroxide ligands pushes the 
cyclobutane ring further away from the Pt centre. 
Figure 4.5 (C) shows the crystal structure viewed along the a axis. Strong H-bonding 
occurs between axial hydroxide ligands and 01/ 02 of two adjacent molecules along 
the b axis with a distance of 1.932 A. Other H-bonds are from the hydroxide ligands 
to H2O and N of the ammines. 
Carboplatin trans-I2 (4). The X-ray structure and selected bond lengths and angles 
for [Pt(CBDCA-O,O ')1 2(NH3 )2f 2 MeOH are shown in Figure 4.5 (B)! (E)! (F) and 
Table 4.2, respectively. This crystal structure exhibits an orthorhombic symmetry 
and belongs to the space group P2 1 2 1 2 1 , as for carboplatin. There are two MeOH 
molecules per complex 4 molecule. The environment around the Pt atom is 
octahedral and the six-membered dicarboxylate chelate ring adopts a boat 
conformation. The presence of two bulky iodo ligands in trans position has a large 
effect on bond lengths and angles. The Pt-N ammine bonds are significantly longer 
and the Pt-Ui! 02 shorter than for carboplatin. Also the C-C bond lengths of the 
cyclobutane ring are significantly increased compared to carboplatin. Furthermore, 
the Pt - Z - C4 angle (see Figure 4.5 (B)) increased compared to carboplatin trans-
(OH)2  structure from 122.97° to 140.12°. The bigger iodide ligands (ionic radius of 1-
is 2.20 A compared to 1.4 A for 02)  push the cyclobutane ring even further away 
from the Pt centre. The Pt-I bond lengths of 2.6591(7)! 2.6474(7) A are in the same 
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range as those for other published Pt" complexes in the Cambridge Structural 
Database (CSD) with an average Pt-I bond length of 2.697 A ± 0.078. In Table 4.2 it 
can be seen that interestingly the Q - C3 - C4 angle is similar for carboplatin, 
carboplatin trans-(OH)2 and carboplatin trans-I2 , but the angles Pt - Z —C4 and Z - Q 
- C3 increase significantly due to the introduction of trans ligands. That means that 
the geometry of the boat conformation of the six-membered dicarboxylate chelate 
ring changes. The prow and stern Pt and C3 are pushed towards the C1-C2-02-Ol 
plane due to the introduction of the trans ligands. 
The diagram of the unit cell in Figure 4.5 (F) shows the crystal structure along the c 
axis. In contrast to the structure of complex 3, all molecules of complex 4 are 
oriented in the same direction. H-bonding occurs between 0 of MeOH and ammine 
N and carboxy 0 of complex 4. 
The space filling models of complexes 3 and 4 (Figure 4.5, (B) and (E)) illustrate 
how the size of the trans ligand influences the position of the cyclobutane ring. The 
position of the cyclobutane ring may have an important influence on the stability of 
the complex in biological media. The bulkiness of the cyclobutane ring could 
sterically hinder or slow down attacks on the trans ligands by common biological 
donor molecules like for example glutathione. Figure 4.5 (B), shows that the trans 
hydroxide 05H is shielded in the direction of the cyclobutane ring. The trans iodo 
ligand Ii in Figure 4.5 (D) is less shielded due to the size of 1. It can therefore be 
speculated that complex 3 will be more stable against attack by biological reducing 
agents than complex 4. 
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Figure 4.4 X-ray crystal structure of [Pt"(CBDCA-O,O ')(NH3)2fDMF with atom 
labelling and the crystal structure indicating the unit cell and hydrogen bonding 
(green dashes) between molecules. 1, Q represent the centroids of the atoms 01 and 
























C 	 a 
Figure 4.5 X-ray crystal structures (A and D). space filling models (B and E) and 
crystal structures with unit cells (C and F) indicating H bonding (green dashes) of 
trans, cis-[Pt(CBDCA-O, 0) (OH)2(NH3)21 (3) and trans, cis-[Pt"(CBDCA-0, 0') 
12(NH3)21 (4), respectively. 
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Table 4.1 Crystal structure data for complexes 1, 3 and 4. 
Complex 1 3 4 





(NH3)21- 2 MeOH 
Formula weight 444.36 477.35 689.15 
Crystal description Colourless block Colourless block Deep red block 
Crystal size (mm) 0.20x0.12x0.10 0.64x0. 19x0.06 0.38x0.28x0.26 
Crystal system Orthorhombic Triclinic Orthorhombic 
Space group P2 1 2 1 2 1 P-i P2 1 2 1 2 
Unit cell dimensions (A) a = 6.0697(10) 
b= 10.6503(17) 
c=20.633(3) 
a = 900 
= 90° 
a = 6.0504(11) 
b=9.4977(17) 
c= 12.461(2) 
a = 85.474(3)° 
P = 84.349(3)° 
a = 9.2474(4) 
b= 11.8063(4) 
c= 15.1843(6) 
a = 900 
P = 90° 
y= 90° 
Z 4 2 4 
Density (calc.) (Mg/M3)  2.213 2.232 2.761 
Absorption 	coefficient 
(mm- ') 
10.538 9.924 12.209 
F(000) 848 460 1256 
0 	range 	for 	data 
collection (deg) 
1.97 to 26.35 1.65 to 26.48 2.68 to 26.45 
Reflections collected 5684 5699 11227 
Independent reflections 2644 2859 3397 
Volume (A) 1333.7(4) 710.4(2) 1657.73(11) 
Temperature (K) 150(2) 150(2) 150(2) 
Wavelength (A) 0.71073 0.71073 0.71073 
Conventional R 0.0236 0.0398 0.0298 
wR2 0.0470 0.0885 0.0623 
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Table 4.2 Selected bond lengths (A) and angles (°) of carboplatin (1), trans. cis-
[Pt"(CBDCA-O, 0 ')(OH)2(NH3)2] (3) and trans, cis-[Pt"(CBDCA-O, 0 ')I(NH] 
(4). 
Complex 1 3 4 
Pt - Ni/ N2 2.014(5)! 2.019(5) 2.012(6)! 2.023(6) 2.032(7)! 2.041(7) 
Pt - 01/ 02 2.027(4)! 2.029(4) 2.015(5)! 2.006(5) 2.003(6)! 2.006(5) 
01-Cl! 02-C2 1.298(8)! 1.290(8) 1.287(10)! 1.307(10) 1.300(10)! 1.273(11) 
Cl -031C2-04 1.215(8)! 1.227(8) 
Cl - C3 1.529(9) 1.540(12) 1.533(13) 
C2 - C3 1.528(9) 1.505(12) 1.5 16(12) 
C3 -C4 1.527(8) 1.548(15) 1.588(13) 
C3 -C6 1.565(8) 1.550(11) 1.573(12) 
C4 - CS 1.528(9) 1.548(13) 1.568(13) 
CS -C6 1.549(9) 1.580(17) 1.573(12) 
Pt - 05! 06 1.996(6)! 2.009(6) 
Pt - 11/12 2.6591(7)! 2.6474(7) 
Ni -Pt-N2 92.38(19) 89.9(3) 93.6(3) 
01 -Pt-02 90.55(15) 92.4(2) 95.3(2) 
C4 - C3 - C6 88.9(5) 88.2(8) 87.4(7) 
C4 - CS - C6 89.5(5) 87.1(8) 89.3(7) 
05-Pt-06 178.0(2) 
11 -Pt-12 177.85(2) 
Pt-Z-C4 94.13 122.97 140.12 
Q-C3-C4 134.63 132.75 130.78 
Z-Q-C3 125.9 154.80 148.45 
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Figure 4.6 X-ray crystal structures of (A) cis-[Pt"Br4(NH3)21 (13), (B) cis-
{ptiVc(Nn)2] (14) and (C) [ItlV(en)4  (15). 
- 
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Table 4.3 Crystal structure data for the X-ray structures cis-[Pt"Br 4(NH3 ) 2] (13), 
cis-[Pt"C14(NH3)2 1 (14) and [Pt"(en)1 4] (15). 
Complex 13 14 15 
Empirical formula [PtBr4(NH3)2
] [PtCI4(NH3)2] [Pt(en)14] 
Formula weight 548.80 370.96 762.79 
Crystal description Orange block Pale yellow plate Red plate 
Crystal size (mm) 0.200.200.20 0.440.370.02 0.1 OxO. 1 OxO.04 
Crystal system Orthorhombic Orthorhombic Monoclinic 
Space group Fdd2 Fdd2 C2/c 
Unit cell dimensions (A) a = 23.113(3) 
b = 6.3951(7) 
c= 10.6279(13) 
a=90° 
a = 22.146(16) 




a = 11.0435(10) 




Z 8 8 4 
Density (calc.) (mg/m') 4.641 3.612 4.545 
Absorption 	coefficient 
(mm') 
38.114 22.019 23.608 
F(000) 1904 1328 1296 
0 	range 	for 	data 
collection (deg) 
3.5 to 27.5 4.03 to 29.01 3.06 to 29.01 
Reflections collected 2070 1612 4506 
Independent reflections 741 686 1392 
Volume (A3) 1570.9(3) 1364.5(17) 1114.66(17) 
Temperature (K) 150(2) 150(2) 150(2) 
Wavelength (A) 0.71073 0.71073 0.71073 
Conventional R 0.0260 0.0383 0.0166 
wR2 0.0569 0.1159 0.0373 
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Table 4.4 Selected bond lengths (A) and angles (°) of the complexes cis-
[Pt"Br4(NH3)2] (13), cis-[Pt"C1 4(NH3 )2] (14) and [Pt"(en)1 4] (15). 
Complex 	13 Complex 	14 Complex 	15 
Pt-NI/N2 2.099(10) Pt-NI/N2 2.035(11) Pt-NI/N2 2.112(3) 
Pt - Br!! Br4 2.4363(12) Pt - Cli! C14 2.312(4) Pt - 11/12 2.6267(3) 
Pt - Br2/ Br3 2.4570(10) Pt - C12/ C13 2.317(4) Pt - 13/14 2.6701(3) 
Ni -Pt-N2 91.8(6) Ni -Pt-N2 92.9(7) CI -C2 1.506(7) 
Ni-Pt-Brl 90.9(3) Ni-Pt-Cll 91.5(4) NI/N2-Cl/C2 1.490(5) 
Ni -Pt-Br4 178.0(3) Ni -Pt-C12 177.3(4) Ni -Pt-N2 82.10(16) 
Br2-Pt-Br3 179.05(6) CII -Pt-C14 179.2(3) NI -Pt-11 93.56(8) 
Ni -Pt-13 175.60(8) 
C2-NI -Pt 108.7(2) 
Tables 4.3 and 4.4 contain crystal structure data and selected bond lengths and angles 
for cis-{Pt"Br 4(NH3)2] (13), cis-[Pt"C1 4(NH3)2] (14) and [Pt"(en)1 4] (15). All three 
complexes were side-products obtained during attempted preparations of 
carboplatin- and [Pt"(CBDCA-O,O')(en)]- Pt' v derivatives. Figure 4.6 shows the X-
ray crystal structures of the three complexes. Ni and N2, the ligands trans to Ni and 
N2, and the two axial ligands are equivalent. The axial ligands Br2 and Br3 in Figure 
4.6 (A) and CI  and C14 in Figure 4.6 (B) lie together with the Pt centre in a mirror 
plane spanned by Br213, Cll/4 - Pt - centroid N1/N2. The crystals of complexes 13 
and 14 both exhibit only slight deviations from octahedral geometry around the Pt 
centre. The Pt - Cl and Pt - Br bond lengths with an average of 2.31 A and 2.45 A 
are consistent with bond lengths of published structures of Pt" complexes in the 
Cambridge Structural Database (CSD) (R < 0.05) containing Pt-Cl and Pt-Br bonds 
(average of published Pt"-CIfBr bond lengths are 2.328 A ± 0.045 and 2.507 ± 0.06, 
respectively). The Pt - N bond length in the crystal of complex 15 of 2.112(3) A is 
slightly longer than for other Pt-ethylenediamine compounds such as for example 
[Pt(en)C'21 (2.034 A). This increase is on the one hand due to the trans effect of the 
iodo ligands, and on the other hand due to the increase of the oxidation number from 
Pt" to PC. The N - C and C - C bond lengths and N  - Pt - N2, C2 - N  - Pt angles 
are very similar to reported values such as for example for [Pt"(CBDCA-O, 0 )(en)] 
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108.2(9)0. ' 
4.3.2.4 Pt oxalate complexes 
Figure 4.7 X-ray crystal structure of [Pt(en)(ox)] (7). 
Table 4.5 Selected bond lengths (A) and angles (°) for [Pt(en)(ox)] in comparison 
with data from published X-ray crystal structures from the Cambridge Structural 
Database (CSD) with R<0.05. 
Complex 7 Average 	bond 	lengths 	and 
angles from CSD 
Pt - NI! N2 2.009(7)! 2.034(7) 2.037 ± 0.020/ 2.039 ± 0.029 
NI -C3/N2 - C4 1.496(10)! 1.501(12) 1.487 ± 0.022/ 1.490 + 0.032 
C3-C4 1.492(12) 1.507±0.056 
Pt - 01/02 2.017(6)/2.026(6) 2.032 ± 0.022 
01 -Cl/02-C2 1.285(10)! 1.286(10) 1.268+0.033/1.291 ± 0.022 
Cl -C2 1.557(13) 1.559±0.025 
Cl -031C2-04 1.213(11)! 1.232(10) 1.235±0.031/1.210±0.017 
NI -Pt-N2 83.8(3) 83.41 ± 0.85 
Pt - NI - C3/ Pt - N2 - C4 110.7(6)! 109.4(5) 109.4 + 1.4/ 109.5 ± 1.8 
NI -C3-C4!N2-C4-C3 108.7(7)! 108.2(7) 108.1±2.96/107.8±2.8 
01 -Pt-02 82.4(2) 82.00 ± 0.57 
01 - Cl - C2/ 02 - C2 - C  114.7(8)/ 116.2(8) 116.4 ± 2.4 
The X-ray crystal structure of [Pt(en)(ox)] is shown in Figure 4.7 and the data 
collection and refinement parameters are summarised in Table 4.6. The complex 
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crystallised in a monoclinic crystal system and belongs to space group P2 1 /c. No 
solvent molecules are present in this crystal structure. The oxalate ligand is planar as 
expected and lies in the plane spanned by NI - Pt - N2. The comparison between the 
bond lengths and angles of this crystal structure and published structures in the CSD 
database of Pt" complexes containing ethylenediamine and oxalate ligands is shown 
in Table 4.5. The bond lengths and angles of this crystal structure fit well to the 
average bond lengths and angles of published crystal structures in the CSD database 
with a R factor < 0.05. 
Figure 4.8 X-ray crystal structure of [Pt"(oxalate)(I,IO-phenanthroline)] (10). 
The X-ray crystal structure of [Pt "(oxalate)(I ,10-phenanthroline)} (10) is shown in 
Figure 4.8 and the data collection and refinement parameters are summarised in 
Table 4.6. No bond lengths and angles are listed for this structure because the 
structure is not refined satisfactorily yet. However, the above structure confirms that 
compound [Pt11(oxalate)( 1,1 0-phenanthroline)1 (10) was obtained. 
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Table 4.6 Crystal structure data of complexes 7 and 10. 
Complex 7 10 
Empirical formula Pt(C2H8N2)(C204) Pt(C 2H3N2)(C2O4)3H2O 
Formula weight 343.21 511.31 
Crystal description Colourless rod Red plate 
Crystal size (mm) 0.350.080.06 0.11 xO.04xO.005  
Crystal system Monoclinic Triclinic 
Space group P2 1 /c P-1 
Unit cell dimensions (A) a = 4.3086(6) 




a = 6.525(2) 





Z 4 4 
Density (calc.) (mg/m 3) 3.299 2.191 
Absorption coefficient (mm') 20.271 9.092 
F(000) 624 960 
0 range for data collection (deg) 2.28 to 26.36 1.11 to 26.42 
Reflections collected 3848 9759 
Independent reflections 1402 5773 
Volume (A3) 691.05(16) 1550.1(8) 
Temperature (K) 150(2) 150(2) 
Wavelength (A) 0.71073 0.71073 
Conventional R 0.0329 0.0405 
wR2 0.0729 0.0699 
4.3.3 Photoreactivity experiments 
The complexes cis, trans-[Pt"(CBDCA-O, 0 ')(NH)2I2] (4) and cis, trans-
[Pt"(CBDCA-O, 0 ')(NH3)2Br2] (5) were tested for their photoreactivity. Solutions of 
complexes 4 and 5 in d7-DMF were irradiated with the 457.9 nm laser line. The light 
power was adjusted for both experiments to 50 mW at the end of the fibre optic. The 
experiments were followed by UV/VIS and NMR spectroscopy. 
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Cis, trans-  IPtR(CBDCA_O,O  ')(NH3)2121 (4) 
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~j 	Irradiation at 457.9 nm 
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Figure 4.9 UV/\TIS spectra of cis, trans-[Pt"(CBDCA-O, 0 ')(NHI] (4) in DMF 
(a) before irradiation and (b) after 41 h irradiation with laser line 457.9 nm (50 mW). 
Figure 4.9 shows the UV[\TIS spectra of a cis, trans- [Pt"(CBDCA-O,O ')(NH3)212] 
(4) solution in DMF before and after the irradiation with the laser line 457.9 nm. The 
colour of the solution changed from dark red to pale orange during the photoreaction. 
The charge transfer band at 366 nm totally disappeared during the irradiation. This 
band is due to the ligand-to-metal charge transfer from the iodide ligands to the Pt 1" 
centre which is known to be at this low energy. 2 The disappearance of this band and 
the colour change from dark red to almost colourless indicates the cleavage of the 
iodo-Pt bond. The disappearance of the ligand-to-metal charge transfer probably 
indicates the photoinduced reduction of the Pt 1" centre to Pt". But further 
experiments are needed to prove that complex 4 can indeed be reduced upon 
irradiation with visible light. 
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Cis, trans-[Pt"(CBDCA-O, 0 ')(NH3)2Br2 1 (5) 
320 
(b) after irradiation 
0I 	 3 
cc 	/
70 
(a) before irradiation 
Irradiation at 457.9 nm 
300 	 400 	 500 	 600 
nm 
Figure 4.10 UV/VIS spectra of cis, trans- [Pt"(CBDCA-O,O ')(NH3)2Br2] (5) in 
DMF (a) before irradiation and (b) after 21 h of irradiation with laser line 457.9 nm 
(50mW). 
Figure 4.10 shows the UV/VIS spectra of cis, trans-[Pt"(CBDCA-O, 0 ')(NHBr2 ] 
(5) in DMF before and after irradiation with the laser line 457.9 nm (50 mW). A 
colour change from bright yellow to colourless occurred during the irradiation. This 
colour change can be associated with the disappearance of the strong band centered 
at 370 nm (Figure 4.10). The band at 370 nm is assigned to ligand-to-metal charge 
transfer from the bromide ligand to the Pt" centre. The band at 320 nm was in 
comparison not affected by the irradiation. This suggests that the Pt-Br bonds are no 
longer present after the irradiation. Complex 5 is therefore sensitive towards visible 
light. 
The same reaction was also followed by 'H NMR to obtain more information about 
the nature of the photoreaction. Figure 4.11 shows the spectra of cis, trans-
[Pt"(CBDCA-O, 0 ')(NI-13)2Br2] (5) in d7-DMF (A) before and (B) after the 
irradiation. There are significant differences between spectra (A) and (B). A new 
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broad peak at 7.8 ppm appeared which is assigned to the ammonium ion which must 
be due to cleavage of Pt-ammonia bonds upon irradiation. The cleavage of Pt-
ammonia bonds was also observed for ammino Pt azide complexes (see chapter 6). 
The coupling of peak 5a disappeared, but the presence of the peaks 5b/5c and Sd 
prove that there is still Pt" complex present. The peaks marked by ellipses are due to 
new photoproducts. Peak 15a at 4.8 ppm exhibits a 'H chemical shift which is typical 
for a Pt" NH3 compound 13  and the quintet 15d at 1.8 ppm is at the same shift as the 
corresponding peak id for carboplatin (Figure 4.2). The peaks 15a and 15d can 
therefore be assigned to a Pt" photoproduct. The two triplet peaks 15b and 15c could 
possibly be due to the same photoproduct. 
This result suggests that cis, trans-[Pt"(CBDCA-O, 0 ')(NH3)2Br2] (5) can be reduced 
to a Pt" species upon irradiation with light of 457.9 nm. The LJVIVIS spectra suggest 
that the bromine atoms are lost during this reaction. But further studies are needed to 
elucidate the mechanism of this photoreaction. 
[Pt"(oxalate)(l,lO-phenanthroline)] (10) 
[Pt"(oxalate)(en)] (7) is pale yellow and therefore absorbs only slightly in the visible 
range of light (450 nm-750 nm). The idea behind the synthesis of[Pt"(oxalate)(l,lO-
phenanthroline)] (10) was to shift the absorbance of the complex more into the 
visible range of light since the objective is to develop compounds which are 
photoactivatable with visible light. On the one hand 1,1 0-phenanthroline is known to 
act as a chromophore in Pt" complexes 20, on the other hand Pt" complexes containing 
1,10-phenanthroline like [Pt(en)(phen)]C1 2 have been shown to bind to DNA by 
intercalation .2 ' Furthermore, Pt" complexes of 1,1 0-phenanthroline and amino acids 
have been shown to exhibit cytotoxicity similar to cisplatin against a human 
leukaemia cell line .22  All these characteristics of 1,1 0-phenanthroline Pt" complexes 
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Figure 4.11 'H NMR spectra of cis, trans- [Pt"(CBDCA-O,O ')(NH3 )2Br2J (5) in d7-
DMF (A) before irradiation and (B) after 21 h of irradiation with 457.9 nm (50 mW). 
The assignments are according to Figure 4.2. 
Figure 4.12 shows the TJVIVIS spectrum of a saturated solution of 
[Pt"(oxalate)( 1,1 0-phenanthroline)] (10) in H 20. The introduction of the 1,10-
phenanthroline ligand led to an extended broad band centered at 480 nm. This band 
is also the reason for the intense red colour of complex 10. 
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Figure 4.12 UV/VIS spectra of [Pt"(ox)(phen)] (10) in H 20 (a) before irradiation 
and (b) after 21 h irradiation with the laser line of 457.9 nm (Ca. 40 mW). 
It is thought that complex 10 could act as a good DNA intercalator due to the 
planarity of the complex. The aim of the irradiation however was to investigate if 
irradiation at 480 nm leads to any change in the UVIVIS spectrum due to a possible 
chemical reaction. Figure 4.12 shows both the spectra (a) before irradiation and (b) 
after 21 h of irradiation with light of 457.9 nm (ca. 40 mW). A slight decrease of the 
band at 480 nm and a slight increase of the band at 370 nm was observed. This 
shows that compound 10 is sensitive to visible light in water and perhaps undergoes 
photochemical reactions. But such reactions depend on many factors such as solvent, 
the presence of any electron donor/ acceptor molecules, irradiation wavelength and 
intensity. Further studies will be needed to find out the potential of this kind of Pt" 
oxalate complexes containing a diimine chromophore ligand. 
4.3.4 Electrochemical studies 
Cyclic voltammetry was carried out on carboplatin (1), cis, trans- [Pt"(CBDCA-
0,0 ')(NH3) 2Br2] (5) and cis, trans-[Pt"(CBDCA-O, 0 ')(NH3)2C12] (6) in DMF using 
a glassy carbon working electrode, a Ag! AgC1 reference electrode and a Pt wire as 
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counter electrode. The carboplatin cyclic voltammogram (CV) at 293 K shows an 
irreversible reduction process at —0.07 V and an irreversible oxidation process at 
+1.25 V (Figure 4.13 (A)). 
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Figure 4.13 Cyclic Voltammograms of (A) carboplatin (1) and (B) cis, trans-
[Pt"(CBDCA-O, 0 ')(NHBr] (5) in DMF/ 0.1 M [NBu 4]BF4 at 293 K. 
The CV of cis, trans- [Pt"(CBDCA-Q,0')(NH 3 )2Br2] (5) (Figure 4.13 (B)) at 293 K 
shows two irreversible reduction processes at —0.5 V and —0.95 V. There is also a 
quasi-reversible oxidation process at +0.5 V. The same CV was repeated at 223 K to 
see if reversibility could be induced by lowering the temperature. But the CV at 223 
K was identical to the one at 293 K and reversibility of the reduction processes can 
therefore not be induced by lowering the temperature. 
Cis, trans-[Pt 1 "(CBDCA-O, 0 ') (NH3)2C'21   (6) exhibited similar redox properties as 
cis, trans- [Pt"(CBDCA-O, 0 ') (NH3)2Br2l  (5), but the peak potentials were shifted to 
—0.75 V and —1.15 V for the reduction processes and to +0.6 V for the oxidation 
process, respectively. 
The peak heights of the reduction and oxidation peaks in the cyclic voltammograms 
were measured at different acquisition scan rates (V/ s). Graphs of the (peak height) 
vs. (scan rate)" resulted all in a straight line. This indicates that the reductions and 
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oxidations are diffusion controlled processes. 23 
Coulometry was carried out both on complexes 5 and 6 to find out the number of 
electrons involved in the reduction/ oxidation processes. The potential at the working 
electrode was held constant and the charge passed for a reduction/ oxidation process 
was measured against time in Coulombs. For cis, trans [PtRI(CBDCA 
0,0 ')(NHBr] (5), the potential was first held at —0.5 V to reduce complex 5 in 
bulk. A colour change from yellow to colourless was observed during the reduction. 
The potential was then changed to +1 V to reoxidise the complex. The colour 
changed back to yellow during this oxidation. A CV was carried out after the 
complete oxidation and this CV was similar to the CV of the starting product cis, 
trans-[Pt"(CBDCA-O, 0 ')(NH3)2Br2J (5). This reduction process can therefore be 
reversed by an oxidation. The passed charges measured during the reduction and 
oxidation were 1.5 and 1.8 Coulombs, respectively. Using the following equation, 
which is based on Faraday's laws, it was determined that the above reduction was a 
one electron reduction. 
Q = n e F with 	Q = passed charge in Coulombs 
n = number of moles of substance 
e = number of electrons per molecule which take part 
in the reaction 
F = Faraday constant (96484 Coulombs/ mol) 
A CV was carried out of the one electron reduction product of complex 5 and 
compared with the CV of free bromide (Br) ions. The oxidation potentials were 
found to be +0.45 V and +1.05 V for the one electron reduction product of complex 
5 and bromide, respectively. This showed that free bromide ions are not released 
upon the one electron reduction of complex 5 as would have been expected from the 
colour change during the reaction. 
For cis, trans-[Pt'(CBDCA-0, 0 ')(N}13)2C12] (6), the potential at the working 
electrode was first held at —1 V for reduction and then changed to +1.35 V for 
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reoxidation. However, no reoxidation of the complex occurred and the complex 
seemed to decompose. From the measured charge passed during the reduction (1.86 
Coulombs), it was determined by using above equation that the reduction is a one 
electron process similar as for complex 5. 
4.4 Conclusions 
Pt" carboplatin ([Pt"(CBDCA-O, Q ')(N}I) 2]) derivatives can be prepared by 
oxidative-addition of two additional axial ligands. The X-ray crystal structures of cis, 
trans-[Pt"(CBDCA-O, 0 ')(NH3)2(OH)2] (3) and cis, trans-[Pt"(CBDCA-
0,O')(NH3)212 ] (4) were obtained, which are the first crystal structures of Pt" 
derivatives of carboplatin. It could be shown that the position of the cyclobutane ring 
is directly influenced by the size of the axial ligands. The presence of axial ligands 
pushed the cyclobutane ring further away from the Pt centre. The cyclobutane ring 
was pushed further away in the case of axial iodo ligands than in the case of axial 
hydroxy ligands due to the larger size of the iodo ligands. 
A novel X-ray crystal structure of carboplatin, which contains one DMF molecule 
per carboplatin molecule, was also obtained. This is the fourth reported crystal 
structure of carboplatin. It contains a puckered cyclobutane ring in contrast to two of 
the reported structures, which exhibit a planar cyclobutane ring. The cyclobutane 
ring lies almost at a right angle above the Pt centre. 
The complexes cis, trans- [Pt"(CBDCA-O,O ')(NH 3 )212] (4) and cis, trans-
[Pt"(CBDCA-O, 0 ')(NH3)2Br2] (5) have been shown to be photosensitive towards 
visible light. The disappearance of the ligand-to-metal charge transfer bands in the 
UV/VIS spectra upon irradiation with light of 457.9 nm indicates that the irradiation 
probably leads to the loss of the halide ligands. The presence of peaks in the 'H 
NMR spectrum due to a pt" ammine complex after the irradiation of complex 5 
shows that a photoreduction from Pt" to Pt" took place. 
The cyclic voltammograms of complexes cis, trans-[Pt"(CBDCA-O, 0 ') (NH3)2Br2l  
(5) and cis, trans-{Pt"(CBDCA-0, 0 ')(NH3)2C12] (6) showed that two reduction 
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processes take place which are irreversible. It could be shown by coulometry that 
these reductions are both one electron processes. The first reduction led to a colour 
change from yellow to colourless. This reduction could only be reversed for complex 
5 but not for complex 6. 
The introduction of a diimine chromophore like 1,1 0-phenanthroline into a Pt" 
oxalate complex leads to an extended band in the visible range of the UVIVIS 
spectrum. Irradiation into this band led to a decrease of this band which proves the 
sensitivity of such complexes against visible light. 
4.5 Future Work 
It was shown so far that Pt" carboplatin derivatives containing axial halide ligands 
are photosensitive towards visible light. Further studies are needed to find out the 
mechanism of the photoreactions and to investigate the difference in sensitivity at 
different irradiation wavelengths. ' 5N labelling of the ammonia ligands of the 
compounds would permit the use of inverse 'H-{' 5N} NMR techniques." 
Photoreactions could directly be followed by NMR and would give evidence of the 
mechanism of the photoreactions. Preparation of ' 5N labelled pure complexes cis, 
trans-[Pt"(CBDCA-O, 0 ')(N"3)2 121 (4), cis, trans-[Pt"(CBDCA-O, 0 ')(NH3)2Br2] (5) 
and cis, trans- [Pt"(CBDCA-O, 0 ')(NH3)2 C12] (6) is therefore the next step in finding 
out more about the photosensitivity of this kind of complex. ' 5N-labelled complexes 
should then also be used for investigating reactions of complexes 4, 5 and 6 with 
biomolecules such as mononucleotides and oligonucleotides both in the presence and 
absence of light. Interactions with biological important reducing agents like 
glutathione and the stability of the complexes in blood plasma should be 
investigated. 
Cytotoxicity studies of the complexes should be carried out to investigate the 
potential of these kind of complexes as photoactive prodrugs. The tests should be 
carried both in the presence and absence of light. 
Finally, new compounds containing different amine ligands should be prepared. The 
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influence both on the photosensitivity and cytotoxicity should be studied. 
The novel Pt oxalate complexes should be tested on their interactions with DNA and 
their cytotoxicity. The photosensitivity of Pt oxalate compounds containing diimine 
chromophores should be further investigated using both visible and UV light. Their 
properties as DNA intercalators should be investigated. Pt' oxalate derivatives 
should be prepared and their photosensitivity tested both by NMR and UV/VIS. 
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Different approaches can be chosen when facing the problem of developing a 
precursor of an active platinum anticancer drug. However, the approach of using a 
Pt" compound as precursor has considerable advantages: 
- Pt" compounds are generally substitution-inert' 
- the formation of an active Pt" species can often be predicted well from the 
structure of the Pta' reactant. 
To design a Pt 1" precursor, which is photoactive and can be transformed to the active 
Pt" species by light, some additional problems have to be considered. Two electrons 
must be donated to the Pt" centre during the photoreaction process in order to obtain 
a Pt" compound. Additionally, two ligands must leave the octahedral Pt" compound 
during the photoreaction to yield a square-planar Pt" compound. As the Pt" 
compound should be photoactive on its own (not dependent on substrates), ligand-to-
metal charge transfer (LMCT) reactions can be considered which involve electronic 
transitions from the molecular orbitals localised on the ligand to molecular orbitals 
localised on the metal. In order that a permanent chemical change can take place, a 
reductive photoelimination reaction must occur which leads to the reduced platinum 
centre and the oxidized leaving group. In order to donate two electrons to the Pt" 
centre, two ligands must be oxidized during the photoreaction, and then leave. 
This concept was first used by Kratochwil et al.,' who prepared the complex trans, 
cis-[Pt(en)(OA0 212]. This is a PC cisplatin analogue with two iodide ligands in cis 
positions. The iodide ligand is known to give rise to LMCT bands at long 
wavelengths. The two iodide ligands can be the source for the reduction of the Pt" 
centre, each of them donating one electron. The resulting Pt" compound could then 
bind covalently to DNA and act as an anticancer drug. 
Indeed, Kratochwil et al. were able to show that Pt" was covalently bound to DNA 
after irradiation of the complex trans, cis-[Pt(en)(OA0 212] with light > 375 nm. 
However, this compound did not show any direct photoreduction from Pt" to Pt" in 
the absence of nucleobases, and its photoreaction in the presence of nucleobases 
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proved not to be a simple photoreductive elimination reaction in which the two 
iodide ligands are oxidized.' 
The photochemistry of halo Pt" complexes is well studied, especially the complex 
[PtC16] 2 which is catalytically active in organic redox reactions'. The Pt" is reduced 
to Pt... or Pt", the fate of the Pt' 11 intermediates depending strongly on the ligands, on 
the reaction partner, or on the solvent. These labile and very reactive Pt' 1 ' complexes 
can undergo either reoxidation to Pt" or further reduction to Pt". 
Another ligand, besides the halides, which has received attention as a ligand able to 
reduce the Pt" centre is: the pseudo-halide azide ion (N 3 ). Vogler et al. have 
investigated the photochemistry of the following compounds: trans-
[Pt(IV)(CN) 4(N3 )2] 2 , trans- [Pt(IV)(CN)4N3 X]2- (X = Cl, Br) and trans-
[Pt(IV)(CN) 4X2 ] 2 (X = Cl, Br).' ,'. They used 300 nm light for irradiation, and water 
and ethanol as solvents. All complexes underwent efficient and complete 
conversions to [Pt(CN) 4] 2 in ethanol. The complexes containing an azide ligand also 
showed a complete reduction to [Pt(CN) 4] 2 in water. For the complexes with two 
trans halide ligands, trans- [Pt(IV)(CN) 4X 2J 2 (X = Cl, Br), a photolysis reaction 
occurred in water and [Pt(CN) 4] 2 was identified, but this reaction was not a simple 
photoreduction to the Pt" product [Pt(CN) 4] 2 because of the occurrence of secondary 
thermal and photochemical reactions'. It was also observed for trans-
[Pt(IV)(CN) 4X2] 2 (X = Cl, Br) complexes that the photoreaction was much less 
efficient in water than it was in ethanol. Vogler et al.' showed that the photoredox 
reaction of trans-[Pt(IV)(CN)4(N3)2]2 takes place by a simultaneous two-electron 
reduction from Pt" to Pt" and the liberation of two azide radicals without forming a 
Pt" intermediate. Azide radicals were detected by low temperature EPR studies. 
Azide radicals are very unstable and decompose in water rapidly into molecular 
nitrogen N 2 . In general, efficient photoredox reactions of transition metal complexes, 
resulting in the reduction of the metal and oxidation of ligands, occur only if the 
photoreduced metal complex is kinetically very labile or if the oxidized ligand 
radicals are efficiently scavenged by secondary reactions.' Otherwise recombination 
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reactions regenerating the starting complex can occur. The fast decomposition of 
azide radicals is believed to be the reason for the efficiency of the photoredox 
reactions of the complexes containing azide ligands. This fast decomposition 
undermines any reoxidation of the platinum centre to the PtR  starting material. The 
above reaction also occurs at room temperature. Therefore the fast decomposition of 
the azide radicals in water makes azide a suitable ligand for an efficient photoredox 
reaction in water. In contrast, halogen radicals do not decompose in water, and as a 
consequence, the recombination to the starting material is an efficient process.' 
These properties of the azide ligand are attractive for incorporation into a 
photoactive Pt" anticancer drug precursor. First of all, two azide ligands are 
necessary for donation of two electrons to the Pt 1" centre. So far, only photoreductive 
trans elimination processes are known, and it was first planned to incorporate the 
azide ligands in the two axial positions, but attempts were also made to synthesise an 
analogue of compound trans, cis-[Pt(en)(OAc) 212] but to use instead of the iodide 
ligand the azide ligand in the hope of obtaining better photochemical properties. 
Additionally, the introduction of azide in cis position is synthetically easier. Another 
concern was the stability and the water solubility of the Pt 1"' complex. The 
knowledge that hydroxide ligands improve water solubility and stabilise the Pt" 
complex' led to the synthesis of the complexes cis, trans-[Pt"(N 3)2(OH)2(NH3)2] and 
cis, trans-[Pt"(en)(N3)2(OH) 2]. The hydroxide ligands can readily be introduced into 
the axial positions by oxidative addition reactions using H 202 . The additional 
knowledge that the azide ligand is a good donor ligand for d-metals led to the 
possibility of developing an inert Pt 1" prodrug which can be transformed into a Pt" 
anticancer complex via a two electron photoredox reaction as illustrated in Scheme 
5.1. 
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Scheme 5.1 Proposed mechanism of the photoreaction of an ammino Pt" diazido 
complex involving reduction to Pt" and release of N 2 . 
The following sections describe the synthesis and characterisation of novel Pt" azide 
cisplatin analogues. The photoreactions were studied directly by 'H and 2D ['H, ' 5N] 
HSQC NMR spectroscopy by directing laser light into the NMR tube via a fibre 
optic and are described in Chapter 6. The Pt" complexes were ' 5N labelled to 
increase the sensitivity of the NMR experiments. 
5.2 Experimental 
5.2.1 Reagents 
K2 [PtC14] was purchased from Johnson Matthey. NH 4C1 and NaN3 were purchased 
from BDH; AgNO 3 , ethylenediamine (en) and diethylenetriamine (dien) was 
purchased from Aldrich, and K1 was purchased from Fisher. Acetic anhydride and 
H202 (30%) was purchased from Prolabo. H 20 was deionized with a USF Elga 
deionizer. Other solvents were generally dried over 3 A molecular sieve and purified 
by standard methods. D 20 and ' 5NH4C1 were purchased from Aldrich. ' 5N-labelled 
ethylenediamine was synthesised according to a literature method.' Glutathione 
(GSH) and Na2 5'-GMP•H 20 were purchased from Acros, d(GpG) sodium salt was 
purchased from Sigma and the human blood plasma (leucocyte depleted, blood 
group 0 Rh D positive) was provided by the Western General Hospital in Edinburgh. 
The sodium salts of HPLC-purified oligonucleotides d(ATACATGGTACATA) and 
d(TATGTACCATGTAT) were supplied by Oswel. 
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5.2.2 NMR spectroscopy 
NMR spectra were recorded at 298 or 310 K on a Bruker DMX 500 MHz ('H 500.13 
MHz; ' 5N 50.7 MHz) or on a Bruker DPX 360 MHz ('H 360 MHz; ' 5N 36.5 MHz) 
NMR spectrometer, using 5-mm amberised NMR tubes. Screw cap NMR tubes were 
used for the observation of photoreactions. A fibre optic (FT-600-UMT, diameter 
600 JLm, Elliot Scientific Ltd.) was inserted into the NMR tube to irradiate the 
sample. All data processing was carried out using XWIN-NMR software version 1.3 
(Bruker Spectrospin Ltd.). All samples were prepared in 90% H 20/10% D 20 or 95 % 
H20/5% D20 and the pH adjusted to Ca. 5 with 0.1 M perchloric acid (HC10 4) unless 
otherwise stated. The chemical shift references were as follows: 'H, TSP sodium 3-
(trimethylsilyl)propionate-2,2,3,3-d 4 (internal, 0 ppm) or dioxane (internal, 3.764 
ppm), ' 5N (external, 1 M 15NH4C1 in 1.5 M HQ. All spectra were recorded at 298 K 
unless otherwise stated. For 'H NMR, typical acquisition conditions for 1D spectra 
were as follows: 45-60° pulses, 16-32 k data points, 1-3 s relaxation delay, collection 
of 32-128 transients, final digital resolution of 0.2-1 Hz/point. The water resonance 
was suppressed by presaturation, or by pulsed-field-gradients. 2D ['H,' 5N] HSQC 
NMR spectra (optimized for 'H) = 73 Hz) were recorded using the sequence of 
Stonehouse et al.'° The ' 5N-spins were decoupled by irradiation with the GARP-1 
sequence during acquisition. Water suppression was achieved by pulsed-field 
gradients. Typically, 8 scans were acquired for each of 128 increments oft, and the 
final resolution was 6 Hz/point for the F2 dimension and 8 Hz/point for the Fl 
dimension. 
5.2.3 Electrospray ionization mass spectrometry 
Positive and negative ion electrospray mass spectrometry was performed on a 
Platform II mass spectrometer (Micromass, Manchester, UK). The samples were 
infused at 8 t1/min and the ions produced in an atmospheric pressure ionization 
(API)/ESI ion source. The source temperature was 338 K, and the drying gas flow 
rate 300 1/h. A potential of 3.5 kV was applied to the probe tip, and cone voltage 
gradients of 10-50 V over 200-1500 Da were used. The acquisition of data was 
performed on a Mass Lynx (V. 2.3) Windows NT PC data system. The samples were 
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prepared in a water/acetonitrile (1/2 v/v) solution. 
5.2.4 Raman spectroscopy 
The Raman spectra were recorded on a ISA Labram 1 confocal microscope laser 
Raman system using the software Labspec V2-09. 
5.2.5 UVNIS spectroscopy 
The UV/VIS spectra were recorded on a Varian Cary 300 Scan UV/visible 
spectrophotometer using 1 cm path length quartz cuvettes. The spectral width was 
from 200-900 nm and the bandwidth 1 nm. Spectra were referenced to solvent alone. 
Data were processed with Microcal Origin 5.0. 
5.2.6 CHN elemental analysis 
Microanalyses were carried out in the Department of Chemistry on a Perkin Elmer 
2400 CHN Elemental Analyser. 
5.2.7 pH measurements 
These were made using a Corning 145 pH meter equipped with an Aldrich micro 
combination electrode calibrated with standard buffer solutions at pH 4, 7 and 10. 
5.2.8 pK determinations 
The 'H chemical shifts were determined on a Bruker DPX 360 MHz NMR 
spectrometer and fitted to the Henderson-Hasselbaich equation using the program 
Kaleidagraph." 
5.2.9 X-ray crystallography 
X-ray crystal structure analyses were carried out by Dr. Simon Parsons at the 
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University of Edinburgh. Crystallographic data were collected on a Bruker Apex 
Smart CCD diffractometer at 150 K using molybdenum radiation X = 0.71073 A. 
5.2.10 Preparations 
Cis- [Pt"(N3)2(NH3)2J (1) 
K2 [PtC14] ( 1 g, 2.41 mmol) was dissolved in 50 ml deionized water in a 100 ml 
round-bottomed flask. KI (4 g, 10 mol eci) was added and the solution stirred for 30 
min at room temperature. NH 4C1 (2 mol eq, 0.26 g, 4.88 mmol) was added to the 
solution. The pH was adjusted to 10 with 1 M NaOH. The yellow precipitate was 
filtered off and washed with water, ethanol and ether. The yellow solid (cis-
[Pt(N}{3)212]) was dried in a desiccator over silica gel. 
Cis-[Pt(NH 3)212] (0.2 g, 0.43 mmol) and 2 mol eq AgNO3 (0.146 g, 0.86 mmol) were 
placed to a round-bottomed flask. Deionised water (20 ml) was added and the 
suspension was stirred in the dark for 24 h. The AgI-precipitate was twice filtered off 
with an inorganic membrane filter (Whatman, Anotop 10, 0.02 jtm). NaN 3 (20 mol 
eq, 0.57 g, 8.77 mmol) was added and the solution stirred for 30 min in the dark at 
room temperature. The solvent volume was reduced to 10 ml on a rotary evaporator 
and the flask put in the fridge overnight. The yellow precipitate was washed with 
ether and dried in air. Yield: 97 mg (72 %). 
Crystals suitable for X-ray crystal structure determination were grown in water at 
277 K in the fridge. ' 5NH4CI was used for the preparation of the ' 5N labelled 
analogue. 
CHN: Found: C, 0.00; H, 2.22; N, 35.99; Calculated for PtH 6N8 : C, 0.00; H, 1.90; N, 
36.19. 
ESI-MS: 313.7 m/z (calc. 313 mlz). 
'H NMR (90% H 20/10% D20): ö 3.80 ppm (s, ' 5N-H3), 'J( 15N-H) 72.3 Hz, 2.J( 195Pt-
H) 57 Hz. 
2D ['H,' 5N] HSQC NMR: 8 ('H, ' 5N/ 3.86, -69.52), 'J( 195Pt-' 5N) 305 Hz. 
Raman (cm'): 192 (weak), 219 (strong), 287.2 (s), 407 (s), 506 (s), 520 (s), 685 (w), 
1281 (s), 1296 (s), 1317(w), 1326 (w), 1374 (w), 2039 (m), 2069 (m), 3170 (w, 
broad), 3288 (w, broad). 
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UV/VIS: 360 nm (E = 250 1 mol' cm'), 320 nm (E = 520 1 mol' cm'), 260 rim (c = 
820 1 mol' cm') 
Cis, trans, cis- [Pt"(N 3)2(OH)2(NH3)2] (2) 
H202 (40 mol eq, 1.2 ml 30% H2021  11.75 mmol) was added to a suspension of cis-
{Pt(N3)2(N}-13)2 1 (0.086 g, 0.27 mmol) in water (10 ml), which led to the dissolving of 
the yellow cis-[Pt(N 3)2(NH3)2]. The solution was stirred in the dark at room 
temperature for 24 h. The volume of the solution was reduced on a rotary evaporator 
and standing in the fridge for 2 d, a yellow precipitate was obtained which was 
filtered off and washed with water and ether. 
Yield: 32.8 mg (35%) 
Crystals suitable for X-ray crystal structure determination were grown from a 
water/ethanol/chloroform (80:10:10 %) mixture in the fridge at 277 K. 
CHN: Found: C, 0.00; H, 2.64; N, 31.85; Calculated for PtH 8N802 : C, 0.00; H, 2.30; 
N, 32.28. 
ESI-MS: 349.7 mlz (calc. 349 m/z). 
'H NMR (90% 1420/10% D20, pH 4.5): 6 5.13 ppm (s, ' 5N-H3), 'J(' 5N-H) 73.5 Hz, 
2J(' 95Pt-H) 46.2 Hz. 
2D ['H,' 5N] HSQC NMR: 6 ('H, ' 5N/ 5.2,-39.8), 'J( 195Pt-' 5N) 258.1 Hz. 
Raman (cm- '): 207 (m), 223.96 (m), 241.4 (w), 421.3 (s), 531.2 (m), 542.6 (m), 571.5 
(s), 1140 (w), 1275 (w), 1290.6 (w), 1342 (w), 2046 (s), 2064 (s), 2990 (w, broad), 
2992 (w, broad), 3050 (w, broad), 3235 (w, broad). 
IJV/VIS: 360 nm (c = 208 1 mol' cm'), 330 nm (s = 240 1 mol' cm'), 260 nm (E = 
400 1 mol' cm'), 457 nm (c = 9 1 mol' cm'), 488 nm (E = 3 1 mol' cm'), 647 nm 
= 1.41 mol' cm'). 
Trans, cis, cis-[Pt"(OCOCH3)2(N3)2(NH3)2J (3) 
H202 (0.5 ml 30% H202, 4.9 mmol) was added to a suspension of cis-
[Pt' 1(N3)2(NH3)2] (0.028 g, 0.09 mmol) in water (5 ml), ), which led to the dissolving 
of the yellow cis-[Pt(N 3)2(NH3)21. The solution was then stirred overnight at room 
temperature in the dark. The solvent was removed on a rotary evaporator, and the 
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yellow precipitate was dried overnight under vacuum. Dichloromethane (5 ml) was 
added to the yellow precipitate, followed by dropwise adding of acetic anhydride (4 
ml, 42.4 mmol) under cooling with an ice bath. The suspension was stirred for one 
week in the dark. The pale yellow precipitate was filtered off and washed with cold 
water and ether and then dried over silica gel. 
Yield: 25 mg (64 %) 
The yellow filtrate was placed into the freezer (253 K). Addition of ether resulted in 
a yellow precipitate from which crystals suitable for X-ray crystal structure 
determination were grown in the fridge at 277 K in methanol/water (1/1 v/v) in a 
NMR tube. 
'H NMR (90% H20/10% D 20, pH 6.46): 6 5.65 (s, ' 5N-H3), 'J(15N-H) 75 Hz, 2J(' 95Pt-
H) 48 Hz; 2.01 (s, OCO-CH 3) ' J(13C-H) 129.5 Hz. 
2D ['H, "N] HSQC NMR: 6 ('H, ' 5N/ 5.75, -44.45), 'J(' 95Pt- 15N) 255.4 Hz. 
[Pt"(' 5N-en)(N3)21 (4) 
' 5N-labelled ethylenediamine was synthesised as previously described .9  '5N-en 
2HC1 (0.052 g, 0.39 mmol) was dissolved in deionized water and the pH adjusted to 
8 with 1 M NaOH. K 2 [PtCl4] (0.162 g, 0.39 mmol) was added and the solution stirred 
at room temperature. The pH was regularly adjusted to 8-9. The obtained yellow 
precipitate ([Pt(' 5N-en)Cl2]) was washed with water and ether and dried over P 205 . 
{Pt( 15N-en)Cl2] (0.04 g, 0.12 mmol) and 2 mol eq AgNO3 (0.041 g, 0.24 mmol) were 
stirred in deionized water in the dark at room temperature for 24 h in a round-
bottomed flask. The white precipitate (AgCl) was twice filtered off with an inorganic 
membrane filter (Whatman, Anotop 10, 0.02 ..tm). NaN 3 (25 mol eq, 0.208 g, 3.2 
mmol) was added to the solution. The volume of the solution was reduced and the 
flask put in the fridge for 2 d. The yellow precipitate was filtered off and washed 
with water and ether. Yield: 23.5 mg (57%) 
Crystals suitable for X-ray crystal structure determination were grown in water in the 
fridge at 277 K. 
CHN: Found: C, 7.26; H, 1.99; N, 33.21; Calculated for PtC 2H8N8 : C, 7.08; H, 2.36; 
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N, 33.04. 
ESI-MS: 339.59 mlz (caic. 339 mlz). 
'H NMR (90% H20/10% D20): ö 5.15 ppm (s, 15N-H2), 'J( 15N-H) 74.5 Hz, 2J(' 95Pt-
H) 52.6 Hz; 2.61 (s, en CH 2)
1 
 3J(' 95Pt-CH2) 39.5 Hz. 
2D [H, "N] HSQC NMR: ö ('H, ' 5N/ 5.1, -33.8), 'J(' 95Pt-' 5N) 337 Hz. 
Raman (cm'): 223 (w), 327 (m), 409 (m), 467 (m), 556 (s), 682 (w), 747 (w), 883 
(w), 1290 (s), 1368 (w), 1565 (w), 2028 (m), 2051 (m), 2963 (w), 3089 (w). 
UV/VIS: 360 nm (c = 132 1 mol' cm'), 320 rim (c = 364 1 mol' cm - '), 260 nm (E = 
695 1 mot' cm- '). 
Cis, trans-[Pt"(en)(N 3)2(OH)2] (5) 
H202 (50 mol eq, 0.3 ml 30% H 202, 2.9 mmol) was added to a suspension of 
[Pt(en)(N 3)2} (0-021 g, 0.06 mmol) in water (5 ml). The suspension was then stirred 
in the dark at room temperature for 24 h. The yellow precipitate was filtered and 
washed with water and ether. 
Yield: 10 mg (40%) 
Crystals suitable for X-ray crystal structure determination were grown in water in the 
fridge at 277 K. 
CHN: Found: C, 6.54; H, 2.37; N, 30.18; Calculated for PtC 2H, 0N802 : C, 6.43; H, 
2.68; N, 30.03. 
ESI-MS: 373.7 mlz (calc. 373 m/z). 
'H NMR (90% H20/10% D 20): ö 6.42 ppm (s, ' 5N-112), 'J(15N-H) 76 Hz, 2J(' 95Pt-
NH2) 43 Hz; 2.83 (s, en CH 2) 3J( 195Pt-CH 2) 23.3 Hz. 
2D ['H,' 5N] HSQC NMR: ö ('H, ' 5N/ 6.52, -5.87) 'J(' 95Pt-' 5N) 275.46 Hz. Raman 
(cm'): 220 (m), 248 (m), 330 (m), 412 (s), 426 (s), 483 (m), 551 (m), 564 (m), 588 
(s), 696 (m), 884 (w), 999 (w), 1059 (w), 1200 (w), 1285 (w), 2052 (m), 2063 (s), 
2963 (m), 2991 (w), 3521 (w). 
IJY/VIS: 380 nm (F = 380 1 mo1 1 cm'), 315 rim ( = 645 1 mol' cm'), 260 nm ( = 
975 1 mol' cm'), 457 rim (e = 38 1 moL' cm'), 488 rim (c = 27 1 mol' cm'), 647 nm 
(s = 10 1 mot' cm - '). 
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[Pt(dien)(N 3)] (NO3) (6) 
[Pt(dien)Cl]Cl was synthesized according to a literature method. 12  [Pt(dien)Cl]C1 
(0.144 g, 0.39 mmol) and 2 mol eq of AgNO 3 (0.133 g, 0.78 mmol) were placed in a 
50 ml flask. Deionized water (20 ml) was added and the suspension stirred in the 
dark at 323 K for two days. The AgC1-precipitate was twice filtered off with an 
inorganic membrane filter (Whatman, Anotop 10, 0.02 tm). NaN 3 (1 mol eq, 0.0255 
g, 0.39 mmol) was dissolved in deionized water and then added to the 
[Pt(dien)(0H2)](NO3)2 solution. The volume was reduced on a rotary evaporator at 
313 K which led to a colour change from colourless to yellow. The solution was 
stirred in the dark at 313 K for one day, the volume was then further reduced on the 
rotary evaporator until only 2 ml solution was left. This solution was filtered and 
pale yellow crystals were obtained overnight in the fridge 277 K. 
Yield: 38.2 mg (25 %) 
CHN: Found: C, 11.90; H, 3.05; N, 24.12; Calculated for PtC 4H, 3N703 : C, 11.94; H, 
3.23; N, 24.38. 
ESI-MS: mlz: 340.4, (caic. M 340 m/z). 
'H NMR (90% H20/10% D20): 6 6.39 (s), 5.35 (s), 5.13 (s), 3.18 (m), 2.9(m), 2.8 
(m). 
Raman (cm'): 264 (w), 339 (m), 419 (w), 485 (s), 545 (s), 600 (s), 709 (w), 896 (w), 
1044 (s), 1298 (m), 2053 (w), 2079 (w), 2878 (m), 2943 (m), 2972 (m), 3000 (m), 
3168 (w), 3252 (w). 
IPt"(dien)(N3) trans-(OH) 2 1 (NO3) (7) 
[Pt(N3 )2(dien)](NO3) (0.024 mg, 0.06 mmol) was dissolved in 5 ml deionized water. 
H202 (0.2 ml 30%, 1.9 mmol) was added, and the solution stirred at room 
temperature in the dark for one day. The volume of the solution was reduced on a 
rotary evaporator until a yellow precipitate appeared. The solution was then placed in 
the fridge at 277 K. 
Yield: 12 mg (50 %) 
ESI-MS: 373.72, (M'374 m/z). 
'H NMR (90% H 20/10% D20): 6 6.75 (s), 3.7 (m), 3.4 (m), 2.87 (m). 
149 
Chapter 5 Preparation and characterisation of Pt(11)1(IV) azide complexes 
Table 5.1 Overview of complexes synthesised and their 'HI ' 5N chemical shifts 
Compound Line structure ('H)/ 	(' 5N) 




cis, trans. cis- 5.2/-39.8 














cis, trans- 6.5/-5.9 
[Pt'"(en)(N 3) 2(OH)2] OH 
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Purification of 14mer oligonucleotides and preparation of 14mer DNA duplex 
The 14mer oligonucleotides d(ATACATGGTACATA) (I) and 
d(TATGTACCATGTAT) (II) were obtained as Na' salts. They were purified by 
passage through an ion exchange column (Bio Rad: Chelating Resin, Chelex 100 
Resin, 200-400 mesh). The strands were then dried in a freeze drier. For the 
preparation of the duplex DNA, equimolar solutions of strand I (0.24 ml, 0.56 tmol) 
and strand 11(0.24 ml, 0.56 tmol) in 0.1 M NaCI0 4 were mixed. The concentrations 
of the strands was determined by measuring the absorption at 260 nrn. The pH was 
adjusted to 6.26 with 0.1 M HC104. The sample was annealed by heating to 343 K 
and slow cooling to ambient temperature. D 20 (25 t1) was added to the sample and 
the purity of the sample checked by 1D 'H NMR by comparing the spectrum with 
that of the same duplex DNA published by our research group.' 3 
5.3 Results and discussion 
5.3.1 Preparations and characterisations 
Caution! Heavy metal azide complexes are known to be shock-sensitive 
detonators, e.g. Pb(N 3)2 and Hg(N3)2 . It is therefore very important to take care when 
handling Pt azide complexes, especially not to put pressure on Pt azide complexes in 
crystalline form. Additionally, NaN 3 is very toxic and contamination must be 
avoided under any circumstances. 
5.3.1.1 Cis- IPt"(N3)2(NH3)2 1 (1) 
Preparation 
The preparation of cis-[Pt"(N 3)2(NH3)2] was carried out by analogy with a literature 
method for the preparation of cisplatin by Dhara.' 4 In that synthesis the chloride 
ligands in K2 [PtC14] are replaced by iodide ions which have a stronger trans-effect 
compared to chloride.' 5 This is important to insure that the diammine product is 
purely the cis-isomer and not a mixture of the cis- and trans-isomer. In order to 
replace the iodide ligands in cis-{Pt1 2(N}I)3 1 with aqua ligands, AgNO 3 was used 
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which forms readily the insoluble AgI salt. This reaction was performed in the dark 
due to the photoactivity of silver salts. Slightly less than 2 mol eq of AgNO 3 were 
used in order to avoid any silver impurities in the product. For the same reason, it 
was important to leave the reaction until completion. Heating to 333 K accelerated 
the reaction. It was also essential to use a good filtration method for the removal of 
all the precipitate. After trying different methods, such as filtration through glass 
microfibre filters with additional centrifugation and filtration through celite, it was 
eventually found that inorganic membrane filters with a pore size of just 0.02 j.Lm 
removed the silver salt completely and were easy to use. The product of this reaction, 
cis-[P0(0H2)2(NH3) 2](NO3)
21 
 is more reactive towards an entering ligand compared 
to cis-[Pt 11 12(NH3)2]. 
The azide (N 3 ) ligand is known to be a good ligand towards d-block ions. However, 
heavy metal complexes or salts, such as Pb(N 3)2 and Hg(N3)2 , are known to be shock-
sensitive detonators.' 6 Sodium azide, NaN 31  which is the starting material for the 
synthesis of most azide compounds, is also very toxic and is used for example as a 
bactericide and fungicide. It is inert at room temperature, but releases N 2 when 
heated. Therefore it was decided to work at room temperature. A NaN 3 excess of 20 
mol eq was chosen to accelerate the reaction. There was also no problem with 
possible NaN3 impurity in the product due to the high solubility of NaN 3 in water. 
The solvent volume was reduced on the rotary evaporator at 313 K under vacuum. 
The reaction confirmed to be very fast. Addition of NaN 3 led to a rapid colour 
change from colourless to yellow indicating the binding of the azide ions to platinum 
(ligand-to-metal-charge transfer). Care was taken when handling the product due to 
its possible high shock-sensitivity. 
Characterisation 
NMR. The ' 5N chemical shift of the amine is dependent on the ligand trans to it. The 
2D ['H,' 5N] HSQC NMR chemical shifts of 1 3.86, -69.52 are typical of a Pt" 
compound with a nitrogen donor in trans position: H 3 15N-Pt" trans to N. The fact that 
there is only one cross-peak in the 2D ['H,' 5N] HSQC NMR spectrum confirms the 
equivalence of both ammines. The 'J(195Pt-'5N) value of 305 Hz is in the range 
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expected for an ammine trans to ammonia. 23 The value of 57 Hz for 2J( 195Pt-H) is 
also within the expected range (2J( 195Pt-H) of cisplatin is Ca. 64 Hz"). Additionally, 
the occurrence of only one NH 3 ammine peak in the 'H NMR spectrum confirms the 
high purity of the compound. 
ESI-MS. The positive electrospray mass spectrum exhibited the typical platinum 
isotope pattern at 313 m/z and was in agreement with the calculated mass pattern 
(calc. m/z for 1 313 mlz). 
I 
313.82 
314.82 1 + Na 
336.77 
338.78 
11 10 	1+K 
353.84 l 
316.70 	III 4 354 . 84 
mlz 
Figure 5.1 Positive ESI-MS spectrum of complex 1 at 313.8 m/z showing the Pt 
isotope pattern. The Na and K adducts are also shown at 336.8 and 353.8 mlz, 
respectively. 
Raman. The Raman spectrum of 1 was compared with data from the literature." -" 
First of all, the azide ligand vibrations are considered. The bands at 2039 and 2069 
cm' were assigned to antisymmetric stretchings v(N 3) of the azide ligands, and 
bands at 1296 and 1281 cm' to symmetric stretchings v (N 3). The bands at 3200 cm 
are assigned to asymmetric and symmetric stretchings of the ammine ligands 
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v(NH3) and v,(NH3). The weak bands at 1300 cm' are assigned to asymmetric and 
symmetric bending modes 8(NH3) and 6(NH3) and those at the wavenumbers of < 
500 cm' are due to Pt ligand stretching and bending modes. The bands at 400 cm' 
are assigned to platinum azide stretching modes v(PtN(azide)), and those at 500 cm' 
to platinum ammine stretching modes v(PtN(ammine)). The bands at lower 
wavenumbers are assigned to bending modes of both platinum azide and platinum 
ammine type. In general there is a good agreement of the Raman spectrum with 
reference data. The Raman spectrum confirms the structure of 1. 
5.3.1.2 Cis, trans-[Pt'(N 3)2(Off) 2(NH3)2] (2) 
Preparation 
The oxidation of cis-[Pt"(N 3)2(NH3)2] to a Pt' s' product was performed as previously 
described with 30% aqueous hydrogen peroxide (H 202). 22 This reaction introduced 
two trans axial hydroxy ligands in the Pt" product. It was decided to use a high 
excess of hydrogen peroxide giving a fast reaction and ensuring that no Pt" reactant 
was left. The reactant slowly dissolved upon adding of 30% aqueous H 202 due to the 
higher solubility of the product compared to the reactant. 
Characterisation 
NMR. The NH3 'H chemical shift of 5.2 ppm for 2 in the 2D ['H,' 5N] HSQC NMR 
spectrum is typical of a Pt" ammine compound ' 2' and the ' 5N chemical shift of —39.8 
ppm is characteristic for H 3 15N-Pt" trans to N. There is only one cross-peak which 
means the two ammine ligands are equivalent and both are trans to an azide ligand. 
This confirms the axial positions of the two hydroxide ligands. Both coupling 
constants, 2J(' 95Pt-H) 46.2 Hz. and 'J( 195Pt-' 5N) 258.1 Hz, are smaller than for 1 
which is characteristic for Pt' compounds 3 . The ratio of the 'J(195Pt-'5N) values 
between Pt" and Pt"' is expected to be 1.5 to 1.2.23  The 'H NMR spectrum exhibits no 
other peaks besides the NH3  ammine peaks confirming the high purity of the 
compound. 
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ESI-MS. The positive electrospray mass spectrum exhibited the typical platinum 
isotope pattern at 349.7 mlz and was in agreement with the calculated mass pattern 
(calc. mlz for 2 349). 
Raman. The bands were assigned by analogy with complex 1. The bands at 2000 
cm' were assigned to asymmetric stretchings v(N 3) of the azide ligands, at 1300 cm 
to symmetric stretchings v (N 3), the two broad bands at 3000 cm' to asymmetric 
and symmetric stretchings of the ammine ligands v 1,(NH3) and v,(NH3). The bands at 
1140 and 3235 cm' are assigned to the platinum hydroxo bending mode and 
antisymmetric and symmetric OH stretchings, respectively. These bands confirm the 
presence of the hydroxy ligands. Those at lower wavenumbers were assigned similar 
to the assignment in the Raman spectrum of 1. 
5.3.1.3 Cis, trans, ciS_[Pt v(OCOCH3)2(N3)2(NH3)2 1 (3) 
Preparation 
The synthesis of complex 3 was carried out by the carboxylation of the hydroxide 
ligands of complex 2 by acetic anhydride. This reaction was first reported in relation 
to the synthesis of orally active Pt" anticancer drugs, 24 and is suitable for ligand 
transformations on kinetically-inert metal centres. It was decided to react 2 with 
acetic anhydride in dichloromethane in order to avoid the exothermic reaction which 
occurs in acetic anhydride. The compound was most soluble in methanol, and it was 
possible to prepare a crystal suitable for X-ray diffraction from a MeOH/H 20 = 1/1 
v/v solution in a NMR tube. 
Characterisation 
NMR. The presence of only one cross-peak in the 2D ['H,' 5N] HSQC NMR 
spectrum at ö ('H, ' 5N) 5.75/ -44.45 confirmed the equivalence of the ammine 
ligands. The 'H chemical shift is typical of a Pt" compound, as is the ' 5N chemical 
shift, with H3 15N-Pt"' trans to N showing that both ammine ligands are each trans to 
an azide ligand. The coupling constants 2j(195  Pt-H) 48 Hz and 'J(' 95Pt-' 5N) 255 Hz 
are also typical values for Pt' ammine compounds. The singlet at 2 ppm originates 
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from the CH3 group of the axial acetate ligands and is in agreement with a literature 
value. 3 Therefore, both acetate ligands are equivalent and in axial positions. 
5.3.1.4 [Pt"(en)(N 3)2 1 4 
Preparation 
For the synthesis of [Pt"(en)(N 3) 2}, ethylenediamine was added directly to a solution 
of K2 [PtC14]. Ethylenediamine was purified by distillation and stored under argon. 
For the synthesis of the ' 5N-labelled derivative, the HC1 salt ' 5N-en•2HC1 was used, 
synthesised by a known literature method.' A yellow precipitate of [Pt"(en)Cl 2] was 
obtained on adding ethylenediamine. This was used directly for the next step, 
removal of Cl - ligands by AgNO3 . This reaction and the subsequent removal of the 
AgC1 salt, and the addition of sodium azide were carried out by analogy with the 
synthesis of complex 1. 
Characterisation 
NMR. The resonances of primary amine ligands bound to platinum shift in both 'H 
and ' 5N dimensions to low field compared to the ammine ligand. 23 The 'HI ' 5N 
chemical shifts of complex 4, 5.1/ -33.8 ppm, are typical for a Pt" en compound, and 
the ' 5N chemical shift of —33.8 ppm indicates the structure Pt 1' en trans to N. 23 The 
presence of only one cross-peak in the 2D ['H, 15N] HSQC NMR spectrum confirms 
the equivalence of both ' 5NH2-en. The 'H singlet at 2.61 ppm is due to the CH 2-en 
protons. The presence of only one singlet in that region confirms the equivalence of 
the CH2-en protons. 
ESI-MS. The positive electrospray mass spectrum exhibited a platinum isotope 
pattern at 339.6 m/z in agreement with the calculated mass pattern (caic. 339 mlz). 
Raman. The bands at 2028 and 2051 cm' were assigned to antisymmetric 
stretchings Vas(N3) of the azide ligands, the band at 1290 cm' was assigned to 
symmetric stretchings v (N 3). 
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5.3.1.5 [Pt"(en)(N 3)2(OH)2] (5) 
Preparation 
The oxidation [P0(en)(N 3)2] was carried out by analogy with the synthesis of 2. The 
addition of 30% aqueous H 202 this time did not lead to the complete dissolving of 
the reactant due to the lower water solubility of 5 compared to compound 2. 
Characterisation 
NMR. The 'HI ' 5N chemical shifts of complex 5, 6.5 ppm! -5.87 ppm, are typical of 
those expected for PC en compounds .23  A ' 5N chemical shift of —5.87 ppm is typical 
of PCen trans to N. 3 The singlet at ö('H) 2.83 ppm is due to the en CH 2 protons 
which are equivalent and shifted to low field by 0.2 ppm compared with the Pt" 
analogue 4. The "'Pt satellites were easily identified and the coupling constant 
3J(' 95Pt-NC'H2) is 23.3 Hz. The presence of only one cross-peak in the 2D ['H,' 5N] 
HSQC NMR spectrum confirms that both azide ligands are in equatorial positions in 
the complex. 
ESI-MS: The positive electrospray mass spectrum exhibited the typical platinum 
isotope pattern at 373.6 m!z, in agreement with the calculated mass pattern (calc. mlz 
for 5 373). 
5.3.1.6 LPt(dien)(N 3)1(NO3) (6) 
Preparation 
The starting compound [Pt(dien)Cl]Cl was synthesised as described in the 
literature," and was of high purity as confirmed by CHN elemental analysis and ESI-
MS. The problem with the synthesis of 6 was to make sure that N 3_was only a ligand 
in the product and not present as a counter ion. In order to remove the chloride ligand 
and the chloride counter ion from the solution, 2 mol eq of AgNO 3 were added. The 
purity of [Pt(dien)Cl]Cl was very important in this step to guarantee the full removal 
of chloride. To the resulting [Pt(dien)(0H 2)](NO3 )2 1 mol eq of NaN3 was added to 
replace the aqua ligand. Only upon reducing the volume on the rotary evaporator at 
313 K, the yellow colour was apparent, an indication of the binding of the azide 
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anion to platinum. It was decided to use nitrate ions in solution as counter ions so 
that it was not necessary to use an anion exchange column. Pale yellow crystals were 
obtained from a concentrated solution in the fridge at 277 K. 
5.3.1.7 [Pt"(dien)(N 3) trans-(OH) 2 1 (NO 3) (7) 
Preparation 
The synthesis of 7 was performed by oxidizing compound 6 with 30% aqueous H 202 . 
The procedure was similar to the synthesis of compound 2. 
5.3.2 X-ray crystal structures 
5.3.2.1 Pt" diazido crystal structures 
Table 5.2 summarises the data collection and refinement parameters for the crystal 
structures of Pt" diazido complexes cis, trans. cis-[Pt"(N3)2(OH)2(NH3)2] (2), cis, 
trans. cis-[Pt"(N 3)2(OCOCH3)2(NH3)2] (3) and cis, trans-[Pt"(en)(N 3)2(OH)2] (5). 
Figure 5.2 shows the X-ray crystal structures of the complexes, and selected bond 
lengths and angles are listed in Table 5.4. Six crystal structures of Pt" azide 
complexes with conventional R factors < 0.05 have been published: trans-
[Pt"(N3)4C12](PPh4)2 19,  [Pt"(N3)6](AsPh4)225 , trans- [Pt"(N3)4(SCN) 2] (PPh4)2 and 
trans-[Pt"(N3)4(SeCN) 2] (PPh4)220, [Pt"(N3 )6](PPh4)2 and [Pt"(N3 )C15](AsPh4)2 . 2 ' The 
average Pt-azide bond lengths and angles were found to be: 
- Pt-azide (Pt-NI/N4) bond length: 2.085 A ± 0.036 A 
- Pt - N,,, - N, angle: 117.89'±2.38 1  
-Na —Np —Ny angle: 173.83°± 1.36 0 
All of the published Pt" azide complexes crystallised in a triclinic crystal system 
with the space group P-i. Complex 2 also crystallised in a triclinic crystal system 
with space group P-i, but complexes 3 and 5 crystallised in a monoclinic crystal 
system with space groups P2,/rn and P2,/c, respectively. Complex 3 has an almost 
orthorhombic crystal system with 0 deviating only slightly from a 90 0 angle. The Pt 
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- azide (Nl/N4) bond lengths of Ca. 2.035 A for all three Complexes are shorter than 
all reported Pt"_ azide bond lengths (minimum 2.045 A), but are in the expected 
range. The significant difference between the Pt - N azide bond length in 
[Pt1"(N3)C1 5](AsPh4)22 ' (2.105(6) A) and complexes 2, 3 and 5 (2.036 A) is 
interesting. This difference can be accounted for by the stronger trans-influence of 
chloride compared to ammonia. The Pt - am(m)ine nitrogen bond lengths are not 
significantly different for all three complexes. The N - N distances of the azide 
ligands are longer for N - N (1.20 A) than for N - N7 (1.16 A). This is in agreement 
with the reported bond lengths for hydrazoic acid HN 3 with N - NaH 1.24 A and N 
- N7 1.13 A.26 This phenomenon can be explained by the resonance of the azide 






L 	Pt 	 Pt 
Scheme 5.2 Resonance structures of the azide ligand. 
The Pt - 0 bond lengths of all three complexes, and the ethylenediamine bond 
lengths and angles in complex 5, are in the expected range. Figure 5.2 (B) shows that 
the structure of complex 3 is disordered at one of the acetate ligands around the two 
oxygen atoms 02 and 04. This is also the reason why the double bond 04 - C3 
(1.357(15) A) is longer than the single bond 02— C3 (1.3 13(14) A). 
The azide ligands are bound with Pt - Na - N angles of 115.5-119.6° which is similar 
to the published structures. The Na - N - N 7 angles of complex 2 and 5 are with 
173.2-175.7° almost linear and fit well to the reported values. The azide ligands of 
complex 3 are, however, less linear with angles of 167.1° and 166°. The torsion 
angles Ni a - Pt - N2a - N are in the range reported in literature 11-2'  and are very 
similar for both azide ligands in complex 3 (59.6° and 57.6°), which are also 
orientated in the same direction. The torsion angles of the two cis azide ligands are 
very different in the complexes 2 and 5 with values of 14°! 77° and 33.7°! -76.4°, 
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respectively. The two azide ligands are oriented in opposite directions in complex 5, 
in contrast to complex 2. 
5.3.2.2 Pt" diazido crystal structures 
The data collection and refinement parameters of the Pt" diazido complexes cis-
[Pt"(N3)2(N}13) 2 1 (1), {Pt"(en)(N 3)2] (4) are summarised in Table 5.3. Figure 5.3 
shows the X-ray crystal structures of complexes 1 and 4, and selected bond lengths 
and angles are listed in Table 5.5. Both complexes crystallised in a monoclinic 
crystal system in the space group P2/n. The Pt - N bond lengths of the Pt" 
complexes are similar to those of the Pt" complexes. The Nl a - Pt - N2a angles are 
between 90.8°-95.7°, and the coordination around the Pt centre is closely square-
planar for both complexes. The azide ligands with Na - N - N. angles of 175 ° are 
almost linear and are bound to Pt with Pt - Na - N angles of 116.5'-121.1'. The 
torsion angles N1 - Pt - N2 0 - N are in the range 30.6°-49.2°, and each of the cis 
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Figure 5.2 The X-ray crystal structures of the complexes (A) cis, trans. cis-
[Pt"(N 3)2(Ol-I)2(NH3)21 (2), (B) CiS, trans. cis-[Pt"(N3)2(OCOCH3)2(NH3)2] (3) and 
(C) cis, trans-[Pt"(en)(N3)2(OH)2] (5). 
LODI 
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Figure 5.3 The X-ray crystal structures of (A) cis-[Pt"(N 3 )2(NH3 )2] and (B) 
Pt"(en)(N3)21. 
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Table 5.2 Crystal structure data for the Pt" diazido complexes cis, trans, cis-
[Pt"(N3)2(OH)2(NH3)2 1 (2), cis, trans, cis-[Pt"(N3)2(OCOCH3)2(N}i3)21 (3) and cis, 
trans-[Pt"(en)(N 3)2(OH)2] (5). 
Complex 2 3 5 
Empirical formula H8N802Pt C4H 12N802Pt C2H 10N802Pt 
Formula weight 347.23 399.31 373.27 
Crystal description Colourless plate Colourless rod Pale yellow chip 
Crystal size (mm) 0.1 3x0.07x0.04 0.1 2x0.04x0.03 0.20x0.09x0.06 
Crystal system Triclinic Monoclinic Monoclinic 
Space group P-1 P2 1 /m P2 1 /c 
Unit cell dimensions 
(A) 
a = 6.3232(11) 
b=7.9816(14) 
c = 8.1663(14) 
a = 82.247(3)° 
13 = 67.294(2)° 
= 68.885(2)° 
a = 8.0563(12) 
b= 15.495(2) 
c = 9.3623(14) 
a = 90° 
13 = 90.009(2)° 
y = 90° 
a = 15.8580(12) 
b=6.2374(5) 
c = 17.5220(13) 
a = 90° 
13 = 102.0720(10)° 
7 = 900 
Z 2 4 8 
Density (caic.) (Mg/M3)  3.251 2.269 2.926 
Absorption 	coefficient 
(mm') 
19.752 12.004 16.545 
F(000) 316 744 1376 
0 	range 	for 	data 
collection (deg) 
2.70 to 24.99 1.31 to 23.28 2.38 to 29.11 
Reflections collected 2624 5085 10251 
Independent reflections 1251 2636 4093 
Volume (A3) 354.67(11) 1168.8(3) 1694.8(2) 
Temperature (K) 100(2) 150(2) 150(2) 
Wavelength (A) 0.71073 0.71073 0.71073 
Conventional R 0.0355 0.0269 0.0263 
wR2 0.0863 0.0743 0.0601 
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Table 5.3 Crystal structure data for the Pt" diazido complexes cis-1Pt"(N 3)2(NH3)2J 
(1) and [Pt"(en)(N 3)21 (4). 
Complex 1 4 
Empirical formula H6N8Pt C2H8N3Pt 
Formula weight 313.22 339.25 
Crystal description Yellow rod Yellow needle 
Crystal size (mm) 0.13x0.06x0.03 0.12x0.06x0.02 
Crystal system Monoclinic Monoclinic 
Space group P2 1 /n P2/n 
Unit cell dimensions 
(A) 
a = 8.6327(10) 




a = 7.778(8) 
b = 3.405(3) 
c= 14.139(14) 
a=90° 
0 = 100.848(15)° 
y - 90° 
Z 4 2 




F(000) 560 308 
0 	range 	for 	data 
collection (deg) 
3.48 to 26.38 2.79 to 26.50 
Reflections collected 3431 2377 
Independent reflections 1270 726 
Volume (A3) 63 1.47(12) 367.8(6) 
Temperature (K) 150(2) 150(2) 
Wavelength (A) 0.71073 0.71073 
Conventional R 0.0241 0.0426 
wR2 0.0622 0.0982 
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Table 5.4 Selected bond lengths (A) and angles (°) for the Pt" complexes 2, 3 and 
5. 
Complex 2 3 5 
Pt - Ni 2.033(9) 2.038(11) 2.033(4) 
Pt - N4 2.036(9) 2.037(11) 2.040(5) 
Pt-N7 2.051(9) 2.072(11) 2.040(4) 
Pt-N8 2.035(9) 2.066(13) 2.045(4) 
Pt-01 2.008(7) 2.023(10) 1.994(3) 
Pt-02 2.008(7) 1.990(15) 2.001(3) 
Ni -N2 1.208(14) 1.201(12) 1.207(6) 
N2-N3 1.164(14) 1.172(13) 1.147(6) 
N4-N5 1.229(14) 1.195(12) 1.211(6) 
N5-N6 1.158(14) 1.172(13) 1.139(6) 
N7 - C1 1.477(7) 
N8 - C2 1.509(6) 
Cl -C2 1.350(15) 1.506(7) 
C3 - C4 1.434(13) 




N1-Pt-N4 93.1(4) 93.4(6) 93.7(2) 
N7-Pt-N8 88.2(4) 91.3(7) 83.71(17) 
N7 - Pt - 01 89.6(3) 89.9(8) 89.42(16) 
01 -Pt-02 176.9(3) 171.6(6) 178.20(14) 
N1-N2-N3 173.2(11) 167.1(19) 173.8(5) 
N4 - N5 - N6 175.7(11) 166(2) 174.4(6) 
Pt-NI -N2 117.7(7) 117.4(4) 118.6(11) 
Pt-N4-N5 115.5(7) 119.6(4) 117.3(11) 
Pt - N7/N8 - C1/C2 109.0(3)! 107.2(3) 
N7/N8 - C1/C2 - C2/C1 107.0(4)! 106.3(4) 
Ni -Pt-N4-N5 14.0 59.6 33.7 
N4-Pt-N1 -N2 77.0 57.6 -76.4 
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Table 5.5 Selected bond lengths (A) and angles (°) of the Pt" complexes 1 and 4. 
Complex 1 4 
Pt-NI 2.031(6) 2.07(3) 
Pt-N4 2.053(6) 2.035(13) 
Pt - N7 2.058(6) 2.05(2) 
Pt-N8 2.048(5) 2.035(13) 
Ni -N2 1.225(8) 1.18(3) 
N2-N3 1.143(8) 1.14(3) 
N4-N5 1.204(8) 1.18(3) 
N5-N6 1.166(9) 
N7 - CI 1.45(3) 
Cl -C2 1.50(3) 
Ni- Pt- N4 93.2(2) 93.7(8) 
N7 - Pt - N8 90.8(2) 95.7(7) 
Pt-NI -N2 121.1(5) 120.6(19) 
Pt-N4-N5 116.5(5) 
NI -N2-N3 175.7(7) 175(2) 
N4-N5-N6 176.7(7) 
Pt-N7/N8-C1/C2 106.4(15) 
N7/N8 - C1/C2 - C2/C1 110.4(13) 
NI - Pt - N4 - N5 41.6 30.6 
N4-Pt-N1 -N2 -36.1 -49.2 
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Figure 5.4 Cyclic voltammograms of (A) cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2) 
and (B) cis, trans, cis-[Pt"(N 3)2(OCOCH3)2(NH3 )2] (3) in aqueous 0.1 M KC1. 
The cyclic voltammograms were recorded in aqueous 0.1 M KC1 solution using a 
glassy carbon electrode as working electrode, a Pt wire as counter electrode and a 
Ag! AgC1 reference electrode. These are the same conditions as Choi et al.27 used 
and allow a direct comparison of the reduction potentials. 
The reduction potentials of complex 2 and 3 were measured to be —0.65 V and —0.69 
V, respectively (see Figure 5.4). The only difference between these two complexes is 
the trans ligands. The presence of an acetate ligand instead of a hydroxide has no 
major influence on the redox properties of the compounds as the reduction potential 
only differs by 0.04 V. The values of the reduction potentials of complexes 2 and 3 
are in the same region as the ones of related complexes like cis, trans, cis-
[Pt"Cl2(OCOCH3)2(NH3)2J 28 with —0.689 V, cis, trans, cis-
[Pt'Cl2(OH)2(isopropylamine)] 27 with —0.73 V and cis, trans-[Pt 1"(en)C1 2(OH)2] 28 
with —0.884 V. Complexes having oxygen-bound trans ligands have generally a 
lower reduction potential than complexes having halides in trans position, e.g. 
[Pt"(en)C14] 28 has a reduction potential at —0.224 V. Complexes 2 and 3 exhibit 
reduction potentials which are among the lowest reported so far. On the one hand 
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this promises that it is difficult to reduce complexes 2 and 3 which could give them 
potential as prodrugs. On the other hand there is no direct correlation between the 
reduction potential and the kinetics of the reduction of Pt a' compounds (see Section 
1.2.5). 
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Chapter 6 
Photoreactivity and stability of platinum(II) 
ILII4L'p4 [Z.I.111.1.111 1. 
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[!1 	m17r. rrr;trT. 
Firstly, the potential of the Pt` diazido complexes shown in Table 6.1 to act as inert 
photoactive prodrugs was studied. The complexes were tested towards possible 
substitution reactions by chloride and nucleobases and reduction by glutathione 
(GSH). Their stability in human blood plasma was also investigated. All of these 
reactions were studied by 'H and 2D ['H, ' 5N] NIVIR in 90% H20/ 10% D20. The pH 
dependence of the 'H NMR resonances of the pt-' 5NH3 and Pt-' 5N}i2-en am(m)ine 
protons was determined beforehand. This was important in order to determine the pH 
at which Pt-' 5NH3/' 5NH2-en 'H resonances could be best detected. 
The ' 5N chemical shifts of Pt am(m)ine complexes are usually diagnostic of the trans 
ligands as summarised in a review.' This information has been used throughout this 
study to assign ligands trans to the amine groups. 
Secondly, the photoreactivity of the Pt" diazido complexes was studied using a laser 
directly coupled to the NMR probe via a fibre optic (see Section 2.2). Photoreactions 
of Pt" diazido complexes with 5'-GMP, d(GpG) and 14mer single strand 
d(ATACATGGTACATA) and duplex d(ATACATGGTACATA) 
.d(TATGTACCATGTAT) oligonucleotides were studied using 'H and 2D ['H, ' 5N] 
NMR. ESI-MS was used for identifying the products. 
The stability and photoreactivity of Pt" diazido complexes was also studied, but to a 
lesser extent. The photoreactivity of Pt'" and Pt" monoazido complexes was studied 
in order to obtain information about the mechanisms of the photoreactions. 
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Table 6.1 Overview of complexes studied and their 'HI ' 5N chemical shifts. 
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6.2 Results 
6.2.1 pH dependence of the am(m)ine 1 H NMR resonances 
6.2.1.1 Pt'" diazido complexes 
Three 5 mM solutions of cis, trans. cis-[Pt"(N 3)2(OH)2(NH3)2] (2), cis, trans, cis-
[Pt"(N3)2(OAc) 2(NH3)2] (3) and cis, trans-[Pt`(en)(N 3)2(OH)2] (5) were prepared in 
90% H20/ 10 % D20. 'H NMR spectra were acquired at 298 K over a range of pH 
values in order to determine the pH dependence of the am(m)ine resonances. Table 
6.2 illustrates the pH dependence of the NH 3 'H resonances of complexes 2 and 3, 
and of the NH 2-en 'H resonances of complex 5, and their relative intensities. The 
relative intensities of complex 2 were obtained by integrating the NH 3! N112-en 'H 
NMR peaks (including the ' 95Pt satellites) and the TSP reference peak and 
calculating the ratio (NH 3 integral)! (TSP integral). The ratio with the highest value 
was normalised to 1 to facilitate comparisons. 
In the case of complex 2, no 'H NMR signal was detected at pH values higher than 7. 
At pH 6.39, the NH 3 'H NMR resonances appeared initially as broad peaks. The 
intensity grew with decreasing pH, and was five times more intense at pH 4. The 
peaks sharpened simultaneously with decreasing pH. On lowering the pH from 6.39 
to 4, the peak shifted 0.07 ppm to low-field. 
In the case of complex 3, the intensities of the NH 3 'H resonances were compared 
with the intensity of the CH 3 'H resonances of the acetate group —OCOCH 3 at 
different pH values. The NH 3 and CH3 'H resonances did not shift markably on 
lowering the pH value. The NH 3 'H resonances were detected at pH 7.22 as a weak 
broad peak in contrast to cis, trans, cis-[Pt"(N 3)2(OH)2(NH3 )2] (2). The intensity of 
the NH3  'H resonances increased on lowering the pH and the peaks sharpened. At pH 
3.66 the intensities of the NH 3 'H- and CH3 acetato 'H resonances were equal. The 
integrals of the NH 3 'H resonances are therefore directly related to the numbers of 
protons at low pH. Figure 6.1 shows the pH dependence of the linewidths at half-
height of the NH3 1H resonances. Broad lines were observed at neutral pH and sharp 
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lines at low pH. 
Table 6.2 'H chemical shifts and relative intensities of 'H NMR resonances of 
complexes 2, 3 and 5 at different pH values at 298 K. 
Complex 2 Complex 3 Complex 5 
pH (lH)a Rib pH 6('H)a (H)C pjd pH (iH)e 5('H)f Rig 
7.73 - 0 7.22 5.80 2.14 0.03 8.61 - 2.94 0 
7.12 - 0 6.60 5.80 2.14 0.07 7.52 - 2.95 0 
6.39 5.12 0.18 4.95 5.79 2.13 0.7 6.80 - 2.94 0 
5.61 5.12 0.28 3.66 5.78 2.12 1 5.77 6.38 2.95 0.2 
5.16 5.12 0.55 5 6.38 2.94 0.4 
4.76 5.13 0.65 4.33 6.42 2.94 0.54 
4.33 5.15 0.82 
4 5.19 1 
- INfl3, - ULULI-i 3 , INI-12-en, Lt-12-en, ku=relative intensities (integral NH 3! integral TSP), ' (integral 
NH3! integral CH3 acetate), g  (integral NH2-en/ integral CH2-en). 
pH 	7.22 	6.60 	4.95 	3.66 
Am/2: 13.8 7.3 Hz 3.0 Hz 2.6 Hz 
A.. 
6.0 5.8 ppm 6.0 5.8 ppm 6.0 5.8 ppm 6.0 5.8 ppm 
Figure 6.1 NH3 'H NMR peaks of complex 3 (5 mlvi) at different pH values. The 
linewidths at half-height (Av,, 2) are indicated. 
In the case of complex 5, no N11 2-en 'H signal was detected at neutral pH. The N112- 
en'H peak intensity increased on lowering the pH, as in the case of complexes 2 and 
3. The NH2-en 'H signal also sharpened at lower pH values. The intensity of the 
N112-en 'H peaks was only half of the intensity of the CH 2-en 'H peak at pH 4.33. 
This means the integrals of the NI-1 2-en 'H signals do not relate directly to their 
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number of protons even at low pH values. The C14 2-en 'H peaks broadened markably 
at lower pH. The NI-12-en 'H peaks shifted only slightly to lower field by 0.03 ppm 
when the pH was lowered from 8.66 to 4.33. 
6.2.1.2 Pt" diazido complex 
The pH dependence of the NH 3 'H NMR resonances of cis-[Pt"(N 3)2(NH3)2] (1) was 
studied, Table 6.3. The difference from the Pt" analogue was of special interest. The 
same conditions as for the complexes cis, trans, cis-[Pt"(N3)2(OH)2(NT-13)2 1 (2), cis, 
trans, cis-[Pt"(N 3 )2(OAc) 2(NH3)2] (3) and cis, trans-[Pt"(en)(N3)2(OH)2] (5) were 
used. The NH3 'H NMR resonances were detectable at high pH values and the 'H 
chemical shifts did not change on lowering the pH from 8.9 to 3.4, but the intensities 
increased by one third. 
Table 6.3 'H chemical shifts and relative intensities of 'H NMR resonances of cis-
[Pt"(N3 )2(NH3)2] (1) at different pH values at 298 K. 
pH ('H) NH 3 Relative intensities 
(integral NH 3)! (integral TSP) 
8.9 3.85 0.65 
7.65 3.85 0.87 
6.5 3.85 0.93 
3.4 3.83 1 
6.2.2 Stability of platinum diazido complexes 
6.2.2.1 Pt" diazido complexes 
(a) Hydrolysis of complex 2 
A solution of cis, trans, cis-[Pt"(N3)2(OH)2(NH 3)2] (2, 3 mM) in 90% H20/ 10% D20 
was prepared. The pH was adjusted to pH 5 by adding 0.1 M 1-1004. The 'H and 2D 
['H, ' 5N] HSQC NMR spectra at 298 K were recorded after 1 h, 3 d, 7 d, 21 d, 40 d, 
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60 d and 90 d. No new peaks due to hydrolysis products were observed during this 
period. Only complex 2 was present after 90 d of reaction time. 
(b) Cl- titration of complex 2 
Solutions of complex 2 (3 mM) in H20 with NaCl-concentrations of 5, 25, 50, 100, 
150 and 300 mM were prepared. The pH values of all solutions was adjusted to 5 
with 0.1 M HC104. The reaction was followed by 'H and 2D ['H, ' 5N] HSQC NMR 
spectroscopy at 298 K for a period of 30 h. 
After 3 h of incubation time, one new cross-peak at 5.19/ -39.09 ppm (peak 8, Figure 
6.2 (A), 'J( 15N- 195Pt) = 261.4 Hz) was present in the 2D ['H, ' 5N] HSQC NMR 
spectrum of the 150 mM NaC1 solution, in addition to the cross-peak of the starting 
complex 2 (Figure 6.2). After 25 h incubation, another new cross-peak at 5.49/ - 
40.53 ppm was present (peak 9, Figure 6.2 (B), 1J(' 5N- 195Pt) = 250.8 Hz). The ' 5N 
chemical shifts of the cross-peaks 8 and 9 are in the region expected for Pt"-NH3 
trans to either a nitrogen or chloride. 
The Pt" cisplatin derivative cis, trans, cis-{Pt"C12(OH)2(NH3)2] (10) was prepared 
for studying the ' 5N chemical shift of Pt"-NH 3 trans to chloride. This was done in 
situ, by adding 50 mol eq of H 202 to a 3 mM solution of cis-[Pt"C1 2(NH3)2]. The 2D 
['H, ' 5N] NMR of this solution showed a cross-peak at 5.72/ -35.02 ppm ('J(15N-
' 95Pt) = 273.6 Hz) which is due to cis, trans, cis-[Pt"C12(OH)2(NH3)2] (10). The ' 5N 
chemical shift of Pt"-NH 3 trans to chloride (complex 10) is 4 ppm at lower field 
than Pt"-NH 3 trans to azide (complex 2). Complex 10 was then isolated and 
dissolved in a 300 mM NaCl solution. After two days, the 2D ['H, ' 5N] HSQC NMR 
spectrum of the solution exhibited two new cross-peaks at 5.89/ -34.80 ppm, and at 
5.63/ -33.96 ppm. These cross-peaks can be assigned to cis, trans, cis-
[Pt"C13(OH)(NH3)2] (11) and cis, trans, cis-{Pt"C14(NH3)2] (12), which are the 
expected products of the above reaction. Pt"-NH 3 groups with ' 5N chemical shifts of 
—39 ppm can therefore be assigned to Pt"-NH 3 trans to azide, and Pt"-NI 3 groups 
with ' 5N chemical shifts of —35 ppm to Pt"-NH 3 trans to chloride. The assignments 
of the NMR cross-peaks are listed in Table 6.4. 
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ESI-MS measurements were obtained to identify cross-peaks 8 and 9. The ESI-MS 
peak assignments are summarised in Table 6.5 (A) and (B). The solution of complex 
2 in 5 mM aqueous NaCl was used after 24 h incubation. A new peak at mass 391.2 
mlz was present in the positive ESI-MS spectrum besides the peaks of complex 2 at 
mass 349 mlz and its monosodium adduct at mass 372 mlz. All peaks showed the 
typical Pt isotope pattern. The peak with mass 391.2 mlz was assigned to the 
monosodium adduct of cis, trans, cis-[Pt"(N 3)2C1(OH)(NH3)2] which has a calculated 
mass of 390.5 mlz, Table 6.5 (A). The corresponding 2D ['H, ' 5N] NMR spectrum of 
this solution exhibited only peak 8 besides the peak of complex 2. Therefore, peak 8 
can be assigned to cis, trans, cis-[Pt"(N3)2Cl(OH)(NH3 )2] (8). In order to identify 
peak 9, the solution of complex 2 in 300 mM NaCl was used for ESI-MS after an 
incubation time of 25 h. A new peak at mass 385.3 m/z was present in the negative 
ESI-MS spectrum besides the peaks with mass 367.2 mlz and mass 349.4 mlz which 
are due to complexes 8 and 2, respectively (Table 6.5 (B)). The peak at mass 385.3 
mlz is assigned to cis, trans, cis-[Pt"(N3)2Cl2(NH3 )2] (9) which has a calculated mass 
of 385.9 mlz. 
The two new cross-peaks which are present in the 2D ['H, ' 5N] NMR spectrum of the 
reaction of complex 2 in chloride solution are therefore due to substitution of the 
hydroxide ligands by chloride. The ' 5N chemical shifts of Pt"-NH 3 trans to azide and 
Pt"-NH3 trans to chloride are sufficiently different to be able to distinguish between 
them unambiguously in the 2D ['H, ' 5N] NMR spectrum. 
The ratio of complex 2 to complexes 8 and 9 was determined from the 2D ['H, ' 5N] 
NMR spectra (see Table 6.6). The integrals for peaks in the spectra of the solutions 
with 25 mM and 150 mM NaCl were determined after 24 h and 25 h incubation time, 
respectively. Complex 8 is the dominant compound in solution. The amount of 
starting complex 2 is reduced to 20.2% in the 25 mlvi NaCl solution and to 11.5% in 
the 150 mM NaCl solution. Complex 9 is present in only a small amount. 
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Figure 6.2 Reaction between cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2, 3 niM) and 
Cl- (150 mM NaCl). The 2D ['H, ' 5N] HSQC NMR spectra were recorded at 298 K 
after (A) 3 h, and (B) 25 h of reaction time. ' 95Pt satellites are labelled with *• 
Table 6.4 'H and ' 5N chemical shifts of the complexes detected during reactions of 
' 5N labelled complexes 2 and 10 with chloride at 298 K. 
Compound `NH3  8('HI' 5N) (trans to) 
Cis, trans, cis-[Pt"(N3 )2(OH)2(' 5NH3)2] (2) 5.30/ -39.64 (N3) 
Cis, trans, cis-[Pt"(N3)2C1(OH)(' 5NH3) 2] (8) 5.18/ -39.16 (N3 ) 
Cis, trans, cis-[Pt"(N3)2C12(' 5NH3 )2] (9) 5.49/ -40.53 (N3) 
Cis, trans, cis-[Pt"C12(OH)2(' 5N}13)2 1 (10) 5.77/ -35.13 (Cl) 
Cis, trans, cis-[Pt"C1 3(OH)(' 5NH3)2] (11) 5.89/ -34.79 (Cl) 
Cis, trans, cis-[Pt"C1 4(' 5NH3)2] (12) 5.63/ -33.96 (Cl) 
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Table 6.5 ESI-MS data. 
Positive ion ESI-MS spectrum of 3 mM of complex 2, 5 mM NaCl. Incubation 
time 24 h. 
Detected Assigned compound Calculated 
masses (mlz) mass (m/z) 
349.3 2 cis, trans. cis-[Pt"(N3)2(OH)2(' 5N}13)21 349.1 
372.4 2+Na 372.1 
391.2 8 + Na cis, trans, cis-[Pt"(N 3)2C1(OH)(' 5N}{3)2] 390.5 
Negative ion ESI-MS spectrum of 3 mM of complex 2, 300 mM NaCl. 
Incubation time 25 h. 
Detected Assigned compound Calculated 
masses (mlz) mass (mlz) 
349.4 2 cis, trans, cis-[Pt"(N3)2(OH)2(' 5NH3)2] 349.1 
367.2 8 cis, trans, cis_[Pt"(N3)2C1(OH)( 15NH 3)21 372.1 
385.3 9 cis, trans, cis_[Pt"(N3)2Cl2( 15NH 3)2] 385.9 
Table 6.6 Ratios between complexes 2, 8 and 9 derived from integrals of 2D ['H, 
' 5N] NMR. 
NaCl concentration (mM) Incubation time (h) Ratio of complexes 
2/8/9(%)  
25 24 20.2 / 76.8 / 3 
150 25 11.5/83.5/5 
(c) Reactions of complexes 2 and 5 with 5'-GMP and d(GpG) 
A 2 mM solution of cis, trans-[Pt"(en)(N 3)2(OH)2] (5) was prepared in 90% H 20/ 
10% D20 and the pH adjusted to 5 with 0.1 M HC10 4 . Two mol eq of 5'-GMP was 
added and the sample stored in the dark for 3 d. The 'H and 2D ['H, ' 5N] HSQC 
NIvIR spectra at 298 K showed no peaks besides the starting complex 5 and free 5'-
GMP (ö ('H) H8 8.12 ppm, Hl' 5.94 ppm). No reaction between complex 5 and 5'- 
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GMP therefore occurs in the dark. 
No reaction was observed between complex 5 (0.9 mM) and the dinucleotide d(GpG) 
(0.9 mM) at 298 K in the dark after 12 h reaction time. The starting complex 5 and 
free d(GpG) (6 ('H) H8 8.03 (s), 7.84 (s) ppm; H(1') 5.94 (t), 5.94 (t) ppm) were the 
only compounds observed in the 'H and 2D ['H, ' 5N] NMR spectra. 
The same experiments were carried out for complex 2 with the same result: no 
reaction with 5'-GMP or d(GpG) occurred when the sample was stored in the dark. 
Stability of complex 2 in blood plasma 
Cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2, 5 mM) was dissolved in human blood 
plasma (leucocyte depleted, blood group 0 Rh D positive). D 20 was added (10% v/v) 
to the solution which was then stored for 14 d at 298 K in the dark. The pH of the 
solution was 8. The pH was adjusted to 6 with 0.1 M HC10 4 . A 2D ['H, ' 5N] HSQC 
NMR spectrum was acquired. One new weak cross-peak at 5.01 -49 ppm was present 
besides the starting complex 5. No cross-peak in the region expected for pt"-NH 3 
compounds was present. The ' 5N chemical shift of the new cross-peak corresponds to 
a Pt"-NH 3 trans to an oxygen-containing ligand. 
Stability of complex 2 towards glutathione (GSH) 
Cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2, 2 mM) was reacted with glutathione (13, 5 
mM) in 90% H20/ 10% D 20 at 298 K in the dark. The pH was adjusted to 5 with 0.1 
M HC1O4 . The reaction was monitored by 'H and 2D ['H, ' 5N] HSQC NMR. Spectra 
were acquired 4 h, 44 h, 19 d and 38 d after mixing. 
Figure 6.3 shows the 'H NMR spectra after 4 h and 38 d, and Figure 6.4 shows the 
2D ['H, ' 5N] HSQC NMR spectra after 4 h and 38 d. 
A new multiplet peak was present at 3.28 ppm (peak 14 c', Figure 6.3 (D)) in the 'H 
NMR spectrum 44 h after mixing. This multiplet was a doublet of doublets with 
coupling constants of 4.22 and 14.3 Hz. Direct comparison with the 'H NMR 
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spectrum of pure oxidized glutathione GSSG (14) showed that this peak was due to 
GSSG. This peak increased in intensity with time. 
I3c7SH 13a 	
0 HC 	
H 2 - 	
ANA 0-  H 2 	H 	 H2 
NH3+ 13b  13d 
Glutathione (13), y-L-Glu-L-Cys-Gly. Proton labels: 13a Glu 13CH2; 13b Glu yCH 2 ; 
13c Cys CH2;  13d Cys NH. 
After 38 d reaction time, more than half of all GSH was transformed into GSSG, as 
determined by (integral peak 14 c') / (0.5 . integral 13 b), Figure 6.3. Table 6.7 gives 
the percentage of GSH transformed to GSSG at different reaction times. 
Table 6.7 Amount of GSH transformed into GSSG during the reaction deduced from 
the 'H NMR spectra. 
Reaction time 4 h 44h 19d 38d 
%GSSG 0 6 34 52 
Oxidation of GSH to GSSG may either be caused by air and/or by complex 2. No 
significant decrease in the intensity of the NH 3 'H peaks of complex 2 was observed 
over the reaction period. No pt"-NH 3 'H peak was present in the 'H NMR spectrum 
after 38 d. The corresponding 2D ['H, ' 5N] HSQC NMR spectra showed no presence 
of any Pt"-NH 3 compounds throughout the reaction, Figure 6.4. Reduction of 
complex (2) to a Pt" compound therefore did not occur. The presence of GSSG must 
be due to autoxidation of GSH by air. 
A new cross-peak at 7.07/ -1.64 ppm was present in the 2D ['H, ' 5N] NMR spectrum 
after 19 d reaction and increased in intensity with time. The peak was also observed 
181 
Chapter 6 Photoreactivity and stability of Pt(11)1(IV) azide complexes 
in the corresponding 'H spectrum at 6.98 ppm, and was assigned to NH4'-  Some of 
the ammine ligands must have dissociated from the Pt" centre. 
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Figure 6.3 'H NMR spectra of (A) GSH, (B) GSSG, and GSH in presence of 0.4 
mol eq of complex 2 after (C) 4 h and (D) 38 d. For peak labels see structure of GSH 
on previous page. 
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Figure 6.4 2D ['H, ' 5N] HSQC NMR spectra of the reaction between complex 2 and 
GSH after 4 h and 38 d of mixing. 
ESI-MS was performed 3 d after mixing complex 2 with GSH. The positive ion ES!-
MS contained major peaks at mass 307.8 mlz (GSH), 349 mlz (complex 2), 373 mlz 
(complex 2 + Na), 391 mlz (complex 2 + K). Peaks were also present with masses 
615 mlz, 637 mlz, 657 mlz, 680 m/z and 699 mlz. The main peak, mass 657 mlz, 
corresponds to an adduct of complex 2 + GSH (calculated mass 656 mlz). No peaks 
for Pt" or Pt"-NH 3 trans to sulfur were present in the 2D ['H, ' 5N] HSQC NMR 
spectra throughout the reaction, Figure 6.4. The GSH adduct of complex 2 therefore 
does not have GSH bound trans to an ammine ligand (Pt-N}-1 3 trans to SG). The slow 
release of ammonia during the reaction suggests that GSH replaced an ammine 
ligand. Peak 637 m/z in the mass spectrum correlates well with the adduct cis, trans, 
cis-[Pt"(N3 )2(OH)2(NH3)(GS)] which has a calculated mass of 637 mlz. These 
adducts can be found in the 'H NMR spectra. The 2D ['H, ' 5N] HSQC NMR 
spectrum after 38 d contained a new weak cross-peak close to the cross-peak of the 
unreacted complex 2, Figure 6.4. This cross-peak could be due to a GSH adduct with 
Pt"-N113 trans azide. 
In summary, no reduction of complex 2 by GSH occurred over the reaction period of 
38 d. However, a small amount of NH 3 released from the complex was detected by 
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NMR spectroscopy and the mass of a complex corresponding to an adduct of 
complex 2 and GSH was detected by ESI-MS. 
6.2.2.2 Platinum" diazido complexes 
Complex 1 in 0.1 M aqueous NaCl solution 
A solution of cis-[Pt"(N3)2(NH 3)2] ( 1, 5 mlVI) in 0.1 M aqueous NaCl was prepared. 
The solution was monitored just after mixing and after 104 h (4 d) by 'H and 2D ['H, 
' 5N] HSQC NMR at 298 K. The solution was stored in the dark at 298 K. Two new 
cross-peaks were present after 104 h at 4.02/ -67.5 ppm 15a and 3.86/ -71.2 ppm 15b 
besides the cross-peak for the starting complex 1 at 3.86/ -69.52 ppm. The intensities 
of the two cross-peaks 15a and 15b were identical, which suggests that both cross-
peaks are due to the same complex. The chemical shifts of cross-peak 15a are similar 
to values reported in literature for complexes with Pt"-NH 3 trans to C1. 2 Also the 
coupling constants 'J( 195Pt- 15N) = 324 Hz and 2J(' 95Pt-'H) = 66 Hz are consistent with 
a complex containing Pt-NH3 trans to Cl. The chemical shifts of cross-peak 15b are 
very similar to the starting complex 1 and can be assumed to be due to Pt-N}1 3 trans 
to N3 . The two cross-peaks 15a and 15b are therefore due to the complex cis-
[Pt"(N3)Cl(NH3)2] (15). Cross-peak 15a is due to the NH 3 trans to Cl and cross-peak 
15b is due to the other NH 3 trans to N3 . Integration suggested that 20% of complex 1 
had been converted into complex 15 after 4 d. No cross-peak for cis-[Pt"C1 2(NR3)2] 
was observed. The rate of substitution of the second azide ligand is therefore very 
slow. 
6.2.3 Photoreactivity of platinum di. and monoazido complexes 
The photoreactivity of platinum azido complexes was studied by 'H and 2D ['H, ' 5N] 
HSQC NMR spectroscopy. An Ar-Kr ion laser was used as the light source. The 
light was directly delivered into the NMR tube by a fibre optic. This setup is 
described in detail in section 2.2. All photo-experiments were carried out the 
following way, 
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The laser was switched on and adjusted to the desired wavelength. 
The light power was measured by a Coherent 210 power meter at the end of the 
fibre optic. 
The light switch at the laser was closed. 
The sample in a screw cap NMR tube was mounted onto the fibre optic. The 
distance between the end of the fibre optic and the solution was about 2 mm. 
The NMR tube was lowered into the NMR probe and the NMR experiments were 
set up. 'H and 1D/2D ['H, ' 5N] HSQC NMR spectra were acquired to check the 
sample and experiments. 
The kinetic NMR experiments were programmed as shown below (from left to 
right with the whole sequence typically repeated 20 times). 
Experiments: 2D ['H, ' 5N] 'H 	Delay 	2D ['H, ' 5N] 'H 	Delay 
Time: 	I 	x 	y I I I................ 
2D ['H, ' 5N] HSQC NMR experiments lasted Ca. 40 mm, 'H NMR experiments Ca. 3-
7 min and a delay was introduced additionally in some experiments. After setting up 
the NMR experiment, the light switch was opened and the NMR experiment started 
simultaneously. 
The reaction was monitored throughout the photoreaction. 
The times listed in the time course of an experiment represent the total irradiation 
time of the sample at the end of the NMR data acquisition. The time points for 
acquisition of NMR spectra however are the midpoints of the NMR acquisition. The 
time courses can befoundfor most experiments in the Appendices. 
The photoexperiments are listed according to the classes of complex under 
investigation. 
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6.2.3.1 Photoreactivity of platinum " diazido complexes 
The photoreactivity of cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2), cis, trans, cis-
[Pt"(N3)2(OAc) 2(NH3)2] (3) and cis, trans-[Pt"(en)(N 3)2(OH)2] (5) towards visible 
light was studied by 'H and 2D ['H, ' 5N] HSQC NMR spectroscopy. Binding of 
complexes 2 and 5 to nucleotides induced by light was studied. ESI-MS was used to 
identify the products of the reactions. 
UVNIS spectra of complexes 2 and 5 
The UV/\TIS absorption spectra of complexes 2 and 5 in H 20 were obtained on a 
Varian Cary 300 scan spectrophotometer at 298 K. An 8.6 mM solution of complex 
2 and a 3.5 mM solution of complex 5 were used and the absorbance was acquired 
every 0.1 nm over the range 200-750 nm. A spectrum of H 20 was used as 
background and substracted from the sample spectra. Figure 6.5 shows the UV/VIS 
spectra of complexes 2 and S. Both spectra exhibit three bands (shoulders) in the 
range 250-450 nm. The extinction coefficients of these bands are listed in Table 6.8. 
The extinction coefficients at the wavelengths of the laser lines which were used for 
irradiation of the samples (457.9 nm, 488 nm and 647.1 nm) are also listed in Table 
Table 6.8 Extinction coefficients () of complexes 2 and 5 in H20. 
2 ?. (nm) c (1 mol' cm) 	5 ?. (nm) c (1 mo1 	cm') 
la 260 398.8 	 lb 255 978.9 
2a 340 234.6 	2b 315 638.2 
3a 390 148.9 	3b 365 303.9 
4a 457.9 8.6 	 4b 457.9 37.5 
5a 488 2.8 	 5b 488 27.1 
6a 647.1 1.4 	 6b 647.1 10.6 
The extinction coefficients of complex 5 are ca. 3x larger than those of complex 2. 
The extinction coefficients at the irradiation wavelengths of 457.1 nm, 488 nm and 
647.1 nm are very small for both complexes. This suggests that the photoreactions 
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will be inefficient when using these three excitation wavelengths. All three 
complexes are yellow in colour and form yellow solutions in H 20. 
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Figure 6.5 UV-VIS spectra in H20 of cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2, 8.6 
mM) and cis, trans-[Pt"(en)(N 3)2(OH)2] (5, 3.5 mM). 
Photoreactions of complexes 1, 3 and 5 in H 20 
(a) Photoreaction of cis, trans, cis-[Pt"(N 3)2(OH) 2(NH3)2] (2) in H20 
A 5 mM solution of complex 2 was prepared in 90% H 20/ 10% D20. The pH was 
adjusted to 5 with 0.1 M HCI04. The laser line of 488 nm was used for irradiating the 
sample and the light power at the end of the fibre optic was adjusted to Ca. 10 mW. 
The sample was irradiated for 20 h, and then a 2D ['H, ' 5N] HSQC spectrum was 
obtained after stopping the irradiation. This spectrum is shown in Figure 6.6. New 
cross-peaks were present in the 'HI ' 5N regions from 5.16 to 5.05/ -40.56 to —39.88 
ppm and 5.05 to 4.94/ -49.33 to —49.01 ppm (boxes (A) and (B), respectively, in 
Figure 6.6). The ' 5N chemical shift of the cross-peaks in box (A) (C: 5.16/ -40.35 
ppm; d: 5.08/ -40.56 ppm; e: 50.05/ -39.88 ppm) correspond to compounds 
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containing Pt"-NH3 trans to N.' The ' 5N chemical shift of the cross-peaks of box (B) 
(f: 5.051 -49.13 ppm; g: 5.00/ -49.33 ppm; h: 4.94/ -49.01 ppm) correspond to 
compounds containing Pt`-NH3 trans to 0. No cross-peak due to a Pt' , compound 
appeared in the spectrum. Cross-peaks c-h have all similar 'J(' 5N-' 95Pt) coupling 
constants of ca. 270 Hz and similar 2J('H-' 95Pt) coupling constants of Ca. 47 Hz. 
The ESI-MS spectrum after the irradiation showed only a peak for the starting 
complex 2 at 348.6 mlz (calc. 349 mlz) and its Na and K adducts at 372.5 mlz and 
388.6 mlz, respectively (caic. 372 mlz for Na adduct and 388 m/z for K adduct). 
These results plus the NMR data suggest that photoisomerization occurs. Trans 
hydroxide ligands change their positions with the azide and ammine ligands. Pt 1"-
NH3 groups trans to OH have the cross-peaks at a ' 5N chemical shift of-50 ppm. 
The same sample stored in the dark for 7 d had a 2D ['H, ' 5N] NMR spectrum 
identical to that obtained 20 h after irradiation. The isomerization process is 
therefore purely a photoreaction. No photoreduction took place during the 
irradiation. 
DUWDPDCOOODDUO 0 0 0 0 0 






Figure 6.6 2D ['H, ' 5N] HSQC spectrum after 20 h irradiation (488 nm, 15 mW) of 
cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2) at 298 K, pH 5. * "Pt satellites. 
Assignments: c, d, e peaks due to 3_plV trans to N3 ; f, g, h peaks due NH 3-Pt" 
trans to OH. 
188 
Chapter 6 Photoreactivity and stability of Pt(11)1(IV) azide complexes 
(b) Photoreaction of cis, trans, cis-IPt"(N3)2(OAc)2(NH3)21 (3) in H20 
A 2 mM solution of complex 3 was prepared in 90% H 20/ 10% D 20. The pH was 
measured to be 6.48. The laser line at 457.9 rim was adjusted to 15 mW light power 
at the end of the fibre optic. The NMR experiment times were as follows 
Experiments: 2D ['H, ' 5N] 'H 	Delay 	2D ['H, ' 5N] 'H 	Delay 
II 	I........... ..... ........ ____________________________________ ................ 
Time: 	38 mm 	1 3.78 	1 h 
mm 
The changes in the NMR spectra during the time course of the photoreaction are 
described in Appendix 1. Figure 6.7 shows the 'H NMR spectra during this 
photoreaction after 0 h, 4.1 h, 7.5 h and 20 h of irradiation. Figure 6.9 shows the 2D 
['H, ' 5N] HSQC spectrum after 7.5 h of irradiation. 
The peaks for complex 3 disappeared during the reaction and peak 16a appears 
simultaneously in the 'H NIVIR spectrum (see Figure 6.7). Figure 6.8 illustrates the 
increase of peak 16a with time and the decrease of peak 3 with time. The data were 
extracted from the 'H NMR integrals of the peaks 3a and 16a. 
The 'H chemical shift of sodium acetate in 90% H 20/ 10% D 20 is 1.92 ppm at pH 
6.7. Peak 16a is therefore not due to free acetate in solution. 
The appearance of peak 16a in the 'H NMR spectrum is directly connected to the 
appearance of the cross-peaks in box 16B (5.3 to 5.0/ -49 ppm) and in box 16C (5.3 
to 5.0/ -39.9 ppm) in the 2D ['H, ' 5N] HSQC NMR spectrum, see Figure 6.9. The ' 5N 
chemical shifts of the cross-peaks in box 16B (49 ppm) correspond to a 
configuration of Pt"-NH 3 trans to 0, and the ' 5N chemical shift of the cross-peaks of 
box 16C (-39 ppm) correspond to a configuration of Pt"-NH 3 trans to N.' The 
chemical shifts and coupling constants of the cross-peaks in box 16B are similar to 
those of complex 2 (5.2/ -39.8 ppm, 'J(' 5N-' 95Pt) = 258 Hz, 2J('H-'95Pt) = 46 Hz). The 
fact that only one CH 3 acetato peak 16a occurs in the 'H NMR spectrum during the 
reaction means that peak 16a is due to the same compounds also responsible for the 
cross-peaks in the boxes 16B and 16C in Figure 6.9. The simultaneous appearance of 
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cross-peaks at ' 5N chemical shifts -49 and -39 ppm suggests that the cross-peaks at - 
49 and -39 ppm have their origin from the same compounds. The shape and 'H 
chemical shift of peak 16a ("Pt satellites weakly visible) suggests that peak 16a is 
due to acetate bound to platinum. Therefore it is very likely that the reaction 
observed is a photoisomerization reaction similar to the one observed for complex 2 
in H20 ' 
CH3 acetato region 
I. 
2.2 	2.1 	ppm 
4.1 h 
5.8 5.6 5.4 5.2 ppm 	2.2 	2.1 	ppm 
16a 
7 h 




457.9 nm 	5.8 5.6 5.4 5.2 ppm 	2.2 	2.1 	ppm 
15 MW 
Figure 6.7 Time course of the 'H NMR spectra of the photoreaction of cis, trans, 
cis-[Pt"(N 3 )2(OAc) 2(NH3)2] (3) in H20 at 298 K, pH 6.48. The N}1 3 ammine region 
and the CH3 acetato region are shown. 
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Figure 6.8 Relative proportions of peaks 3 and 16a derived from 'H NMR (see 
Figure 6.7) of the acetato region during the photoreaction (irradiation at 457.9 run, 
15 mW). 
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Figure 6.9 2D ['H, ' 5N] HSQC NMR spectrum after 7.5 h of irradiation (457.9 nm, 
15 mW) of complex 3 in H 20 at 298 K, pH 6.48. * '95Pt satellites. 
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(c) Photoreaction of cis, trans-[Pt"(en)(N3)2(OH)2 1 (5) in H20 
A 2 mM solution of complex 5 was prepared in 90% H20/ 10% D20. The pH was 
adjusted to 5 with 0.1 M HC1O4. The laser line at 457.9 nm was adjusted to 20 mW 
at the end of the fibre optic. The NMR experiments were set up identically as in the 
photoreaction of complex 3. 
The time courses of the 'H and 2D ['H, ' 5N] HSQC NMR spectra during this 
photoreaction are listed in Appendix 2. The 2D ['H, ' 5N] HSQC NMR spectrum and 
the corresponding 'H NMR spectrum after 4 h of irradiation is shown in Figure 6.10. 
New cross-peaks appeared in three ' 5N regions of the 2D ['H, ' 5N] NMR spectra 
(Figure 6.10): at -6 ppm (A), -16 ppm (B) and -48 ppm (C), see Figure 6.10. These 
' 5N chemical shift are characteristic for the following configurations:' 
Pt"-NH2 en trans to N 
Pt1"-NH2 en trans to 0 
Pt"-NH2 en trans to 0 
The cross-peaks in box (A) of Figure 6.10 are due to Pt' v-NH2-en trans to N 
compounds. The coupling constants 'J(' 5N-' 95Pt) and 2J( 'H- ' 95Pt) of the cross-peaks 
in box (A) are identical to the coupling constants of complex 5. The four new cross-
peaks in box (A) are therefore likely to be due to Pt'-NH 2 of en trans to N3 due to 
the similarity of their ' 5N chemical shifts and coupling constants with those of 
reactant 5. The cross-peaks in box (A) are likely to be due to isomers of cis, trans-
[Pt"(en)(N 3)2(OH)2]. The cross-peaks in box (B) are then due to Pt 1"-NH2 en trans to 
O isomers of cis, trans-[Pt"(en)(N3)2(OH)2]. The two cross-peaks in box (C) must be 
due to Pt"-NH 2 en trans to OW 0112 as there is no other oxygen ligand than H 20 
available in the reaction solution. 
Figure 6.11 shows the development of the integrals of the reactant (complex 5) and 
the two Pt" products. About 90% of complex 5 has disappeared after 4 h irradiation, 
but only ca. 5% of it underwent a photoreduction reaction to Pt". All peaks had 
almost disappeared by the end of the irradiation due to the formation of a precipitate. 
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The identity of this precipitate is not known as it was insoluble in all common 
solvents and no NMR data could be acquired. 
51 	5P# 
r 
Pt"-NH, en trans 0 (C) 
: 17b 	; 
Pt"-N11 2 en trans 0 
0*0 05 0 
(A) 	10 ° © Pt'-NH2 en trans N 
•00 
0 
75 	70 	65 	60 	ppm 
6('H) 
Figure 6.10 2D ['H, ' 5N] HSQC NMR spectrum of the photoreaction of complex 
cis, trans-[Pt'(en)(N3)2(OH)2 ] (5) in 90% H20/ 10% D20 (pH 5, 298 K) after 4 h 
irradiation (457.9 nm, 20 mW) and the corresponding 'H NMR spectrum. * 
satellites. 
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Figure 6.11 Time course of the integrals (derived from 2D ['H, ' 5N] NIVIR) of the 
cross-peaks of reactant 5 and the two Pt" photoproducts 18a and 18b. 
Photoreaction of complex 2 in 0.1 M NaCl aqueous solution 
The photoreaction of cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2) in 0.1 M NaCl 
solution was studied by NMR spectroscopy. A solution of complex 2 (4.35 MM) was 
prepared in 0.1 M NaCl aqueous solution. D 20 (10% v/v) was added and the pH 
adjusted to 5 with 0.1 M HC104. The solution was stored in the dark for 18 h at 298 
K before starting the photoreaction. The laser line at 457.9 nm was adjusted to ca. 30 
mW at the end of the fibre optic. The sequence of NMR acquisition was as follows: 
Experiments: 2D ['H, ' 5N] 'H 	Delay 	2D ['H, ' 5N] 'H 	Delay 
Time: 	39.6 mm 	 Oh 	.I I 
mm 
The changes in the 'H and 2D ['H, ' 5N] HSQC NMR spectra during the above 
experiment are described in Appendix 3. Figure 6.12 shows the 2D ['H, ' 5N] HSQC 
NMR spectra of the reaction after (A) 0 h and (B) 6.9 h irradiation. 
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The ' 5N chemical shifts of the photoproducts are all around -70 ppm (Figure 6.12, 
(B)). Such a ' 5N chemical shift can be assigned to either Pt"-NH 3 trans to N or Pt"-
NH3 trans to Cl. The coupling constants of the major product 19c at 4.02/ -68.00 
ppm are 'J( 15N- 195Pt) = 286 Hz and 2J('H-'95Pt) = 56 Hz. Compounds with Pt"-NH3 
trans to NH3 have been found to have similar 'J( 15N- 195Pt) values.' None of the 
products is cisplatin cis-[Pt"C1 2(NH3 )2]
1 
 which was reported to have a 'HI ' 5N 
chemical shifts of 4.04/ -68.77 ppm, 'J(' 5N-' 95Pt) = 328 Hz and 2J('H-'95Pt) = 64 Hz.' 
A yellow precipitate was observed at the end of the irradiation. This precipitate is the 
reason for the overall large loss of intensity in the NMR spectra. The sum of the 
intensity of the two cross-peaks of the products 19a and 19c is only about 3% of the 
intensity of complex 2 before the start of the irradiation. 
PPM (A) (B) 
	
5(15 N) 
—50 	 1 
—40 	 021 	 9c 
6 	5 	4 ppm 	5 	4 ppm 
Figure 6.12 2D [ 1 H, ' 5N] HSQC and 'H NMR spectrum of the photoreaction of 
complex 2 in 0.1 M NaCl aqueous solution after (A) 0 h irradiation and at (B) 6.9 h 
irradiation, 298 K, pH 5. 
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Photoreactions of complexes 2 and 5 in the presence of nucleotides 
and oligonucleotides 
1) Photoreactions in the presence of S LGMP 
(a) Photoreaction of complex 2 in the presence of 5'-GMP. 
A solution of cis, trans, cis-{Pt"(N 3)2(OH)2(NH3)2] (2, 1 mlvi) and 5'-GMP (2 mM) 
was prepared in 95% H20/ 5% D20. The pH was adjusted to 5 with 0.1 M HC104 . 
The laser line at 457.9 nm was used for the photoreaction and the light power was 
adjusted to Ca. 10 mW at the end of the fibre optic. The NMR experiment times of 
were as follows: 
Experiments: 2D ['H, ' 5N] 'H 	Delay 	2D ['H, ' 5N] 'H 	Delay 
Time: 	39.6 min 	7.37 	0 h 	 I I 
mm 
Figure 6.13 shows the 2D ['H, ' 5N] HSQC spectra of this reaction after (A) Oh and 
(B) 7.68 h irradiation and Figure 6.14 shows the 'H NMR spectra after (C) 0 h and 
(D) 7 h irradiation. The cross-peak for reactant 2 (5.08/ -40.37 ppm) decreased 
during the 7.68 h of irradiation while new cross-peaks were appearing in the region 
3.9 to 4.5/ -60 to —68 ppm, Figure 6.13. Table 6.9 shows the 'HI ' 5N chemical shifts 
of the photoproducts. 
Table 6.9 'HI ' 5N chemical shifts of the products of the photoreaction of complex 2 
in the presence of 5'-GMP. Chemical shifts are derived from 2D ['H, ' 5N] HSQC 
NMR spectra, 298 K, pH 5. 
Compound ('W ' 5N) Compound ö('HJ 15N) 
20 4.161-64.76 24 3.87/-64.95 
21 4.49/ -67.18 25 3.97/ -62.21 
22 4.141-68.13 26 4.15/-59.97 
23 4.03/ -67.75 
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Figure 6.13 2D ['H, ' 5N] HSQC spectrum of the photoreaction of complex 2 in the 
presence of 2 mol eq 5'-GMP at (A) 0 h irradiation (457.9 rim, 10 mW) and at (B) 
7.68 h. * ' 95Pt satellites. 
The time course of the 'H NMR spectra is shown in Figure 6.14. New peaks were 
present in the H8 region of 5'-GMP (6('H) H8 5'-GMP = 8.12 ppm). The new peaks 
were all to low-field of the H8 peak for free 5'-GMP. The major new peak (40% of 
all new peaks) has a 'H chemical shift of 8.78 27 and is therefore shifted by 0.63 
ppm to low-field. The 'H chemical shifts of the H8 of the reactant 5'-GMP shifted by 
0.05 ppm from 8.12 to 8.17 ppm during 7 h of irradiation. Additionally, new peaks 
were present in the region of Hi' (6('H) Hi' 5'-GMP = 5.94 ppm (d), 3J(H1')-(H2') = 
6.05 Hz). New peaks were also present in the region from 4.6 to 4 ppm. Table 6.10 
lists the 'H chemical shifts of the peaks present after 7 h irradiation. 
The intensity of the H8 peak of the reactant 5 '-GMP was reduced to 14% of its initial 
value by the end of the irradiation. Similarly the intensity for the Hi' peak of 5'-
GMP was reduced to 17.5% of its starting value. Both intensities were calibrated 
with the internal standard peak of dioxane. This means that Ca. 80% of 5'-GMP must 
have undergone a reaction. 
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Figure 6.14 'H NMR spectra of the photoreaction of complex 2 and 2 eq 5'-GMP 
after (C) 0 h irradiation and (D) 7 h irradiation (457.9 nm, 10 mW). Box (E) are the 
5'-GMP adducts. The ratio H8 5'-GMP! H8 box (E) is 40%! 60%. 
Table 6.10 'H chemical shifts of H8 and Hl' protons plus the coupling constant 
3J(H1')-(H2') [Hz] of 5'-GMP in the photoreaction with complex 2. The chemical 
shifts are derived from the 'H NIMR spectrum after 7 h irradiation (457.9 Mn, 10 
mW), 298 K ((D), Figure 6.14). 
Compound 6('H) H8 region ('H) Hi' region 
[3J(Hi ')-(H2')] 
Free 5GMP 8.17 5.94 [6.05] 
Products 8.90, 	8.87, 	8.78, 	8.77, 6.02 [5.14], 5.99 [5.69], 
8.65, 	8.60, 	8.54, 	8.53, 5.91 [4.95], 5.89 [4.95] 
8.46 
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The ratio between the intensities of the H8 peaks of the reactant 5'-GMP and the 
products to low-field of free 5'-GMP was 40% to 60%. The 195Pt satellites of the 
products which were too broad to detect were included in the calculation by adding 
33.8% (natural abundance of the Pt isotope 195Pt) intensity to the product peaks. A 
low-field shift of the H8 'H NMR signal is typical of metal binding to N7 of 5'-
GMP. 3 
The 'HI ' 5N cross-peaks of the photoproducts appeared in the region 3.9 to 4.5/ -60 to 
—68 ppm (box (B), Figure 6.13), which is characteristic for Pt"-NH 3 trans to N or Cl.' 
Care was taken to avoid chloride in the solution, and therefore all new 'HI ' 5N cross-
peaks must be due to Pt"-NH 3 trans to N. This together with the low-field shift of the 
H8 'H NMR signal suggests that all seven cross-peaks are due to Pt binding to N7 of 
5 '-GMP. 
The coupling constants 3J(H1')-(H2') of the products are reduced by Ca. 1 Hz 
compared to free 5'-GMP, from 6 to 5 Hz. This was also observed in literature for Pt 
binding to N7.4 
Compound 21 in Figure 6.13 can be assigned to cis-[Pt"(NH 3)2(GMP-N7)2] 
according to literature values.' Figure 6.15 gives the time course of the intensities of 
the four most intense Pt"-NH 3 cross-peaks in the 2D ['H, ' 5N] HSQC NMR spectra. 
The cross-peak due to complex 2 is reduced to ca. 5% of its initial value during the 
photoreaction. A first-order exponential decay curve was fitted to the curve yielding 
a rate constant of k = 0.74 s'. 
It is remarkable that all the intensities of the Pt"-NH 3 cross-peaks together add up 
only to 27% of that for complex 2 before the irradiation. The lost signal of complex 2 
is likely to be due to exchange of the NH 3 protons with the solvent which is much 
faster for Pt" compounds than for Pt" (see section 6.2.1). That means that most of 
complex 2 has not reacted after 7 h irradiation. No cross-peaks outside the region 3.9 
to 4.5/ -60 to —68 ppm were detected. Intermediate compounds containing OW OH 2 
ligands, such as cis-[Pt"(NH 3)2(GMP-N7)(OHJ OH2)]
1 
 were not detected during the 
irradiation. The photoproducts of complex 2 must therefore bind rapidly to N7 of 5- 
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Figure 6.15 Time course of the intensities (derived from cross-peaks of 2D ['H, 15N] 
HSQC NMR spectra) of reactant 2 and the four most intense products during the 
irradiation (457.9 nm, 10 mW. 298 K). 
(a) Photoreaction of complex 5 in the presence of 5'-GMP. 
A solution of cis, trans- [Pt"(en)(N3)2(OH)2] (5. 2 mM) and 5'-GMP (4 mM) was 
prepared in 90% H 20/ 10 D20. The pH was adjusted to ca. 5 with 0.1 M HCI04. The 
laser line at 457.9 rim was adjusted to ca. 15 mW at the end of the fibre optic. The 
photoreaction was carried out for 65.3 h and was followed by 2D ['H, ' 5N] and 'H 
NMR spectroscopy at 298 K. The experiment times were as follows: 
Experiments: 2D ['H, 15N] 'H 	Delay 	2D ['H. ' 5N] 'H 	Delay 
Time: 	38 mm 	3.78 	1 h 	
I I 
mm 
The time course of the NMR spectra during the photoreaction of complex S in the 
presence of 5'-GMP is described in Appendix 4. Figure 6.16 shows the 'H NMR 
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Figure 6.17 shows the 2D ['H, ' 5N] HSQC TOCSY NMR spectrum, which was 
acquired after 65.3 h of irradiation. 
A 2D ['H, ' 5N] HSQC TOCSY NMR experiment was obtained after the end of the 
irradiation, Figure 6.17. The CH2 en peak 28b belongs to the same spin system as the 
two cross-peaks 28 (5.78/ -30.74, 5.71/ -30.77 ppm). The simultaneous appearance 
of the peaks 28a and 28b suggests that both peaks are due to the same compound. 
The ' 5N chemical shifts of the cross-peaks 28 of —30.74 ppm are characteristic of Pt"-
en trans to N and the low-field shift of 0.5 ppm of peak 28a (8.59 ppm) compared to 
free 5'-GMP (8.12 ppm) is indicative of metal binding to N7 of GMP. 1 ' 6 The peaks 
28, 28a, 28b and 28c can be assigned to the compound [Pt"(en)(N7-GMP) 2] (28) 
when compared with literature data (Table 6.13)? 
The other major peaks in the 2D ['H, ' 5N] HSQC NMR spectrum are the cross-peaks 
for 29 at 5.34/ -32.82 d, 5.36/ -31.58 e and 5.41/ -31.58 ppm f. All three cross-peaks 
belong to the same spin system with the en-CH 2 peak 29b at ('H) 2.72 ppm, Figure 
6.17. Peaks 29a and 29b appear simultaneously and increase in intensity 
simultaneously and are therefore due to the same compound. The two cross-peaks at 
6( 15N) —31.5 ppm (e and 1) add up together in intensity to the same value as the 
cross-peak at 8(' 5N) —32.82 ppm d throughout the experiment. Peaks e and f are 
therefore each a hydrogen attached to the same nitrogen in the en group. Peak d is 
due to two equivalent hydrogens attached to the other nitrogen in the en group. The 
corresponding en-CH2 protons at o('H) 2.72 ppm are equivalent. Both the ' 5N 
chemical shift and the low-field shift of the H8 o('H) of compound 29 indicate that 
Pt is bound to N7-GMP. 
The weak cross-peaks appearing at 6(' 5N) —56 ppm at the end of the irradiation are 
probably due to Pt"-en trans to 0. Reported ' 5N chemical shifts for Pt"-en trans to 0 
are —50.4 ppm for [Pt"(en)C1(0H 2)1' at pH 3.11 and —45.5 ppm for 
{Pt"(en)(0H 2)(N7-GMP)] at pH 4.8. 
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Figure 6.16 Time course of the 'H NMR spectra during the irradiation of cis, trans-
[Pt"(en)(N 3) 2(OH)2] (5) in the presence of 2 mol eq 5'-GMP, 298 K, at (A) 0 h, (B) 
19.4 h and (C) 64.5 h of irradiation (457.9 nm, 15 mW). Peaks 28a/b/c are assigned 
to {Pt"(en)(N7-GMP) 2]. 
The peaks of box 30a (8.53, 8.49, 8.47, 8.46, 8.40 ppm) in Figure 6.16 represent 
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indicates Pt binding to N7-GMP. No cross-peaks were detected in the 2D ['H, ' 5N] 
HSQC NMR spectra which were due to these products. 
The ratio of the products at the end of the irradiation is shown in Table 6.12. About 
20% of 5'-GMP did not react, 45% 5'-GMP is incorporated into [Pt"(en)(N7-GMP) 2]
1 
 
15% is incorporated into compound 29 and about 19% of 5'-GMIP is part of the 
minor products of group 30a, Figure 6.16. 
9 	8 7 	6 	5 	4 	ppm 
6(1ff) 
Figure 6.17 2D ['H, ' 5N] HSQC TOCSY NIMR spectrum after 65.3 h irradiation of 
complex 5 (457.9 nm, ca. 15 mW), 298 K. Cross-peak 5 is assigned to reactant 5, 
cross-peak 28 to [Pt"(en)(N7-GMP) 2]. 
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Table 6.12 Relative intensities of H8 5'-GMP peaks after 64.5 h irradiation at 298 K 
(33.8% intensity was added to the intensity of the new peaks for the "Pt satellites 
which are broad and were not detected). 
Peak (ppm) Relative 	intensity 
(%) 
8.12 (free 5'-GMP) 21 
8.5928a 44 
8.63 29a 16 
8.54, 8.52, 	8.50, 8.47, 
8.45, 8.43 30a 
19 
Table 6.13 Comparison between reported 'HI ' 5N chemical shifts for [Pt"(en)(N7-
GMP)2] 3 and peaks 28, 28a, 28b, 28c (Figure 6.17). 
Group 5('H/ ' 5N) 
[Pt"(en)(N7-GMP) 2] 
pH 6. 1, Ref. 3 
Peaks 28, 28a, 28b, 28c 
en-CH2 2.84 2.84 
en-NH2 ö('H): 5.79, 5.96 
8(15 N): -30.2 
('H): 5.75, 5.88 
( 5N): -30.7 
H8 GMP 8.64 8.59 
H1'GMP 5.93 5.93 
pH dependence of H8 'H chemical shifts: 
Table 6.14 pK values derived from the pH titration curves in Figure 6.18. 
Compound pK(l) pK(2) 
{P0(en)(N7-GMP) 2] (28) 5.87 ± 0.07 9.20 ± 0.07 
29 6.10±0.06 8.70±0.05 
Free 5'-GMIP 6.25 7 9•497 
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Figure 6.18 pH titration of the H8 'H chemical shifts of (a) free 5'-GMP, (b) 
compound 28 and (c) compound 29 after the end of the irradiation of complex 5 in 
the presence of 5'-GMP. T = 298 K. The curves represent best fits to the Henderson-
Hasselbaich equation with PK a values listed in Table 6.14 (previous page). 
ESI-MS: The sample used for the NMR irradiation experiment was used after the 
irradiation for an electrospray mass spec analysis. The positive ion electrospray mass 
spectrum contained a peak exhibiting the Pt isotope pattern at 682.8 mlz. This mass 
is in good agreement with the mass of compound [Pt"(' 5N-en)(OH2)(N7-GMP)] 2 
(calculated mass 682.2 mlz). A peak at 1070.1 mlz was assigned to the compound 
[Pt"(' 5N-en)(N7-GMP) 2] 2 (28) (calculated mass 1071.4 mlz). 
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2) Photoreactions in the presence of d(GpG) 
The photoreactions of complexes cis, trans-[Pt"(en)(N 3)2(OH)2J (5) and cis, trans, 
cis-[Pt"(N3)2(OH)2(NH3)2 1 (2) in the presence of d(GpG) were carried out in 95% 
H20/ 5% DO. The pH was adjusted to Ca. 5 with 0.1 M HC1O 4 for all reactions. The 
laser line at 457.9 rim was used for all reactions unless stated otherwise and the light 
power at the end of the fibre optic varied from 10 mW to 25 mW. The NMR 
experiment times were for all reactions as follows, 
Experiments: 2D ['H, ' 5N] 'H 	Delay 	2D ['H, ' 5N] 'H 	Delay 
Time: 	39.6 mm 	7.37 	Oh 	 I I 
mm 
(a) Photoreaction of complex 5 in the presence of d(GpG). 
Two photoreactions were carried out with complex 5 and the dinucleotide d(GpG). 
In the first photoreaction, a 1 mM solution of complex (5) and d(GpG) (1 mlvi) was 
irradiated with a light power at the end of the fibre optic of ca. 25 mW. A delay of 1 
h before each 2D ['H, ' 5N] HSQC spectrum was built in. 
Figure 6.19 shows the 'H NIMR spectra after (A) 0 hand (B) 47 min of irradiation. 
The 2D ['H, ' 5N] HSQC NMR spectra are shown in Figure 6.20. 
Figure 6.19 shows the 'H NMR spectra (A) before the irradiation and (B) after 47 
mm. The NH2-en peaks 5a are not present any more in the spectrum after 47 mm 
irradiation and the CH 2-en peak 5b has moved to ('H) 2.85 ppm 32d (spectrum B). 
The H8 peaks of d(GpG) (31a and 31b) shifted to low-field by ca. 0.4 ppm (32a and 
32b). The Hi' peaks 31c and 31d overlap in spectrum (B) with 32c. The low-field 
shift of the H8 'H chemical shifts is characteristic for Pt binding to the N7 position of 
d(GpG). 6 The 2D ['H, ' 5N] HSQC NIMR spectrum which was acquired directly after 
the start of the irradiation contained only one cross-peak at 5.60/ -31 ppm 32e 
(Figure 6.20). This cross-peak consists of four resonances of equal intensity and are 
separated into two pairs associated with distinct ' 5N chemical shifts: 5.68, 5.63/ - 
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30.90 ppm and 5.58, 5.55/ -31.22 ppm. This ' 5N chemical shift is characteristic for 
Pt"-(en) trans to N.' A comparison with literature values for the 'HI ' 5N chemical 
shifts suggests that product 32 is [Pt(en) {d(GpG)-N7( 1), N7(2)} ] 21 . 8 ' 9 Table 6.15 lists 
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Figure 6.19 'H NMR spectra of the photoreaction of cis, trans-[Pt"(en)(N 3)2(OH)2] 
(5) in the presence of d(GpG) after (A) 0 h irradiation, and (B) 47 min irradiation at 
457.9 nm, 25 mW, 298 K. Assignments: (A): d(GpG): 31a H8 3'-G, 31b H8 5'-G, 
31c/d Hl'; cis, trans-{Pt''(en)(N 3)2(OH)2]: 5a NH2-en, Sb CH2-en. (B): 
[Pt(en){d(GpG)-N7(1), N7(2)1J 2 : 32a H8 3'-G, 32b H8 5'-G, 32c Hi', 32d CH2-en. 
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The experiment was repeated using a solution containing cis, trans-
[Pt"(en)(N 3)2(OH) 2] (5, 0.75 mM) and d(GpG) (31, 0.5 mM) and a lower light power 
of Ca. 10 mW at the end of the fibre optic in order to slow down the photoreaction. 
Only 2D ['H, ' 5N] HSQC NMR spectra were acquired during the photoreaction. The 
time course of the photoreaction is shown in Figure 6.20. No intermediates were 
present throughout the reaction time course, just the reactant 5 and the product 
[Pt(en){d(GpG)-N7(1), N7(2)}] 2 (32). The photoproducts of cis, trans-
[Pt"(en)(N 3)2(OH) 2] (5) must therefore react rapidly with d(GpG) to give the product 
[Pt(en){d(GpG)-N7(1), N7(2)}] 2 (32). A small amount of a yellow precipitate was 
observed at the end of the photoreaction in the NMR tube. 
The intensities of the cross-peaks in the 2D ['H, ' 5N] HSQC NMR spectra are used 
plotted against time in Figure 6.21. 
Table 6.15 'H and ' 5N chemical shifts of the reactants d(GpG) (31), cis, trans-
[Pt'(en)(N 3)2(OH) 2] (5) and the photoproduct [Pt"(en){d(GpG)-N7(1), N7(2)}] 2 
(32) at 298 K. 
Compound 6H8 8H1'/ 6N'H-en 6C'H-en 
3J(H1'-H2') (Hz) (5' 5NH) 5'-G 3'-G 
d(GpG) (31) 7.92 8.13 6.20 (t)I 13.2 
6.05 (t)/ 14.5 
5 6.52, 6.37 2.95 
(-6.92) 
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Figure 6.20 Time course of 2D [ 1 H, ' 5N] HSQC NMR spectra of the photoreaction 
of cis, trans-[Pt t"(en)(N3)2(OH)2] (5) in the presence of d(GpG) after (A) 1.32 h, (B) 
3.3 h, (C) 6.6 h and (D) 12.54 h irradiation, 298 K. * "'Pt satellites. Assignments: 5a 
cis, trans-[Pt"(en)(N 3 )2(OH)2] (5),32e [Pt(en) {d(GpG)-N7( 1), N7(2)) ]4  (32). 
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100 
75 I 	[Pt(en){d(GpG)-N7(1), N7(2)}] 2 (32) 
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Figure 6.21 Plot of the intensity variation of the cross-peaks in the 2D ['H, ' 5N] 
HSQC NMR spectra in the photoreaction (457.9 nm, 10 mW) of cis, trans-
[Pt"(en)(N3)2(OH)2] (5, 0.75 mlvi) in the presence of d(GpG) (0.5 mM) at pH 5, 298 
K. If all of 5 were converted to 32, then the % reaction would be 67% as indicated by 
the dashed line ( --- ). Ratio 5:d(GpG) = 3:2. 
pH dependence of H8 peaks 32a and 32b 
Figure 6.22 (next page) shows the pH dependence of (a) peak 32a and (b) peak 32b 
from Figure 6.19. The lines represent the best fits to the Henderson-Hasselbalch 
equation and the p1K 3 values are listed in Table 6.16. 
Table 6.16 pIK3 values derived from the pH titration curves in Figure 6.22 (next 
page). 
H8 proton p1K3 
3'-G 32a 7.98 ± 0.08 
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Figure 6.22 pH dependence of the H8 peaks (a) 32a and (b) 32b. The lines represent 
the best fits to the Henderson-Hasselbalch equation. The pK values are listed in 
Table 6.16. 
(b) Photoreaction of complex 2 in the presence of d(GpG). 
A solution of cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2, 0.7 mM) and d(GpG) (0.5 
mM) was prepared in 95% H20/ 5% D20. The light power was adjusted to Ca. 10 
mW at the end of the fibre optic. 
The changes of the 'H and 2D ['H, ' 5N] HSQC NMR spectra during the 
photoreaction of complex 2 in the presence of d(GpG) are listed in Appendix 5. 
Figure 6.23 shows the 2D ['H, ' 5N] HSQC NMR spectra of this photoreaction after 
(A) 0 h, (B) 1.43 h, (C) 3.74 h and (D) 8.36 h of irradiation. The corresponding 'H 
NMR spectra are shown in Figure 6.24. Table 6.17 summarises the 'HI ' 5N chemical 
shifts of the reactants and products. 
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The H8 peaks 31a and 31b shifted to low-field after 0.77 h of irradiation by 0.4 and 
0.3 ppm, respectively. The Hi' peaks 31c and 31d disappeared and peak 33e 
appeared. No free d(GpG) was detected in the 'H NMR spectrum after 0.77 h 
irradiation, however unreacted cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2) was 
detected. The ' 5N chemical shifts of —68.50 ppm for the two new cross-peaks 33a 
and 33b which were present after 0.66 h irradiation are characteristic of Pt"-NH 3 
trans to N. The low-field shift of the H8 'H NMR peak which is indicative for Pt 
binding to N7 of guanine and the ' 5N chemical shifts of the cross-peaks 33a and 33b, 
suggests that the two cross-peaks 33a and 33b are due to the adduct cis-
1Pt"(NF13 )2 {d(GpG)-N7(1), N7(2)}] 2 (33). 
Peaks due to free d(GpG) disappeared after 0.77 h irradiation. Further irradiation of 
the sample solution led to the continuous disappearance of the cross-peak of reactant 
2. The intensities of the cross-peaks 33a and 33b (cis-[Pt"(NH3)2 {d(GpG)-N7(1), 
N7(2)}] 2 ) stayed constant during the further irradiation confirming that all d(GpG) 
had already reacted with Pt after only 0.77 h of irradiation. The new cross-peak 35, 
which became more intense during the time course of the irradiation, can be assigned 
to N114'which is due to NH3  ligands released from of Pt compounds. The 'H 
chemical shift of ' 5NH4C1 was determined to be 7.07 ppm, which is in agreement 
with the 'H chemical shifts of compound 35. It is remarkable that no other Pt" 
products besides cis-[Pt"(NH3)2 {d(GpG)-N7(1), N7(2)}] 2 (33) were detected. This 
can be explained by the appearance of a yellow precipitate at the end of the reaction. 
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Figure 6.23 Time course of 2D ['H, ' 5N] HSQC NMR spectra for the photoreaction 
of cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2) in the presence of d(GpG) at (A) 0 h, (B) 
1.43 h, (C) 3.74 h and (B) 8.36 h, 298 K. * represent 195Pt satellites. Assignments: 2 
cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2); 33a, 33b cis-[Pt(NH 3 )2 {d(GpG)-N7(1), 
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Figure 6.24 'H NIvIR spectra of the photoreaction of cis, trans, cis-[Pt"(N3)2(OH)2 
(NH3)2 1 (2, 0.7 mM) in the presence of d(GpG) (0.5 mM) after (A) 0 h, (B) 0.77 h 
and (C) 8.47 h irradiation with 457.9 nm, 10 mW, 298 K. Assignments: (A): d(GpG) 
(31): 31a H8 3'-G, 31b H8 5'-G, 31c/d Hi'; cis, trans, cis-[Pt"(N 3 )2(OH)2(NH3 )2] 
(2): 2 NH 3 . (B)! (C): cis- [Pt(NH 3)2 {d(GpG)-N7(i), N7(2)}] 2 (33): 33a, 33b NH 3 
33c H8 3'-G, 33d H8 5'-G, 33e Hi', 33f NH 2 d(GpG). 
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(8' 5NH) 5'-G 3'-G 
d(GpG) (31) 7.97 8.17 6.21 (t)/ 13.2 
6.06 (t)/ 14.5 
- 
2 - - - 5.33 (-38.88) 
33 8.27 8.57 6.23 (t)/ 14, 14.5 4.45 (-68.30), 
4.38 (-68.51) 
35 - - - 7.07 (-81.32) 
(c) Photoreaction of complex 2 in the presence of d(GpG) using 647.1 nm light 
for irradiation. 
The time course of the NMR spectra of this photoreaction can be found in Appendix 
6. Figure 6.25 shows the 2D ['H, ' 5N] HSQC NMR spectrum of this photoreaction 
after 18.36 h of irradiation and the corresponding 'H NMR spectrum. 
A solution of complex (2, 1 mM) and d(GpG) (1 mM) was irradiated with light of 
647.1 nm (ca. 75 mW). The product was identical to cis-[Pt(NH 3)2 {d(GpG)-N7( 1), 
N7(2)}] 2 (33) as judged by the similar 'H and ' 5N chemical shifts. The intensity of 
the cross-peak 33 was ca. 5% of the intensity of cross-peak 2 at the end of the 
irradiation. A cross-peak due to Pt" NH 3 trans to 0 at 5.30/ -49 ppm was already 
detectable after only 0.66 h irradiation. This cross-peak may be due to an isomer of 
reactant 2, and was observed throughout the whole reaction. There were two 
additional peaks present in the H8 region of the 'H NMR spectrum besides the peaks 
33c and 33d at 8.18 and 7.92 ppm, but they could not be identified. The 'H chemical 
shift is not typical for a Pt N7-d(GpG) adduct, which normally exhibits a low-field 
shift of ca. 0.3-0.5 ppm. 
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Figure 6.25 2D ['H, ' 5N] HSQC and 'H NMR spectra for the photoreaction of cis, 
trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2, 1 mM) in the presence d(GpG) (1 MM) after 
18.48 h and 18.36 h irradiation for the 1D and 2D spectra, respectively, with light of 
647.1 nm (ca. 75 mW, 298 K). * 195Pt satellites. Assignments: d(GpG) (31): 31a H8 
3'-G, 31b H8 5'-G, 31c/d Hi'; cis, trans, cis-[Pt"(N3)2(OH)2(NIi3)2] (2): 2 NH 3 ; cis-
[Pt(NH3)2 {d(GpG)-N7(1), N7(2)}] 2 (33): 33a, 33b NH 3, 33c H8 3'-G, 33d H8 5'-G. 
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pH dependence of the H8 peaks: 
Figure 6.26 shows the pH dependence of the peaks 31a and 31b Figure 6.26 shows 
the pH dependence of the peaks 31a and 31b from Figure 6.25 (A) before irradiation 
and (B) 12 h after irradiation. Table 6.18 lists the pK values derived from the curves 
in Figure 6.26. 
8.6. N7 bound to Pt 
8.4 	 33c 3'-G 








2 4 6 8 10 12 14 
pH 
Figure 6.26 pH dependence of the H8 'H chemical shifts of d(GpG) in the 
photoreaction of cis, trans. cis-[Pt"(N 3)2(OH)2 (NH3)2] (2) in the presence of d(GpG). 
(A) shows the pH dependence before the irradiation and (B) after irradiation for 12 h 
with light of 457.9 nm, 30 mW. T = 298 K. The curves in (B) represent best fits to 
the Henderson-Hasselbalch equation with pK values listed in Table 6.18. 
Table 6.18 pK values derived from the pH titration curves in Figure 6.26, (B). 
118 proton pKNl 
33c 3'-G 8.34 ± 0.06 
33d 5'-G 8.28 ± 0.09 
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(d) Photoreaction of complex 2 in 0.1 M NaCl aqueous solution in the presence 
of d(GpG). 
A solution of cis, trans, cis-[Pt"(N 3 )2(OH)2(NH3)2] (2, 1 mM) and d(GpG) (0.3 MM) 
in 0.1 M NaCl (90% H 20/ 10% D20) was kept in the dark for 19 h before the 
photoreaction was started. The pH was adjusted to 5 with 0.1 M HC1O4 just before 
the start of the irradiation. The laser line at 457.9 rim was used for the irradiation and 
the light power was adjusted to Ca. 30 mW at the end of the fibre optic. 
The time course of the 'H and 2D ['H, ' 5N] HSQC NMR spectra is described in 
Appendix 7. Figure 6.27 shows the 'H NMR spectra during this photoreaction after 
(A) 0 h, (B) 0.77 hand (C) 1.54 h of irradiation. 
The two cross-peaks in the 2D ['H, ' 5N] HSQC NMR spectrum at 4.41/ -68.03 33a 
and 4.35/ -68.34 ppm 33b were identified as cis-[Pt(NH 3)2 {d(GpG)-N7(1), N7(2)}] 2 
(33) by comparison of the chemical shifts with those obtained for 33 in the reaction 
described under (b) in this section. The H8 peaks at 8.55 33c and 8.26 ppm 33d 
which appeared in the 'H NMR spectrum after. 0.77 h irradiation are also due to 
compound 33, and the ratio between d(GpG) bound in compound 33 and free 
d(GpG) is 2/ 3. 
All the peaks due to free d(GpG) had disappeared after 1.54 h of irradiation (Figure 
6.27, (C)). Four weak peaks were present besides the peaks for compound 33 at 8.89, 
8.45, 8.14 and 8.07 ppm. The peaks at 8.89 36a and 8.14 ppm 36b and at 8.45 37a 
and 8.07 ppm 37b may be related to each other since their integrals are similar. The 
two peaks 36a and 36b, and the peaks 37a and 37b, had a similar intensity and are 
therefore thought to be due to the same compounds. A new cross-peak appeared 
simultaneously in the 2D ['H, ' 5N] HSQC NMR spectrum at 4.21/ -66.03 ppm. Other 
very weak cross-peaks in the same region were also detected. These cross-peaks are 
in the region characteristic for Pt" NH 3 trans to N, Cl. The 'H chemical shifts of 
peaks 36b and 37b are similar to the 'H chemical shift of H8 protons of free d(GpG). 
Peaks 36a and 37a are shifted to low-field by 0.8 and 0.4 ppm, respectively. This is 
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typical for Pt binding to N7. The peaks 36a, 36b, 37a, 37b are therefore likely to be 
due to the complex cis-[Pt"(NH 3)2 {d(GpG)-N7} Cl]'. These compounds together 












8.5 	8.0 ppm 
. jj 




. . 	 ......... I .................. I ........ . 
5.4 	5.2 ppm 
\ 33a 




4.6 	4.4 ppm 
Figure 6.27 Time course of the 'H NMR spectra during the photoreaction of cis, 
trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2, 1 mM) in the presence of d(GpG) (0.3 MM) in 
0.1 M NaCl aqueous solution (298 K, pH 5, laser light: 457.9 run, 30 mW) after (A) 
0 h, (B) 0.77 h and (C) 1.54 h of irradiation. Assignments: d(GpG): 31a H8 3'-G, 
31b H8 5'-G; 2a, 2b NH3 cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2); cis-
[Pt(NH3)2 {d(GpG)-N7(l), N7(2)}] 2 (33): 33a Pt-N'H 3 , 33b Pt-N'H3 , 33c H8 3'-G, 
33d H8 5'-G; H8 'H of [Pt"(NH3)2 {d(GpG)-N7}Cl]: 36a,b + 37a,b. 
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(e) Photoreaction of complex 2 in the presence of d(GpG) and glutathione 
(GSH). 
A solution of cis, trans. cis-[Pt"(N3)2(OH)2(NH3 )21 (2, 2 MM), glutathione (5 MM) 
and d(GpG) (0.35 mM) in 95% H20/ 5% D20 was stored in the dark for 16.5 h 
before the start of the irradiation. The light power was adjusted to 30 mW at the end 
of the optic fibre. 
The time course of the 'H and 2D ['H, ' 5N] HSQC NMR spectra of this 
photoreaction is listed in Appendix 8. Figure 6.29 shows the time course of the 'H 
NMR spectra during the photoreaction and Figure 6.30 shows the 2D ['H, ' 5N] 
HSQC NMR spectrum after 3.74 h of irradiation. 
A cross-peak at 3.80/ -69.15 ppm 1 appeared in the 2D ['H, ' 5N] HSQC NMR 
spectrum after the sample was stored 16.5 h in the dark. The coupling constants 
11( 15N- 195Pt) = 306.3 Hz and 2J('H- 195Pt) = 57.2 Hz and the 'HI ' 5N chemical shifts 
suggest that this cross-peak is due to cis-[Pt"(N 3)2(NH3)2] (1). The intensity of this 
cross-peak is ca. 5% of the intensity of that of reactant cis, trans, cis-
[Ptiv(N3)2(OH)2(NH3)2] (2). The observation of GSSG in the sample after 16.5 h in 
the dark means that ca. 5% of cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2) was reduced 
by GSH to cis-[Pt"(N 3)2(NH3)2] (1). 
Peaks due to GSSG appeared during the reaction. Figure 6.28 shows the time course 
of the conversion of GSH into GSSG. About 14% of GSH was transformed into 
GSSG during 16.5 h in the dark, the rest was transformed during 3.08 h of 
irradiation. The irradiation of the sample definitely had a strong influence on the rate 
of the GSH to GSSG conversion. The intensity of the cross-peak at 7.06/ -81.22 ppm 
35, which was assigned to NH4 , increased ca. 20-fold during the same period. The 
intensity of the Pt-NH 3 peaks in the 'H NMR spectra of complex cis, trans, cis-
[Pt"(N3)2(OH)2(NH3 )2] (2) decreased by ca. 50% during the same period. The fast 
conversion of GSH to GSSG is therefore likely to be connected with the presence of 
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5% DO was irradiated with light of the same wavelength and light power for 10 h 
but no conversion at all from GSH to GSSG was detected. Light together with cis, 
trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2) are therefore causing the conversion of GSH to 
GSSG. 
Start of 
Figure 6.28 Time course for the formation of GSSG (100% GSSG = 0% GSH). The 
data were derived from the 'H NMR spectra by integrating the peaks 14c' and 13b 
(see Figure 6.29). 
The two cross-peaks at 4.41/ -68.08 33a and 4.34/ -68.45 ppm 33b (Figure 6.30) 
were identified as cis-1Pt(NH 3)2 {d(GpG)-N7(1), N7(2)}] 2 (33) by comparison of the 
chemical shifts. No peaks due to compound 33 were detected after the first 2.31 h of 
irradiation. The compound cis-[Pt(NH 3)2 {d(GpG)-N7(1), N7(2)}] 2 (33) appears only 
after all GSH is converted into GSSG. The two cross-peaks 38a and 38b must also 
be due to Pt" NH 3 trans to N because of their 'HI ' 5N chemical shifts. It is likely to be 
a compound in which Pt is bound to N7 of d(GpG) because there is no H8 'H NMR 
peak for free d(GpG) left at the end of the irradiation. 
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Figure 6.29 Photoreaction of cis, trans, cis-[Pt1"(N3)2(OH)2(NH3 )2] (2, 2 mlvi) in the 
presence of d(GpG) (0.35 mM) and GSH (5 mM) (298 K, pH 5,457.9 nm, 30 mW) 
at (A) 0 h, (B) 0.77 h and (C) 3.08 h of irradiation time. Assignments: cis, trans, cis-
[Ptt"(N3)2(OH)2(NH3)2] (2): 2a, 2b: Pt-N'H3 ; d(GpG): 31a H8 3'-G, 31b H8 5'-G, 
31c, d Hi'; GSH: 13a: Glu 13CH2 ; 13b: Glu 1CH2 ; 13c: Cys j3CH 2 ; GSSG: 14c', 
14c": Cys 13CH 2; 14d: Cys NH. 
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Figure 6.30 2D ['H, ' 5N] HSQC NMR spectrum for the photoreaction of cis, trans, 
cis-[Pt"(N3) 2 (OH)2(NH3) 2] (2, 2 mM) in the presence of d(GpG) (0.35 MM) and GSH 
(5 mM) after 3.74 h of irradiation (457.9 run, 30 mW, 298 K). Assignments: 33a, 
33b NH3 of cis-[Pt(NH3) 2 {d(GpG)-N7(l), N7(2)}] 2 (33); 2 NH 3 of cis, trans, cis- 
[Pt1"(N3 )2 (OH)2(NH3) 2] (2); 35 NH4 . 
3) Photoreactions in the presence of single and duplex Miner DNA 
The following two 14mer DNA strands were used for these experiments: 
ATACATGGTACATA 	I 
TATGTACCATGTAT 	II 
Duplex DNA 	 III = I +11 
The NMR structure of these oligonucleotides in solution and their interaction with 
cisplatin has been studied in our research group previously." 
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Both the photoreaction of the complexes cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2) 
and cis, trans-[Pt"(en)(N 3)2(OH)2] (5) in the presence of the single strand I and 
duplex III were investigated by 2D [ 1 H, ' 5N] HSQC and 'H NMR spectroscopy with 
experiment times of 39.6 min for the 2D and 7.3 min for the 1D experiments, 
respectively. No delay time between the experiments was used. 
(a) Photoreaction of complex 2 in the presence of 14mer DNA strand I. 
A solution of cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2, 1 mlvi) and 14mer DNA 
strand I (0.1 mM) was prepared in 0.1 M NaC10 4. D20 (5% v/v) was added to the 
solution and the pH was adjusted to 5 with 0.1 M HC104. The laser line at 457.9 nm 
was adjusted to ca. 15 mW at the end of the fibre optic. The photoreaction was 
followed by 2D ['H, ' 5N] HSQC and 'H NMR spectroscopy. The peaks of strand I in 
the 'H NMR spectra broadened strongly during the time course of the photoreaction 
(see Figure 6.31). 
The time course of the 2D ['H, ' 5N] HSQC NMR spectra is described in Appendix 9. 
Figure 6.31 shows 'H NMR spectra at different time points during the irradiation. 
The irradiation was stopped after 18 h. The solution was still yellow and a yellow 
precipitate was observed at the bottom of the NMR tube and no cross-peaks were 
detected in the 2D ['H, ' 5N] HSQC NMR spectrum. A 15 p.1 aliquot of 0.1 M HC1O 4 
was added to the sample and a 2D ['H, ' 5N] HSQC NMR spectrum was acquired. 
Two cross-peaks at 5.31/ -38.71 ppm 2 with 'J(' 5N-' 95Pt) = 256 Hz and 2J('H-' 95Pt) = 
47 Hz and 7.07/ -81.23 ppm 35 were present. The corresponding 'H NMR spectrum 
showed peaks at 5.33 ppm and 5.30 ppm due to complex 2. Two additional peaks 
were found at 7.07 ppm which are due to NH4'.  No resonances were found to 
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Figure 6.31 'H NMR spectra during the photoreaction of cis, trans, cis-
[Pt"(N3)2(OH)2(NH3)2] (2) in the presence of single 14mer DNA strand I after 0 h, 
0.77 h, 1.54 hand 2.31 h of irradiation (457.9 nm, 15 mW, 298 K). Peak broadening 
occurs for the 14mer DNA peaks during the time course of the photoreaction. 
(b) Photoreaction with complex 5 in the presence of 14mer DNA strand I. 
The pH of a solution of cis, trans-[Pt"(en)(N3)2(OH) 2] (5, 1.5 mM) and 14mer DNA 
strand I (0.35 mM) in 95% H20/ 5% DO was adjusted to 5 with 0.1 M HC10 4. The 
laser line of 457.9 nm was used for the irradiation of the sample and adjusted to ca. 
10 mW at the end of the fibre optic. The photoreaction was followed by 2D ['H, ' 5N] 
HSQC and 'H NMR spectroscopy at 310 K. 
The time course of the 'H and 21) ['H, ' 5N] HSQC NMR spectra can be found in 
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Appendix 10. Figure 6.32 shows the 2D ['H, ' 5N] HSQC NMR spectra after (A) 0.66 
h and (B) 6.82 h of irradiation. Figure 6.33 shows the time course of the intensities of 
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Figure 6.32 2D ['H, ' 5N] HSQC NMR (310 K) spectra of the photoreaction (457.9 
rim, 10 m W) of cis, trans-[Pt"(en)(N3)2(OH)2] (5, 1.5 mM) and 14mer DNA strand 
ATACATGGTACATA I (0.35 mM) after (A) 0.66 h, and (B) 6.82 h irradiation. 
Figure 6.33 shows the time course of the cross-peaks of the reactant cis, trans-
{Pt"(en)(N 3)2(OH)2 1 (5) and the new product 43. The 'HI ' 5N chemical shifts of 
product 43 are characteristic of Pt"-en trans to N.' Figure 6.32 shows that at the end 
of the irradiation the cross-peak of product 43 has an intensity of ca. 20% of that of 
cis, trans-[Pt"(en)(N3)2(OH)2] (5) at the start of the irradiation. The mole ratio of the 
two reactants cis, trans-[Pt"(en)(N3) 2(OH)2] (5) : strand I was 1:0.2 at the start of the 
irradiation. This suggests that product 43 arises from binding of Pt"-en to the 14mer 
DNA strand I. It is also likely that Pt"-en is bound to the GG position in strand I 
ATACATGGTACATA because of the similar chemical shifts of product 43 and the 
adduct [Pt(en){d(GpG)-N7(1), N7(2)}] 2 (32, 5.6/ -30.9 ppm). 
226 
1 	2 	3 	4 	5 	6 	7 	8 	9 





Chapter 6 Photoreactivity and stability of Pt(11)1(IV) azide complexes 
Figure 6.33 Time course of the intensities of the cross-peaks of the reactant cis, 
trans-[Pt"(en)(N 3)2(OH)2] (5) and the product 43 during the photoreaction (457.9 
nm, 10 mW) of cis, trans-[Pt''(en)(N 3)2(OH)2J (5) in the presence of 14mer DNA 
strand I. All intensities are taken from 2D ['H, ' 5N] HSQC NMR spectra, see Figure 
6.32. 
(c) Photoreaction of complex 2 in the presence of 14mer duplex DNA III. 
A solution of cis, trans, cis-[Pt"(N 3)2(OH)2(NH3 )2] (2, 1 MM) and 14mer duplex 
DNA III (1 mM) was prepared in 0.1 M NaC10 4 . D20 (5% v/v) was added to the 
solution. The pH was 9 and was then adjusted to 6.26 with 0.1 M HC10 4. This 
solution was then stored in the dark for 16.5 h. The 'H and 2D ['H, ' 5N] HSQC NMR 
spectra were identical before and after the 16.5 h in the dark. Figure 6.34 shows both 
the 2D ['H, ' 5N] HSQC and 'H NMR spectra after 16.5 h. The 'H NMR spectrum of 
the 14mer duplex DNA was compared to a reference spectrum which was acquired 
in our research group confirming the duplex structure." 
The time course of the NMR spectra can be found in Appendix 11. Figure 6.34 
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shows the 'H and the 2D ['H, ' 5N] HSQC NMR spectrum of duplex DNA III in the 
presence of complex 2 after 16.5 h in the dark. 
CH3 thymine 
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8 7 6 5 4 3 	ppm 
6( 1H) 
Figure 6.34 (A), (B): 'H and 2D ['H, ' 5N] HSQC NMR spectra of 14mer duplex 
DNA III (1 niM) and cis, trans, cis-[Pt"(N3)2(OH)2(NH3 )2] (2, 1 mM), respectively, 
after storing sample in the dark for 16.5 h (298 K). * ' 95Pt satellites. 
A yellow precipitate was observed at the bottom of the NMR tube. The pH was 
measured to be 6.6. The pH was adjusted to 5.2 and a 2D ['H, ' 5N] HSQC and 'H 
NMR spectrum was each acquired. A weak cross-peak at 5.101 -40.30 ppm was 
observed which is due to cis, trans, cis-[Pt"(N3)2(OH)2(N113)2] (2). No other cross-
peaks were found. 
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(d) Photoreaction of complex 5 in the presence of 14mer duplex DNA III. 
The same sample as for reaction (c) was used. The solution was centrifuged to 
remove the yellow precipitate obtained in reaction (c). Cis, trans-
[Pt1"(en)(N3)2(OH)2] (5) was added to the solution and the pH was measured to be 
5.1. The laser line of 457.9 imi was used for the irradiation and the light power was 
adjusted to Ca. 10 mW at the end of the fibre optic. The photoreaction was followed 
by 2D ['H, ' 5N] HSQC and 'H NMR spectroscopy at 310 K and the changes of the 
NMR spectra during the reaction are described in Appendix 12. 
Figure 6.35 shows the 2D [tH,  ' 5N] HSQC NMR spectra of the photoreaction after 
(A) 0 h and (B) 7.59 h of irradiation. 
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Figure 6.35 2D ['H, ' 5N] HSQC NMR spectra of the photoreaction of cis, trans-
[Pt"(en)(N 3 )2(OH)2] (5) in the presence of 14mer duplex DNA III (457.9 rim, 10 
mW, 310 K) after (A) 0 hand (B) 7.59 h of irradiation. 
The 'HI ' 5N chemical shifts of product 44 are characteristic for Pt"-en trans to N and 
very similar to the chemical shift of compound [Pt(en){d(GpG)-N7(1), N7(2)}] 2 
(32). 
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6.2.3.2 Photoreactivity of Pt" diazido complexes 
The photoreactivity of [Pt"(en)(N 3)2] (4) was investigated in H 20 and in 0.1 M NaCl 
aqueous solution by 2D ['H, ' 5N] HSQC and 'H NMR spectroscopy. The experiment 
times were 39.6 min for the 2D and 7.3 min for the 1D spectra, respectively. Light of 
the wavelength 457.9 nm and ca. 30 mW at the end of the fibre optic was used for 
irradiation of the samples. 
Photoreactions of [Pt"(en)(N 3)2] (4) in H20 and 0.1 M aqueous NaCl 
solution 
A solution of [P0(en)(N 3)2] (4, 4 mM) was prepared in 95% H20/ 5% DO. The 
NMR spectra were acquired at 298 K, pH 6.5. 
The time course of the 'H and 2D ['H, ' 5N] HSQC NMR spectra for the 
photoreaction of complex 4 in H 20 is described in Appendix 13. 
The intensities of the two cross-peaks 45 and 46, which appeared during the 
photoreaction, are identical throughout the reaction. Cross-peaks 45 and 46 therefore 
probably arise from the same compound. The sum of the two cross-peaks 45 and 46 
make up ca. 12% of the cross-peak of {Pt"(en)(N 3)2] (4) at the end of reaction. Cross-
peak 47 is a minor product with a max. intensity of 0.5% of the intensity of 4. 
Cross-peaks 45 and 46 have both 'HI ' 5N chemical shifts which are typical for Pt"-en 
trans to N or Cl. ESI-MS spectra were acquired for the sample after the irradiation. 
Peaks at 340 m/z and 364 mlz were observed in the positive ESI-MS spectrum. Both 
of these peaks exhibited a Pt isotope pattern. No other peaks were observed. The 
peak at 340 m/z was assigned to the reactant [Pt"(en)(N 3)2] (4) (calculated mass 341 
mlz) and the peak at 364 m/z to the adduct [Pt"(en)(N 3)2] (4) + Na (calculated mass 
364 mlz). 
For the photoreaction in 0.1 M NaCl, a solution of [Pt' 1 (en)(N3)2] (4, 4 mM) in 0.1 M 
NaCl aqueous solution (95% H201 5% D20) was prepared. The NMR spectra were 
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acquired at 298 K, pH 6.5. 
The time course of the NMR spectra for this photoreaction is described in Appendix 
14. Figure 6.36 shows the 2D ['H, ' 5N] HSQC NMR spectra and the corresponding 
'H NIVIR spectra of the photoreaction of complex 4 in 0.1 M NaCl aqueous solution 
after (A) 0 h and (B) 0.66 h irradiation. 
Figure 6.37 shows that the cross-peaks 48a and 49a have similar intensities 
throughout the reaction and are therefore due to the same compound. The ' 5N 
chemical shift and coupling contants of the cross-peak 48a ((' 5N) = -34.4 ppm, 
'J( 15N- 195Pt) = 333 Hz, 2J('H-' 95Pt) = 53.7 Hz) are very similar to those of the reactant 
[Pt"(en)(N 3 )21 (4) ((' 5N) = -33.8 ppm, 145N- 195Pt) = 337 Hz, 2J('H-' 95Pt) = 52.6 Hz). 
Cross-peak 48a is therefore likely to be due to pt" N'H-en trans to N3 . The cross-
peak 49a with a ' 5N chemical shift of 4 ppm to lower field than 48a and coupling 
constants of (8(15  N) = -30.8 ppm, 'J(' 5N-' 95Pt) = 379 Hz, 2J('H-'95Pt) = 66 Hz) can be 
assigned to Pt" NH-en trans to Cl. This means that one azide ligand of [Pt"(en)(N 3)2] 
(4) has been replaced by Cl during the photoreaction. 
The intensities of all cross-peaks decreased during the photoreaction, see Figure 
6.37. A small amount of a yellow precipitate was observed at the end of the 
photoreaction which is the reason for the loss of intensity of the cross-peaks during 
the reaction. 
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Figure 6.36 2D ['H, ' 5N] HSQC and 'H NMR spectra of the photoreaction of 
[Pt"(en)(N3)21 (4, 4 mM) in 0.1 M NaCl aqueous solution after (A) 0 h and (B) 0.66 h 
irradiation (457.9 nm, Ca. 30 mW). * "Pt satellites. 
232 
Chapter 6 Photoreactivity and stability of Pt(11)1(IV) azide complexes 
• [Pt"(en)(N] 4a 
X, + 50a, 51a 
1 	2 	3 	4 	5 	6 	7 	8 
Irradiation time (h) 
Figure 6.37 Time course of the intensities of the cross-peaks 4a, 48a, 49a, 50a and 
51a (taken from the 2D ['H, ' 5N] HSQC NMR spectra) during the photoreaction 
(457.9 rim, 30 mW) of [Pt"(en)(N 3)2] (4, 4 mM) in 0.1 M NaCl aqueous solution. 
6.2.3.3 Photoreactions of [Pt"(dien)(N 3)J(NO3) (6) and (Pt(dien)(N 3) trans-
(OH') 2J(NO3) (7) in H20 
The laser line of 457.9 nm was used for the photoreaction and adjusted to Ca. 30 mW 
at the end of the fibre optic. The photoreactions were followed by 'H NMR 
spectroscopy. The experiment time was 7.3 min and a delay of 30 min was 
introduced between each experiment. 
A solution of [Pt"(dien)(N 3)](NO3) (6, 5 mM) was prepared in 95% H20/ 5% DO. 
The pH was adjusted to 5 with 0.1 M HCIO4. The irradiation time was 21 h 15 mm. 
There was no difference between the spectrum before and after the irradiation. 
Therefore, no photoreaction of {Pt"(dien)(N 3)J(NO3) (6) occurred. 
A solution of [Pt(dien)(N 3) trans-(OH)21(NO 3 ) (7) in 95% H20/ 5% DO and pH 5 
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photoreaction of [Pt(dien)(N 3) trans-(OH) 21(NO3) (7) occurred. 
6.3 Discussion 
6.3.1 pH dependence of the am(m)ine 1H NMR resonances 
The am(m)ine 'H NMR resonances of the different Pt diazido complexes were of 
great importance in following the photoreactions by 'H and 21) ['H, ' 5N] HSQC 
NMR spectroscopy. The pH dependences of the am(m)ine 'H NMR resonances were 
of special interest as all experiments were carried out in H 20. 
'H am(m)ine NMR resonances of both Pt" and pt" am(m)ine compounds were 
detected by 'H and 2D ['H, ' 5N] HSQC NMR spectroscopy during photoreactions. 
No strong pH dependence of the 'H NMR resonances of the NI-I3 protons was found 
for complex cis-[Pt"(N3)2(N}1 3)21 (1) (section 6.2.1.2) on lowering the pH from 8.9 to 
3.4. The intensities were also similar at pH 6.5 and 3.4. The 'H am(m)ine NMR 
resonances of Pt" diazido am(m)ine compounds can therefore be observed over a 
wide pH range and their intensity and lineshape do not change. Similar 
characteristics of the Pt" am(m)ine compound cisplatin cis-[Pt"C1 2(NH3)2] allowed 
experiments with cisplatin to be carried out over a wide pH range. 2 The exchange of 
NH protons with the solvent is therefore slow for Pt" am(m)ine compounds. 
The pH dependences of 'H am(m)ine NMR resonances of the Pt" diazido complexes 
cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2), cis, trans, cis-[Pt"(N3)2(OAc) 2(NH3)2] (3) 
and cis, trans-[Pt"(en)(N3 )2(OH)2] (5) are very different. The 'H am(m)ine 
resonances of the three complexes can either not be observed (complexes 2 and 5) at 
all or are very weak at neutral pH (complex 3). There is a clear difference in the pH 
dependence of the 'H N11 3 resonances between complexes 2 and 3. The trans ligands 
are influencing 'H NH 3 resonances. The NH protons in complex 3 with the acetate 
trans ligands exchange more slowly with the solvent than the NH protons in complex 
2 with the hydroxide ligands. The strength of the Pt-O bond relates therefore directly 
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to the NH proton exchange rate with the solvent. The stronger the trans ligand is 
bound the faster is the NH proton exchange with the solvent. The 'H am(m)ine NMR 
resonances of Pt" am(m)ine compounds with trans acetate ligands can be observed 
at physiological conditions in contrast to Pt" am(m)ine compounds with trans 
hydroxide ligands. 
This relation can also be expressed in terms of PK a values for the proton exchange 
Pt-NH3 - 	Pt-NH2- + H. The pK0 values for the different compounds follow t 
the order: 
PtiVNH 3/NH2 R trans-OH < Pt'-NH 3/NH2-R trans-OAc < Pt"-NH 3/NH2-R 
This made the previous 'H and 2D ['H, ' 5N] HSQC NMR study of the compound 
trans, cis-[Pt"(en)(OAc) 2(I)2] possible at pH 6.2 which was carried out in our 
research group by Kratochwil et al. 12 
The pH adjustment of the samples to Ca. 5 whenever the complexes 2 or 5 were used 
was necessary to observe any 'H am(m)ine NMR resonances. Experiments with 
complex 3 could in contrast be carried out without pH adjustment. In general, the 'H 
NMR am(m)ine resonances of Pt"' am(m)ine compounds are strongly pH dependent 
and the pH dependence is determined by the type of ligands bound in cis and also 
trans positions. 
6.3.2 Stability of platinum diazido complexes 
An important aspect in the design of a prodrug is its stability under physiological 
conditions. Only by remaining in its unactive state until activation can a prodrug be 
site-specific and therefore reduce side-effects. The reactivity of the Pt" diazido 
complexes towards substitution and reduction was therefore studied in this work. 
The stability of the photoactive azide ligands is of special importance as loss of the 
azide ligands means loss of the photoactivity. 
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Hydrolysis of complex 2 
No hydrolysis process was observed over 90 d for complex cis, trans, cis-
[Pt"(N3 )2(OH)2(NH3)2] (2). Hydrolysis would therefore not be a problem if 2 was 
used as a prodrug. 
Stability of complex 2 towards C1 
The Cl- concentration outside cells is Ca. 104 mM and Cl could therefore react with 
complex 2. 13  Of special importance is the question if Cl - can replace an N 3- ligand as 
such a substitution means the loss of photoactivity. It was shown (see section 6.2.2.1) 
that Cl - reacts with complex 2 even at low Cl - concentrations of 5 MM. The NH3 ' 5N 
chemical shifts of these products are similar to that of complex 2 at Ca. —40 ppm. The 
preparation of cis, trans, cis-[Pt"Cl 2(OH)2(NH3)2] gave the necessary information to 
distinguish between Pt" NH 3 trans N3 ((' 5N) = -40 ppm) and Pt' V  NH3 trans Cl 
(8(' 5N) = -35 ppm). These results show the strong influence of the trans ligands on 
the (' 5N) of Pt" am(m)ine complexes. 
The data from the ESI-MS experiments made the identification of the products 
possible. Reaction of Cl - with complex 2 led to the substitution of the OH ligands 
and not the N 3 - ligands, and give the products cis, trans, cis-[Pt"(N3)2C1(OH)(NH3)2] 
(8) and cis, trans, cis-[Pt"(N3)2Cl2(NH3)2] (9). The NH3 ' 5N NMR chemical shifts of 
complexes 2, 8 and 9 are similar which means that the axial ligands have no 
significant influence on the NH 3 ' 5N NMR chemical shift of Pt" am(m)ine 
compounds. The complexes 8 and 9 are expected to be photoactive due to the azide 
ligands and can therefore act as prodrugs. The expected photoproduct is cisplatin 
according to the following Scheme 6.1. 
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Scheme 6.1 Proposed mechanism for the photoreaction of complexes 8 and 9. 
The photoreactions of complexes 8 and 9 are important as it was estimated from the 
2D ['H, ' 5N] HSQC results that ca. 80 % of complex 2 is transformed into 8 and 9 in 
Cl- concentrations as high as in the blood plasma after 24 h. The photoreactivity of 
complexes 8 and 9 was not further investigated in this work. 
A substitution of one azide ligand in the Pt" analogue cis-[Pt"(N3)2(NH 3)2] (1) was 
observed in 0.1 M NaCl aqueous solution. This again shows how much more 
reactive Pt" compounds are compared to Pt". Further studies should be carried out to 
investigate the cytotoxicity of complex 1. 
(c) Stability of complexes 2 and 5 towards nucleotides 
It is generally accepted that DNA platination is the ultimate event in the mechanism 
of action of Pt anticancer drugs.' 4 The major adduct formed after attack of cisplatin 
on the DNA is the intrastrand cross-link between N7 atoms of two adjacent guanine 
(G) residues. A Pt based prodrug should not bind to nucleotides until it is activated to 
the reactive species. Both complexes cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2) and 
cis, trans-[Pt"(en)(N3)2(OH)2] (5) did not react with either 5'-GMP or d(GpG) in the 
dark. This result was expected as Pt" compounds are more substitution inert than Pt" 
compounds, and it is believed that Pt" compounds are reduced to Pt" before reacting 
with DNA.' 5 However, Choi et al. ' 6 have shown that 5'-GMP can reduce a Pt" 
compound and activate it. 
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(d) Stability of complex 2 in blood plasma and towards glutathione (GSH) 
Glutathione (y-L-Glu-L-Cys-Gly) is the most abundant reducing agent in cells with a 
concentration of 0.1-10 mM.' 7 Such reducing agents are believed to reduce Pt" 
anticancer drugs to Pt" species which then act as the active drug.' 8 A potential 
photoactivatable Pt" prodrug should not be reduced or only very slowly so that there 
is enough prodrug left at the site where the drug is activated by light. A fast 
reduction of the photoactivatable prodrug to Pt" would not only diminish its use as a 
prodrug but also the advantage of a site specific treatment. Pt" compounds are much 
more reactive than Pt" compounds and could therefore react with numerous donor 
molecules. This study of the interaction of the potential photoactivatable prodrug cis, 
trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2) and glutathione gives important information as 
to whether 2 could be used as a potential prodrug. 
No cross-peak for a Pt"-NH 3 compound was found in the 2D ['H, ' 5N] HSQC NMR 
spectra throughout the 38 d of reaction. Either no reduction of complex 2 occurred or 
all the ammonia ligands of the Pt" products have left the Pt centre. A total 
substitution of the ammonia ligands is very unlikely because of the strong Pt"-NH 3 
bond. Therefore, it can be concluded that the Pt" complex 2 is not reduced or 
reduced only slowly by glutathione. A small amount of NH 4 was detected in the 2D 
['H, ' 5N] HSQC NMR spectrum after 38 d indicating that some interaction between 
complex 2 and glutathione took place. 
About half of the reduced glutathione (GSH) was transformed into the oxidized form 
GSSG. This is thought to be due to autoxidation by air because the sample was not 
kept under a protecting inert atmosphere. 
The stability of complex 2 was also studied in human blood plasma. Blood plasma 
contains a variety of donors and reducing agents. The Pt'" anticancer compound cis, 
trans, cis-[Pt''Cl2(OAc)2(cha)(NH 3)] (cha = cyclohexylamine) JM2 16, which is in 
clinical trial, is fully metabolised 15 min after administration into human blood 
plasma.' 9 Complex 2 was monitored in human blood plasma by 2D ['H, ' 5N] HSQC 
NMR. Inverse 'H-{' 5N} NMR made it possible to follow complex 2 without 
interference of all other 'H resonances which were completely filtered out. The pH 
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value of 8 of the sample solution was adjusted to 6 before acquiring the NMR 
spectrum in order to be able to detect any NH 3 'H resonances. Only the cross-peak of 
compound 2 and a weak cross-peak at 5.0/ -49 ppm was present after the sample was 
stored in the dark for 14 d. No Pt" species was observed. The additional cross-peak 
could possibly be due to an isomer of complex 2 in which Pt" NH 3 is trans to OH 
because of the ' 5N chemical shift of -49 ppm which is characteristic for Pt" N}1 3 
trans to 0.' This means that complex 2 is very stable against substitution and 
reduction and could act as a good prodrug. 
Both, the reaction with glutathione and in human blood plasma, show that cis, trans, 
cis-[Pt"(N3)2(OH)2(NH3)2] (2) is remarkably inert against substitution and reduction. 
The reduction potential of 2 is -650 mV (see section 5.3.3) which is a low potential 
compared with other Pt" compounds, but cis, trans-[Pt"(en)(Cl) 2(OH)2 1 was 
reported to have a potential of -884 mV. 2° Comparing with structures of other Pt" 
compounds, there are several features of complex 2 which may play a part in making 
the complex so inert. Trans hydroxide ligands are reported to stabilise the Pt 1'' state 
and reduce the reduction rates . 21 The cis configuration as opposed to trans is another 
feature which seems to be characteristic for inert Pt" compounds, and, most 
important, the absence of any halide ligands. Halides are relatively good leaving 
groups and therefore prone to attack by reducing agents. Halides ligands are one of 
the common features of second-generation Pt" drugs such as JM2 16. Azide ligands 
are strongly bound due their strong donor properties. Azide ligands appear to be 
more inert than halides. 
6.3.3 PhotoreactMty of platinum' diazdo complexes 
Photoreactons of complexes 2, 3 and 5 in H 20 
Cis, trans, cis-[Pt"(N3)2(OH)2 (N}1 3) 2 1 (2) was irradiated with light of 488 nm and cis, 
trans, cis-[Pt"(N 3)2(OAc)2(NH3)2] (3) and cis, trans-[Pt"(en)(N 3)2(OH)2] (5) with 
light of 457.9 run. Although the extinction coefficients for all three compounds are 
very small at these two wavelengths (6457 = 8.6 and 37.5 for complexes 2 and 5, 
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respectively), photoreactions were observed in all three experiments. However, a 
photoreduction process was observed only for the photoreaction of complex 5. 
The 20 h irradiation of cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2) with light of 488nm 
(ca. 15 mW) led to new cross-peaks at the ' 5N chemical shifts of —40 and —50 ppm. 
These ' 5N chemical shifts are characteristic for Pt" NH 3 trans to N and Pta' NH 
trans to 0. The ' 5N chemical shifts of the new cross-peaks at —40 ppm (box A, 
Figure 6.6) and their 'J(' 5N-' 95Pt) coupling constants were similar to complex 2. The 
presence of only one peak at 348.6 mlz (calc. mass of complex 2 349 mlz) in the 
ESI-MS spectrum confirmed that an isomerisation of complex 2 took place. Such 
isomerisation reactions of Pt" complexes promoted by light have been reported 
before. 22 Six geometric isomers of complex 2 are possible (Figure 6.38). Isomers 2 to 
6 can be formed by irradiation of complex (2, isomer 1, Figure 6.38). The ammonia 
group can either be cis or trans to N3 , OH or NH3 . Compounds with PtR  NH3  trans to 
N3 , NH3 and Pt' NH3 trans to OH have a characteristic ' 5N chemical shift of ca. —40 
ppm and —50 ppm, respectively. The former are responsible for the cross-peaks of 
box (A) in Figure 6.6, and the latter for cross-peaks of box (B) in Figure 6.6. No 
photoreduction of Pt"' to Pt" was observed in this reaction. This is probably due to 
the low light power used and the weak absorption of complex 2 at 488 nm. 
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Figure 6.38 The six geometric isomers of complex 2. 
Light of the wavelength 457.9 nm and ca. 15 mW was used for the irradiation of cis, 
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trans, cis-[Pt"(N 3)2(OAc) 2(NH3)2] (3). Both the NH 3 and CH3 acetato 'H peaks of 
complex 3 decrease during the time course of the irradiation. Whereas several new 
weak peaks appeared in the NH 3 region at 5.3-5.0, only one new peak appeared in 
the CH3 acetato region (peak 16a, Figure 6.7) at 2.06 ppm. The shoulders of peak 
16a, indicating ' 95Pt satellites, confirm that the acetate group of the photoproduct is 
bound to Pt. The 'H chemical shift of 2.06 ppm of peak 16a does not agree with free 
acetate which has a 'H chemical shift at 1.92 ppm at a similar pH. Therefore, peak 
16a is due to a new Pt" product containing two acetate ligands because no peaks due 
to Pt" compounds were present. The 2D spectra confirmed this conclusion. Only 
cross-peaks due to Pt" compounds are present (ö('H) 5.3-5.0 ppm) and the ' 5N 
chemical shifts indicate Pt" NH3 trans to 0 for (' 5N) —50 ppm (box (16B) Figure 
6.9) and Pt" NH 3 trans to N for 5(15  N) —40 ppm (box (16C) Figure 6.9). The cross-
peaks at (' 5N) —40 ppm have similar ' 5N chemical shifts as complex 2 but distinct 
ones from complex 3. The simultaneous appearance of cross-peaks at (' 5N) —40 
ppm and (' 5N) —50 ppm suggests that the cross-peaks are due to the same species. 
The presence of only one peak 16a in the 'H spectrum agrees with this conclusion. 
These cross-peaks are likely to be due to a similar photoisomerisation process as 
observed for complex 2 and which was previously reported. 22 
All of complex 3 was converted into the new Pt" species (Figure 6.8). Further 
irradiation of these species led to a yellow precipitate in the NMR tube. This could 
be due to Pt" reduction products which are less soluble or due to the formation of 
polymer species of the photoproducts. Further work is needed to characterise this 
precipitate. 
A precipitate was also observed when complex 5 was irradiated with light of 457.9 
nm and 20 mW. A photoreduction process was confirmed in this reaction by the 
appearance of the cross-peaks 18a and 18b in the 2D ['H, ' 5N] spectra (Figure 6.10). 
These two cross-peaks are unambiguously due to pt" en trans to 0. The cross-peaks 
in box (C), Figure 6. 10, show in contrast to the cross-peaks in the boxes (A) and (B) 
no "Pt satellites. This is due to chemical shift anisotropy (CSA) relaxation which is 
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larger in Pt" compounds than in Pt" compounds.' The appearance of cross-peaks at 
' 5N chemical shifts –6 and –17 ppm (A and B in Figure 6.10) before cross-peaks 18a 
and 18b appeared suggests that a photoisomerisation reaction of complex 5 took 
place at the same time as the photoreduction reaction. This reaction confirms that the 
light power of 20 mW at 457.9 nm is sufficient for a photoreduction reaction of Pt" 
diazido complexes. The ' 5N chemical shift of (' 5N) –50 ppm of the photoreduction 
products suggests a mechanism of the photoreduction in which the two azide ligands 
donate two electrons and leave the Pt centre upon irradiation into the azide to pt" 
ligand-to-metal-charge transfer band as shown below. 
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Scheme 6.2 Proposed mechanism of the photoreaction of complex 5 using light of 
457.9 nm (20 mW). 
The presence of small gas bubbles at the end of the irradiation suggests that the 
photoreduction takes place via the formation of N 2, as it was reported for other 
photoreactions with Pt" azide compounds. 23 ' 24 The decrease in intensity of all peaks 
during the photoreaction suggests that the photoproducts tend to form insoluble 
adducts. The formation of a precipitate during irradiation was observed for all three 
complexes 2, 3 and 5. The precipitates were insoluble, and no NMR data were 
therefore acquired. Other techniques like JR and elemental analysis may be used to 
better characterise these precipitates. 
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Photoreaction of complex 2 in 0.1 M NaCl aqueous solution 
The Cl- concentration outside cells is ca. 104 mM. 13 This experiment was carried out 
to investigate how such a high Cl - concentration would affect the photoreactivity and 
the resulting photoproducts. Cis, trans. cis-[Pt"(N3)2(OH)2(NH3)2] (2) was stored for 
18 h in the dark at room temperature (293 K) before the irradiation reaction. Only a 
small amount of 2 reacted with Cl - which confirms that complex 2 is relatively inert 
towards any substitution reaction. The relatively intense irradiation with light of 
457.9 nm and Ca. 30 mW compared to the previous discussed experiments led to a 
fast decrease in intensity of the resonances of complex 2. A photoreduction process 
was observed already after 1.44 h by the appearance of Pt" NH 3 resonances at around 
4/ -70 ppm. The expected product cisplatin, cis-{Pt"C1 2(NH3)2]
1 
 was not observed. 
Cross-peak 19c (Figure 6.12) however has similar 'HI ' 5N chemical shifts as cisplatin 
(19c 4.02/ -68.00, cisplatin 4.04/ -68.77 ppm). 2 The 'J(' 5N-' 95Pt) value of 286 Hz of 
cross-peak 19c is characteristic for Pt" NH 3 trans to NH3 " An explanation for this is 
a possible cis-trans photoisomerisation process in which the ammonia ligands 
change configuration from cis to trans. Such cis-trans photoisomerisation processes 
of Pt" compounds have been reported before. 25 
No resonances due to Pt" NH 3 trans to 0 were observed. This means that Cl - replaces 
OW OH2  ligands rapidly after the photoreduction took place. This is not surprising 
as aqua ligands are known to be good leaving groups. A yellow precipitate appeared 
also in this reaction. It seems to be characteristic for the photoproducts of Pt" 
diam(m)ine diazido complexes to form insoluble solids. 
Photoreactions of diazido Pt (DV) complexes 2 and 5 in the presence of 
5'-GMP 
It is generally accepted that it is the interaction of cisplatin with DNA that is 
responsible for its antitumour activity. 26 Nucleotides are ideal models for looking at 
the interactions of Pt and its biological target DNA. Many studies of the interaction 
between the nucleotide 5'-GMP (Figure 6.39) and Pt compounds were carried out as 
the preferred binding site for cisplatin at physiological pH is N7 of guanine. 6 
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In order to investigate if the Pt' complexes 2 and 5 could act as photoactive 
prodrugs of highly reactive Pt" compounds towards DNA, the photoreactions of 
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Figure 6.39 Structures of the mononucleotide 5'-GMP (at physiological pH) and the 
two complexes 2 and 5 under investigation. 
(a) Photoreaction of cis, trans, cis-IPt`(N3)2(OH)2(NH3)2 1 (2) in the presence of 
5'-GMP 
The NMR data suggest that all products are due to Pt" (NH 3)2 trans to (N7 5'-GMP) 
adducts. This confirms that it is possible to initiate Pt binding to 5'-GMP of a 
substitution inert Pt" compound by irradiation with blue light. Complex 2 is totally 
inert towards binding to 5'-GMP in the dark, and light can therefore be used to 
promote Pt binding to nucleotides. 
No cross-peaks were observed for any intermediate photoproducts such as cis-
[Pt"(NH 3)2(OHJ OH2)2] or cis-[Pt"(NH3)2(OH/ 0H2)(N7-5'-GMP)]. This indicates 
that {Pt" (NH 3)2 1 2 is bound to two 5'-GMP ligands. The intensity of the H8 5'-GMP 
and Hi' 5'-GMP peaks decreased to 14% and 17.5% at the end of the irradiation, 
respectively. This means that ca. 80% of 5'-GMP had undergone a reaction. We 
would expect from this that the intensities of the cross-peaks of the Pt"-(5'-GMP) 2 
adducts (box (B) Figure 6.13) add up to ca. 80% of the initial intensity of complex 2 
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before the irradiation (ratio 2/5'-GMP = 1/2), but they only add up to ca. 27% of the 
initial intensity of complex 2. This can be partly explained by the exchange of the 
NH3 protons with the solvent which influences the intensities. If two 5'-GMP are 
bound to each of the Pt" products (compounds 20-26), then Ca. 70% of all 5'-GMP 
would be still unbound. But only 14% free 5'-GMP is left according to the 'H NMR 
spectrum after the irradiation. 5'-GMP must have reacted also otherwise in order to 
explain these data. Some 5'-GMP may be chemically modified by the photoreaction 
and some of the peaks to low-field of the H8 5'-GMP may therefore actually be due 
to such modified 5'-GMP. It can be assumed that blue light can lead to chemical 
modifications of nucleotides. It is therefore important to use low power light for 
irradiation reactions. 
(b) Photoreaction of cis, trans-[Pt"(en)(N 3)2(OH) 2J (5) in the presence of 5'-
GMP. 
The compound [Pt"(en)(N7-GMP) 2] (28) was identified as a product by comparing 
the 'H/ ' 5N NMR chemical shifts of the peaks 28, 28a, 28b and 28c (Figure 6.17) 
with reported shifts? An estimated 44% of 5'-GMP was incorporated into compound 
[Pt"(en)(N7-GMP) 2 1 (28) at the end of the 65.3 h irradiation. 
Another major product, besides [Pt"(en)(N7-GMP) 2] (28), was observed as 
compound 29, which is estimated to account for about 16% of all Pt-en (N7 5'-GMP) 
adducts (Table 6.1 and Figure 6.17). Peak 29a was assigned to the H8 proton of 5'-
GMP bound via N7 to Pt and is part of complex 29. 
Berners-Price et al. stated that NH 2-en protons on the same N atom, that is cis to N7 
5'-GMP, are nonequivalent.' Complex 29 shows these characteristics only for the 
protons on one nitrogen, but not for the protons on the other nitrogen. 
Six other H8 5'-GMP peaks were detected to low-field of H8 of free 5'-GMP (8.12 
ppm). These peaks are likely due to other minor Pt-en (N7 5'-GMP) adducts. These 
peaks add up together to over 18% of all Pt-en (N7 5'-GMP) adducts. The large 
number of Pt-en (N7 5'-GMP) adducts formed can be attributed to the influence of 
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the light, because reported reactions of Pt" am(m)ine complexes with 5'-GMP only 
resulted in one species each. 3 ' 27 ' 28 
pH titration of the H8 'H chemical shifts 
In order to further investigate the binding of complex 5 to 5'-GMP, an NMR pH 
titration was performed. 5'-GMP binds two protons at the phosphate group and one 
at the purine moiety (Figure 6.39). The pK values of 5'-GMP have been reported in 
literature and are listed below.' 
Table 6.20 PKa values of 5'-GMP. 7 Deprotonation site is given in brackets. 
pK (-P(0)-(OH) 2) plc (H N7) p 	(-P(0)(0)(OH)) plc (H Ni) 
0.3 ± 0.2 2.48 ± 0.04 6.25 ± 0.02 9.49 ± 0.02 
For free 5'-GMP, protonation of N  and N7 causes 'H chemical shift changes of the 
H8 signal to lower field and phosphate protonation causes shift changes to higher 
field . 29 This is confirmed in graph (a), Figure 6.18, which represents the 'H chemical 
shift dependence of the H8 signal of free 5'-GMP. In contrast to curve (a), the curves 
(b) and (c) in Figure 6.18 which are due to the peaks 28a and 29a (Figure 6.16) do 
not show any low-field shift in the pH range 1 to 4. That means that N7 protonation 
is absent in the complexes 28 and 29. This confirms that Pt" must be bound to the N7 
position of 5'-GMP in both complexes. The curves (b) and (c) in Figure 6.18 show 
similar features at acidic pH, but the pK values which were derived by least-squares 
fits to the Henderson-Hasselbalch equation are very different (see Table 6.14). The 
pK of NI of complex 29 is 8.70 and differs by 0.8 units from the pK Ni of free 5'-
GMP (9.49). The pK of Ni of complex 28 is 9.20 and differs by only 0.3 units from 
the pK of free 5'-GMP. As diamagnetic metallation produces effects quite similar to 
protonation, the binding of Pt" to the N7 of 5'-GMP should have the effect of 
acidifying the proton at Ni, causing a decrease in the P1a  of Ni This effect is 
much stronger in the case of complex 29 than in complex 28. 
In comparison, the coordination of pt" of cisplatin to N7 of 5'-GMP decreases the 
pK ofNl by one unit. 28 
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Photoreactons of complexes 2 and 5 in the presence of d(GpG) 
Cis-[Pt"(NH 3 )2 {dGpG}] accounts for 60-65% of all cisplatin DNA adducts. 26 
Diguanosine phosphate Pt complexes have therefore been used as simple models of 
the local structures of an intrastrand cross-link of two adjacent guanosines in DNA. 
The structural features of cis-{Pt"(NH 3)2 {d(GpG)}] have been studied by NIVIR, CD 
and X-ray crystallography. 9 ' 3 ' Both the NMR and X-ray studies show Pt bound to the 
N7 position of guanine. The two guanines have a "head-to-head" configuration, with 
the two 06 on the same side of the Pt coordination plane. 
The aim of this experiment was to investigate whether the photoproducts of cis, 
trans, cis-[Pt"(N3)2(OH)2(NH3 )2] (2) and cis, trans-[Pt"(en)(OH) 2(NH3)2J (5) can 
form guanosine cross-links with d(GpG). The structure of d(GpG) is shown on the 
next page. 
(a) Photoreactions of cis, trans- LPt"(en)(N3)2(OH)2] (5) in the presence of 
d(GpG). 
Two photoreactions of cis, trans-[Pt1"(en)(N3)2(OH)2] (5) with light of 457.9 nm 
were carried out. One major product was detected and identified as [Pt(en){d(GpG)-
N7(1), N7(2)) ]2+  (32) by comparing the 'HI ' 5N chemicals shifts with literature 
values. 1,32  Figure 6.19 shows that the H8 peaks of free d(GpG) (o('H) 8.11, 7.90 
ppm) disappeared after an irradiation time of 47 mm (457.9 nm, 25 mW). 
Two new peaks at ('H) 8.49 (32a) and 8.18 (32b) ppm were present together with 
some other weak peaks in the same ('H) range. The Hi' proton peaks 31c and 31d 
overlap to one peak 32c after 47 min of irradiation. This was also previously reported 
for complex [Pt(en){d(GpG)-N7(1), N7(2)}] 2 (32). 9 No reactant peaks were 
observed any more both in the 'H and 2D ['H, ' 5N] HSQC NMR spectra. This means 
that the photoreaction was already completed after 47 min irradiation and was 
therefore very rapid. 
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The photoreaction was repeated with a lower light intensity in order to gain more 
information about the reaction mechanism. Less than half the light intensity (10 
mW) and a different mol ratio of complex 5 and d(GpG) was used (5 / d(GpG) = 3 / 
2). No intermediate was detected during this photoreaction; only signals due to 
complex 5 and {Pt(en){d(GpG)-N7(l), N7(2)}] 2 (32) were present. The time course 
of the intensities of the cross-peaks of the two complexes 5 and 32 is plotted in 
Figure 6.21. The appearance of the resonances of complex [Pt(en) {d(GpG)-N7( 1), 
N7(2)) ]21  (32) occurred simultaneously with the disappearance of the resonances of 
reactant 5. The photoproducts of cis, trans-[Pt''(en)(N 3 )2(OH)2] (5) therefore react 
rapidly with d(GpG). There is no remarkable increase in the intensity of the cross-
peak for [Pt(en) {d(GpG)-N7( 1), N7(2)} ]2+  (32) after 5  h of irradiation, although the 
intensity of complex 5 further decreases. This could be either due to the formation of 
other Pt d(GpG) adducts, or due to the inaccuracy of the intensities of the N}1 2 en 'H 
resonances. It is most probably due to both because additional H8 proton peaks 
besides those for 32a and 32b were detected in the 'H NMR spectra (Figure 6.19), 
and slight changes of the pH value can strongly affect the intensities (see section 
6.2.1). 
The important feature however is that the rate determining step in the formation of 
[Pt(en){d(GpG)-N7(1), N7(2)}] 2 (32) is the photoreduction step from Ptiv  to Pt" of 
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complex 5 as illustrated in Figure 6.40. Cis, trans-[Pt''(en)(N 3)2(OH)2] (5) therefore 
has the characteristics required for a photoactivatable prodrug - inert on its own, but 


















Figure 6.40 Mechanism of the photoreaction of cis, trans-[Pt"(en)(N 3 )2(OH)2J (5) 
and the following rapid binding to the N7 positions of d(GpG). Only NMR 
resonances of complexes 5 and 32 were observed during the photoreaction. 
pH titration of the H8 'H peaks of complex [Pt(en){d(GpG)-N7(1), N7(2)]]2 (32) 
Figure 6.22 shows the pH titration curves of the two H8 protons of complex 32 fitted 
to the Henderson-Hasselbaich equation by least-squares fits. The two H8 protons of 
d(GpG) were assigned according to Girault et al.9 They measured the deuterium 
exchange rates of the H8 protons of complex 32 at pD 10. The titration curve with 
the large chemical shift variation was assigned to the more slowly exchanged proton. 
For complex 32, the H8 5'-G is the more slowly exchangeable of the two H8 protons 
at pD 10. The reason for this is the shielding of the H8 5'-G by the anionic phosphate 
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group which slows down the deuterium exchange. Therefore curve (b) in Figure 6.22 
was assigned to H8 5'-G. The pH titration curves are in agreement with titration 
curves for complex 32 in literature. 9 ' 32 The only titrations observed for both the H8 5' 
and H8 3' curves with pK values of 7.98 and 8.26, respectively, are due to Ni 
deprotonation. No N7 protonation effect was observed at around pH 2.4 which 
confirms that Pt is bound to both N7 of d(GpG). The pK values of N  deprotonation 
of complex 32 are much lower than the corresponding one of free 5'-GMP which is 
9.5. Pt binding to N7 therefore strongly acidifies the Ni positions of the guanine 
rings of d(GpG). 
(b) Photoreaction of cis, trans, cis-IPt"(N3)2(OII) 2(NH3)2 1 (2) in the presence of 
d(GpG) 
Complex cis-[Pt" (NH3)2 {d(GpG)-N7(l), N7(2)}] 2 (33) (Figure 6.23) was observed 
as a single product during the photoreaction, exhibiting two cross-peaks with distinct 
"5N chemical shifts at —68.30 33a and —68.51 33b ppm. The pH titration curves of the 
H8 'H chemical shifts (Figure 6.26, (B)) after irradiation show no N7 protonation 
effect, which means that Pt must be bound to the N7 of the guanines of d(GpG). It 
can therefore be concluded that the peaks 33 are due to complex cis-[Pt" 
(NH3)2 {d(GpG)-N7(i), N7(2)}] 2 (33). All d(GpG) was bound as cis-[Pt" 
(NH3)2 {d(GpG)-N7(i), N7(2)}] 2 after 0.77 h irradiation. The excess of complex cis, 
trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2) reacted with light and is responsible for the 
formation of a yellow precipitate which was observed in the NMR tube at the end of 
the irradiation. Cross-peak 35, due to NH 4 , was observed during the irradiation and 
increased in intensity throughout the reaction. Irradiation of Pt ammine complexes 
must initiate the breakage of the Pt-ammine bond. This reaction was previously 
observed during other photoreactions with cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2). 
In contrast to these observations, no en was ever observed to be released from cis, 
trans-[Pt"(en)(N 3 )2(OH)2] (5) during a photoreaction. 
The 'HI ' 5N chemical shifts of the compound cis-[Pt"(NH3)2(5'-GMP-N7) 2]2 are 
reported to be 4.67/ -66.6 ppm at pH 7.9 and 4.47/ -67.5 ppm at pH 4,43  The 'HI ' 5N 
chemical shifts of product 33 are therefore in the expected 'HI ' 5N chemical shift 
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range. 
After the successful formation of cis-[Pt" (NH3)2 {d(GpG)-N7(1), N7(2)}] 2 (33) by 
using light of 457.9 nm for irradiation, another experiment was carried out using 
light of 647.1 nm. The reason for this experiment is that red light penetrates deeper 
into tissue and is therefore better suitable for use in clinics than blue light. 13  Figure 
6.25 shows that it is possible to photoreduce cis, trans, cis-[Pt"(N3 )2(OH)2(NH3)2] (2) 
by light of 647.1 run, and initiate the formation of cis-[Pt" (NH3)2 {d(GpG)-N7(1), 
N7(2)}] 2 (33). This is remarkable because complex 2 has practically no absorption 
in the red. About 5% of complex 2 was converted into cis-[Pt" (NH 3)2 {d(GpG)-
N7(1), N7(2)}] 2 (33) after 18.4 h of irradiation. This result gives hope that intense 
red light could be used for activating such Pt" diazido complexes in vivo which 
would make these systems much more suitable for an application. It may be possible 
to use pulsed red laser light to improve the activation rate. A pulsed laser has much 
higher intensity for a short period and has therefore the potential of activating Pt 1" 
diazido complexes more efficiently. 
Dependence of H8 'H chemical shifts on pH (Figure 6.26) 
The same sample was used for the pH titration as for the irradiation experiment with 
light of 647.1 run. Graph (A) in Figure 26 shows the pH dependence of the 'H 
chemical shifts of the H8 protons of free d(GpG). Two effects are observed the 
deprotonations of Ni with a pK of ca. 9.5 and N7 with a pK of ca. 2.5. The 
protonation of the phosphate would take place at very low pH and is not relevant in 
this study. The curves were assigned to H8 of 3'-G and 5'-G according to Girault et 
al. 9 Graph (B) shows the situation after the sample was irradiated for 12 h with light 
of 457.1 nm (30 mW). The pK ofNi decreased by one unit to 8.34 for 3'-G and 8.28 
for 5'-G, respectively. No protonation of N7 at pH 2 to 4 was observed indicating 
that the N7 position is blocked by Pt. This result confirms that Pt binding to N7 is 
initiated by light. 
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(c) Photoreaction with cis, trans, cis[Pt"(N3)2(OH)2(NH3)2 1 (2) in 0.1 M NaCl 
aqueous solution in the presence of d(GpG) 
This reaction was carried out in order to investigate if the photoproducts of cis, trans, 
cis-[Pt"(N3)2(OH)2(NH3)2] (2) would directly bind to d(GpG), as was observed for 
the reaction in H 201  or if they would first react with the highly abundant Cl - and then 
bind to d(GpG). Complex 2 was little affected by the 19 h in the dark in 0.1 M NaCl 
solution as can be seen in spectrum (A) in Figure 6.27. This shows that complex 2 is 
intert towards substitution. The light intensity used for this irradiation experiment 
was around three times higher than used for the experiment in H 20 ((b) this section). 
After 0.77 h of irradiation, peaks for cis-[Pt" (NH 3)2 {d(GpG)-N7(1), N7(2)}] 2 (33) 
were observed in the NMR spectra (Figure 6.27, (B)). At that time no other product 
than cis-[Pt" (NH3)2 {d(GpG)-N7(1), N7(2)}] 2 (33) was observed. About 40% of 
d(GpG) was, at that time, bound in complex 33. The additional peaks in the Pt" 
ammine region ('H) 5.5-5.0 suggest that the irradiation led to isomerisation and Cl 
substitution reactions of complex 2. The exclusive formation of cis-[Pt" 
(NH3)2 {d(GpG)-N7( 1), N7(2)1 ]2+  suggests that there is a strong preference for the Pt" 
photoproducts to bind to d(GpG). 
Comparing the kinetics of the formation of 33 in this reaction with those of the 
reaction in H 201  the high Cl - concentration slowed down the reaction remarkably. A 
three times weaker light intensity and a slightly higher d(GpG) concentration were 
used for the reaction in H 20 (see (b) this section), but despite this all the d(GpG) was 
bound in complex 33 after 0.77 h irradiation. 
In summary, the presence of Cl - in a high concentration did not hinder the formation 
Of cis-[Pt" (NH3 )2 1d(GpG)-N7(l), N7(2)}] 2 (33). However, the formation rate 
decreased remarkably compared with the reaction in absence of Cl - and two side-
products were observed. These side-products are thought to be cis-[Pt" 
(NH3)2 {d(GpG)-N7}Cl] and account for ca. one quarter of all products. It is very 
likely that the amount of these side-products increases when the d(GpG) 
concentration is lower. Further studies are required to verify the presence of the 
compound cis-[Pt" (NH3)2 {d(GpG)-N7}ClJ. A pH titration curve might confirm that 
only one N7 of d(GpG) is bound to Pt. 
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(d) Photoreaction of cis, trans, cis(Pt"(N 3)2(OH)2(NH3)2] (2) in the presence of 
d(GpG) and glutathione (GSH) 
The aim of this experiment was to investigate if binding to d(GpG) also takes place 
as effectively in the presence of an excess of the reducing agent GSH, which is also a 
very good donor ligand. 
Figure 6.28 represents the time course of the GSSG concentration throughout the 
reaction. It is evident that light strongly accelerates the oxidation of GSH. In order to 
find out if this is due to the reaction of light with GSH, a 10 mM solution of GSH 
was prepared and irradiated with the same wavelength and light power for 10 h. No 
GSSG was observed at all, which suggests that light plus complex 2 are involved in 
the rapid oxidation of GSH. The cross-peak of NH 4 increased strongly and no Pt"-
(NH3)2 cross-peak due to the expected Pt" photoproducts was observed. A rapid 
photoreaction involving GSH and complex 2 had taken place yielding GSSG and 
ammonia, which must have been released from Pt" photoproducts. The loss of 
ammonia of the Pt" photoproducts is likely the reason why no Pt"-(NH 3) cross-peaks 
were observed. 
Interestingly, no reaction at all between d(GpG) and the photoproducts of complex 2 
was observed during the irradiation as long as free GSH was still in solution. After 
all GSH was oxidised to GSSG, d(GpG) reacted rapidly with the photoproducts of 
complex 2 to form cis-[Pt" (NH 3 )2 {d(GpG)-N7(1), N7(2)}] 2 (33), which was 
identified by comparison of the chemical shifts. The following compounds were 
observed by NMR at the end of the irradiation: 
cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2), cis-[Pt" (NH3 )2 d(GpG)-N7( 1), N7(2)1 ]1 
(33), NH4 , an isomer of complex 2, and another Pt"-(NIE-1 3 )2 product with Pt-NH 3 
trans to N complex (38). 
The exciting fact about this result is that all d(GpG) is bound in cis-[Pt" 
(N}13 ) 2 {d(GpG)-N7(1), N7(2)}] 2 (33), despite the complete oxidation of GSH. It is 
also remarkable that there is still unreacted complex 2 left in the solution after the 
end of the irradiation. The oxidation of 2.5 mol eq GSH should have completely 
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reduced complex 2 according to the expected overall reaction: 
2 GSH + cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] -+ GSSG + cis-[Pt"(N3)2(NH3)2]. 
No Pt" (NH 3)2 trans to S complexes were observed by NMR. Such complexes would 
be expected from the reaction of the photoproducts of complex 2 with GSH or 
GSSG. 34 This may be due to the loss of the ammonia ligands of these complexes 
which was reported in binding studies between cisplatin (cis-[Pt"C1 2(NH3)2]) or the 
cisplatin diaqua analogue cis- [Pt"(OH 2)2(NH3)2] 2 and glutathione. 35 It has been 
reported that coordination of thiolate sulfur to Pt" labilises coordinated ammonia. 35 
The strong increase of NH in solution during the photoreaction suggests that 
glutathione was bound via sulfur to Pt" which led to the labilisation and loss of 
ammonia ligands. Chelate amine ligands such as en are bound more strongly to Pt 
and would not be displaced so easily. It would therefore be useful to repeat the 
reaction with cis, trans-[Pt"(en)(N 3)2(OH)2] (5). Perhaps Pt" trans to S resonances 
could be observed and give more evidence of the reaction pathway. 
Photoreactions of complexes 2 and 5 in the presence of single and 
duplex 14mer DNA 
After the successful light-induced binding of Pt" to the dinucleotide d(GpG) by 
irradiating the complexes cis, trans-[Pt"(en)(N 3)2(OH)2] (5) and cis, trans, cis-
[Pt"(N3)2(OH)2(NH3)2] (2) with blue and red light, light-induced Pt" binding to 
14mer single and duplex DNA via irradiation of complexes 2 and 5 was investigated. 
The reason for choosing the strands d(ATACATGGTACATA) I and 
C1(TATGTACCATGTAT) II is that both the NMR structures of the unmodified 
duplex and the platinated duplex were determined in our group.' 36 It was therefore 
possible to confirm the complete annealing of the strands by comparing the 'H NMR 
spectrum with a 'H NMR spectrum obtained from the previous determination of the 
NMR solution structure of the same duplex. 
Berners-Price et al. 36 reported that the major platination site of the duplex 1111 = I + III 
with cisplatin is G(7)N7 G(8)N7 of strand II and that there is very little platination of 
the G residues on the complementary strand, or of other residues. It was therefore 
expected that a photoreaction of complex 2 and 5 would yield in a Pt-{G(7)N7 
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G(8)N7, strand lI} adduct. Two conformations of the GG chelate were detected as 
end products of the reaction of cisplatin with duplex DNA, with 'HI ' 5N chemical 
shifts of (a) 4.4/ -69 ppm, 4.2/ -69 ppm and (b) 4.65/ -67.8 ppm, 4.7/ -66.2 ppm. 36 (a) 
was assigned as a kinked platinated duplex, and (b) as one or more distorted forms in 
which the [Pt"(NH3)2] 2 environment resembles that of the single strand Pt GG 
adduct. Transitions of the platinated duplex from kinked to distorted forms can be 
induced by pH changes (1K = 4.8), increase of the temperature, or a change in ionic 
strength. 36 Different forms of the 14mer duplex were also found when it is platinated 
at GG with [Pt"(en)] 2 . The 'HI ' 5N chemical shifts of the different forms were in the 
area 4.9 to 6/ -29 to —33 ppm dependent on pH, temperature and ionic strength. 16 
Pt adducts were found only in the photoreactions with cis, trans-[Pt"(en)(N3)2(OH)2] 
(5), but no products at all were found for cis, trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2). 
Various conditions were investigated and the best were found to be a low light power 
of ca. 10 mW and a higher temperature of 310 K. The 'H/ ' 5N chemical shifts of the 
products obtained from the photoreaction of cis, trans-[Pt"(en)(N3)2(OH)2J (5) in the 
presence of strand I and the duplex III are very similar, 5.7/ -31 ppm for 43 and 5.5/ 
-30.2 ppm for 44. These shifts are indicative for Pt"-(en) trans to N and very similar 
to the shifts of the complex cis-[Pt" (en){d(GpG)-N7(l), N7(2)}] 2 (32) (5.68, 5.63./ 
-30.90 ppm, 5.58, 5.55/ -31.22 ppm). This suggests that Pt is bound to G N7 of the 
single strand I and the duplex III. No cross-peaks other than for 43 and 44 were 
observed in the 2D spectra which suggests that a Pt-G(7)N7G(8)N7 chelate was 
formed. The Pt-G(7)N7G(8)N7 chelate is known to be the major product between the 
reaction of cisplatin and strand 1.36  Figure 6.33 shows the time course of the intensity 
of cross-peak 43 during the photoreaction. All of strand I had reacted with Pt" 
photoproducts of complex S after 5 h irradiation. This shows that the Pt" 
photoproducts of complex 5 are also highly reactive towards N7 of G in 
oligonucleotides. 
The photoreactions with complex 2 were not as successful. No resonances for a 
product of the reaction with strand I and duplex HI was observed. The pH value 
increased rapidly after start of the irradiation, for example in the reaction with the 
duplex 1111 in 1.43 h from pH 6.26 to 7.7. The intensities of Pt" ammine resonances 
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are very sensitive to such pH value increases (see section 6.3.1) which was the 
reason why no resonances were observed after a short time of irradiation. The use of 
an appropriate buffer could prevent this problem as long as it does not interfere with 
the photoreaction. A yellow precipitate was found at the bottom of the NMR tubes 
after both reactions. The photoproducts of complex 2 must react rapidly further and 
form insoluble polymeric species. This pathway must be more efficient than binding 
to the oligonucleotides. NH was also detected in solution. The formation of a 
precipitate and the presence of was observed in most photoreactions of 
complex 2. 
6.3.4 Photoreactivity of platinum'" and platinum" monoazido 
complexes 
The mechanism of the photoreaction of Pt` diazido complexes such as cis, trans-
{Pt"(en)(N 3)2(OH)21 (5) and cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2) is likely to be 
due to charge transfer of an electron from each azide ligand to the Pt'" centre via the 
irradiation into a ligand-to-metal charge transfer band. This mechanism requires that 
the Pt1" complex must possess two azide ligands in order to be reduced to a Pt 11 
species. In order to verify this, the novel complex [Pt"(dien)(N 3 ) trans —(OH)21(NO3) 
(7) was prepared. This complex has only one azide ligand which can donate one 
electron to the Pt 1 " centre. The other ligands, then and hydroxide, are strongly bound 
to Pt'" and do not have a ligand-to-metal charge transfer in the blue range of light 
(around 450 rim). They are therefore not expected to participate in a light-induced 
reduction of the Pt 1" centre. 
Complex 7 was synthesised in situ by adding an excess of H 202 into an aqueous 
solution of [Pt"(dien)(N 3)](NO3) (6). This solution was then irradiated with laser 
light (457.9 rim, 30 mW) for 24 h. The 'H NMR spectrum at the end of the 
irradiation was identical to that before the irradiation. This suggests that complex 7 is 
not undergoing any photoreduction reaction, because the then peaks would have 
been expected to shift to high field upon reduction of the Pt centre. Therefore, one 
azide ligand on a Pt" is not sufficient for a two electron reduction to pt ", and it is 
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essential for Pt" azide complexes to have two azide ligands in order that a light 
induced reduction to Pt" can occur. 
[Pt11(dien)(N 3)](NO3) (6) was also tested for photoactivation. This compound showed 
as expected no signs of any photoreaction upon irradiation with blue light (457.9 nm, 
30 mW). It would be interesting to investigate if the only azide ligand of 6 can easily 
be replaced by CY upon irradiation as it was the case with complex 4. 
Summarised, the irradiation experiment with [Pt"(dien)(N 3) trans —(OH)21(NO3) (7) 
did not yield any reduction products indicating that one azide ligand bound to Pt" is 
not sufficient for a light-induced (ligand-to-metal-charge transfer) reduction of the 
Pt" centre to Pt". 
!iii.i 1Tfl[.]ui 
Cis, trans, cis_[Pt"(N3)2(OH)2(NH3 )2] (2), cis, trans, cis-[Pt' V(N3)2(OAc)2(NH3)2] (3) 
and cis, trans-[Pt"(en)(OH) 2(NH3)2] (5) are highly photoreactive in water. Irradiation 
with weak blue light at 457.9 and 488 nm, where compounds 2 and 5 show only 
weak absorbance (s - 10 mot' cm'), leads to Pt" photoproducts and 
photoisomerization processes which change the complex configuration. The Pt" 
photoproducts are reactive and can undergo further reactions with donor groups. 
Upon irradiation of complex 2 and 5, rapid Pt" binding to the N7 position of 5'-GMP 
and d(GpG) was observed. Binding of Pt to a 14mer single-strand and duplex DNA 
strand containing two adjacent guanosine bases was shown upon irradiation of 
compound 5. It was also shown that compounds 2 and 5 do not bind to nucleobases 
in the dark and are stable in water. They react only slowly with the important 
biological reducing agent glutathione (GSH), which makes them candidates as 
prodrugs. 
The photoreaction of compound 2 in the presence of d(GpG) and glutathione still 
leads to binding to N7 of d(GpG). High chloride concentrations (0.05 - 0.15 M) lead 
to a substitution of the hydroxide ligands by chloride ions, but the azide ligands are 
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not substituted. This means that the complexes can still be photoactive even at high 
chloride concentrations. 
Gas bubbles which developed during the photoreactions indicate that the photoredox 
reactions involve a photoreductive elimination mechanism. Each of the azide ligands 
donates an electron to the platinum centre upon irradiation into the ligand-to-metal 
charge transfer band. The formed azide radicals are not stable in water and combine 
rapidly to molecular nitrogen making a recombination to the reactant impossible. 
The lack of photoreaction of the monoazide complex [Pt"(dien)(N 3) trans-
(OH)21(NO3) (7) confirmed that two azide ligands are necessary for photoactivity. 
In summary, the concept of using a Pt' cisplatin analogue with two azide ligands as 
a photoactive precursor complex proved to be very promising. On the one hand, the 
complexes are stable towards substitution reactions and even towards reduction by 
the biological reducing agent glutathione (GSH). This makes them potentially useful 
as Pt" prodrugs. On the other hand, rapid photoreduction from Pt" to Pt" takes place 
upon irradiation of the complexes by blue light. The Pt" photoproducts bind 
efficiently to N7 of G bases. Binding to the N7 position of d(GpG) was also 
demonstrated when using red light. Therefore, the introduction of two azide ligands 
into Pt' anticancer prodrugs could be a useful method for development of a 
photoactive platinum anticancer prodrug. 
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Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans, cis-[Pt"(N 3)2(OAc)2(NH3)2J (3, 2 mM) in H20. 
The time course of the 'HNMR experiments was as follows (Figure 6.7): 
- 0 h: Starting material complex 3: NH 3 : 5.87 3', 5.72 3" ppm; CH3 acetato: 2.14 
ppm 3 (s); 'J('H-' 3C) = 130 Hz. 
- 0.7 h: Two new peaks are present besides CH 3 acetato peak of complex 3: 2.03 
(s), 2.02 (s) ppm. 
- 2.4 h: The peaks at 2.03 and 2.02 ppm disappeared and a new peak at 2.06 ppm 
(s) 16a was present. 
- 4.1 h: The peak at 2.06 ppm 16a increased and the peak at 2.14 ppm 3 due to 
complex 3 decreased. The peaks due to NH 3 of complex 3 did also decrease. 
- 5.8-27 h: The peak at 2.06 ppm 16a increased further and is the dominant peak 
after 27 h irradiation. Peak 3 at 2.14 ppm almost completely disappeared. The 
NIH3  peaks of complex 3 disappeared, weak peaks in the range 5.3-5.0 ppm 
appeared. 
The time course of the 2D ['H, ' 5N] NMR spectra was the following (Figure 69): 
- 0 h: Starting material complex 3: 5.75/ -44.46 ppm. 'J(' 5N-' 95Pt) = 254 Hz, 2J('H-
' 95Pt) = 48 Hz. 
- 2.3 h: Two new cross-peaks at 5.12/ -39.96 ppm and 5.051 -49.18 ppm are 
present besides the cross-peak of complex 3 at 5.75/ -44.46 ppm. 
- 4 h: Two more cross-peaks are present at 5.3 to 5.01 -49 ppm and three more 
cross-peaks are present at 5.3 to 5.01 -39.9 ppm. 
- 5.7 - 27 h: The cross-peak of complex 3 5.75/ -44.46 ppm decreased with time. 
The cross-peaks at 5.3 to 5.0/ -49 ppm (16B) and 5.3 to 5.01 -39.9 ppm (16C) 
increased with time, Figure 6.9. The coupling constants of the cross-peaks in box 
(16B) are similar: 'J('5N-' 95Pt) = 265 Hz, 2J('H-'95Pt) = 47 Hz. Also all cross-
peaks in box (16C) exhibit similar coupling constants: 'J(15N- 195Pt) = 275 Hz, 
2J('H-'95Pt) = 48 Hz. A new cross-peak appeared after 7.4 h at 7.08/ -9.28 ppm. 
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This peak is likely due to N}I I released from complex 3. 
- 27 h - 48 h: The cross-peak of complex 3 5.75/ -44.46 ppm fully disappeared. 
The cross-peaks of (16B) and (16C) decreased, too. A yellow precipitate was 
observed at the bottom of the NMR tube at the end of the irradiation. 
Appendix 2 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans-[Pt"(en)(N 3)2(OH) 2 ] (5, 2 mM) in H20. 
The time course of the 'H NMR spectra was as follows: 
- 0 h: Complex 5: CH2 en region: 2.84 (s) ppm, 3J('H.) 95Pt) = 22 Hz; NH 3 region: 
6.50 (s) 5', 6.35 (s) 5" ppm. 
- 1.4 h: CH2 en region: 5 new peaks were present besides the peak of complex 5 at 
2.84 ppm: 2.75, 2.70, 2.64, 2.64, 2.48 and 2.40 ppm. NH2 en region: the 
following pairs of peaks separated by 'J('H-'5N) = 73 Hz were present besides 
peaks of complex 5: 6.80, 6.65; 6.75, 6.60; 5.69, 5.54 ppm. 
- 3.1 h: CH2 en region: the 5 new peaks increased while the peak of complex 5 at 
2.83 ppm decreased. A broad peak at 2.95 ppm appeared. NH 2 en region: the 
peaks due to complex 5 (6.50, 6.35 ppm) decreased. Peaks 6.80, 6.65 ppm and 
5.69, 5.54 ppm increased most. A new peak at 6.14 ppm appeared. 
- 4.8 h: CH2 en region: Peak at 2.83 ppm due to complex 5 further decreased. A 
new peak at 2.55 ppm was present. NH 2 en region: new peaks at 5.76, 5.62 ppm 
and 5.57, 5.42 ppm were present. Peaks 6.50, 6.35 ppm due to complex 5 further 
decreased. 
- 6.5 h - 24 h: Peaks due to complex 5 disappeared. The intensities of all peaks 
reduced with time simultaneously. A yellow precipitate was observed after the 
end of the photoreduction. 
The time course of the 2D ['H, ' 5N] NMR spectra was as follows (Figure 6.10): 




0.6 h: 4 new cross-peaks were present in the region 6.2 to 6.8/ -6 ppm ((A), 
Figure 6.10). 2 new cross-peaks appeared at the ' 5N chemical shift —16 ppm: 
6.67/-16.21 ('J(' 5N-' 95Pt) = 306 Hz, 2J('H-' 95Pt) = 44 Hz) 17a, 6.95/ -16.72 ppm 
17b ((B), Figure 6.10). One new cross-peak at 5.70/ -48.38 ppm 18a appeared. 
2.3 h: The 4 new cross-peaks in box (A) increased while the cross-peak of 
complex 5 decreased. The cross-peaks 17a and 17b also increased in intensity. A 
new cross-peak at 5.59/ -49.92 ppm 18b appeared while the cross-peak 18a 
increased in intensity. 
- 4 h: No new cross-peaks appeared. The cross-peak of complex 5 further 
decreased. 
5.7 h - 24 h: The cross-peak of complex 5 fully disappeared. The intensity of all 
cross-peaks decreased with time. After 24 h there was only one cross-peak left at 
7.05/ -1.69 ppm. This peak is likely to be due to NH 4 released during the 
photoreaction. 
r1i !JS1] ii' tK] 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans, cis-[Pt"(N 3)2(OH)2(NH3)2J (2, 4.35 mM) in 0.1 M NaCl aqueous solution. 
The time course of the reaction was as follows (see Figure 612): 
Dark reaction: Two new weak cross-peaks were present in the 2D ['H, ' 5N] NMR 
spectrum after 18 h in the dark at 5.26/ -40.37 ppm and 5.46/ -41.33 ppm besides the 
cross-peak of complex 2 at 5.13/ -40.08 ppm. 
Irradiation 
- 1.44 h: 2D ['H, ' 5N] NMR: the water band at 4.8 ppm broadened. The cross-peak 
for complex 2 overlapped with the water peak. Two new cross-peaks appeared at 
3.87/ -66.47 ppm 19a, 3.80/ -67.26 ppm 19b. 
- 2.3 h: 2D ['H, ' 5N] NMR: two new cross-peaks appeared in the region of 19a and 
19b: 4.02/ -68.00 ppm 19c and 4.02/ -72.04 ppm 19d. 
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'H NMR: 4 pairs of peaks with identical intensity and separated by 'J('H-' 5N) = 
73 Hz were present: 4.13, 3.99 ppm 19c; 3.98, 3.83 ppm 19a; 3.92, 3.77 ppm; 
3.90, 3.76 ppm. No peaks due to complex 2 or other Pt" compounds were 
present. 
- 2.3 h - 13.2 h: 2D ['H, ' 5N] NMR: the intensities of the cross-peaks 19c and 19a 
increased during the irradiation, cross-peaks 19b and 19d decreased. No new 
cross-peaks appeared. 
'HNMR: the two peaks at 3.92 and 3.77 ppm disappeared, the other three pairs of 
peaks did increase. The two most intense peaks were the peaks at 4.13 and 3.99 
ppm corresponding to cross-peak 19c. 
ri.jsiiir. t•I 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans-[Pt"(en)(N 3)2(OH) 2 ] (5, 2 mM) in the presence of 5'-GMP (4 mM). 
The time course of the 'HNMR experiments was the following (Figure 616): 
H8 5'-GMP region (8-9 ppm): 
- Oh: free 5'-GMP:8.l2ppm 
- 2.4 h: Two new peaks are present to low-field of H8 of free 5'-GMP: 8.53 28a, 
8.59 29a ppm. 
- 9.2 h: Five new small peaks are present to low-field of H8 of free 5'-GMP: 8.53, 
8.49, 8.47, 8.46, 8.40 ppm . The H8 of free 5'-GMP peak at 8.12 ppm had 
decreased in intensity while the peaks 28a and 29a were increasing in intensity. 
- 9.2 - 65 h: The H8 of free 5'-GMP peak decreased further in intensity during the 
irradiation. Peaks 28a and 29a and the other peaks at low-field of 8.12 ppm 
increased in intensity. The relative intensities of the H8 peaks are listed in Table 
6.12. The following H8 peaks were present after the irradiation: 8.12 (free 5'-
GMP), 8.59 28a, 8.63 29a, 8.54, 8.52, 8.50, 8.47, 8.45, 8.43 ppm. 
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CH2-en region of complex 5 (2-3 ppm): 
- 0 h: 2.94 ppm (reactant 5), 3J(tHI95Pt) = 24.8 Hz. 
- 2.4 h: Two new peaks were present at higher field: 2.84 ppm 28b, 2.72 ppm 29b. 
- 9.2 h: Peaks 28b and 29b increased in intensity, the peak of complex 5 decreased 
in intensity. No 195Pt satellites were detected for the peaks 28b and 29b. 
- 19.4 h: A new broad peak appeared at 2.78 ppm. 
- 19.4 - 65 h: Peaks 28b and 29b grew further and the reactant peak decreased 
further in intensity. 
NH2-en, NH2 5'-GMP, Hi' 5'-GMP region (5-7 ppm): 
- 0 h: NH2-en complex 5: 6.46, 6.31 ppm 2J('H-'95Pt) = 44 Hz; NH2 5'-GMP: 6.34 
ppm; Hi' 5'-GMP 5.95 ppm. 
- 2.4 h: NH2-en complex 5 peaks decreased in intensity. A small new peak 
appeared at 6.01 ppm (d) just beside the Hi' 5'-GMP peak. J= 4.7 Hz. 
- 9.2 h: New peaks appeared: 6.57, 6.53, 5.88, 5.85, 5.77, 5.69, 5.46, 5.32 ppm. 
All were broad and very weak in intensity. 
- 19.4 h: NH2-en peaks further decreased in intensity. All other peaks increased in 
intensity: The peaks at 5.88, 5.85 and 5.77 ppm merged into one broad peak. 
- 19.4 - 65 h: NH2-en peaks of complex 5 disappeared fully. Three broad peaks 
remained in the NH 2 5'-GMP region at 6.57, 6.53 and 6.36 ppm. Three peaks 
remained in the Hi' 5'-GMP region at 6.02, 5.94 and 5.87 (broad) and five broad 
peaks remained at 5.72, 5.52, 5.46, 5.37, 5.31 ppm. 
The time course of the 2D ['H, ' 5N] HSQC NMR spectra was as follows. 
- 0 h: Complex 5 6.3 5/ -7.27 ppm. 
- 2.35 h: Two new cross-peaks close to reactant 5 were present: 6.28/ -7.22 and 
6.5 1/ -6.42 ppm. Four new cross-peaks appeared at around 5(' 5N) -31 ppm: 5.78/ 
-30.74, 5.71/-30.7728 and 5.35/ -32.98, 5.32/ -31.70 ppm 29. 
- 9.15 h: Two additional cross-peaks appeared in the region of reactant 5: 6.73/ - 
6.40, 6.24/ -6.72 ppm. The cross-peak of reactant 5 had decreased in intensity, all 
the new cross-peaks had increased in intensity. 
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- 19.35 h: The two cross-peaks 5.38/ -31.67 and 5.33/ -31.69 ppm were detected at 
the place where previously only one cross-peak was detected. 
- 29.55 h: Two new cross-peaks appeared at 5.68/ -56.92 and 5.87/ -56.13 ppm. 
- 64.45 h: The above two cross-peaks had changed into three cross-peaks: 5.69/ - 
56.90, 5.90/ -56.29 ppm and 5.83/ -56.33 ppm. 
V !2S11 MM 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans, cis-[Pt"(N 3)2(OH')2(NH3)2 1 (2, 0.7 mM) in the presence of d(GpG) (0.5 
MM). 
The time course was followed by 2D ['H, ' 5N] HSQC NMR experiments 
(Figure 623). 
- 0 h: cis, trans, cis-{Pt t"(N3)2(OH)2(NH3 )2] (2): 5.29/ -38.88 ppm 
- 0.66 h: Two new cross-peaks were present at 4.41/ -68.30 33a and 4.34/ -68.51 
ppm 33 b. 
- 1.43 h: Three additional cross-peaks were present besides the cross-peak for 
complex 2 and cross-peaks 33a and 33b: 5.24/ -49.76 34a, 5.15/ -49.65 ppm 34b 
and 7.07/ -81.32 ppm 35. 
- 2.2 h: The cross-peaks 34a and 34b disappeared. The cross-peak due to complex 
2 decreased in intensity. The cross-peaks 33a and 33b did not change in intensity 
and cross-peak 35 increased in intensity. 
- 2.97 - 8.36 h: The cross-peak due to complex 2 decreased in intensity during the 
irradiation until no complex 2 could be detected after 8.36 h. The cross-peaks 
33a and 33b stayed constant in intensity during the irradiation. Cross-peak 35 
increased steadily in intensity. 
The time course was also followed by 'HNMR experiments (Figure 624). 
- 0 h: d(GpG) (31): H8: 8.17 Ma, 7.97 31b; Hi': 6.21 31c, 6.06 31d; cis, trans, 
cis-[Pt"(N3)2(OH)2(NH3)2] (2): NH3  5.40, 5.25 ppm. 
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- 0.77 h: d(GpG): The H8 peaks 31a and 31b shifted to low-field by 0.4 and 0.3 
ppm, respectively, to 8.57 33c and 8.27 33d. The Hi' peaks 31c and 31d 
disappeared, but instead a new multiplet peak is present at 6.23 ppm 33e. NH3 
region: four peaks are present plus their "Pt satellite peaks at: 5.36, 5.31, 5.21, 
5.16 ppm. Two pairs of peaks appeared at 4.52, 4.37 ppm ('.J('H-'5N) = 73 Hz) 
33a and 4.45, 4.31 ('J('H-' 5N) = 73 Hz) ppm 33b. 
- 1.54 h: H8 region: no changes. NH 3 region: the peaks at 5.36, 5.21 ppm 
decreased in intensity, the peaks 33a and 33b did not change. 
- 2.31 - 8.47 h: H8 region: no changes during the irradiation. NH 3 region: no 
changes to the peaks 33a and 33b. Peaks in the region 5.40 to 5.10 ppm have 
disappeared. 
r3.J.I1.r. rii 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2, 1 mM) in the presence of d(GpG) (1 mM). 
The time course of the 2D ['H, ' 5N] HSQC NMR experiments was the following 
(Figure 625): 
- 0 h: cis, trans, cis-[Pt1"(N3)2(OH)2(NH3)2] (2): 5.23/ -39.25 ppm 2 
- 1.43 h: Three weak cross-peaks appeared besides the cross-peak 2: 5.33/ -49.77, 
5.26/ -49.65 ppm and 7.06/ -81.31 ppm 35. 
- 3.74 h: Two additional weak cross-peaks were present: 4.32/ -68.54 33a and 
4.39/ - 68.13 ppm 33b. 
- 3.74 - 18.48 h: The cross-peaks 33a and 33b increased slowly in intensity. They 
make up 5% of the intensity of the reactant cis, trans, cis-[Pt"(N3)2(OH) 2(NH3)2] 
(2) at the end of the irradiation. Cross-peak 35 increased in intensity, too, but the 
cross-peaks at 5.30/ -49 ppm stayed weak in intensity. 
The time course of the 'HNMR experiments was the following (Figure 625): 
- 0 h: d(GpG) (31): H8: 8.10, 7.88; Hi': 6.20, 6.05; cis, trans, cis-[Pt"(N 3)2(OH)2 
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(NH3)21 (2): 5.36, 5.22 
- 3.85 h: H8 region: very weak peaks appeared at low field of the H8 of d(GpG) at 
8.57 33c, 8.28 33d, 8.18 and 7.92 ppm. Pt-NH 3 region: peaks appeared at 4.52, 
4.46, 4.38 and 4.32 ppm 33a, 33b. 
- 3.85 - 18.36 h: Slow increase of the intensities of the above peaks. No other 
changes in the spectrum occurred. 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2, 1 mM) in the presence of d(GpG) (0.3 mM). 
The time course of the 'HNMR experiments was as follows (Figure 6.27): 
- 0 h: d(GpG): H8: 8.06 31a, 7.83 31b ppm; Hi': 6.18, 6.03; cis, trans, cis-
[Pt"(N3 )2(OH)2(NH3 )2] (2): NH3 : 5.34 2a, 5.19 2b. 
- 0.77 h: H8 region: two new peaks appeared: 8.55 33c, 8.26 33d ppm besides the 
ones of free d(GpG). Hi' region: A new multiplet peak appeared at 6.22 ppm 
besides the peaks of free d(GpG) at 6.18 and 6.03 ppm. Pt-NH 3 region: Four new 
peaks appeared at 4.50, 4.36 33a, 4.44 and 4.30 33b ppm. 
- 1.54 h: H8 region: the peaks due to free d(GpG) at 8.06 31a and 7.83 31b ppm 
had disappeared. The peaks at 8.55 33c, 8.26 33d ppm increased in intensity and 
were the main peaks in that region. Four new weak peaks were present at 8.89 
36a, 8.45 37a, 8.14 36b and 8.07 37b ppm. Hi' region: the peaks at 6.18 and 
6.03 ppm had disappeared and the peak at 6.22 ppm increased in intensity. Pt-
NI-I3 region: new peaks appeared at 5.35 and 5.20 ppm and the peaks 4.50, 4.36 
33a, 4.44 and 4.30 33b ppm increased in intensity. 
- 11.54 - 22 h: H8 region and Hi' region: no changes were observed in these 
regions. Pt-NH 3 region: all peaks in this region strongly decreased in intensity. 
Three pairs of peaks each with 'J('H-'5N) = 73 Hz were present at the end of the 
irradiation: 5.11/ 5.26 ppm, 5.21/ 5.36 and 5.41/ 5.56 ppm. The four peaks at 
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4.50, 4.36 33a, 4.44 and 4.30 33b ppm increased in intensity. 
The time course of the reaction was also followed by 2D ['H, 15N] HSQC NMR 
experiments. 
- 0 h: Cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2): 5.23/ -39.25 ppm. 
- 0.66 h: Two new cross-peaks appeared at 4.35/ -68.34 ppm 33b and 7.08/ -81.06 
ppm. 
- 2.20 h: Two cross-peaks appeared in the region of the cross-peak of reactant 2 at 
5.5 1/ -34.59 and 5.26/ -40.40 ppm. Two cross-peaks were present at 4.41/ -68.03 
33a and 4.35/ -68.34 ppm 33b and a weak cross-peak at 4.21/ -66.59 ppm. 
Me IJiD-F1I] 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans, cis-IPt"(N3)2(OH)2(NH3)2] (2, 2 mM) in the presence of GSH (5 mM) 
d(GpG) (0.35 mM). 
The time course of the NMR experiments was as follows (Figures 6.28, 629 and 
6.30): 
- 16.5 h in the dark: 'H NMR: a new peak appeared at 3.28 ppm 14c' which is 
due to GSSG (14). Peaks were detected for free d(GpG): H8: 8.09 31a, 7.88 31b; 
Hi' 6.21, 6.06 ppm. Peaks due to cis, trans, cis-[Pt"(N3)2(OH)2(NH3 )2] (2) were 
found at 5.37 2a and 5.22 ppm 2b. 
2D ['H, ' 5N] HSQC: Three cross-peaks were found at 5.27/ -38.95 2, 3.80/ -68.79 
1 and 7.06/ -81.22 ppm 35. 195Pt satellites of the cross-peak at 3.80/ -68.79 1 ppm 
could be detected and the coupling constants are 'J(' 5N-' 95Pt) = 306 Hz and 
2J('H- 195Pt) = 57 Hz. 
Jirradiation of the sample: 
- 0.66 h: 2D ['H, ' 5N] HSQC: The cross-peak at 3.80/ -68.79 ppm 1 decreased in 
intensity, the cross-peak at 7.06/ -81.22 ppm increased in intensity. 
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- 0.77 h: 'H NMR: peaks 14c' increased strongly in intensity. No changes were 
observed for the other peaks. 
- 1.43 h: 2D ['H, ' 5N] HSQC: the cross-peak at 3.80/ -68.79 ppm 1 was not present 
any more. The cross-peak at 7.06/ -81.22 ppm 35 had increased further. A new 
cross-peak at 4.06/ -68.18 ppm appeared. 
- 2.31 h: 'H NMR: all GSH was transformed into GSSG (peaks 14c' and 14c" had 
the same intensity). The peaks due to free d(GpG): H8: 8.09 31a, 7.88 31b; Hi' 
6.21 31c, 6.06 ppm 31d were still present. 
- 2.97 h: 2D ['H, ' 5N] HSQC: the cross-peak at 7.06/ -81.22 ppm 35 had increased 
strongly. The cross-peak at 4.06/ -68.13 ppm had also increased. New weak 
cross-peaks appeared at 4.41/ -68.08 33a and 4.34/ -68.45 ppm 33b. 
- 3.08 h: 'H NMR: The peaks due to free d(GpG) had decreased greatly in 
intensity. Two new broad peaks appeared at 8.26 33d and 8.52 ppm 33c and a 
multiplet peak appeared at 6.20 ppm. The N}-1 3 peaks of cis, trans, cis-
[Pt"(N3)2(OH) 2(NH3)2] (2) had decreased greatly in intensity. 
- 3.74 h: 2D ['H, ' 5N] HSQC: the two cross-peaks at 4.41/ -68.08 33a, 4.34/ -68.45 
ppm 33a increased, two new cross-peaks in the same region appeared at 4.13/ - 
64.73 38a and 4.04/ -64.77 38b. The cross-peak at 7.06/ -81.22 ppm 35 had 
increased further. Two cross-peaks were present at 5.08/ -37.77 ppm and 5.22/ - 
39.55 ppm. 
.J s111'I. ts: 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans, cis-LPt"(N 3)2(OH)2(NH3)2] (2, 1 mM) in the presence of 14mer DNA strand 
I (0.1 MM). 
The time course of the 2D ['H, ' 5N] HSQC NMR spectra was as follows. 
- 0 h: Cross-peak at 5.11/ -40.10 ppm 2 due to cis, trans, cis-
[Pt"(N3)2(OH)2(NH3)21 (2). 
- 0.66 h: A cross-peak at 5.15/ -40.01 ppm 39 was present besides the cross-peak 
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of cis, trans, cis-[Pt"(N3)2(OH)2(NH3)2] (2). The coupling constants are 
' 95Pt) = 254 Hz and 2J('H-' 95Pt) =44 Hz. 
- 1.43 h: Two other cross-peaks appeared: 5.22/ -39.62 40 and 4.97/ -37.27 ppm 
41. 
- 2.20 h: Cross-peak 41 had increased in intensity, reactant 2 had decreased in 
intensity. No other cross-peaks were present. 
- 2.97 h: All cross-peaks had further decreased in intensity. 
- 6.82 h: No cross-peaks were present any more. 
0 M4=6 tLii 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans-[Pt"(en)(N 3)2(OH)2 ] (5, 1.5 mM) in the presence of 14mer DNA strand I. 
The time course of the 2D ['H, ' 5N] HSQC was as follows (Figure 6.32). 
- 0 h: Cross-peak at 6.44/ -6.88 ppm 5 due to cis, trans-[Pt'v(en)(N3)2(OH)2J (5). 
- 1.43 h: A new cross-peak was present at 6.80/ -6.39 ppm 42. New weak cross- 
peaks emerged in the region 5.9 to 5.51 -30 to -32 ppm 43. 
- 2.20 h: Cross-peak 42 had increased in intensity, cross-peak 5 had decreased in 
intensity. The cross-peaks 43 had also increased in intensity. 
- 2.20 - 7.59 h: Cross-peaks 5 and 42 had disappeared. Only cross-peaks in the 
region 5.7 to 5.3/ -28 to -31 ppm 43 were present (Figure 6.32). 
The time course of the 'HNMR experiments. 
The peaks due to 14mer DNA strand I broadened during the time course of the 
reaction. The CH 2-en peak at 2.94 ppm (3J('H-' 95Pt) = 25 Hz) decreased in intensity 
throughout the reaction. A new broad peak at 2.86 ppm appeared and increased 




Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans, cis-[Pt"(N 3)2(OH)2(NH3)2] (2, 1 mM) in the presence of 14mer duplex 
DNA III (1 mM). 
The time course of the 2D ['H, ' 5N] HSQC NMR experiments was as follows (Figure 
6.34). 
- 0 h: Cross-peak at 5.09/ -40.38 ppm 2 due to cis, trans, cis- 
[Pt"(N3)2(OH)2(NH3)2] (2). 
- 1.43 h: No resonances were observed any more. 
Therefore, the irradiation was stopped and the pH of the solution measured. The pH 
was measured to be 7.7 and was then adjusted to 5 with 0.1 M HC104. The 
irradiation of the sample was then continued. 
- 4.40 h: No resonances were observed. 
The pH was adjusted to 4.7 with 0.1 M HC10 4 and more complex 2 (2 mg) was 
added to the sample. The light power was additionally increased to ca. 25 mW at the 
end of the fibre optic. The sample was then further irradiated. 
- 24 h: no resonances were observed. 
Changes in the NMR spectra during the time course of the photoreaction of cis, 
trans-[Pt"(en)(N 3)2(OH)2] (5, 1.5 mM) in the presence of 14mer duplex DNA 
strand III. 
The time course of the 2D ['H, "NJ HSQC NMR experiment was as follows (Figure 
6.35). 
- 0 h: Cross-peak at 6.45/ -6.98 ppm 5 due to complex cis, trans-
[Pt1"(en)(N3)2(OH)2] (5) was present. 




- 2.20 - 7.59 h: Cross-peak 5 decreased in intensity during the time course of the 
irradiation. No cross-peak for reactant 5 was observed after 7.59 h irradiation. 
Cross-peaks 44 increased in intensity during the reaction and was the only cross-
peak observed at the end of the irradiation. 
J!JSI1 ID I!K] 
Changes in the NMR spectra during the time course of the photoreaction of 
[Pt"(en)(N 3)2] (4, 4 mM) in water. 
The time course of the 2D ['H, ' 5N] HSQC experiments was as follows. 
- 0 h: Cross-peak at 5.09/ -33.76 ppm 4 due to [Pt"(en)(N 3)2] (4) ('J(' 5N-"'Pt) = 
333 Hz, 2J('H-' 95Pt) = 54.5 Hz). 
- 1.43 h: Two new cross-peaks were present besides the cross-peak of the reactant 
(4): 5.41/ -36.70 45 and 5.33/ -30.28 ppm 46. 
- 2.20 h: A new cross-peak was present at 5.44/ -48.56 ppm 47 besides the cross-
peaks 4, 45 and 46. 
- 2.20 -14.66 h: No further changes occurred during the time course of the 
irradiation. 
The time course of the 'H NMR experiments was as follows. 
- 0 h: Peaks at 5.21, 5.06 ppm (2J('H-'95Pt) = 52 Hz), 2.61 ppm (3J(CIHt 9sPt) 
37.6 Hz) due to complex 4. 
- 1.54 h: Four triplets appeared at 5.39 45b, 5.31 46b, 5.24 45c and 5.16 ppm 46c 
with 'J('H)5N) = 73 Hz and J = 10.5 Hz. 
- 4.62 h: A new peak appeared at 2.81 ppm besides the CH 2-en peak of 
[Pt"(en)(N3)2] (4). The peaks 45b, 45c and 46b, 46c further increased in intensity. 
No other changes occurred during the irradiation. 
273 
Appendices 
Changes in the NMR spectra during the time course of the photoreaction of 
[Pt"(en)(N 3)2 1 (4,4 mM) in 0.1 M NaCl aqueous solution. 
The time course of the 2D ['H, "NJ HSQC experiments was as follows (Figure 6.36). 
- 0 h: Cross-peak at 5.10/ -33.82 ppm 4a due to [Pt"(en)(N 3)2] (4). 
- 0.66 h: Two cross-peaks exhibiting ' 95Pt satellites were present besides 
[Pt"(en)(N 3)2] (4) at 5.03/ -34.47 48a ('.J( 15N- 195Pt) = 333 Hz, 2J('H-' 95Pt) = 53.7 
Hz) and 5.28/ -30.84 ppm 49a ('J(' 5N-' 95Pt) = 379 Hz, 2J('H- 195Pt) = 66 Hz). Two 
other cross-peaks are present at 5.42/ -34.57 50a and 5.34/ -29.96 ppm 51a. 
- 0.66 -12.21 h: No new cross-peaks appeared. All peaks decreased in intensity 
during the time course of the photoreaction. 
The time course of the 'H experiments was as follows (Figure 636). 
- 0 h: peaks at 5.20 4b, 5.05 4c (2J('H-' 95Pt) = 53 Hz), 2.61 ppm 4d due to 
[P0(en)(N3)2] (4). 
- 0.77 h: N'H-en region: New peaks appeared at 5.38 49b, 5.23 49c, 5.13 48b, 
4.98 48c, 5.52 50b, 5.36 50c, 5.44 51b and 5.29 51c. CH2-en region: New peaks 
appeared at 2.90 and 3.34 ppm. 
- 0.77 - 12.33 h: All peaks decreased in intensity over the time course of the 
photoreaction. The new peaks increased in intensity in comparison with the 
peaks of reactant [Pt' 1(en)(N 3 )2] (4). 
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